"","language_a","language_b","a_text","b_text","sentence_length_b","sentence_length_a"
"1","es","en","Actraphane 10 NovoLet 100 UI/ ml suspensión inyectable Insulina humana, (ADNr) Vía subcutánea","Actraphane 10 NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use",14,13
"2","es","en","Actraphane 10 NovoLet que no se esté utilizando debe conservarse en nevera (entre 2°C y 8°C).","The NovoLet that is not being used is to be stored in a refrigerator (2°C - 8°C).",17,16
"3","es","en","Actraphane 30 FlexPen 100 UI/ ml suspensión inyectable en una pluma precargada","Actraphane 30 FlexPen 100 IU/ ml suspension for injection in a pre-filled pen.",13,12
"4","es","en","Actraphane 40 Penfill 100 UI/ ml suspensión inyectable en un cartucho","Actraphane 40 Penfill 100 IU/ ml suspension for injection in a cartridge.",12,11
"5","es","en","Actraphane se inyecta bajo la piel (administración subcutánea).","Actraphane is for injection under the skin (subcutaneously).",8,8
"6","es","en","Actrapid debe protegerse del calor y la luz solar excesivos.","Actrapid must be protected from excessive heat and sunlight.",9,10
"7","es","en","Actrapid FlexPen Capuchón de la pluma","Actrapid FlexPen Pen cap",4,6
"8","es","en","Actúa reduciendo la intensidad de la reacción alérgica.","It works by reducing the intensity of the allergic reaction.",10,8
"9","es","en","Actualmente se desconoce la causa y las consecuencias a largo plazo de estos cambios.","The cause and long-term health effects of these conditions are not known at this time.",15,14
"10","es","en","Actualmente se desconocen las consecuencias a largo plazo de estos acontecimientos.","The long-term consequences of these events are currently unknown.",9,11
"11","es","en","ad de hemoglobina necesario para controlar los síntomas de la anemia.","th in patients with anaemia associated with cancer.",8,11
"12","es","en","Adalimumab es un anticuerpo monoclonal humano recombinante expresado en células de Ovario de Hámster Chino.","ris Adalimumab is a recombinant human monoclonal antibody expressed in Chinese Hamster Ovary cells.",14,15
"13","es","en","Además de los estudios de toxicología reproductiva, se han llevado a cabo los siguientes estudios con BOTOX:","Other studies In addition to the reproductive toxicology, the following preclinical safety studies of BOTOX have been performed:",18,17
"14","es","en","Además puede pasar a la leche materna y llegar a su bebé.","Also, it can pass into the breast milk and can reach your baby.",13,12
"15","es","en","Además, dasatinib inhibe las kinasas de la familia SRC a concentraciones subnanomolares.","Additionally, dasatinib inhibits SRC family kinases at subnanomolar concentrations.",9,12
"16","es","en","Además, debe presentarse un Plan de Gestión del Riesgo actualizado","In addition, an updated RMP should be submitted",8,10
"17","es","en","Además, el 81% de estos episodios hemorrágicos necesitaron sólo una única perfusión de Advate.","In addition, 81% of these bleeding episodes required only a single treatment with Advate.",14,14
"18","es","en","Además, invierte parcialmente la reducción de corrientes dependientes de GABA y glicina inducidas por zinc y ß-carbolinas.","In addition, it partially reverses the reductions in GABA- and glycine-gated currents induced by zinc and β -carbolines.",18,17
"19","es","en","Además, la presencia de esta sóla mutación, no afectó la respuesta en el brazo de INTELENCE.","Furthermore, the presence of this mutation alone did not affect the response in the INTELENCE arm.",16,16
"20","es","en","Además, la selección de L74V y K65R se redujo cuando se coadministró con ZDV (K65R: sin ZDV:","In addition, the selection of L74V and K65R was reduced when co-administered with ZDV (K65R: without ZDV:",17,17
"21","es","en","Además, podrá celebrarse una reunión extraordinaria del CPMP en caso necesario.","The electronic CTD format was approved in 2002 through the trilateral EU-Japan-US International Conference",14,11
"22","es","en","ADHIERA AQUÍ LA ETIQUETA CON CÓDIGO DE BARRAS","AFFIX BAR-CODE LABEL HERE",4,8
"23","es","en","Administración concomitante con ciclosporina A (ver sección 4.5).","Concomitant administration with ciclosporin A (see section 4.5).",8,8
"24","es","en","administrándose insulina de acción rápida junto con las comidas.","In patients with diabetes mellitus optimised glycaemic control delays the onset and slows the Me",15,9
"25","es","en","Administrar con alimento o directamente en la boca.","To be administered with food or directly into the mouth.",10,8
"26","es","en","Administrar únicamente a perros en ayunas.","Administer only to fasted dogs.",5,6
"27","es","en","Adminístrese la inyección de Avonex justo antes de acostarse.","Use your Avonex injection just before bedtime.",7,9
"28","es","en","ADMINSTRACIÓN CADA 2 SEMANAS.","ADMINSTRATION EVERY 2 WEEKS.",4,4
"29","es","en","ADN del VHB indetectable (< 300 copias/ ml por PCR)c","Viral load reduction (log10 copies/ ml)c HBV DNA undetectable (< 300 copies/ ml by PCR)c",15,10
"30","es","en","Adoptada en abril de 1996","Adopted in April 96",4,5
"31","es","en","Adoptada en junio de 1997","Adopted in June 1997",4,5
"32","es","en","Adoptado en noviembre de 2001 Publicado para consulta en febrero de 2001","November 2001 EMEA Annual Report 2001",6,12
"33","es","en","adsorbido en fosfato de aluminio (AlPO4)","adsorbed on aluminium phosphate (AlPO4)",5,6
"34","es","en","Adultos y adolescentes de 12 y más años de edad:","Adults and adolescents 12 years and older:",7,10
"35","es","en","Adultos, adolescentes (12 años y mayores) y niños (de 6 a 11 años)","Adults, adolescents (12 years and over) and children (6 – 11 years)",12,13
"36","es","en","Advagraf es un medicamento que contiene el principio activo tacrolimus.","Advagraf is a medicine containing the active substance tacrolimus.",9,10
"37","es","en","ADVATE 1000 UI polvo para solución inyectable Octocog alfa Vía intravenosa,","ADVATE 1000 IU powder for solution for injection Octocog alfa IV use",12,11
"38","es","en","adverso no mencionado en este prospecto, informe a su médico o farmacéutico.","please tell your doctor or pharmacist.",6,12
"39","es","en","ADVERTENCIA ESPECIAL DE QUE EL MEDICAMENTO DEBE MANTENERSE en","SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT lP",11,9
"40","es","en","ADVERTENCIA ESPECIAL DE QUE EL MEDICAMENTO DEBE MANTENERSE FUERA DE LA VISTA Y DEL ALCANCE DE LOS NIÑOS","SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN",17,18
"41","es","en","ADVERTENCIA ESPECIAL QUE INDIQUE“ MANTÉNGASE FUERA DEL ALCANCE DE LOS NIÑOS”","THE WORDS “ KEEP OUT OF THE REACH AND SIGHT OF CHILDREN”",12,11
"42","es","en","Advertencia para el usuario: ,léase el prospecto antes de utilizar el medicamento.","For operator warnings – read the package leaflet before use.",10,12
"43","es","en","ADVERTENCIA(S) ESPECIAL(ES) SI PROCEDE(N)","SPECIAL WARNING(S), IF NECESSARY",4,4
"44","es","en","Advertencias sobre la vacunación en pacientes con infección asintomática por el VIH","Warnings vaccination in those with for asymptomatic HIV infection.",9,12
"45","es","en","Advertencias y precauciones especiales de empleo","Special warnings and precautions for use",6,6
"46","es","en","Advertencias y precauciones especiales de empleo).","There are no data available for use of< invented name > in children aged under 4 years.",17,6
"47","es","en","Advocate solución para unción dorsal puntual para perros grandes","Advocate spot-on solution for large dogs",6,9
"48","es","en","Aerinaze fue más eficaz para reducir los síntomas que cualquiera de los dos principios activos tomados por separado.","Aerinaze was more effective in reducing symptoms than either of the two active substances taken alone.",16,18
"49","es","en","Aerius está indicado para adultos y adolescentes (12 años de edad y mayores).","Aerius is indicated for adults and adolescents (12 years of age and older).",13,13
"50","es","en","Agarrarlo con fórceps y retirarlo.","Grasp it with forceps and remove.",6,5
"51","es","en","Agencia Europea para la Evaluación de Medicamentos 1997 - 1998","European Agency for the Evaluation of Medicinal Products 1997 - 1998",11,10
"52","es","en","Agenerase solución oral también contiene 4 mg de sodio por ml.","Agenerase oral solution also contains 4 mg sodium per ml.",10,11
"53","es","en","Agentes quelantes del hierro, código ATC:","Iron chelating agents, ATC code:",5,6
"54","es","en","Agitar bien después de la adición del disolvente.","Shake well after addition of the solvent.",7,8
"55","es","en","Agitar bien para disolver.","Shake well to dissolve.",4,4
"56","es","en","Agitar el inhalador antes de usarlo","Shake the inhaler before use.",5,6
"57","es","en","Agitar suavemente para facilitar la completa","Agitate gently to facilitate complete dissolution of the powder.",9,6
"58","es","en","Agitar suavemente para mezclar completamente.","Gently agitate to dissolve completely.",5,5
"59","es","en","Agua purificada Ácido málico Hidróxido de sodio","Purified water Malic acid Sodium Hydroxide",6,7
"60","es","en","Aguja de la pluma (no incluida)","Schematic diagram of the pen",5,6
"61","es","en","Ahora puede retirar la aguja de la piel.","Remove needle from skin.",4,8
"62","es","en","Ahora ya puede retirar su dosis del vial.","Now you can withdraw your dose from the vial.",9,8
"63","es","en","Ajuste de la dosis para mantener los valores de hemoglobina (Hb) en la","Dose adjustment in order to maintain haemoglobin (Hb) values at the desired level:",13,13
"64","es","en","Al bloquear la producción de nuevas proteínas, las bacterias no pueden multiplicarse y finalmente mueren.","By blocking the production of new proteins, the bacteria cannot multiply and they eventually die.",15,15
"65","es","en","Al cabo de 5 meses se procede a la revacunación y, después, se administran vacunas de refuerzo anuales.","This should be followed by revaccination 5 months later, and afterwards by yearly booster vaccinations.",15,18
"66","es","en","Al controlar los niveles de azúcar en sangre, se reducen los síntomas y las complicaciones de la diabetes.","By controlling the level of blood sugar, the symptoms and complications of diabetes are reduced.",15,18
"67","es","en","Al igual que con todas las vacunas inyectables, siempre debe estar preparado el tratamiento médico to","au Quintanrix is for deep intramuscular injection, preferably in the anterolateral thigh.",12,16
"68","es","en","Al igual que otros medicamentos anti-cobre como la penicilamina, sus síntomas pueden empeorar después de empezar el tratamiento.","As with other anti-copper agents such as penicillamine, your symptoms may get worse after starting the treatment.",17,18
"69","es","en","Al igual que todos los medicamentos, ADENURIC puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, ADENURIC can cause side effects, although not everybody gets them.",13,18
"70","es","en","Al igual que todos los medicamentos, Avamys puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Avamys can cause side effects, although not everybody gets them.",13,18
"71","es","en","Al igual que todos los medicamentos, CellCept puede tener efectos adversos, aunque no todas las personas los sufran.","Like all medicines, CellCept can have side effects, although not everybody gets them.",13,18
"72","es","en","Al igual que todos los medicamentos, DaTSCAN puede tener efectos adversos, aunque no todas las personas los sufran.","Like all medicines, DaTSCAN can cause side effects, although not everybody gets them.",13,18
"73","es","en","Al igual que todos los medicamentos, Extavia puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Extavia can cause side effects, although not everybody gets them.",13,18
"74","es","en","Al igual que todos los medicamentos, Glivec puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Glivec can cause side effects, although not everybody gets them..",13,18
"75","es","en","Al igual que todos los medicamentos, Jalra puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Jalra can cause side effects, although not everybody gets them.",13,18
"76","es","en","Al igual que todos los medicamentos, LYRICA puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, LYRICA can have side effects, although not everyone gets them.",13,18
"77","es","en","Al igual que todos los medicamentos, Nespo puede producir efectos adversos, aunque no todas las to","Like all medicines, Nespo may cause side effects, although not everybody gets them. ro",14,16
"78","es","en","Al igual que todos los medicamentos, Ovitrelle puede tener efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Ovitrelle can cause side effects, although not everybody gets them.",13,18
"79","es","en","Al igual que todos los medicamentos, Puregon puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Puregon can cause side effects, although not everybody gets them.",13,18
"80","es","en","Al igual que todos los medicamentos, RISPERDAL puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, RISPERDAL can cause side effects, although not everybody gets them.",13,18
"81","es","en","Al igual que todos los medicamentos, Tamiflu puede producir efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Tamiflu can cause side effects, although not everybody gets them.",13,18
"82","es","en","Al igual que todos los medicamentos, Tygacil puede tener efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Tygacil may have side effects, although not everybody gets them.",13,18
"83","es","en","Al igual que todos los medicamentos, Xarelto puede tener efectos adversos, aunque no todas las personas los sufran.","Like all medicines, Xarelto can cause side effects, although not everybody gets them.",13,18
"84","es","en","Al menos 1 de cada 100 pacientes y menos de 1 de cada 10 pacientes Poco frecuentes:","The frequency of the side effects listed below is defined using the following convention:",14,17
"85","es","en","Al principio, sólo parece afectar a los glóbulos blancos.","This is because the red blood cells have a",9,9
"86","es","en","Al reducir la cantidad de VIH en la sangre, puede mejorar el funcionamiento de su sistema inmunitario.","Reducing the amount of HIV in the blood may improve the functioning of your immune system.",16,17
"87","es","en","Al tomar estos medicamentos conjuntamente con Vivanza puede verse afectada gravemente su tensión arterial","Taking these medicines with Vivanza could seriously affect your blood pressure.",11,14
"88","es","en","Al tratarse de una enfermedad rara, muchos de los niños participaron en más de uno de los estudios.","Because the disease is rare, many of the children were included in more than one of the studies.",18,18
"89","es","en","Albúmina humana Cloruro sódico","Albumin, human Sodium chloride",4,4
"90","es","en","Alcon Romania S.R.L.: + 40 21 203 93 24","Alcon Romania S.R.L..: + 40 21 203 93 24",9,9
"91","es","en","Alcon-Couvreur N.V., Rijksweg 14, B-2870 Puurs, Bélgica","Alcon - Couvreur N. V., Rijksweg 14, B-2870 Puurs, Belgium",10,7
"92","es","en","Alemania Schwarz Pharma Deutschland","Germany Schwarz Pharma Deutschland GmbH Alfred-Nobel-Str.",6,4
"93","es","en","Alergia Hipersensibilidad generalizada (p. ej. reacción anafiláctica) o reacciones inmunológicas como la vasculitis.","Allergy Generalised hypersensitivity reactions (e. g. anaphylactic reaction), or immunological reactions such as vasculitis.",14,13
"94","es","en","alfa-2b (3 MUI TVS)","alfa-2b (3 MIU TIW)",4,4
"95","es","en","Algunas de, o todas, estas actividades pueden contribuir a los efectos terapéuticos del interferón.","Any or all of these activities may contribute to interferon's therapeutic effects.",12,14
"96","es","en","Algunas personas se deprimen cuando toman Viraferon solo o en tratamiento de combinación con","Some people get depressed when taking Viraferon alone or in combination treatment with ribavirin, and in some Me",18,14
"97","es","en","Algunas reacciones adversas son muy frecuentes.","Some side effects are very common.",6,6
"98","es","en","Algunos efectos pueden ser graves:","Some effects could be serious:",5,5
"99","es","en","Algunos medicamentos pueden influir en el uso de Clopidogrel BMS o viceversa.","Some other medicines may influence the use of clopidogrel or vice versa.",12,12
"100","es","en","Algunos medicamentos pueden reducir la calidad de la imagen obtenida.","Some medicines may reduce the quality of the picture obtained.",10,10
"101","es","en","Algunos pacientes han experimentado los siguientes efectos adversos al tomar Efficib junto con una sulfonilurea:","Some patients have experienced the following side effects while taking Efficib with a sulphonylurea:",14,15
"102","es","en","Algunos pacientes pueden responder mejor con una gota tres veces al día.","Some patients may have a better response with one drop three times a day.",14,12
"103","es","en","algunos tamaños de envase. en","Not all pack sizes may be marketed.",7,5
"104","es","en","Aliskiren es una sustancia que pertenece a una nueva clase de medicamentos llamados inhibidores de la renina.","Aliskiren is a substance that belongs to a new group of medicines called renin inhibitors.",15,17
"105","es","en","Alivio sintomático del dolor asociado a torceduras y a tendinitis aguda traumática.","Symptomatic relief of pain associated with sprains and acute traumatic tendinitis.",11,12
"106","es","en","alli 60 mg cápsulas duras:","alli 60 mg hard capsules:",5,5
"107","es","en","Alopecia, prurito*, sequedad cutánea*, rash*, aumento de la sudoración","Hepatomegaly Hepatotoxicity, (including fatality)",4,9
"108","es","en","Alpharma Limited Whiddon Valley Barnstaple EX32 8NS, Reino Unido","Alpharma Limited Whiddon Valley Barnstaple EX32 8NS, UK",8,9
"109","es","en","Altargo se utiliza en adultos y niños mayores de 9 meses.","Altargo is for adults and children aged nine months and older.",11,11
"110","es","en","Alteración renal y hepática:","Impaired renal and hepatic function:",5,4
"111","es","en","Alteraciones de los vasos sanguíneos Muy frecuentes:","Blood vessel disorders very common: common: uncommon:",7,7
"112","es","en","Alteraciones del estado de ánimo, trastornos del sueño","Mood altered, Sleep disturbances",4,8
"113","es","en","Alteraciones en el lugar de la inyección.","Changes at the injection site.",5,7
"114","es","en","Alteraciones que afectan al cuerpo en su conjunto Frecuentes:","Disorders affecting the body as a whole common:",8,9
"115","es","en","Alucinaciones Las alucinaciones constituyen una reacción adversa conocida en el tratamiento con agonistas dopaminérgicos y levodopa.","Hallucinations Hallucinations are known as a side-effect of treatment with dopamine agonists and levodopa.",14,16
"116","es","en","Am Euro Platz 2 A-1120 Wien Tel: + 43-(0) 1 813 12 31","Am Euro Platz 2 A-1120 Wien Tel: + 43-(0) 1 813 12 31",13,13
"117","es","en","Amarillo anaranjado S (E110) 1,7 mg por comprimido","Sunset yellow (E110) 1.7 mg per tablet",7,8
"118","es","en","Ambirix suspensión inyectable Vacuna (HAB) (adsorbida) antihepatitis A (inactivada) y antihepatitis B (ADNr)","Ambirix– Suspension for injection Hepatitis A (inactivated) and hepatitis B(rDNA) (HAB) vaccine (adsorbed).",13,13
"119","es","en","Ambos casos fueron leves y no se comunicaron secuelas.","Both cases were unremarkable and no sequelae were reported.",9,9
"120","es","en","Ambos fármacos se 7 Westferry Circus, Canary Wharf, London E14 4HB, RU Tel.:","The main measure of effectiveness 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.",15,13
"121","es","en","Ambos pueden interferir con el status del Helicobacter pylori.","Both might interfere with the Helicobacter pylori status.",8,9
"122","es","en","Amgen Europe B. V.","Amgen Europe B. V.",4,4
"123","es","en","Amgen Manufacturing Limited PO Box 4060, Road 31 km 24.6 Juncos, PR 00777-4060 Puerto Rico","Amgen Manufacturing Limited PO Box 4060, Road 31 km 24.6 Juncos, PR 00777-4060 Puerto Rico",15,15
"124","es","en","Amlodipino no afecta la conducción auriculoventricular y no tiene un efecto inotrópico negativo.","Amlodipine does not impair AV conduction and does not have a negative inotropic effect.",14,13
"125","es","en","AMMONAPS se receta a pacientes con trastornos del ciclo de la urea.","AMMONAPS is prescribed to patients with urea cycle disorders.",9,12
"126","es","en","Ampliaciones de solicitudes centralizadas Solicitudes abreviadas Arbitrajes/remisiones","Variations type I Variations type II Transfers Scientific advice New MRL applications",12,7
"127","es","en","an 5.2 Propiedades farmacocinéticas","ed 5.2 Pharmacokinetic properties",4,4
"128","es","en","an La jeringa precargada (0,3 ml) contiene 1,5 mg de fondaparinux sódico.","ho One pre-filled syringe (0.3 ml) contains 1.5 mg fondaparinux sodium.",11,12
"129","es","en","an No se han realizado estudios formales de interacción entre la pomada de tacrolimus y otros","is Formal topical drug interaction studies with tacrolimus ointment have not been conducted.",13,16
"130","es","en","an Solución inyectable (inyectable) en jeringa precargada.","or Solution for injection (injection) in a pre-filled syringe.",9,7
"131","es","en","an una tapa de plástico transparente (PET).","ho clear plastic (PET) thermoformed tray with a desiccant and covered with a clear plastic (PET) lid.",17,7
"132","es","en","Añadir el agua para inyección e.","Adding water for injections e.",5,6
"133","es","en","Ancianos (de 65 años o más)","Elderly (aged 65 and older)",5,6
"134","es","en","Ancianos: no es necesario ajustar la dosis en función de la edad del paciente.","Elderly: no dosage adjustment based on age is required.",9,14
"135","es","en","André BROEKMANS Executive Director College ter Beoordeling van Geneesmiddelen P.O.","Dr André BROEKMANS Executive Director Medicines Evaluation Board P.O.",9,10
"136","es","en","anemia parestesias, disguesia (alteración del gusto) hemorragia, úlcera duodenal, gastritis, disfagia, dolor abdominal, sequedad de boca","anaemia paraesthesia, dysgeusia (taste perversion) haemorrage, duodenal ulcer, gastritis, dysphagia, abdominal pain, dry mouth",14,16
"137","es","en","Anexo 3 - Documentos de referencia","Annex 3 - Reference documents",5,6
"138","es","en","Anexo II para todas las especies productoras de alimento","Annex II for all food producing species",7,9
"139","es","en","Angiox es un anticoagulante: impide que se formen coágulos de sangre.","By using Angiox during ACS or PCI, the risk of a blood clot forming is greatly reduced.",17,11
"140","es","en","Anhidrosis Eritema multiforme Prurito Síndrome de Stevens- Johnson","Renal and urinary disorders General disorders and administration site conditions",10,8
"141","es","en","Anomalías en la acomodación, Midriasis, Trastornos visuales","Abnormality of accommodation, Mydriasis, Visual disturbance,",6,7
"142","es","en","Anorexia Hipertrigliceridemia§, hiperuricemia, aumento del apetito","Anorexia Hypertriglyceridemia§, hyperuricemia, increased appetite",5,6
"143","es","en","Ansiedad, Insomnio Mareo, Cefalea,","Anxiety, Insomnia Dizziness, Headache",4,4
"144","es","en","Antecedentes de hipersensibilidad al principio activo o a cualquiera de los excipientes (véase 6.1).","History of hypersensitivity to the active substance or to any of the excipients (see section 6.1).",16,14
"145","es","en","Antecedentes de psicosis en forma de episodios de delirio.","A past history of psychoses in the form of episodes of delirium.",12,9
"146","es","en","Antes de cada utilización debe insertar una aguja nueva.","A new injection needle must be attached before each use.",10,9
"147","es","en","Antes de comenzar la infusión, elimine todas las burbujas de aire presentes.","Before starting the infusion remove any air bubbles.",8,12
"148","es","en","Antes de interrumpir el tratamiento, póngase en contacto con su médico o farmacéutico.","Contact your doctor or pharmacist before stopping.",7,13
"149","es","en","Antes de inyectarse LITAK, debe hacer lo siguiente:","Before you inject LITAK, you must do the following:",9,8
"150","es","en","Antes de la administración, la vacuna debe agitarse bien, para obtener una suspensión blanca ligeramente opaca.","Before administration, the vaccine should be well shaken to obtain a slightly opaque, white suspension.",15,16
"151","es","en","Antes de la hiposensibilización, deberá considerarse la suspensión temporal de TRITAZIDE.","A temporary discontinuation of TRITAZIDE should be considered prior to desensitization.",11,11
"152","es","en","Antes de la inyección, elimine todas las burbujas de aire (ver instrucciones de uso de la pluma).","Before injection remove any air bubbles (see instructions for using the pen).",12,17
"153","es","en","Antes de la primera utilización, guarde Humalog Mix50 Pen en nevera (entre 2ºC y 8ºC).","Before the first use store your Humalog Mix50 Pen in a refrigerator (2°C – 8°C).",15,15
"154","es","en","Antes de que le administren Atriance 3.","Before you are give Atriance 3.",6,7
"155","es","en","Antes de que se le administre Savene 3.","Before you are given Savene 3.",6,8
"156","es","en","ANTES DE QUE SU HIJO RECIBA QUINTANRIX","BEFORE YOUR CHILD RECEIVES QUINTANRIX",5,7
"157","es","en","Antes de su uso deberá leer el prospecto.","Read the package leaflet before use.",6,8
"158","es","en","Antes de tomar Alendronat HEXAL 3.","Before you take Alendronate HEXAL 3.",6,6
"159","es","en","Antes de tomar Azomyr comprimidos bucodispersables 3.","Before you take Azomyr orodispersible tablet 3.",7,7
"160","es","en","ANTES DE TOMAR CLOPIDOGREL BMS","BEFORE YOU TAKE CLOPIDOGREL BMS",5,5
"161","es","en","Antes de tomar Diován 3.","Before you take Diovan 3.",5,5
"162","es","en","ANTES DE TOMAR EUCREAS","BEFORE YOU TAKE EUCREAS",4,4
"163","es","en","ANTES DE TOMAR GLUSTIN","BEFORE YOU TAKE GLUSTIN",4,4
"164","es","en","Antes de tomar Irbesartan Krka 3.","Before you take Irbesartan Krka 3.",6,6
"165","es","en","Antes de tomar Kivexa 3.","Before you take Kivexa 3.",5,5
"166","es","en","Antes de tomar LITAK, debe saber que","You should know before taking LITAK that",7,7
"167","es","en","ANTES DE TOMAR MICOFENOLATO MOFETILO TEVA","BEFORE YOU TAKE MYCOPHENOLATE MOFETIL TEVA",6,6
"168","es","en","ANTES DE TOMAR OPRYMEA","BEFORE YOU TAKE OPRYMEA",4,4
"169","es","en","Antes de tomar PritorPlus 3.","Before you take PritorPlus 3.",5,5
"170","es","en","Antes de tomar Revatio 3.","Before you take Revatio 3.",5,5
"171","es","en","ANTES DE TOMAR STARLIX","BEFORE YOU TAKE STARLIX",4,4
"172","es","en","ANTES DE TOMAR TESAVEL","BEFORE YOU TAKE TESAVEL",4,4
"173","es","en","ANTES DE TOMAR VELMETIA","BEFORE YOU TAKE VELMETIA",4,4
"174","es","en","ANTES DE TOMAR XELODA","BEFORE YOU TAKE XELODA",4,4
"175","es","en","ANTES DE TOMAR ZYRTEC","BEFORE YOU TAKE ZYRTEC",4,4
"176","es","en","ANTES DE USAR APIDRA","BEFORE YOU USE APIDRA",4,4
"177","es","en","ANTES DE USAR BONVIVA","BEFORE YOU USE BONVIVA",4,4
"178","es","en","Antes de usar DaTSCAN 3.","Before you use DaTSCAN 3.",5,5
"179","es","en","ANTES DE USAR FABRAZYME","BEFORE YOU USE FABRAZYME",4,4
"180","es","en","ANTES DE USAR GANFORT","BEFORE YOU USE GANFORT",4,4
"181","es","en","Antes de usar Humalog BASAL KwikPen 3.","Before you use Humalog BASAL KwikPen 3.",7,7
"182","es","en","Antes de usar Insulin Human Winthrop Basal 3.","Before you use Insulin Human Winthrop Basal 3.",8,8
"183","es","en","Antes de usar IVEMEND 3.","Before you use IVEMEND 3.",5,5
"184","es","en","Antes de usar Levemir InnoLet","Before using Levemir InnoLet",4,5
"185","es","en","ANTES DE USAR LIPROLOG BASAL PEN","BEFORE YOU USE LIPROLOG Basal PEN",6,6
"186","es","en","Antes de usar MabThera 3.","Before you use MabThera 3.",5,5
"187","es","en","Antes de usar Myocet 3.","How to use Myocet.",4,5
"188","es","en","Antes de usar NEVANAC 3.","Before you use NEVANAC 3.",5,5
"189","es","en","Antes de usar ORENCIA, su médico le hará la prueba de la tuberculosis o una prueba cutánea.","Before you use ORENCIA, your doctor will examine you for tuberculosis or do a skin test.",16,17
"190","es","en","Antes de usar Prepandrix 3.","Before you receive Prepandrix 3.",5,5
"191","es","en","Antes de usar Prometax 3.","Before you use Prometax 3.",5,5
"192","es","en","ANTES DE USAR REGRANEX","BEFORE YOU USE REGRANEX",4,4
"193","es","en","ANTES DE USAR TEMODAL","BEFORE YOU USE TEMODAL",4,4
"194","es","en","Antes de usar Vidaza 3.","Before you use Vidaza 3.",5,5
"195","es","en","Antes de utilizar OptiSet, realice siempre la prueba de seguridad.","Always perform a safety test before using OptiSet.",8,10
"196","es","en","Antes del tratamiento con MABTHERA:","Prior to MABTHERA treatment",4,5
"197","es","en","Anthony Humphreys fueron nombrados Jefes Adjuntos de Sector.","as Deputy Heads of Sector.",5,8
"198","es","en","Anti-PRN (5 EL. U/ ml)","Anti-PRN (5 EL. U/ ml)",5,5
"199","es","en","anticuerpos neutralizantes, los cuales pueden reaccionar con Extavia (actividad neutralizante).","antibodies, which may react with Extavia (neutralising activity).",8,10
"200","es","en","antitrombótica de fondaparinux es consecuencia de la inhibición selectiva del factor Xa mediada por la antitrombina III (antitrombina).","The antithrombotic activity of fondaparinux is the result of antithrombin III (antithrombin) mediated selective inhibition of Factor Xa.",18,18
"201","es","en","Antiviral para uso sistémico, código ATC:","Antiviral for systemic use, ATC code:",6,6
"202","es","en","Apidra es una insulina de acción corta.","Apidra is a short-acting insulin.",5,7
"203","es","en","Aplicar una banda de 1 cm (0,2 g) de crema por cada 10 cm2 de lesión.","Apply a 1 cm strip (0.2 g) of cream per 10 cm2 of lesion.",14,16
"204","es","en","Approved Prescription Services Ltd 41 Brampton Road Hampden Park, Eastbourne East Sussex, BN22 9AG, Reino Unido","Approved Prescription Services Ltd 41 Brampton Road Hampden Park, Eastbourne East Sussex, BN22 9AG, UK",15,16
"205","es","en","Aprovel 75 mg comprimidos recubiertos con película irbesartan","Aprovel 75 mg film-coated tablets irbesartan",6,8
"206","es","en","Aproximadamente el 75% de la dosis administrada se elimina por las heces y el resto por la orina.","Approximately 75% of the administered dose is",7,18
"207","es","en","Aproximadamente un tercio de los pacientes estaba recibiendo insulina en combinación con metformina y/o sulfonilurea.","Approximately one third of patients were receiving insulin in combination with metformin and/ or a sulphonylurea.",16,15
"208","es","en","APTIVUS está contraindicado en la insuficiencia hepática moderada o grave (ver secciones 4.2 y 4.3).","APTIVUS is contraindicated in moderate or severe hepatic impairment (see sections 4.2 and 4.3).",14,15
"209","es","en","Aranesp 10 microgramos solución inyectable en pluma precargada.","Aranesp 10 micrograms solution for injection in a pre-filled pen.",10,8
"210","es","en","Aranesp 15 µg inyectable Darbepoetin alfa SC","Aranesp 15 µg injection Darbepoetin alfa SC",7,7
"211","es","en","Aranesp 300 μ g inyectable Darbepoetin alfa","Aranesp 300 µg injection Darbepoetin alfa",6,7
"212","es","en","Aranesp 60 microgramos solución inyectable en jeringa precargada.","Aranesp 60 micrograms solution for injection in a pre-filled syringe.",10,8
"213","es","en","Arbitrajes y remisiones 3%","Arbitrations and referrals 3%",4,4
"214","es","en","ARICLAIM 30 mg cápsulas duras gastrorresistentes","ARICLAIM 30 mg hard gastro-resistant capsules",6,6
"215","es","en","Aripiprazol y otros medicamentos antipsicóticos deben ser utilizados con precaución en pacientes con riesgo de neumonía por aspiración.","Aripiprazole and other antipsychotic drugs should be used cautiously in patients at risk for aspiration pneumonia.",16,18
"216","es","en","Arixtra 7,5 mg/0,6 ml inyectable Fondaparinux Na","Arixtra 7.5 mg/ 0.6 ml injection fondaparinux Na",8,7
"217","es","en","Arlacel 83V (sesquioleato de sorbitán) Tween 80 (polioxietileno sorbitán monooleato) Cloruro de sodio","Pharmacologically active substance Mineral oils Arlacel 83V (sorbitan sesquioleate) Tween 80 (polyoxyethylene sorbitan monooleate)",14,13
"218","es","en","Artículo 3 - Independencia de los ponentes [inspectores] y los expertos","Article 3 - Independence of [Inspectors] Rapporteur and Experts",9,11
"219","es","en","Artritis psoriásica y espondilitis anquilosante.","Psoriatic arthritis and ankylosing spondylitis",5,5
"220","es","en","ARVs previos totales ≤ 101 ARVs previos totales > 101","Total prior ARVs ≤ 101 Total prior ARVs > 101",10,10
"221","es","en","Aseguramiento de la calidad de las evaluaciones, incluida una mayor coherencia reglamentaria y científica.","Assuring the quality of assessments, including strengthened regulatory and scientific consistency.",11,14
"222","es","en","Asegurar la limpieza adecuada del pezón (y de la ubre- si es necesaria) antes de la infusión.","Ensure adequate cleansing of the teat (and udder - if needed) before infusion.",13,17
"223","es","en","Asegúrese de comunicar a su médico inmediatamente si está dando el pecho.","Be sure to tell your doctor immediately if you are breast-feeding.",11,12
"224","es","en","Asegúrese de preguntar a su médico cuándo debe ponerse las inyecciones y sobre las consultas de seguimiento.","Make sure you discuss with your doctor when you will have your injections and your follow-up appointments.",17,17
"225","es","en","Asegúrese de que la insulina no se contamina con alcohol u otros desinfectantes, ni con otras sustancias.","Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.",14,17
"226","es","en","Asegúrese de que la solución se encuentra a temperatura ambiente en el momento de la inyección.","Be sure the solution is at room temperature at the time of injection.",13,16
"227","es","en","Asegúrese de que prepara la solución sobre una superficie limpia y seca.","Ensure you prepare the solution on a clean and dry surface.",11,12
"228","es","en","Asegúrese de que se lleva el Liprolog que le ha recetado su médico.","Make sure you get the Liprolog that your doctor has told you to use.",14,13
"229","es","en","Así pues, la bacteria es idónea para usarla en una vacuna.","This makes it suitable for use in a vaccine.",9,11
"230","es","en","Así pues, no se debe tomar durante el embarazo.","Therefore, PROTELOS should not be taken during pregnancy.",8,9
"231","es","en","Así se evita que el ADN se rompa, dañando así a la célula.","This avoids that the DNA breaks, which would damage the cells.",11,13
"232","es","en","Así, los efectos adversos relacionados fueron más frecuentes en el grupo de Xeomin que en el de Botox.","Thus, related adverse effects occurred more frequently in the Xeomin group compared to Botox.",14,18
"233","es","en","Asimismo es posible tomar Wilzin con un poco de proteína, como la carne (ver epígrafe 4.5).","It is also possible to take Wilzin with a little protein, such as meat (see section 4.5).",17,16
"234","es","en","Asimismo, la Unidad se ocupará de la mejora continua de los procedimientos de trabajo conexos.","The Unit will also look at the continuing improvement of related operational procedures.",13,15
"235","es","en","Asimismo, los estudios de interacción realizados con omeprazol y varios AINEs no han revelado interacción alguna.","Furthermore, interaction studies performed with omeprazole and several NSAIDs have not shown any interaction.",14,16
"236","es","en","Asimismo, se administraron inyecciones de insulina de efecto rápido a la hora de las comidas.","Injections of fast-acting insulin were also used at mealtimes.",9,15
"237","es","en","Aspecto de ATryn y contenido del envase","What ATryn looks like and contents of the pack",9,7
"238","es","en","Aspecto de FIRMAGON y contenido del envase","What FIRMAGON looks like and contents of the pack",9,7
"239","es","en","Aspecto del producto y contenido del envase","What Aerinaze looks like and contents of the pack",9,7
"240","es","en","Aspecto del producto y tamaño del envase","What GONAL-f looks like and contents of the pack",9,7
"241","es","en","Astellas Pharma S. p. A Via delle Industrie 1 20061 Carugate (Milano) Italia","Via delle Industrie 1 20061 Carugate (Milano) Italy",8,13
"242","es","en","astenia fiebre enfermedad tipo gripe","asthenia fever influenza like illness",5,5
"243","es","en","AstraZenca BV Postbus 599","AstraZenca BV Postbus 599",4,4
"244","es","en","AstraZeneca Österreich GmbH Schwarzenbergplatz 7 Postfach 153, A-1037 Vienna Austria *","AstraZeneca Österreich GmbH Schwarzenbergplatz 7 Postfach 153, A-1037 Vienna Austria",10,11
"245","es","en","ataque cardíaco durante los tres meses previos al tratamiento con BEROMUN.","attack within three months prior to BEROMUN treatment.",8,11
"246","es","en","ATC no disponible Prevención Postmenopáusico osteoporosis","ATC not yet available Prevention on post- menopausal osteoporosis",9,6
"247","es","en","Atempere los dos viales sin perforar a una temperatura confortable (no superior a 37 °C).","Warm both unopened vials in your hands to a comfortable temperature (do not exceed 37 °C).",16,15
"248","es","en","Atriance 5 mg/ ml solución para perfusión Nelarabina","Atriance 5 mg/ ml solution for infusion Nelarabine",8,8
"249","es","en","Atripla es un medicamento antirretroviral.","Atripla is an antiviral medicine.",5,5
"250","es","en","Atrofia muscular, dolores óseos, Síndrome del túnel carpiano.","arthralgia, myalgia Uncommon: muscle atrophy, bone pain, carpal tunnel syndrome",10,8
"251","es","en","ATryn se administra normalmente en combinación con heparina o heparina de bajo peso molecular.","ATryn is normally given in association with heparin or low molecular weight heparin.",13,14
"252","es","en","au n co n to me","n g lo no u ct rod",7,6
"253","es","en","AUC: ↓ 35% (↓ 13 a ↓ 40) Cmax: ↓ 13% (↓ 0 a ↓ 23) 4-hidroxi atorvastatina:","AUC: ↓ 35% (↓ 13 to ↓ 40) Cmax: ↓ 13% (↓ 0 to ↓ 23) 4-hydroxy atorvastatin:",18,18
"254","es","en","AUC: ↔ Cmax: ↔","AUC: ↔ Cmax: ↔",4,4
"255","es","en","AUC0-∞ (UI × hr/ dl)","AUC0- ∞ (IU × hr/ dl) Half-life",7,5
"256","es","en","Aumenta la producción de orina, disminuyendo la cantidad de líquido en la sangre y reduciendo la presión arterial.","Hydrochlorothiazide is a diuretic, which is another type of treatment for hypertension.",12,18
"257","es","en","Aumento de la amilasa en suero.","Rises in serum amylase.",4,6
"258","es","en","Aumento de la creatinina en sangre.","Blood lactate dehydrogenase increased Blood creatinine increased",7,6
"259","es","en","Aumento del apetito Anorexia, disminución del apetito, polidipsia","Increased appetite Anorexia, decreased appetite, polydipsia",6,8
"260","es","en","Aumento del recuento de reticulocitos ≥ 40.000/μ l ó aumento de Hb ≥ 1 g/ d","However, if the haemoglobin",4,16
"261","es","en","Aumento del tejido graso","insufficient function of your transplanted organ",6,4
"262","es","en","Aún nos quedan muchas tareas que afrontar juntos.","There is much work yet to do - to be achieved together.",12,8
"263","es","en","Aunque estos efectos adversos son generalmente reversibles, en algunos pacientes su resolución","While these effects are generally reversible, in a few patients full resolution took up to three weeks.",17,12
"264","es","en","Aunque muy raramente se ha notificado necrosis local tras la extravasación, Caelyx se considera un agente irritante.","Although local necrosis following extravasation has been reported very rarely, Caelyx is considered to be an irritant.",17,17
"265","es","en","Ausencia de fístulas que drenan","Absence of any draining fistulas",5,5
"266","es","en","Autorización de fabricación expedida el 4 de marzo de 1997 por el Ministerio de Agricultura, España.","Manufacturing Authorisation issued on 4 March 1997 by Ministerio de Agricultura, Spain.",12,16
"267","es","en","Av. de Roma n° 30 – 3° Dto.","Av. de Roma n° 30 – 3° Dto.",8,8
"268","es","en","Avamys es un pulverizador nasal que contiene el principio activo denominado fluorato de fluticasona.","AVAMYS is a nasal spray that contains the active substance fluticasone furoate.",12,14
"269","es","en","AVANDIA 2 mg comprimidos recubiertos con película rosiglitazona","AVANDIA 2 mg film-coated tablets rosiglitazone",6,8
"270","es","en","Avastin se utiliza también para el tratamiento del cáncer renal avanzado.","Avastin is also used for treatment of advanced kidney cancer.",10,11
"271","es","en","Avelox 400 mg filmsko oblož ene 400 mg tablete","Avelox 400 mg filmsko oblož ene 400 mg tablete",9,9
"272","es","en","Aventis Pasteur SA 2, avenue Pont Pasteur F-69007 LYON – Francia Tel:","Aventis Pasteur SA 2, avenue Pont Pasteur F-69007 LYON – France Tel:",12,12
"273","es","en","AVENTIS PHARMA DEUTSCHLAND GmbH 65926 Frankfurt am Main Alemania","DEUTSCHLAND GmbH 65926 Frankfurt am Main Germany",7,9
"274","es","en","Avenue Molière 225 B-1050 Bruxelles/ Brussel Tél: +32 2 340 2828","Avenue Molière 225 B-1050 Bruxelles/ Brussel Tél: +32 2 340 2828",11,11
"275","es","en","Avise inmediatamente a su médico o farmacéutico.","Advise immediately your doctor or your pharmacist.",7,7
"276","es","en","AVONEX debe administrarse tan pronto como sea posible después de la reconstitución.","AVONEX should be administered as soon as possible after reconstitution.",10,12
"277","es","en","Axura 10 mg/ g gotas orales en solución.","Axura 10 mg/ g oral drops, solution.",7,8
"278","es","en","Ayuda a controlar la reacción alérgica y sus síntomas.","It helps control your allergic reaction and its symptoms.",9,9
"279","es","en","AZILECT es un medicamento que contiene el principio activo rasagilina.","AZILECT is a medicine containing the active ingredient rasagiline.",9,10
"280","es","en","Azomyr 5 mg comprimidos desloratadina","Azomyr 5 mg tablet desloratadine",5,5
"281","es","en","B CONDICIONES DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN","B CONDITIONS OF THE MARKETING AUTHORISATION",6,7
"282","es","en","b) lepirudin c) Part A","b) lepirudin c) Part A",5,5
"283","es","en","B3 B4 B5 TOTAL B","B3 B4 B5 TOTAL B",5,5
"284","es","en","Baix Llobregat, 3 – 5 E-08970 Sant Joan Despí (Barcelona) Tel: +34 93 4956500","Baix Llobregat, 3-5 E-08970 Sant Joan Despí (Barcelona) Tel: +34 93 4956500",12,14
"285","es","en","Baraclude no debe utilizarse durante el embarazo si no es claramente necesario.","Baraclude should not be used during pregnancy unless clearly necessary.",10,12
"286","es","en","base de plantas medicinales que contengan Hipérico (Hypericum perforatum).","This is due to induction of drug metabolism enzymes and/ or transport proteins by St.",15,9
"287","es","en","Baxter AG Industriestrasse 67 A-1221 Viena, Austria","Baxter AG Industriestrasse 67 A-1221 Vienna, Austria",7,7
"288","es","en","Bayer AG Pharma Deutschland D-51368 Leverkusen","Bayer AG Pharma Deutschland D-51368 Leverkusen",6,6
"289","es","en","Bayer HealthCare AG 51368 Leverkusen Alemania","Iceland Bayer HealthCare AG 51368 Leverkusen Germany",7,6
"290","es","en","Bayer HealthCare AG, D-51368 Leverkusen Alemania","Bayer HealthCare AG D-51368 Leverkusen Germany",6,6
"291","es","en","Bayer Ltd Animal Health Division The Atrium Blackthorn Road Dublin 18 Irlanda","Bayer Ltd Animal Health Division The Atrium Blackthorn Road Dublin 18 Ireland",12,12
"292","es","en","Bayer S. p. A.","Bayer S. p. A.",4,4
"293","es","en","Bayer Schering Pharma AG Müllerstrasse 178 13342 Berlin ALEMANIA","Bayer Schering Pharma AG Müllerstrasse 178 13342 Berlin GERMANY",9,9
"294","es","en","Beech am Group US","Beech am Group US",4,4
"295","es","en","België / Belgique / Belgien Pfizer S. A. / N. V.","België / Belgique / Belgien Pfizer S. A. / N. V.",11,11
"296","es","en","België/ Belgique/ Belgien Fort Dodge Animal Health Benelux B. V.","België/ Belgique/ Belgien Fort Dodge Animal Health Benelux B. V.",10,10
"297","es","en","België/ Belgique/ Belgien S. C. S.","België/ Belgique/ Belgien S. C. S.",6,6
"298","es","en","België/ Belgique/ Belgien Tél/ Tel: +32 3 280 54 11","België/Belgique/Belgien Tél/Tel: +32 3 280 54 11",7,10
"299","es","en","België/ Belgique/ Belgien, Luxembourg/ Luxemburg Ipsen NV S. A.","België/ Belgique/ Belgien, Luxembourg/ Luxemburg Ipsen NV S. A.",9,9
"300","es","en","België/Belgique/Belgien Luxembourg/Luxemburg Wyeth Pharmaceuticals S.A./N.V.","België/ Belgique/ Belgien Luxembourg/ Luxemburg Wyeth Pharmaceuticals S. A. / N. V.",12,5
"301","es","en","België/Belgique/Belgien Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Duitsland/Allemagne/Deutschland Tél/Tel: +49 (0)69 1503 – 1","België/Belgique/Belgien Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Duitsland/Allemagne/Deutschland Tél/Tel: +49 (0)69 1503 – 1",16,16
"302","es","en","Belgique/ België/ Belgien Novartis Pharma N. V.","Belgique/ België/ Belgien Novartis Pharma N. V.",7,7
"303","es","en","Belgique/Belgien Tél/ Tel: + 32 (0)2 656 21 11","Belgique/Belgien Tél/ Tel: + 32 (0)2 656 21 11",9,9
"304","es","en","Beneficio-riesgo en niños El perfil beneficio-riesgo de vigabatrina como monoterapia en niños con epilepsia parcial es negativo.","Risk-benefit in children The risk-benefit profile of vigabatrin monotherapy in children with partial epilepsy is negative.",16,17
"305","es","en","BeneFIX 1000 UI polvo y disolvente para solución inyectable Nonacog alfa (factor IX de coagulación recombinante) Administración intravenosa","BeneFIX 1000 IU powder for solution for injection Nonacog alfa (recombinant coagulation factor IX) Intravenous use",16,18
"306","es","en","BeneFIX debe administrarse mediante una jeringa de plástico desechable estéril.","BeneFIX should be administered using a single sterile disposable plastic syringe.",11,10
"307","es","en","BEROMUN 1 mg/ 5 ml polvo y disolvente para solución para perfusión Tasonermina","BEROMUN 1 mg/ 5 ml powder and solvent for solution for infusion Tasonermin",13,13
"308","es","en","Betaferon es un tipo de medicamento conocido como interferón, utilizado en el tratamiento de la esclerosis múltiple.","Betaferon is a type of medicine known as interferon used to treat multiple sclerosis.",14,17
"309","es","en","Biala 3 00-895 Warszawa Polonia","Biala 3 00-895 Warszawa Poland",5,5
"310","es","en","Bialfar - Produtos À Av. da Siderurgia Nacional P. O.","Portugal Bialfar - Produtos À Av. da Siderurgia Nacional P. O.",11,10
"311","es","en","Binocrit 1000 UI/ 0,5 ml inyectable","Binocrit 1000 IU/ 0.5 ml injection",6,6
"312","es","en","Binocrit 7000 UI/ 0,7 ml inyectable","Binocrit 7000 IU/ 0.7 ml injection",6,6
"313","es","en","Bio Science Park Archimedesweg 2 2333 CN Leiden Países Bajos","Bio Science Park Archimedesweg 2 2333 CN Leiden Netherlands",9,10
"314","es","en","Biogen Idec Inc 5000 Davis Drive Research Triangle Park NC 27709-4627 USA","Biogen Idec Inc 5000 Davis Drive Research Triangle Park NC 27709-4627 USA",12,12
"315","es","en","Bisfosfonatos, combinaciones, código ATC:","Bisphosphonates, combinations, ATC code:",4,4
"316","es","en","Blanquecino o de color amarillo pálido.","Off-white to pale yellow powder.",5,6
"317","es","en","Bleomycin Teva, Pulver 15 U (USP)/ vial og væske til injeksjonsvæske,","Bleomycin Teva 15 U (USP)/ vial",6,11
"318","es","en","Blíster (PVC opaco / aluminio)","Blister (opaque PVC/ ALU)",4,5
"319","es","en","blíster (PVC/ Aclar/ alu)","Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet",10,4
"320","es","en","Blister con 11 comprimidos recubiertos con película de 0,5 mg de vareniclina","Blister Pack of 11 x 0.5 mg varenicline film-coated tablets",10,12
"321","es","en","BLÍSTER DE 110 mg","BLISTER FOR 110 mg",4,4
"322","es","en","Blister de aluminio conteniendo una cápsula de 125 mg y dos cápsulas de 80 mg.","Aluminium blister containing one 125 mg capsule and two 80 mg capsules.",12,15
"323","es","en","Blister de PVC/ PVdC-aluminio transparentes en tamaños de envase de 100 ó 300 cápsulas por estuche.","Transparent PVC/ PVdC – aluminium blisters in pack sizes of 100 or 300 capsules per carton.",16,16
"324","es","en","Blister PVC/ PVDC/ Aluminio","PVC/ PVdC/ aluminium foil blister.",5,4
"325","es","en","Blister termosellado de PVC/ aluminio","Oral use Oral use",4,5
"326","es","en","Blister transparente (Aclar/ PVC/ Aluminio) de 14 comprimidos.","Clear (Aclar/ PVC/ Aluminium) blister of 14 tablets.",8,8
"327","es","en","Blísters de PVC/ PCTFE/ aluminio, envases de 14, 28, 56 y 84 cápsulas duras.","PVC/ PCTFE/ aluminium blisters, packs of 14, 28, 56, and 84 hard capsules.",13,14
"328","es","en","Blisters opacos (PVC/ PVdC/ aluminio).","Opaque blisters (PVC/ PVDC/ aluminium).",5,5
"329","es","en","Bloquea una enzima (la proteasa) que participa en la reproducción del VIH.","It blocks an enzyme called protease, which is involved in the reproduction of HIV.",14,12
"330","es","en","Boehringer Ingelheim France 12, rue André Huet 51100 Reims Francia","Boehringer Ingelheim France 12, rue André Huet 51100 Reims France",10,10
"331","es","en","Boehringer Ingelheim Pharma GmbH & Co.","Boehringer Ingelheim Pharma GmbH & Co.",6,6
"332","es","en","Boehringer-Gasse 5-11 A-1121 Wien Tel: +43 1 80 105-0","Boehringer-Gasse 5-11 A-1121 Wien Tel: +43 1 80 105-0",9,9
"333","es","en","Bomba de perfusión continua subcutánea","Continuous subcutaneous infusion pump",4,5
"334","es","en","Bondronat no se debe mezclar con soluciones que contengan calcio.","Bondronat should not be mixed with calcium containing solutions.",9,10
"335","es","en","Bonviva 150 mg 2,5 mg de ácido dosis mensual ibandrónico (N=396) dosis diaria (%) (N=395) (%)","Bonviva 150 mg ibandronic acid once monthly 2.5 mg daily (N=396) (N=395) (%) (%)",14,16
"336","es","en","Box 179 5530 AD Bladel Países Bajos","Box 179 5530 AD Bladel The Netherlands",7,7
"337","es","en","Box 51407 3505 Lemesos Cyprus","Box 51407 3505 Lemesos Cyprus",5,5
"338","es","en","Box 6185 S-102 33 Stockholm","Sverige Box 6185 S-102 33 Stockholm",6,5
"339","es","en","Box 721 S-16927 Solna, SWEDEN","Box 721 S-16927 Solna, SWEDEN",5,5
"340","es","en","Bradicardia Prolongación del intervalo QTc (ver sección 4.4)","Bradycardia QTc prolongation (see section 4.4)",6,8
"341","es","en","Bravnič arjeva 13 1000 Ljubljana Eslovenia","Bayer d. o. o., Bravnič arjeva 13, 1000 Ljubljana Slovenia",10,6
"342","es","en","Brexin 20 Mg, Comprimé Effervescent","Brexin 20 Mg, Comprimé Effervescent",5,5
"343","es","en","Bristol-Myers Squibb Commpany 6000 Thompson Road, East Syracuse New York 13057 USA","Bristol-Myers Squibb Company 6000 Thompson Road, East Syracuse New York 13057 USA",12,12
"344","es","en","BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH Reino Unido","Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH",8,14
"345","es","en","Bristol-Myers Squibb Pharmaceuticals Ltd 141-149 Staines Road Hounslow TW3 3JA","Bristol-Myers Squibb Pharmaceuticals Ltd 141-149 Staines Road Hounslow TW3 3JA",10,10
"346","es","en","Broich (DE) y al Dr.","Broich (DE) as Rapporteur and Dr.",6,5
"347","es","en","broncospasmo, dolor faringolaríngeo, rinorrea, taquipnea, congestión de las vías respiratorias superiores","bronchospasm, pharyngolaryngeal pain, rhinnorhoea, tachypnoea, upper respiratory tract congestion",9,11
"348","es","en","Brucknerstraβ e 1 D-55127 Mainz Tel: + 49 6131 903 115","Novo Nordisk Pharma GmbH Brucknerstraße 1 D-55127 Mainz Tel: +49 6131 903 115 Eesti",14,11
"349","es","en","BTVPUR AlSap 8 se ha autorizado en « circunstancias excepcionales ».","BTVPUR AlSap 8 has been authorised under ‘ Exceptional Circumstances’.",10,11
"350","es","en","Bucharest Business Park Ş os.","NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER",8,5
"351","es","en","Busque un lugar cómodo y bien iluminado en el que se pueda sentar y reclinarse.","Find a comfortable, well-lit place to sit and where you can lie back.",13,15
"352","es","en","Byk Gulden Lomberg Chemische Fabrik GmbH","Byk Gulden Lomberg Chemische Fabrik GmbH",6,6
"353","es","en","Č eská republika Abbott Laboratories s. r. o.","Česká republika Abbott Laboratories s. r. o.",7,8
"354","es","en","Č eská republika Boehringer Ingelheim spol. s r. o.","Č eská republika Boehringer Ingelheim spol. s r. o.",9,9
"355","es","en","Č eská republika JANSSEN-CILAG s. r. o.","Č eská republika JANSSEN-CILAG s. r. o.",7,7
"356","es","en","Č eská republika Ke Š tvanici 3","Česká republika Ke Štvanici 3 CZ-186 00 Praha 8 Tel: +420 221771250",12,7
"357","es","en","Č eská republika NEOMED s. r. o.","Č eská republika NEOMED s. r. o.",7,7
"358","es","en","C linical investigation of medicinal products for the treatment of p e r ipheral arterial occlusive disease (revision)","Clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease (revision)",14,18
"359","es","en","C) Tratamiento o prevención de infecciones después de un trasplante de médula ósea (alotrasplante de médula ósea).","C) Treatment or prevention of infections after a bone marrow transplantation (allogeneic bone marrow transplantation).",15,17
"360","es","en","CAD {Mes/ Año} Utilizar inmediatamente después de su reconstitución.","EXP (mm/ yyyy) Use immediately after reconstitution",7,9
"361","es","en","CAD disolvente {Mes/ Año} CAD vacuna {Mes/ Año}","EXP solvent {month/ year} EXP vaccine {month/ year}",8,8
"362","es","en","Cada 24 horas, al menos un día, hasta que se logre la curación.","Every 24 hours, at least 1 day, until healing is achieved.",11,13
"363","es","en","Cada ampolla contiene 30 mg de alemtuzumab.","Each ampoule contains 30 mg of alemtuzumab.",7,7
"364","es","en","Cada caja contiene un frasco.","Each carton contains one bottle.",5,5
"365","es","en","Cada cápsula consta de un cuerpo blanco opaco y de una tapa azul pálido opaco.","Each capsule has a white opaque body with a light blue opaque cap.",13,15
"366","es","en","Cada cápsula contiene 10 mg de lenalidomida.","Each capsule contains 10 mg of lenalidomide.",7,7
"367","es","en","Cada cápsula contiene 133,3 mg de lopinavir y 33,3 g de ritonavir.","Kaletra 100 mg/ 25 mg film-coated tablets lopinavir/ ritonavir",9,12
"368","es","en","Cada cápsula contiene 15 mg de lansoprazol.","Each gastro-resistant capsule contains 15 mg lansoprazole.",7,7
"369","es","en","Cada cápsula contiene 2 mg de nitisinona.","Each capsule contains 2 mg nitisinone.",6,7
"370","es","en","Cada cápsula contiene 30 mg de duloxetina (como hidrocloruro)","Each capsule contains 30 mg of duloxetine (as hydrochloride)",9,9
"371","es","en","Cada cápsula contiene 50 mg de amprenavir.","Each capsule contains 50 mg of amprenavir.",7,7
"372","es","en","Cada cápsula dura contiene 15 mg de estavudina","Each hard capsule contains 15 mg stavudine.",7,8
"373","es","en","Cada cápsula dura contiene 250 mg de temozolomida.","Each hard capsule contains 250 mg temozolomide.",7,8
"374","es","en","Cada cápsula dura contiene 80 mg de aprepitant.","Each hard capsule contains 80 mg of aprepitant.",8,8
"375","es","en","Cada cápsula dura de 125 mg contiene 125 mg de aprepitant.","Each 125 mg hard capsule contains 125 mg of aprepitant.",10,11
"376","es","en","Cada cartucho contiene 3,15 ml de solución inyectable, equivalentes a 315 UI de insulina.","Each cartridge contains 3.15 ml of solution for injection, equivalent to 315 IU insulin.",14,14
"377","es","en","Cada comprimido bucodispersable contiene < microgránulos con cubierta gastrorresistente de color naranja a pardo oscuro >.","Each oro-dispersible tablet contains < white to pale brownish white enteric-coated granules >.",13,16
"378","es","en","Cada comprimido bucodispersable contiene 30 mg de aripiprazol.","Each orodispersible tablet contains 30 mg of aripiprazole.",8,8
"379","es","en","Cada comprimido contiene 10 mg de amlodipino (DOE) como maleato de amlodipino.","Each tablet contains 10 mg of amlodipine (as amlodipine maleate).",10,12
"380","es","en","Cada comprimido contiene 100 mg de levodopa, 25 mg de carbidopa y 200 mg de entacapona.","Each tablet contains 100 mg of levodopa, 25 mg of carbidopa and 200 mg of entacapone.",16,16
"381","es","en","Cada comprimido contiene 15 mg de pioglitazona en forma de hidrocloruro.","Each tablet contains 15 mg of pioglitazone as hydrochloride.",9,11
"382","es","en","Cada comprimido contiene 2,5 mg de desloratadina y 120 mg de pseudoefedrina (como sulfato).","Each tablet contains 2.5 mg desloratadine and 120 mg pseudoephedrine (as sulphate).",12,14
"383","es","en","Cada comprimido contiene 30 mg de cinacalcet (como hidrocloruro).","Each tablet contains 30 mg cinacalcet (as hydrochloride).",8,9
"384","es","en","Cada comprimido contiene 4 mg de rosiglitazona (como maleato) y 1.000 mg de hidrocloruro de metformina.","Each tablet contains 4 mg of rosiglitazone (as maleate) and 1000 mg of metformin hydrochloride.",15,16
"385","es","en","Cada comprimido contiene 5 mg de ambrisentan.","Each tablet contains 5 mg of ambrisentan.",7,7
"386","es","en","Cada comprimido contiene 50 mg de sildenafilo (como citrato).","Each tablet contains 50 mg of sildenafil (as citrate) Excipient:",10,9
"387","es","en","Cada comprimido contiene 60 mg de toremifeno (como citrato)","Each tablet contains 60 mg toremifene (as citrate)",8,9
"388","es","en","Cada comprimido contiene 80 mg de atorvastatina como atorvastatina cálcica trihidratada.","Each tablet contains 80 mg of atorvastatin as atorvastatin calcium trihydrate.",11,11
"389","es","en","Cada comprimido contiene lactosa (aproximadamente 6 mg)","Each tablet contains lactose (approximately 6 mg).",7,7
"390","es","en","Cada comprimido contiene: irbesartan 300 mg e hidroclorotiazida 12,5 mg","Each tablet contains: irbesartan 300 mg and hydrochlorothiazide 12.5 mg",10,10
"391","es","en","Cada comprimido contine 200 mg de lamotrigina","Each tablet contains 200 mg lamotrigine",6,7
"392","es","en","Cada comprimido de Cozaar 100 mg contiene 51,0 mg de lactosa monohidrato.","Each Cozaar 100 mg tablet contains 51.0 mg lactose monohydrate.",10,12
"393","es","en","Cada comprimido de Karvea 75 mg contiene 75 mg de irbesartan.","Each tablet of Karvea 75 mg contains 75 mg irbesartan.",10,11
"394","es","en","Cada comprimido de liberación prolongada contiene 500 mg de ranolazina.","Each prolonged-release tablet contains 500 mg ranolazine.",7,10
"395","es","en","Cada comprimido dispersable/ masticable de Lamictal 5 mg contiene 5 mg de lamotrigina.","Each Lamictal 5 mg dispersible/ chewable tablet contains 5 mg lamotrigine.",11,13
"396","es","en","Cada comprimido recubierto con película contiene 10 mg de rivaroxaban.","Each film-coated tablet contains 10 mg rivaroxaban.",7,10
"397","es","en","Cada comprimido recubierto con película contiene 150 mg de irbesartan (como hidrocloruro).","Each film-coated tablet contains 150 mg irbesartan (as hydrochloride).",9,12
"398","es","en","Cada comprimido recubierto con película contiene 30, 60, 90 o 120 mg de etoricoxib.","Each film coated tablet contains 30, 60, 90 or 120 mg of etoricoxib.",13,14
"399","es","en","Cada comprimido recubierto con película contiene 300 mg de irbesartan.","Each film-coated tablet contains 300 mg of irbesartan.",8,10
"400","es","en","Cada comprimido recubierto con película contiene 500 mg de levetiracetam.","Each film-coated tablet contains 500 mg levetiracetam.",7,10
"401","es","en","Cada comprimido recubierto contiene 20 mg de olanzapina","Each coated tablet contains 20 mg olanzapine",7,8
"402","es","en","Cada comprimidos recubierto con película contiene 600 mg ó 800 mg de gabapentina.","Each film-coated tablet contains either 600 mg or 800 mg gabapentin.",11,13
"403","es","en","Cada dosis contiene 0,5 ml de suspensión en un vial.","Each dose contains 0.5 ml of suspension for injection in a vial.",12,10
"404","es","en","Cada dosis de Epivir debe tomarse aproximadamente cada 12 horas.","Each dose of Epivir should be taken approximately 12 hours apart.",11,10
"405","es","en","Cada dosis pipeta de STRONGHOLD suministra:","Each unit dose (tube) of STRONGHOLD delivers",7,6
"406","es","en","Cada envase blister contiene: • un vial monodosis de concentrado y • un vial monodosis de disolvente.","Each blister pack contains: • one single-dose vial of concentrate and, • one single-dose vial of solvent.",17,17
"407","es","en","Cada envase contiene 1 vial.","Each pack contains 1 vial.",5,5
"408","es","en","Cada envase contiene un vial de 5 ml.","Each pack contains one 5 ml vial.",7,8
"409","es","en","Cada frasco tiene un volumen de llenado de 3 ml.","Each bottle has a fill volume of 3 ml.",9,10
"410","es","en","Cada jeringa debe utilizarse sólo para una inyección única.","Each syringe should be used for a single injection only.",10,9
"411","es","en","Cada jeringa precargada (0,5 ml) contiene 22 microgramos (6 MUI*) de interferón beta-1a**.","Each pre-filled syringe (0.5 ml) contains 22 micrograms (6 MIU*) of interferon beta-1a**.",13,13
"412","es","en","Cada jeringa precargada contiene 100 mg de anakinra.","Each pre-filled syringe contains 100 mg of anakinra.",8,8
"413","es","en","Cada jeringa precargada de 0,4 ml contiene 80 microgramos de darbepoetin alfa (200","Each 0.4 ml pre-filled syringe contains 80 micrograms darbepoetin alfa (200 micrograms/ ml).",13,13
"414","es","en","Cada jeringa precargada es para un solo uso.","Each pre-filled syringe is for single use only.",8,8
"415","es","en","Cada mililitro de solución contiene 10 mg de icatibant.","Each ml of the solution contains 10 mg of icatibant.",10,9
"416","es","en","Cada ml contiene 100 UI de insulina humana (equivalente a 3,5 mg).","Each ml contains 100 IU insulin human (equivalent to 3.5 mg).",11,12
"417","es","en","Cada ml contiene 4 mg de temoporfina.","Each ml contains 4 mg of temoporfin.",7,7
"418","es","en","Cada ml de Flexicam 1,5 mg/ ml suspensión oral contiene:","Each ml of Flexicam 1.5 mg/ ml oral suspension contains:",10,10
"419","es","en","Cada ml de Rapamune contiene 1 mg de sirolimus.","Each ml of Rapamune contains 1 mg of sirolimus.",9,9
"420","es","en","Cada parche de 30 cm2 contiene 16,5 mg de fentanilo","Each patch of 30 cm2 contains 16.5 mg fentanyl.",9,10
"421","es","en","Cada parche está envasado individualmente en un sobre.","Each patch is packed in a separate sachet.",8,8
"422","es","en","Cada parche libera 50 microgramos de fentanilo por hora.","Each patch releases 50 micrograms fentanyl per hour.",8,9
"423","es","en","Cada perfusión dura una hora, aunque algunos pacientes con neumonía necesitan perfusiones de cuatro horas de duración.","Each infusion lasts for one hour, although some patients with pneumonia may need infusions lasting four hours.",17,17
"424","es","en","Cada pipeta de 0,70 ml contiene:","Each 0.70 ml pipette contains:",5,6
"425","es","en","Cada pluma contiene 3 ml de solución (300Unidades).","Each pen contains 3 ml solution (300 Units).",8,8
"426","es","en","Cada pluma precargada de 0,3 ml contiene 150 microgramos de darbepoetin alfa (500","Each 0.3 ml pre-filled pen contains 150 micrograms darbepoetin alfa (500 micrograms/ ml).",13,13
"427","es","en","Cada sobre contiene 2 g de Ranelato de Estroncio.","Each sachet contains 2 g strontium ranelate.",7,9
"428","es","en","Cada solución contiene 10 mg/ ml de Rituximab","Each solution contains 10 mg/ ml of Rituximab.",8,8
"429","es","en","cada uno los Días 1 y 2","Leucovorin on Day 1 and 2",6,7
"430","es","en","Cada vial aporta 120 microgramos/0,5 ml de peginterferón alfa-2b en su reconstitución como se recomienda.","Each vial provides 120 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.",13,15
"431","es","en","Cada vial contiene 1 ml de solución.","Each vial contains 1ml of solution.",6,7
"432","es","en","Cada vial contiene 10 mg de basiliximab.","Each vial contains 10 mg of basiliximab.",7,7
"433","es","en","Cada vial contiene 100 mg de pemetrexed (como pemetrexed disódico).","Each vial contains 100 mg of pemetrexed (as pemetrexed disodium).",10,10
"434","es","en","Cada vial contiene 25 mg de etanercept.","Each vial contains 25 mg of etanercept.",7,7
"435","es","en","Cada vial contiene 40 mg de mecasermina.","Each vial contains 40 mg of mecasermin.",7,7
"436","es","en","Cada vial contiene 50 mg de tigeciclina.","Each vial contains 50 mg tigecycline.",6,7
"437","es","en","Cada vial contiene 90 mg de ustekinumab en 1 ml.","Each vial contains 90 mg ustekinumab in 1 ml.",9,10
"438","es","en","Cada vial contiene nominalmente 500 UI de nonacog alfa, (factor IX de coagulación recombinante).","Each vial contains nominally 500 IU nonacog alfa (recombinant coagulation factor IX).",12,14
"439","es","en","Cada vial de polvo contiene 500 UI de octocog alfa.","Each powder vial contains 500 IU octocog alfa.",8,10
"440","es","en","Cada vial es para un solo uso.","Each vial is for single use only.",7,7
"441","es","en","Caducidad {Mes/ año} Una vez abierto, utilizar en 3 horas.","EXP {month/ year} Once broached, use within 3 hours.",9,10
"442","es","en","Caelyx 2 mg/ ml concentrado para solución para perfusión Doxorubicina clorhidrato liposomal pegilada","Caelyx 2 mg/ ml concentrate for solution for infusion Pegylated liposomal doxorubicin hydrochloride",13,13
"443","es","en","CAJA 15 mg (todos los tamaños)","CARTON LABEL, 15 mg (ALL PACK SIZES)",7,6
"444","es","en","Caja de 10 viales","Box of 10 vials",4,4
"445","es","en","CAJA DE 7 PARCHES - SEMANA 4","BOX OF 7 PATCHES – WEEK 4",7,7
"446","es","en","CAJA DE CARTÓN / Solución inyectable","CARDBOARD CARTON / Solution for injection",6,6
"447","es","en","Caja de cartón con 1, 2 ó 10 blísters Al/ Al.","Cardboard box containing 1, 2 or 10 Alu/ Alu blisters.",10,11
"448","es","en","Caja exterior – envase de inicio del tratamiento conteniendo 4 cajas de 14 comprimidos recubiertos con película","Outer carton - treatment initiation pack containing 4 cartons of 14 film-coated tablets",13,17
"449","es","en","Caja externa para Efficib 50 mg/ 1.000 mg comprimidos recubiertos con película","Outer carton for Efficib 50 mg/ 1,000 mg film-coated tablets",10,12
"450","es","en","Caja para el Blister Película/ Lámina (blister de PVC-PE-PCTFE/ Al)","Carton for Film/ Foil Blister (PVC-PE-PCTFE/ Al blister)",8,10
"451","es","en","Cajas de cartón para los blisters","Paper cartons for the blister",5,6
"452","es","en","Calci-chew D3 500mg/ 200 I. E","Calci-chew D3 500mg/ 200 I. E",6,6
"453","es","en","Calcium ""Sandoz"" forte - Brausetabletten","Calcium ""Sandoz"" forte - Brausetabletten",5,5
"454","es","en","Calcular el número de cápsulas que son necesarias para preparar la mezcla por este procedimiento:","Determine the number of capsules that are needed to prepare a mixture with this procedure:",15,15
"455","es","en","Calcule el volumen requerido de Erbitux.","Calculate the required volume of Erbitux.",6,6
"456","es","en","Cambio a Insuman Comb 50","Transfer to Insuman Comb 50",5,5
"457","es","en","Cambio medio respecto al valor basal de HbA 1c (%) en la semana 24","HbA 1c (%) at week 24",6,14
"458","es","en","Can Guasch, 2 - Parets del Vallès E-08150, Barcelona Tel: +34 93 571 01 00","Can Guasch, 2 - Parets del Vallès E-08150, Barcelona Tel: +34 93 571 01 00",15,15
"459","es","en","Cáncer de cabeza y cuello","Head and neck cancer",4,5
"460","es","en","CANTIDAD DEL (DE LOS) PRINCIPIO(S) ACTIVO(S)","QUANTITY OF THE ACTIVE SUBSTANCE(S)",5,6
"461","es","en","Cantidad y concentración de los comprimidos para su administración Peso","Number and Strength of Tablets to be Administered Bodyweight",9,10
"462","es","en","Capecitabina (2.500 mg/ m2/ día)","Capecitabine (2,500 mg/ m2/ day)",5,5
"463","es","en","Cápsulas < color >.","Agopton 15 mg: < colour > capsules.",7,4
"464","es","en","Cápsulas de CellCept: almidón de maíz pregelatinizado croscarmelosa sódica povidona (K-90) estearato magnésico","CellCept capsules: pregelatinised maize starch croscarmellose sodium polyvidone (K-90) magnesium stearate",11,13
"465","es","en","Carbamazepina Riesgo de hiponatremia asintomática.","Carbamazepine Risk of symptomatic hyponatremia.",5,5
"466","es","en","Carcinoma de paratiroides e hiperparatiroidismo primario","Parathyroid Carcinoma and Primary Hyperparathyroidism",5,6
"467","es","en","Carga viral baja Carga viral alta Genotipo 4 RVR","Low viral load High viral load Genotype 4 RVR",9,9
"468","es","en","CARTÓN PAXENE 300 mg/ 50 ml","CARTON TEXT FOR PAXENE 300 mg/50 ml",7,6
"469","es","en","CARTÓN Y ETIQUETA DEL FRASCO","CARTON AND BOTTLE LABEL",4,5
"470","es","en","CARTONAJE PARA LAS CÁPSULAS DURAS GASTRORRESISTENTES DE 60 MG","CARTONS FOR 60 MG HARD GASTRO-RESISTANT CAPSULES",7,9
"471","es","en","CARTONAJE/ VIAL DE 10 ML","OUTER CARTONS / 10 ML VIAL",6,5
"472","es","en","cartucho (vidrio) para OptiClik","cartridge (glass) in disposable pen",5,4
"473","es","en","CARTUCHO TEXTO Puregon 300 UI/ 0,36 ml","CARTRIDGE TEXT Puregon 300 IU/ 0.36 ml",7,7
"474","es","en","Cartuchos sin abrir Conservar en nevera (entre 2ºC y 8ºC).","Unopened cartridges Store in a refrigerator (2°C - 8°C).",9,10
"475","es","en","Casos similares han ocurrido en asociación con el uso de lamotrigina.","Similar cases have occurred in association with the use of lamotrigine.",11,11
"476","es","en","Caspofungina no es dializable.","Caspofungin is not dialysable.",4,4
"477","es","en","Cefalea, mareo Hipercinesia, temblor, disfonía, parestesia, hipoestesia, hiperestesia, problemas de concentración, somnolencia","Headache, dizziness Hyperkinesia, tremor, dysphonia, paresthaesia, hypoaesthesia, hyperaesthesia, concentration impaired, somnolence",11,12
"478","es","en","Ceftriaxona atraviesa la placenta y se excreta en leche humana en bajas concentraciones.","Ceftriaxone crosses the placenta and is excreted in human milk at low concentrations.",13,13
"479","es","en","Ceftriaxona Tyrol Pharma 2 g La sustancia activa es Ceftriaxona disódica 3,5 H2O.","Ceftriaxone Tyrol Pharma 2g The active substance is ceftriaxone disodium 3.5 H2O.",12,13
"480","es","en","Cefuroxima axetilo 500 mg contiene 0,4 mg de aspartamo por comprimido.","Cefuroximaxetil 500 contains 0,4 mg aspartame per tablet",8,11
"481","es","en","Celecoxib no afecta la farmacocinética de tolbutamida (sustrato del CYP2C9), o de glibenclamida de forma clínicamente relevante.","Celecoxib does not affect the pharmacokinetics of tolbutamide (CYP2C9 substrate), or glibenclamide to a clinically relevant extent.",17,17
"482","es","en","CELSENTRI 300 mg dos veces al día y los INTIs pueden","CELSENTRI 300 mg twice daily and NRTIs can be co- administered without dose",13,11
"483","es","en","Celulosa microcristalina Crospovidona Hipromelosa Estearato de magnesio Sílice coloidal anhidra","Cellulose microcrystalline Crospovidone Hypromellose Magnesium stearate Silica, colloidal anhydrous",9,10
"484","es","en","Celvapan se ha estudiado en adultos, incluidos ancianos (de más de 60 años).","Celvapan has been studied in adults, including the elderly (above 60 years of age).",14,13
"485","es","en","Centrafarm Services B. V., Nieuwe Donk 9, P. O. Box 289, 4870 Ag Etten-Leur, The Netherlands","Centrafarm Services B. V., Nieuwe Donk 9, P. O. Box 289, 4870 Ag Etten-Leur, The Netherlands",16,16
"486","es","en","Cepa similar a A/ Wisconsin/ 67/ 2005 (H3N2) (NYMC X-161) 15 microgramos HA**","A/ Wisconsin/ 67/ 2005 (H3N2) like strain (NYMC X-161) 15 micrograms HA**",12,13
"487","es","en","Cephalon Europe, 5 Rue Charles Martigny, 94700 Maisons Alfort, Francia","Cephalon Europe, 5 Rue Charles Martigny, 94700 Maisons Alfort, FRANCE",10,10
"488","es","en","CEPROTIN 500 UI polvo y disolvente para solución inyectable","CEPROTIN 500 IU powder and solvent for solution for injection",10,9
"489","es","en","Cerenia 10 mg/ml solución inyectable para perros está disponible en viales de vidrio ámbar de 20 ml.","Cerenia 10 mg per ml solution for injection for dogs is available in 20 ml amber glass vials.",18,17
"490","es","en","Cerezyme contiene la sustancia activa imiglucerasa.","Cerezyme contains the active substance imiglucerase.",6,6
"491","es","en","Certificados de medicamentos, 2000-2002","clinical trials and adverse reaction reporting.",6,4
"492","es","en","Česká republika Pfizer s.r.o.","Česká republika Pfizer s.r.o.",4,4
"493","es","en","Česká republika sanofi-aventis, s.r.o.","Č eská republika sanofi-aventis, s. r. o.",7,4
"494","es","en","Cetrotide 3 mg inhibe los efectos de una hormona natural denominada hormona liberadora de la hormona luteinizante (LHRH).","Cetrotide 3 mg inhibits the effects of a natural hormone, called luteinising hormone releasing hormone (LHRH).",16,18
"495","es","en","CEVA VETEM S. p. A.","CEVA VETEM S. p. A.",5,5
"496","es","en","CIALIS pertenece a un grupo de medicamentos denominados inhibidores de la fosfodiesterasa tipo 5.","CIALIS belongs to a group of medicines called phosphodiesterase type 5 inhibitors.",12,14
"497","es","en","Ciclosporina Tacrolimus Rapamicina (saquinavir/ritonavir) Analgésicos narcóticos","Ciclosporin Tacrolimus Rapamycin (saquinavir/ ritonavir) Narcotic analgesics",7,6
"498","es","en","Cilindro (Alu) Cilindro (Alu)","Packaging Gas cylinder (aluminium) Gas cylinder (aluminium)",7,4
"499","es","en","Cipla (Uk) Limited 53a High Street Esher Surrey Kt10 9qr","Cipla (Uk) Limited 53a High Street Esher Surrey Kt10 9qr United Kingdom",12,10
"500","es","en","Ciprofloxacino Kabi 400 2 mg/ ml mg/ 200 ml, Solución para perfusión","Ciprofloxacin Kabi 400 2 mg/ ml mg/ 200 ml, solution for infusion",12,12
"501","es","en","Ciproxin Ciproxin Ciflox Ciprobay Ciproxin Ciproxin Ciproxin Ciproxin Ciproxina Ciproxin Baycip Ciproxin","Ciproxin Ciproxina Ciproxin Baycip Ciproxin Ciproxin",6,12
"502","es","en","Circovirus porcino inactivado tipo 2 (PCV2)............................................ ≥ 2,1 log10 unidades ELISA Excipiente:","Inactivated porcine circovirus type 2 (PCV2)................................................ ≥ 2.1 log10 ELISA. Units Excipient:",12,12
"503","es","en","Citrato sódico Cloruro sódico Edetato de disodio Polisorbato 80 Hidróxido sódico Agua para inyectables","Sodium citrate Sodium chloride Disodium edetate Polysorbate 80 Sodium hydroxide Water for injections",13,14
"504","es","en","Citrobacter freundii Enterobacter cloacae Haemophilus influenzae Moraxella spp.","Citrobacter freundii Enterobacter cloacae Haemophilus influenzae Moraxella spp.",8,8
"505","es","en","Clasificación de órganos del sistema","System organ class Blood and lymphatic system disorders",8,5
"506","es","en","Clasificación de Órganos del Sistema MedDRA Infecciones e infestaciones","MedDRA System Organ Class Infections and infestations",7,9
"507","es","en","Clomicalm 80 mg --- --- --- --- 1/ 2 comprimido 1 comprimido","Clomicalm 80 mg --- --- --- --- ½ tablet 1 tablet",11,12
"508","es","en","Cloruro de sodio (NaCl) Cloruro de magnesio (MgCl2) Cloruro de calcio (CaCl2)","Magnesium chloride (MgCl2) Calcium chloride (CaCl2)",6,12
"509","es","en","Cloruro de sodio Agua para preparaciones inyectables.","Sodium chloride Water for injections",5,7
"510","es","en","Cloruro sódico Ácido acético (99%) Acetato sódico Agua para inyección","Sodium chloride Acetic acid (99%) Sodium acetate Water for injections",10,10
"511","es","en","Colecalciferol y algunos de sus metabolitos activos llegan a la leche materna.","Colecalciferol and some of its active metabolites pass into breast milk.",11,12
"512","es","en","Colirio en solución; 1 x 5 ml 3 x 5 ml","Eye drops, solution; 1 x 5 ml 3 x 5 ml",11,11
"513","es","en","Colocación de la aguja.","Put on the needle.",4,4
"514","es","en","coloidal anhidra, povidona K25, estearato de magnesio.","colloidal anhydrous silica and magnesium stearate.",6,7
"515","es","en","Coma, hemorragias cerebrales, derrame cerebral, parálisis, trastorno cerebral, alteraciones del habla y del lenguaje, problemas de memoria","coma, bleeding in the brain, stroke, paralysis, brain disorder, speech and language abnormalities, memory problems",15,17
"516","es","en","combinación con doxorubicina, o trastuzumab o capecitabina.","combination with doxorubicin, or trastuzumab, or capecitabine.",7,7
"517","es","en","comercialización de irbesartan/ hidroclorotiazida, también se han comunicado las","In addition, since introduction of irbesartan/ hydrochlorothiazide in the market the following adverse reactions have also been reported:",18,9
"518","es","en","Comience de nuevo con otra bandeja de dosis.","Start again with another dose tray.",6,8
"519","es","en","COMITÉ DE MEDICAMENTOS DE USO HUMANO (CHMP)","COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)",8,7
"520","es","en","Comité de Medicamentos Huérfanos","Unit for the Post-authorisation evaluation of medicines for human use",10,4
"521","es","en","COMITÉ DE MEDICAMENTOS PARA USO VETERINARIO (CVMP)","COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)",8,7
"522","es","en","Como amina cuaternaria, la capacidad de la metilnaltrexona para atravesar la barrera hematoencefálica es reducida.","As a quaternary amine, the ability of methylnaltrexone to cross the blood-brain barrier is restricted.",15,15
"523","es","en","Como con todas las vacunas inyectables, hay un riesgo extremadamente pequeño de reacciones alérgicas.","may occur before leaving the doctor’ s surgery.",8,14
"524","es","en","Como consecuencia los recién nacidos deben monitorizarse con cuidado.","Consequently, newborns should be monitored carefully.",6,9
"525","es","en","Como las prostaglandinas son sustancias que desencadenan dolor, exudación e inflamación, Previcox reduce esas reacciones.","As the prostaglandins are substances that trigger pain, exudation and inflammation, Previcox, therefore, reduces those responses.",16,15
"526","es","en","Como Luminity es administrado únicamente por profesionales sanitarios no se incluirá ninguna información en Braille.","As Luminity is only intended for administration by healthcare professionals no information will be included in Braille.",17,15
"527","es","en","Cómo manejar los viales","How to handle the vials",5,4
"528","es","en","Cómo retirar el parche usado","How to remove a used patch",6,5
"529","es","en","CÓMO SE ADMINISTRARÁ SYNAGIS A SU HIJO","HOW WILL MY CHILD RECEIVE SYNAGIS",6,7
"530","es","en","CÓMO SE LE ADMINISTRA ELAPRASE","HOW ELAPRASE IS GIVEN TO YOU",6,5
"531","es","en","Como sucede con cualquier otra terapia administrada por vía inhalatoria, puede aparecer broncoespasmo paradójico (ver el apartado 4.4.","As with other inhalation therapy, paradoxical bronchospasm may occur (see 4.4 Special Warnings and Precautions for Use).",17,18
"532","es","en","Como todos los retinoides, la isotretinoína es teratógena y está contraindicada en el embarazo para prevenir malformaciones congénitas.","Like all retinoids, isotretinoin is teratogen and is contraindicated during pregnancy to avoid congenital defects.",15,18
"533","es","en","Cómo tomar Actos 4.","How to take Actos 4.",5,4
"534","es","en","Cómo tomar Azomyr comprimidos bucodispersables 4.","How to take Azomyr orodispersible tablet 4.",7,6
"535","es","en","Cómo tomar Cozaar 4.","How to take Cozaar 4.",5,4
"536","es","en","Cómo tomar Exelon 4.","How to take Exelon 4.",5,4
"537","es","en","CÓMO TOMAR IRBESARTAN HYDROCHLOROTHIAZIDE BMS","HOW TO TAKE IRBESARTAN HYDROCHLOROTHIAZIDE BMS",6,5
"538","es","en","Cómo tomar Lysodren 4.","How to take Lysodren 4.",5,4
"539","es","en","Cómo tomar OSSEOR 4.","How to take OSSEOR 4.",5,4
"540","es","en","Cómo tomar Ribavirina Teva 4.","How to take Ribavirin Teva 4.",6,5
"541","es","en","Cómo tomar Tasigna 4.","How to take Tasigna 4.",5,4
"542","es","en","Cómo tomar ZYPREXA VELOTAB 4.","How to take ZYPREXA VELOTAB 4.",6,5
"543","es","en","Como tratamiento de la IUE, Duloxetine Boehringer Ingelheim se ha estudiado en un total de 2.850 mujeres.","For the treatment of SUI, Duloxetine Boehringer Ingelheim has been studied in a total of 2,850 women.",17,17
"544","es","en","Cómo usar AZOPT 4.","How to use AZOPT 4.",5,4
"545","es","en","Cómo usar DUKORAL 4.","How to use DUKORAL 4.",5,4
"546","es","en","CÓMO USAR FORCALTONIN dic","HOW TO USE FORCALTONIN",4,4
"547","es","en","CÓMO USAR HUMALOG BASAL PEN","HOW TO USE HUMALOG BASAL PEN",6,5
"548","es","en","CÓMO USAR INSULIN HUMAN WINTHROP BASAL","HOW TO USE INSULIN HUMAN WINTHROP BASAL",7,6
"549","es","en","Cómo usar Insuman Comb 50 4.","How to use Insuman Comb 50 4.",7,6
"550","es","en","CÓMO USAR LIPROLOG BASAL KWIKPEN","HOW TO USE LIPROLOG Basal KWIKPEN",6,5
"551","es","en","Cómo usar Osigraft 4.","How to use Osigraft 4.",5,4
"552","es","en","Cómo usar Pandemrix 4.","How Pandemrix is given 4.",5,4
"553","es","en","Cómo usar Remicade 4.","How to use Remicade 4.",5,4
"554","es","en","Cómo usar Viani 4.","How to take Viani 4.",5,4
"555","es","en","Cómo usar VISTIDE 4.","How to use VISTIDE 4.",5,4
"556","es","en","Comparador N=238, 252, 248, 252, 249, 230, 224, 216, 253.","Comparator N= 253, 238, 252, 248, 252, 249, 230, 224, 216, 253.",12,10
"557","es","en","completarse el tratamiento antitumoral antes de iniciar el tratamiento con somatropina.","therapy must be completed prior to starting therapy.",8,11
"558","es","en","Complicaciones relacionadas con la diabetes","Hospitalisation for heart failure Complications related to diabetes",8,5
"559","es","en","Componente de un envase múltiple formado por 10 envases, cada uno conteniendo 14 comprimidos.","Component of a multipack comprising 10 packs, each containing 14 tablets.",11,14
"560","es","en","COMPOSICION CUALITATIVA Y CUANTITATIVA","QUALITATIVE and QUANTITATIVE COMPOSITION",4,4
"561","es","en","Composición de Clopidogrel Winthrop El principio activo es clopidogrel.","What Clopidogrel Winthrop contains The active substance is clopidogrel.",9,9
"562","es","en","Composición de Diacomit 500 mg • El principio activo es el estiripentol.","What Diacomit 500 mg contains • The active substance is stiripentol.",11,12
"563","es","en","Composición de Insuman Rapid","What Insuman Rapid contains",4,4
"564","es","en","Composición de Kaletra Los principios activos son lopinavir y ritonavir.","The active substances are lopinavir and ritonavir.",7,10
"565","es","en","Composición de Lamictal comprimidos dispersables/ masticables El principio activo es lamotrigina.","What Lamictal dispersible/chewable tablets contain The active substance is lamotrigine.",10,11
"566","es","en","Composición de Liprolog Mix50 100 U/ml suspensión inyectable en cartucho","What Liprolog Mix50 100 U/ml suspension for injection in cartridge contains",11,10
"567","es","en","Composición de NovoMix 30","What NovoMix 30 contains",4,4
"568","es","en","Composición de Ribavirina Teva","What Ribavirin Teva contains",4,4
"569","es","en","Composición de VIRACEPT -El principio activo es el nelfinavir.","The active substance is nelfinavir.",5,9
"570","es","en","Comprimido recubierto con película","Clarithromycin increased the Cmax and AUC of atorvastatin by 56% and 80% respectively.",13,4
"571","es","en","Comprimido recubierto con película, forma ovalada, de color rojo y con la inscripción “ 577” en una cara.","Capsule-shaped, red film-coated tablet with “ 577 ” debossed on one side.",12,18
"572","es","en","Comprimido redondo, plano, de color amarillo oscuro, liso por las dos caras.","A dark yellow, flat, round tablet, plain on both sides.",10,12
"573","es","en","Comprimido redondo, plano, de color verde, liso por las dos caras.","A green, flat, round tablet, plain on both sides.",9,11
"574","es","en","COMPRIMIDOS - ENVASE DE 40 COMPRIMIDOS RECUBIERTOS (5 BLISTER DE 8 CÁPSULAS)","ORAL SOLUTION - BOTTLE LABEL",5,12
"575","es","en","Comprimidos amarillos con forma de almendra y llevan grabado ‘ C 20’ en una cara.","Yellow and almond shaped tablets, marked ""C 20"" on one side.",11,15
"576","es","en","comprimidos de CHAMPIX 1 mg comprimidos recubiertos con película en una caja.","coated tablets in a carton.",5,12
"577","es","en","Comprimidos de color rojo claro, de superficie plana, redondos, moteados, marcados por un lado con una “ A”","Light-red, flat-faced, round, speckled tablets, one side branded with “ A”",11,18
"578","es","en","Comprimidos recubiertos con película","Film-coated tablets Film-coated tablets Film-coated tablets",6,4
"579","es","en","comprimidos recubiertos con película vía oral comprimidos recubiertos con película vía oral comprimidos recubiertos con película vía oral","oral use oral use oral use intravenous use intravenous use intravenous use intravenous use",14,18
"580","es","en","Comprimidos redondos de color naranja, con una ‘ v’ en una cara y un 20 en la otra.","Orange round tablets marked with a ‘ v’ on one side and “ 20” on the other side.",18,18
"581","es","en","Comprobar la apariencia de Ratiograstim.","Check the appearance of Ratiograstim.",5,5
"582","es","en","Comprobar que la dosis es correcta 9.","Check you have the right dose 9.",7,7
"583","es","en","Compruebe la fecha de caducidad (CAD.) en la etiqueta de la jeringa.","Check the expiry date on the pre-filled syringe label (EXP).",10,12
"584","es","en","Compruebe que en la ventana de la dosis aparece “0” después de la prueba de seguridad.","Check that the dose window shows “0” following the safety test.",11,16
"585","es","en","Compruebe que esto es así antes de ponerse cada inyección.","Check this each time you inject yourself.",7,10
"586","es","en","Compruebe que la punta de la aguja ha atravesado el tapón.","Look for the needle tip inside the stopper window.",9,11
"587","es","en","Compruebe siempre dos veces la dosis preparada.","Always double -check your dosage.",5,7
"588","es","en","Compruebe su azúcar sanguíneo.","Check your blood sugar.",4,4
"589","es","en","Compruebe visualmente si hay burbujas de aire.","Visually inspect the syringe for air bubbles.",7,7
"590","es","en","Compruébelo cada vez que se inyecte.","Check each time you inject yourself.",6,6
"591","es","en","Compruébelo con su doctor o enfermera si no está seguro.","Check with your doctor or nurse if you are unsure.",10,10
"592","es","en","Computerweg 10 3542 DR Utrecht Holanda","Computerweg 10 3542 DR Utrecht The Netherlands",7,6
"593","es","en","Comtess 200 mg comprimidos recubiertos con película entacapona","Comtess 200 mg film-coated tablets entacapone",6,8
"594","es","en","Con cuidado dé la vuelta al conjunto del vial, el adaptador y la jeringa.","Carefully turn the vial, adapter and syringe assembly upside down.",10,14
"595","es","en","Con dosis ≥ 80 mg/ kg/ día se observaron lesiones necróticas en la cola.","Necrotic lesions of the tail were observed at ≥ 80 mg/ kg/ day.",13,14
"596","es","en","Con el émbolo totalmente presionado, inserte una de las jeringas de dosificación en la abertura del adaptador.","With the plunger fully depressed, insert one of the dosing syringes into the opening in the adapter.",17,17
"597","es","en","Con el fin de evitar la lipodistrofia los puntos de inyección deben rotarse dentro de una región anatómica.","Injection sites should be rotated within an anatomic region in order to avoid lipodystrophy.",14,18
"598","es","en","Con esto se pretende fomentar la participación de expertos externos en las reuniones del CPMP.","This is aimed at improving the involvement of external experts in meetings of the CPMP",15,15
"599","es","en","Con la otra mano sujete la jeringa como si fuera un lápiz.","With your other hand, hold the syringe as you would a pencil.",12,12
"600","es","en","Con METALYSE son frecuentes (> 1/ 100, < 1/ 10) los siguientes efectos adversos:","The following side effects are common (> 1/ 100, < 1/ 10) with METALYSE:",14,14
"601","es","en","con ningún otro fármaco antirreumático modificador de la enfermedad.","Study III evaluated 619 patients with moderately to severely active rheumatoid arthritis who were ≥ 18 t uc",18,9
"602","es","en","Con Pedea, se han comunicado los siguientes efectos adversos:","The following side effects have been reported with Pedea:",9,9
"603","es","en","Con una mano, tome un pliegue de piel que ceda con facilidad.","Remove the needle guard.With one hand, pinch a fold of loose skin.",12,12
"604","es","en","concentraciones de 40 a 50 µg/ g.","Sparfloxacin concentrates preferentially in macrophages, in which concentrations of 40-50 mg/ g are reached.",14,7
"605","es","en","Concentrado para solución para perfusión.","Concentrate for Solution for Infusion.",5,5
"606","es","en","Concentrado para solución Vía intravenosa para perfusión","Concentrate for solution for infusion",5,7
"607","es","en","CONCLUSIONES CIENTÍFICAS Y MOTIVOS DE LA MODIFICACIÓN DEL RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO PRESENTADAS POR LA EMEA","SCIENTIFIC CONCLUSIONS AND GROUNDS FOR AMENDMENT OF THE SUMMARIES OF PRODUCT CHARACTERISTICS PRESENTED BY THE EMEA",16,18
"608","es","en","CONDICIONES DE LA AUT ORIZACIÓN DE COMERCIALIZACIÓN","CONDITIONS OF THE MARKETING AUTHORISATION",5,7
"609","es","en","CONDICIONES DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN INCLUYENDO RESTRICCIONES DE SUMINISTRO Y USO","CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY OR USE",11,12
"610","es","en","CONDICIONES DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN, INCLUIDAS RESTRICCIONES DE DISPENSACIÓN Y USO","CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION HOLDER REGARDING SUPPLY OR USE",12,12
"611","es","en","CONDICIONES GENERALES DE DISPENSACIÓN","GENERAL CLASSIFICATION FOR SUPPLY",4,4
"612","es","en","CONDICIONES O RESTRICCIÓN DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN RESPECTO A UN USO SEGURO Y EFICAZ","CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO THE SAFE AND EFFECTIVE USE",15,15
"613","es","en","Conducción y uso de maquinas","Driving and using machines:",4,5
"614","es","en","Conducción y uso de máquinas","Driving and using machines",4,5
"615","es","en","Conducción y uso de máquinas Es poco probable que Plavix altere su capacidad de conducir o manejar maquinaria.","Plavix is unlikely to affect your ability to drive or to use machines.",13,18
"616","es","en","Conducción y uso de máquinas Oprymea puede causar alucinaciones (ver, oír o sentir cosas que no están presentes).","Driving and using machines Oprymea can cause hallucinations (seeing, hearing or feeling things that are not there).",17,18
"617","es","en","Conducción y uso de máquinas VIAGRA puede producir mareos y afectar a la visión.","Driving and using machines VIAGRA can cause dizziness and can affect vision.",12,14
"618","es","en","Confusión, Ansiedad, Labilidad emocional, Intento de suicidio, (ver también sección 4.4)","Confusion, Anxiety, Emotional lability, Suicide attempt (see also section 4.4)",10,11
"619","es","en","Conjuntivitis, dolor ocular, visión anormal, alteración de la glándula","Conjunctivitis, eye pain, abnormal vision, lacrimal gland disorder no",9,9
"620","es","en","Consejo: no presione el émbolo con rapidez.","Don’t push the plunger quickly.",5,7
"621","es","en","Conservación de Aerius 6.","How to store Aerius 6.",5,4
"622","es","en","CONSERVACIÓN DE AZOMYR LIOFILIZADO ORAL","HOW TO STORE AZOMYR ORAL LYOPHILISATE",6,5
"623","es","en","CONSERVACIÓN DE CIPROFLOXACINO HIKMA","HOW TO STORE CIPROFLOXACIN HIKMA",5,4
"624","es","en","CONSERVACIÓN DE DULOXETINE BOEHRINGER INGELHEIM","HOW TO STORE DULOXETINE BOEHRINGER INGELHEIM",6,5
"625","es","en","Conservación de FABLYN 6.","How to store FABLYN 6.",5,4
"626","es","en","Conservación de Glucomed 6.","Possible side effects 5 How to store Glucomed 6.",9,4
"627","es","en","Conservación de HBVAXPRO 10 microgramos/ ml 6.","How to store HBVAXPRO 10 micrograms/ ml 6.",8,7
"628","es","en","CONSERVACIÓN DE HUMALOG MIX50 PEN","HOW TO STORE HUMALOG MIX50 PEN",6,5
"629","es","en","Conservación de Insulin Human Winthrop Infusat 6.","How to store Insulin Human Winthrop Infusat 6.",8,7
"630","es","en","Conservación de Irbesartan BMS 6.","How to store Irbesartan BMS 6.",6,5
"631","es","en","Conservación de KOGENATE Bayer 2000 UI 6.","How to store KOGENATE Bayer 2000 IU 6.",8,7
"632","es","en","CONSERVACIÓN DE LIPROLOG MIX50 KWIKPEN","HOW TO STORE LIPROLOG MIX50 KWIKPEN",6,5
"633","es","en","Conservación de Neoclarityn 6.","How to store Neoclarityn 6.",5,4
"634","es","en","CONSERVACIÓN DE REFACTO AF","HOW TO STORE REFACTO AF",5,4
"635","es","en","Conservación de TachoSil No conservar a temperatura superior a 25ºC.","Storage of TachoSil Do not store above 25°C.",8,10
"636","es","en","Conservación de Trazec 6.","How to store Trazec 6.",5,4
"637","es","en","CONSERVACIÓN DE VACUNA ANTIGRIPAL PREPANDÉMICA (H5N1) (DE VIRUS FRACCIONADOS, INACTIVADOS, ADYUVADA) GLAXOSMITHKLINE BIOLOGICALS 3,75 µg","HOW TO STORE PREPANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS 3.75 µg",15,15
"638","es","en","Conservación de Viraferon 6.","How to store Viraferon 6.",5,4
"639","es","en","Conservación de Xyrem 6.","Possible side effects 5 How to store Xyrem 6.",9,4
"640","es","en","Conservación de Zomarist 6.","How to store Zomarist 6.",5,4
"641","es","en","Conservar el vial en el embalaje exterior para protegerlo de la luz.","Keep the vial in the outer carton in order to protect from light.",13,12
"642","es","en","Conservar el vial en el envase original para protegerlo de la luz.","Store in the original carton in order to protect from light..",11,12
"643","es","en","Conservar el vial en la caja de cartón.","Keep the vial in the outer carton.",7,8
"644","es","en","Conservar en el embalaje original (blister) para protegerlo de la humedad.","Store in the original package (blister) in order to protect from moisture.",12,11
"645","es","en","Conservar en el embalaje original para protegerlo de la humedad.","Store in the original package in order to protect from moisture.",11,10
"646","es","en","Conservar en el embalaje original para protegerlo de la luz y la humedad.","Store in the original package in order to protect from light and moisture.",13,13
"647","es","en","Conservar en el embalaje original para protegerlo de la luz.","Store in the original package in order to protect from light.",11,10
"648","es","en","Conservar en el embalaje original.","Store in the original container.",5,5
"649","es","en","Conservar en el envase original para protegerlo de la humedad y de la luz.","Store in the original blister in order to protect from moisture and light.",13,14
"650","es","en","Conservar en el envase original.","Store in the original package.",5,5
"651","es","en","Conservar en lugar seco.","Store in a dry place.",5,4
"652","es","en","Conservar en nevera (2°C - 8°C).","Store in a refrigerator (2 C – 8 C).",9,6
"653","es","en","Conservar en nevera (entre 2 ºC y 8 ºC).","Store in a refrigerator (2 °C – 8 °C).",9,9
"654","es","en","Conservar en nevera (entre 2°C y 8°C).","Store in a refrigerator (2°C - 8°C).",7,7
"655","es","en","Conservar en nevera (entre 2ºC y 8 ºC).","Store in a refrigerator (2-8°C).",5,8
"656","es","en","Conservar en nevera (entre 2ºC y 8ºC).","Store in a refrigerator (2°C – 8°C).",7,7
"657","es","en","Conservar entre 2 – 8°C.","Store at 2 - 8°C.",5,5
"658","es","en","Conservar los viales en su caja de cartón para protegerlos de la luz.","Keep the vials in the outer carton in order to protect from light.",13,13
"659","es","en","Conservar y transportar refrigerado (2ºC-8ºC).","Store and transport refrigerated (2°C - 8°C).",7,5
"660","es","en","Conservar y transportar refrigerado (entre 2 ºC y 8 ºC) y protegido de la luz.","Store and transport refrigerated (+2 to +8 °C) and protected from light.",12,15
"661","es","en","Conserve el blíster en la caja de cartón externa para protegerlo de la luz.","Keep the blister in the outer carton in order to protect from light.",13,14
"662","es","en","Considerando el diseño del estudio, no se pueden sacar conclusiones de los resultados del análisis independiente.","Considering the design of the study, no conclusions can be drawn from the results of the separate analysis.",18,16
"663","es","en","constante durante los ensayos I, II y III.","ed trials I, II and III.",6,8
"664","es","en","Consulte a su médico o farmacéutico antes de utilizar cualquier medicamento.","Ask your doctor or pharmacist for advice before taking any medicine.",11,11
"665","es","en","Consulte a su médico o farmacéutico antes de utilizarr Ceftriaxona Tyrol Pharma 2 g.","Ask your doctor or pharmacist for advice before you use Ceftriaxone Tyrol Pharma 2g.",14,14
"666","es","en","Consulte a su médico o farmacéutico si no está seguro.","You should check with your doctor or pharmacist if you are not sure.",13,10
"667","es","en","Consulte a su médico o farmacéutico si tiene dudas.","Always take Ovitrelle exactly as your doctor has told you.",10,9
"668","es","en","Consulte a su médico si observa cambios en su grasa corporal.","Tell your doctor if you notice changes in your body fat.",11,11
"669","es","en","Consulte a su médico si tiene dudas.","You should check with your doctor if you are not sure.",11,7
"670","es","en","Consulte con su médico.","Ask your doctor for advice.",5,4
"671","es","en","Contacte con su médico si ha tomado más solución oral de la que debiera.","Contact your doctor if you took more Keppra than you should.",11,14
"672","es","en","Contacte inmediatamente con su médico si se queda embarazada, piensa que podría estar embarazada o en","Tell your doctor if you are breast-feeding or if you are planning to breast-feed your baby. tn",17,16
"673","es","en","CONTENIDO EN PESO, EN VOLUMEN O EN UNIDADES","CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER OF DOSES",10,8
"674","es","en","CONTENIDO EN PESO, VOLUMEN O EN UNIDADES na co to en am dic Me","CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT tn uc rod lp ina dic Me",15,14
"675","es","en","CONTENIDOS EN PESO, EN VOLUMEN O EN UNIDAD","CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT",8,8
"676","es","en","Contiene 1 parche transdérmico.","Contains 1 transdermal patch.",4,4
"677","es","en","Contiene el principio activo alglucosidase alfa.","It contains the active substance alglucosidase alfa.",7,6
"678","es","en","Contiene sacarosa Para mayor información consultar el prospecto.","Contains sucrose See leaflet for further information",7,8
"679","es","en","Contribuir a la protección y promoción de la salud humana y animal mediante:","To contribute to the protection and promotion of public and animal health by:",13,13
"680","es","en","controlada durante los seis meses previos (ver sección 4.4);","in the previous six months (see section 4.4); 121",9,9
"681","es","en","Convenia 80 mg/ ml en polvo y disolvente para solución inyectable para perros y gatos","Convenia 80 mg/ ml powder and solvent for solution for injection for dogs and cats",15,15
"682","es","en","Copalia 5 mg/ 80 mg","Copalia 5 mg/ 80 mg",5,5
"683","es","en","CORRECCIONES A LA FICHA TÉCNICA O RESUMEN DE LAS CARACTERISTICAS DEL PRODUCTO, ETIQUETADO Y PROSPECTO","AMENDMENTS TO SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET AND LABELLING",11,15
"684","es","en","Corso Vittorio Emanuele Ii, 72 10121 Torino Italia","Corso Vittorio Emanuele Ii, 72 10121 Torino Italy",8,8
"685","es","en","Corte la matriz humedecida de InductOs en 6 piezas iguales (aproximadamente de 2,5 x 5 cm).","Cut the wetted matrix of InductOs into 6 equal (approximately 2.5 x 5 cm) pieces.",15,16
"686","es","en","Coup Oe Kouparoussos & Sia Agias Varvaras 53 Dafni 17235 Grecia","Coup Oe Kouparoussos & Sia Agias Varvaras 53 Dafni 17235 Greece",11,11
"687","es","en","Cozaar comp se suministra en los siguientes tamaños de envase:","Cozaar Comp is supplied in the following pack sizes:",9,10
"688","es","en","CPMP/ 1357/ 99 5.3 Datos preclínicos sobre seguridad","In the dog, the results of an electrophysiological CPMP/ 1357/ 99",11,8
"689","es","en","CPMP/ 4060/ 03 4.6 Embarazo y lactancia","CPMP/ 4060/ 03 4.6 Pregnancy and lactation",7,7
"690","es","en","CPMP/ 459/ 04 4.2 Posología y método de administración","Posology and method of administration CPMP/ 459/ 04",8,9
"691","es","en","CPMP/ BWP/ 198/ 95","CPMP/ BWP/ 198/ 95",4,4
"692","es","en","CPMP/ EWP/ 563/ 95","CPMP/ EWP/ 563/ 95",4,4
"693","es","en","Creatinina sérica a Día - X Creatinina sérica a Día - Y","Serum creatinine at Day - X Serum creatinine at Day - Y",12,12
"694","es","en","Crema de naranja natural con otros aromas naturales","Natural orange cream with other natural flavours",7,8
"695","es","en","Crisis hipertensivas Hipotensión ortostática2 Frialdad periférica","Hypertensive crisis Orthostatic hypotension2Pe ripheral coldness",6,6
"696","es","en","CRIXIVAN 200 mg cápsulas duras Indinavir","CRIXIVAN 200 mg hard capsules Indinavir",6,6
"697","es","en","croscarmelosa sódica, sílice coloidal anhidro, estearilfumarato sódico.","croscarmellose sodium, silica colloidal anhydrous, sodium stearyl fumarate.",8,7
"698","es","en","Cualquier signo de inflamación o infección.","In some patients with advanced HIV infection",7,6
"699","es","en","Cualquier solución restante así como la bolsa deben ser desechadas adecuadamente, de acuerdo con los requerimientos locales.","Any unused solution and the bag should be adequately disposed of, in accordance with local requirements.",16,17
"700","es","en","Cuando este reconocimiento no es posible, se solicita a la EMEA un arbitraje vinculante.","Where this is not possible, the EMEA is called on to prepare a binding arbitration.",15,14
"701","es","en","Cuando éste se vacía ya no se puede volver a utilizar.","Once the cartridge is empty, do not use it again.",10,11
"702","es","en","Cuando indinavir se administra en monoterapia los virus resistentes aparecen rápidamente (ver sección 5.1).","When indinavir is administered as monotherapy resistant viruses rapidly emerge (see section 5.1).",13,14
"703","es","en","Cuando la ingesta se reduce, se debe utilizar la siguiente fórmula:","Where feed intake is reduced, use the following formula:",9,11
"704","es","en","Cuando la pluma está vacía no se puede volver a usar.","When the Pen is empty you cannot use it again.",10,11
"705","es","en","Cuando los síntomas desaparezcan o mejoren, la perfusión puede continuar.","When these symptoms go away, or improve, the infusion can be continued.",12,10
"706","es","en","Cuando Plavix se presenta en cualquier blíster de aluminio no requiere condiciones especiales de conservación.","If Plavix is supplied in all aluminium blisters, it does not require any special storage conditions.",16,15
"707","es","en","Cuando recuerde tomar ADARTREL, tome la siguiente dosis a la hora habitual.","When you do remember to take ADARTREL, take your next dose of ADARTREL at the usual time.",17,12
"708","es","en","Cuando se diluye Busilvex, se obtiene una solución transparente e incolora.","When diluted Busilvex is a clear colourless solution.",8,11
"709","es","en","Cuando se produce una erupción, suele aparecer","If a rash occurs, it usually appears soon after anti-HIV",10,7
"710","es","en","Cuando se reconstituye con 2 ml de disolvente, se proporcionan 20 mg/ml de parecoxib.","When reconstituted with 2 ml solvent, provides 20 mg/ ml of parecoxib.",12,14
"711","es","en","Cuando se reinicie el tratamiento se seguirán las instrucciones detalladas en la sección 4.2.","Re-introduction must follow the guidelines detailed in section 4.2.",9,14
"712","es","en","Cuando se use Norvir a dosis completas se tomarán las siguientes precauciones.","The following warnings apply when Norvir is taken as a full dose.",12,12
"713","es","en","Cuando se utilice en pacientes con cáncer de mama, se administrará con un quimioterápico llamado paclitaxel.","When used for patients with breast cancer, it will be administered with a chemotherapy called paclitaxel.",16,16
"714","es","en","Cuando sea necesario, Irbesartan Hydrochlorothiazide BMS puede administrarse junto con otros tratamientos para la hipertensión.","Irbesartan Hydrochlorothiazide BMS may be added to other treatments for hypertension.",11,15
"715","es","en","Cuando sea necesario, Irbesartan Hydrochlorothiazide Winthrop puede administrarse junto con otro medicamento antihipertensivo (ver sección 4.5).","When necessary, Irbesartan Hydrochlorothiazide Winthrop may be administered with another antihypertensive medicinal product (see section 4.5).",16,16
"716","es","en","Cuánto EXJADE debe tomar La dosis de EXJADE está relacionada con el peso corporal para todos los pacientes.","How much EXJ ADE to take The dose of EXJADE is related to body weight for all patients.",18,18
"717","es","en","Cuatro de los estudios compararon RoActemra con placebo (un tratamiento ficticio).","Four of the studies compared RoActemra with placebo (a dummy treatment).",11,11
"718","es","en","Cubierta del comprimido recubierto de 10 mg:","Tablet coat for 10 mg film-coated tablet:",7,7
"719","es","en","Cubierta pelicular: hipromelosa, dióxido de titanio (E171), lactosa, triacetina, laca aluminio que contiene carmín de índigo (E 132).","hypromellose, titanium dioxide (E171), lactose, triacetin, indigo carmine aluminium lake (E132)",11,18
"720","es","en","curativo para las personas que puedan recibir tratamiento oral, cuando sea","treatment for persons able to receive treatment by oral route when clinically appropriate.",13,11
"721","es","en","Curvas de Kaplan-Meier para la supervivencia global (población por intención de tratar)","Kaplan-Meier curves for overall survival (Intent to Treat population)",9,12
"722","es","en","CYSTAGON 150 mg cápsulas duras","CYSTAGON 150 mg hard capsules",5,5
"723","es","en","CZ-18600 Praha 8 Tel: +420 236 080300 ic","CZ-18600 Praha 8 Tel: +420 236 080300 in ic",9,8
"724","es","en","da Reúna los elementos necesarios antes de comenzar:","ed Preparation Collect nece ssary items before you begin:",9,8
"725","es","en","Dabigatrán etexilato Dabigatrán etexilato 150 mg 220 mg","Dabigatran etexilate 220 mg",4,8
"726","es","en","Daiichi Sankyo Europe GmbH","Daiichi Sankyo Europe GmbH",4,4
"727","es","en","Damastown, Mulhuddart IRL-Dublin 15 Tél. / Tel: + 353 1 822 5404","Damastown, Mulhuddart IRL-Dublin 15 Tél. / Tel: + 353 1 822 5404",12,12
"728","es","en","Danmark Dr Helle HARTMANN FRIES (1) Prof.","Danmark Dr Helle HARTMANN FRIES (1) Prof.",7,7
"729","es","en","Danmark Merck Sharp & Dohme Tlf: +45 43 28 77 66 dkmail@merck. com","Danmark Merck Sharp & Dohme Tlf: +45 43 28 77 66 dkmail@merck. com",13,13
"730","es","en","Danmark Orion Pharma Animal Health Tlf: +45 49 12 67 65","Danmark Orion Pharma Animal Health Tlf: +45 49 12 67 65",11,11
"731","es","en","Darbepoetin alfa se produce por ingeniería genética en células de ovario de Hamster Chino (CHO-K1).","Darbepoetin alfa is produced by gene-technology in Chinese Hamster Ovary Cells (CHO-K1).",12,15
"732","es","en","Daronrix, suspensión inyectable en jeringa precargada.","Daronrix, suspension for injection in a prefilled syringe.",8,6
"733","es","en","Dasatinib y sus metabolitos se excretan mínimamente por vía renal.","Dasatinib and its metabolites are minimally excreted via the kidney.",10,10
"734","es","en","Datos a tres años del 4411","Three year data in study MF 4411",7,6
"735","es","en","Datos de reacciones adversas al medicamento","ACUITY trial; adverse drug reaction data",6,6
"736","es","en","Datos de sensibilidad in vitro","In vitro Susceptibility Data",4,5
"737","es","en","David Drakeford trabajó en Telecom Eireann, donde dirigió la instalación de una red nacional de comunicación de datos.","David Drakeford worked with Telecom Eireann where he managed the implementation of a national data communication network.",17,18
"738","es","en","de · Disentería porcina","Minimum of 7 days and up",6,4
"739","es","en","DE = Desviación estándar","SD – Standard Deviation.",4,4
"740","es","en","de descompensación hepática y muerte.","Co-infected patients with advanced cirrhosis receiving HAART may be at increased risk of hepatic decompensation and death.",17,5
"741","es","en","de espalda, dolor en las extremidades como en los dedos de las manos y los pies","pain, pain in extremities such as fingers and toes",9,16
"742","es","en","De esta forma ayudará a proteger el medio ambiente.","These measures will help to protect the environment",8,9
"743","es","en","De esta forma el Liprolog se mantendrá estéril y no habrá pérdidas.","This will keep the Liprolog sterile and prevent leaking.",9,12
"744","es","en","De éstas, las más significativas son: anafilaxis, celulitis, flebitis, y anticuerpos neutralizantes.","Of these the most significant include: anaphylaxis, cellulitis, phlebitis, and neutralising antibodies.",12,12
"745","es","en","De este modo protege contra las enfermedades causadas por tales virus.","This will help to protect against the diseases caused by these viruses.",12,11
"746","es","en","De este modo, se puede lograr una disminución más rápida de la población de pulgas del hogar.","This can result in a more rapid reduction in the household flea population.",13,17
"747","es","en","De hecho, los datos clínicos disponibles son muy limitados y no permiten obtener conclusiones fiables al respecto.","Indeed, the available clinical data are very limited and preclude any reliable conclusion in the field.",16,17
"748","es","en","DE LA PRIMERA AUTORIZACIÓN/ REVALIDACIÓN DE","DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION",8,6
"749","es","en","DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE","DATE FOR FIRST AUTHORISATION / RENEWAL OF AUTHORISATION...............................................",8,5
"750","es","en","De los metabolitos hallados en orina, sólo un 1% aproximadamente se ha formado por oxidación.","Of the metabolites found in urine only about 1% have been formed through oxidation.",14,15
"751","es","en","De manera alternativa, pueden tomarse 120 mg (dos comprimidos) por la mañana.","Alternatively, 120 mg (two tablets) may be taken in the morning.",11,12
"752","es","en","DE/ H/ 0740/ 003/ MR Austria Alemania España Francia Países Bajos","Austria Germany Spain France The Netherlands United Kingdom",8,11
"753","es","en","Debe abandonarse el tratamiento con mirtazapina en caso de que el paciente entrase en una fase maníaca","The majority of withdrawal reactions are mild and self-limiting.",9,17
"754","es","en","Debe advertirse a los pacientes que extremen las precauciones para evitar una hipoglucemia mientras conducen.","Patients should be advised to take precautions to avoid hypoglycaemia whilst driving.",12,15
"755","es","en","Debe advertirse a los pacientes que no deben ingerir la cápsula con desecante incluida en el frasco.","Patients should be advised not to swallow the desiccant capsule found in the bottle.",14,17
"756","es","en","Debe colocarse el primer parche del nuevo ciclo en cuanto se acuerde.","The user should apply the first patch of the new cycle as soon as remembered.",15,12
"757","es","en","Debe considerarse este hecho cuando se prescriba Faslodex a pacientes en riesgo.","This should be taken into consideration when prescribing Faslodex to patients at risk.",13,12
"758","es","en","Debe considerarse la interrupción del tratamiento con Betaferon (ver también sección 4.3 y 4.8).","Cessation of therapy with Betaferon should be considered (see also section 4.3 and section 4.8).",15,14
"759","es","en","Debe considerarse la monitorización de la función renal.","Monitoring of renal function should be considered.",7,8
"760","es","en","Debe considerarse la reducción de la dosis de CRIXIVAN a 400-600 mg cada 8 horas.","Dose reduction of CRIXIVAN to 400-600 mg every 8 hours should be considered.",13,15
"761","es","en","Debe contactar con su médico inmediatamente si observa cualquiera de los siguientes efectos:","You must contact your doctor immediately if you notice any of the following:",13,13
"762","es","en","Debe desecharse la solución no utilizada.","Any unused solution should be discarded.",6,6
"763","es","en","Debe evitarse el consumo de alcohol y los medicamentos que lo contengan.","Avoid consumption of alcohol and medicinal products containing alcohol.",9,12
"764","es","en","Debe evitarse la administración concomitante de fármacos potencialmente neurotóxicos.","Concurrent administration of potential nephrotoxic drugs should be avoided.",9,9
"765","es","en","Debe evitarse la administración concomitante de voriconazol y rifabutina a menos que el beneficio sea superior al riesgo.","Concomitant use of voriconazole and rifabutin should be avoided unless the benefit outweighs the risk.",15,18
"766","es","en","Debe informar a su médico si está embarazada, si sospecha que pudiera estarlo o si planea quedarse embarazada.","You must tell your doctor if you think that you are (or might become) pregnant.",15,18
"767","es","en","Debe informar a su médico sobre cualquier enfermedad que tenga o que haya padecido.","You should tell your doctor about any medical conditions that you have or have had.",15,14
"768","es","en","Debe iniciarse un tratamiento antipirético de acuerdo a las directrices de tratamiento local.","Antipyretic treatment should be initiated according to local treatment guidelines.",10,13
"769","es","en","Debe intentar tomar su dosis diaria a la misma hora cada día.","You should try to take your daily dose at about the same time each day.",15,12
"770","es","en","Debe manejarse con cuidado.","It must be handled with care.",6,4
"771","es","en","Debe mostrarse el prospecto o el etiquetado al médico.","The package insert or the label should be shown to the physician",12,9
"772","es","en","Debe prestarse especial atención a la exactitud de la dosis.","Particular care should be taken with regard to the accuracy of dosing.",12,10
"773","es","en","Debe recibir formación sobre cómo inyectarseAvonex.","You should have had training in how to inject Avonex.",10,6
"774","es","en","Debe saber que estos dos trastornos pueden estar causados por este tipo de medicamentos.","You should be aware that both of these conditions may be caused by this type of medicine.",17,14
"775","es","en","Debe subrayarse además que la lamotrigina no está indicada para el tratamiento agudo.","It should be also underlined that lamotrigine is not indicated for acute treatment.",13,13
"776","es","en","Debe tenerse en cuenta la posibilidad de interacciones en los pacientes tratados con AZOPT.","The potential for interactions must be considered in patients receiving AZOPT.",11,14
"777","es","en","Debe tenerse precaución a la hora de recetarlo a mujeres embarazadas.","Caution should be exercised when prescribing to pregnant women.",9,11
"778","es","en","Debe tomarse diariamente un comprimido masticable de 4 mg por la noche.","One 4 mg chewable tablet daily to be taken in the evening.",12,12
"779","es","en","Debe transcurrir al menos 1 mes entre la administración de una vacuna de virus vivos y ProQuad.","At least 1 month should elapse between receipt of a live virus vaccine and ProQuad.",15,17
"780","es","en","Debe utilizarse con precaución en pacientes que tengan problemas de hígado.","It should be used with caution in patients who have problems with their liver.",14,11
"781","es","en","Deben considerarse los estándares médicos actuales en el tratamiento de emergencia.","The current medical standards for emergency treatment are to be observed.",11,11
"782","es","en","Deben mantenerse las recomendaciones inmunoprofilácticas frente a la hepatitis B establecidas localmente.","Locally established immunoprophylactic measures against hepatitis B should be maintained.",10,12
"783","es","en","Deben tenerse en cuenta las recomendaciones oficiales sobre el uso apropiado de agentes antibacterianos.","Vaccination may not be sufficient to prevent meningococcal infection.",9,14
"784","es","en","Deben utilizarse con precaución otros medicamentos antiagregantes plaquetarios (ácido acetilsalicílico, dipiridamol, sulfinpirazona, ticlopidina ó clopidogrel), y los AINEs.","Other antiplatelet medicinal products (acetylsalicylic acid, dipyridamole, sulfinpyrazone, ticlopidine or clopidogrel), and NSAIDs should be used with caution.",18,18
"785","es","en","Deberá controlarse su respiración durante tres días después de la vacunación.","Their breathing should be monitored for up to three days after vaccination.",12,11
"786","es","en","Deberá evitarse el contacto cutáneo con el contenido de la pipeta.","Skin contact with the pipette content should be avoided.",9,11
"787","es","en","deberá fundarse en una valoración individual de los riesgos globales de cada paciente.","on an assessment of the individual patient's overall risks,",9,13
"788","es","en","Deberá interrumpir el tratamiento con OSSEOR si recibe tetraciclinas o quinolonas (dos tipos de antibiótico) por vía oral.","You should stop taking OSSEOR if you have to take oral tetracyclines or quinolones (two types of antibiotics).",18,18
"789","es","en","Deberá tenerse una especial precaución para evitar el embarazo en las pacientes (ver secciones 4.6 y 5.3).","Extreme care must be taken to avoid pregnancy in female patients (see sections 4.6 and 5.3).",16,17
"790","es","en","Deberá tomar Clopidogrel BMS durante el tiempo que su médico continúe prescribiéndoselo.","You should take clopidogrel for as long as your doctor continues to prescribe it.",14,12
"791","es","en","Deberá usarse la vía de administración subcutánea.","The subcutaneous route of administration should be used.",8,7
"792","es","en","Deberán tenerse en cuenta las disposiciones oficiales sobre la incorporación de premezclas medicamentosas a la alimentación animal.","Consideration should be given to official guidance on the incorporation of medicated premixes in final feed.",16,17
"793","es","en","Debería mantenerse la dosis diaria total y la frecuencia de administración.","The total daily dose and frequency of administration should be maintained.",11,11
"794","es","en","Debido a que CoAprovel contiene hidroclorotiazida, no se recomienda su administración durante el primer trimestre del embarazo.","Since CoAprovel contains hydrochlorothiazide, it is not recommended during the first trimester of pregnancy.",14,17
"795","es","en","Debido a un defecto metodológico, la eficacia no pudo demostrarse.","Because of a methodological flaw, efficacy could not be demonstrated.",10,10
"796","es","en","Debido al perfil de la cetirizina, no se esperan interacciones con otros fármacos.","Due to the profile of cetirizine, no interactions with other drugs are expected",13,13
"797","es","en","Debido al tipo de proceso de producción, Optaflu no contiene proteínas de pollo/ huevo.","Due to the kind of manufacturing Optaflu is free of chicken/ egg protein.",13,14
"798","es","en","decidirá qué medicamentos son mejores en su caso.","Your doctor will determine which medicines are best for you.",10,8
"799","es","en","DECLARACIÓN DE SUSTANCIA(S) ACTIVA(S)","STATEMENT OF ACTIVE SUBSTANCE(S)",4,4
"800","es","en","Deje que el cartucho adquiera la temperatura ambiente y muévalo suavemente.","Allow the cartridge to come to room temperature and gently swirl.",11,11
"801","es","en","Deje que la jeringa se desplace hacia arriba hasta que la aguja quede totalmente protegida.","Allow the syringe to move up until the entire needle is guarded.",12,15
"802","es","en","del Medicamento (EMEA) http: / /www. emea. europa. eu/ am dic Me","Agency (EMEA) http: / /www. emea. europa. eu/ i na dic Me",12,12
"803","es","en","Del mismo modo, la administración conjunta de nelfinavir con amiodarona, quinidina, pimozida y derivados del cornezuelo está contraindicada.","Similarly, concomitant administration of nelfinavir with any of amiodarone, quinidine, pimozide and ergot derivatives is contraindicated.",16,18
"804","es","en","del riñón y el hígado.","through the kidney and liver.",5,5
"805","es","en","del uso previo de darunavir y de la carga viral en la selección.","of darunavir and screening viral load.",6,13
"806","es","en","Denominación común internacional (DCI):","International Non-proprietary Name (INN):",4,4
"807","es","en","Denominación Común Internacional (DCI): doxiciclina monohidrato","International Non-Proprietary Name (INN): doxycycline monohydrate",6,6
"808","es","en","Denominación común internacional (DCI): salmeterol / fluticasone","International Non-Proprietary Name (INN): salmeterol / fluticasone",7,7
"809","es","en","DENOMINACIÓN DE LOS PRINCIPIOS ACTIVOS Y OTRAS SUBSTANCIAS","STATEMENT OF ACTIVE AND OTHER SUBSTANCES",6,8
"810","es","en","DENOMINACIÓN DEL MEDICAMENTO VETERINARIO","NAME OF THE VETERINARY MEDICINAL PRODUCT",6,4
"811","es","en","DENOMINACIÓN DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN","NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION",9,7
"812","es","en","DENOMINACIÓN DEL PRINCIPIO ACTIVO Y OTRA(S) SUSTANCIA(S)","STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS",8,7
"813","es","en","DENOMINACIÓN DEL PRINCIPIO O PRINCIPIOS ACTIVOS Y OTRA(S) SUSTANCIA(S)","STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)",8,9
"814","es","en","Dependiendo de, y después de la implementación de la vacuna cuando tenga lugar la primera pandemia.","Depending on and after implementation of vaccine when first pandemic will take place.",13,16
"815","es","en","DepoCyte debía administrarse mediante inyección intratecal.","DepoCyte was to be injected intrathecally.",6,6
"816","es","en","Depresión Durante el uso de benzodiazepinas o fármacos tipo benzodiazepinas, puede desenmascararse una depresión preexistente.","Depression Pre-existing depression may be unmasked during benzodiazepine or benzodiazepine-like agent use.",12,15
"817","es","en","derivation and characterisation of cell substrates used for production of biotechnological/biological products","derivation and characterisation of cell substrates used for production of biotechnological/ biological products",13,12
"818","es","en","Desde el punto de vista microbiológico, el producto debe utilizarse inmediatamente después de la reconstitución (ver sección 6.3).","From a microbiological point of view, the product should be used immediately after reconstitution (see section 6.3).",17,18
"819","es","en","Desde entonces las circunstancias han variado mucho, y ha aumentado la carga de trabajo para la EMEA.","The environment has changed greatly since that time, with new workload demands made on the EMEA.",16,17
"820","es","en","Desde un punto de vista microbiológico, el producto debe utilizarse inmediatamente.","From a microbiological point of view, the product should be used immediately.",12,11
"821","es","en","Desde un punto de vista microbiológico, la solución reconstituida debe diluirse inmediatamente.","From a microbiological point of view, the reconstituted solution should be diluted immediately.",13,12
"822","es","en","Desechar inmediatamente la solución no utilizada.","Dispose of any unused solution immediately.",6,6
"823","es","en","Desechar la solución sobrante después del uso.","Discard any remaining solution after first use.",7,7
"824","es","en","Desechar transcurridos 15 desde que se abrió por primera vez","Discard the oral solution 15 days after first opening the bottle.",11,10
"825","es","en","Deseche la jeringuilla y la aguja en un lugar seguro.","Dispose of the syringe and needle safely.",7,10
"826","es","en","DESECHE LA VACUNA RECONSTITUIDA SI NO ES UTILIZADA EN 30 MINUTOS.","DISCARD IF RECONSTITUTED VACCINE IS NOT USED WITHIN 30 MINUTES.",10,11
"827","es","en","Deséchela siguiendo las instrucciones que le haya dado su médico o farmacéutico.","Dispose of it as your doctor or pharmacist has instructed.",10,12
"828","es","en","Desenrosque totalmente la aguja dándole de 3 a 5 vueltas completas a la capucha externa de la aguja.","Unscrew the needle all the way by giving the large needle cover 3 to 5 complete turns.",17,18
"829","es","en","Deshacerse del vial adecuadamente.","Discard the vial appropriately.",4,4
"830","es","en","deshidratación, infección grave, shock, administración intravascular de medios de contraste yodados (ver sección 4.4).","dehydration, severe infection, shock, intravascular administration of iodinated contrast agents (see section 4.4).",13,14
"831","es","en","designa, cuya integridad se asegura mediante una declaración pública de intereses.","possible quality of the Agency’ s scientific opinions.",8,11
"832","es","en","Desinfecte con alcohol el tapón de goma del dispositivo a utilizar.","Disinfect the rubber seal of the device with alcohol.",9,11
"833","es","en","Desirudina es un producto obtenido por la tecnología del ADN recombinante derivado de células de levadura.","Desirudin is a recombinant DNA product derived from yeast cells.",10,16
"834","es","en","Deslizar la palanca, alejándola, hasta que se oiga un “ click”.","Slide the lever away from you as far as it will go until it clicks.",15,11
"835","es","en","Despegue las láminas y abra el sobre.","Peel apart the foil and open the sachet.",8,7
"836","es","en","Desplace el émbolo hasta abajo para eliminar el aire de la jeringa.","Push the plunger right down to get air out of the syringe.",12,12
"837","es","en","Después de administrar busulfano mediante perfusión intravenosa, se logra una disponibilidad inmediata y completa de la dosis.","Immediate and complete availability of the dose is obtained after intravenous infusion of busulfan.",14,17
"838","es","en","Después de cada dosis, la pipeta debe lavarse y secarse y el tapón del frasco debe enroscarse firmemente.","After each dose, the pipette should be washed and dried and the bottle cap screwed back on tightly.",18,18
"839","es","en","Después de haber completado estos pasos puede quedar una pequeña cantidad de líquido en el vial.","After you have completed these steps, a small amount of liquid may remain in the vial.",16,16
"840","es","en","Después de la administración de Zactran no deberá sacrificarse al ganado durante 64 días.","After the last administration of Zactran, cattle should not be slaughtered for 64 days.",14,14
"841","es","en","Después de la administración es recomendable ocluir el conducto nasolagrimal o cerrar suavemente los ojos.","Nasolacrimal occlusion or gently closing the eyelid after administration is recommended.",11,15
"842","es","en","Después de la dilución, 1 mililitro contiene 5 mg de bivalirudina.","After dilution 1 ml contains 5 mg bivalirudin.",8,11
"843","es","en","Después de la ingestión oral, la urea marcada alcanza la mucosa gástrica.","After oral ingestion the labelled urea reaches the gastric mucosa.",10,12
"844","es","en","Después de la inyección, se une rápidamente a los receptores específicos de una gran variedad de células.","After injection it is quickly bound to specific receptors of a large variety of cells.",15,17
"845","es","en","Después de la prueba de seguridad la ventana de la dosis debe marcar “ 0”.","The dose window must show “ 0” following the safety test.",11,15
"846","es","en","Después de la reconstitución con el disolvente proporcionado, la concentración de cetrorelix es 1 mg/ ml.","After reconstitution with the solvent provided, the concentration of cetrorelix is 1 mg/ ml.",14,16
"847","es","en","Después de la reconstitución, cada mililitro contiene 250 microgramos (8 millones de UI) de interferón beta-1b.","After reconstitution each millilitre contains 250 microgram (8 million IU) Interferon beta-1b.",12,16
"848","es","en","Después de la reconstitución, cada ml de solución contiene aproximadamente 500 UI de moroctocog alfa.","After reconstitution, each ml of solution contains approximately 500 IU moroctocog alfa.",12,15
"849","es","en","Después de la reconstitución, una dosis (0,5 ml) contiene:","After reconstitution, one dose (0.5 ml) contains:",7,9
"850","es","en","Después de tres dosis N=330†","After three doses N=330†",4,5
"851","es","en","Después, introduzca de nuevo la pluma en la nevera.","Then re turn the pen to the refrigerator.",8,9
"852","es","en","Después, tras un intervalo mínimo de 14 días, debe determinarse nuevamente la concentración plasmática de A771726.","Thereafter, the A771726 plasma concentration must be determined again after an interval of at least 14 days.",17,16
"853","es","en","DETERMINACIÓN DE LOS LMR","STATEMENT OF THE MRLs",4,4
"854","es","en","Deutschland Bayer Vital GmbH Tel: +49-(0)214-30 513 48","Deutschland Bayer Vital GmbH Tel: +49-(0)214-30 513 48",8,8
"855","es","en","Deutschland ESTEVE GmbH Max-Planck-Strasse 11 D-85716 Unterschleissheim, Deutschland HRB München 99927 Tel: +49-89-321419-64","Deutschland ESTEVE GmbH Max-Planck-Strasse 11 D-85716 Unterschleissheim, Deutschland HRB München 99927 Tel: +49-89-321419-64",13,13
"856","es","en","Deutschland MSD SHARP & DOHME GmbH, Tel: +49 (0) 89 4561 2612 Infocenter@msd. de","Deutschland MSD SHARP & DOHME GmbH, Tel: +49 (0) 89 4561 2612 Infocenter@msd. de",14,14
"857","es","en","Deutschland Roche Pharma AG Tel: +49 (0) 7624 140","Deutschland Roche Pharma AG Tel: +49 (0) 7624 140",9,9
"858","es","en","Deutschland Servier Deutschland GmbH Tel: +49 (0)89 57095 01","Deutschland Servier Deutschland GmbH Tel: +49 (0)89 57095 01",9,9
"859","es","en","Deutschland Valeant Pharmaceuticals Germany GmbH Tel: +49 (0) 6196 99 88 90","Deutschland Valeant Pharmaceuticals Germany GmbH Tel: +49 (0) 6196 99 88 90",12,12
"860","es","en","Diacomit 250 mg polvo para suspensión oral Estiripentol","Diacomit 250 mg powder for oral suspension Stiripentol",8,8
"861","es","en","Diagnóstico La acidosis láctica se caracteriza por disnea acidótica, dolor abdominal e hipotermia seguidos por coma.","Lactic acidosis is characterised by acidotic dyspnoea, abdominal pain and hypothermia followed by coma.",14,16
"862","es","en","Diarrea Reflujo gastrointestinal Dolor abdominal Estreñimiento Trastornos de la piel y tejido subcutáneo","Diarrhoea Gastrointestinal reflux disease Abdominal pain Constipation Skin and subcutaneous tissue disorders",12,13
"863","es","en","Diarrea, sequedad de boca, flatulencia Dolor abdominal, estreñimiento, dispepsia, vómitos Gastritis","Diarrhoea, dry mouth, flatulence, Abdominal pain, constipation, dyspepsia, vomiting Gastritis",10,11
"864","es","en","Dicha fecha está impresa en las etiquetas y en la caja.","It is printed on the labels and on the carton.",10,11
"865","es","en","Dicural comprimidos recubiertos deberá administrarse una vez al día durante al menos 5 días.","Dicural Coated Tablets should be given once a day for at least 5 days.",14,14
"866","es","en","Diez pacientes obtuvieron una respuesta del tumor durante el retratamiento.","Ten patients achieved a tumour response due to re-treatment.",9,10
"867","es","en","Digoxina La administración concomitante de lansoprazol y digoxina puede aumentar la concentración plasmática de digoxina.","Digoxin Coadminitration of lansoprazole and digoxin may lead to increased digoxin plasma levels.",13,15
"868","es","en","Diltiazem/ Efavirenz (240 mg una vez al día / 600 mg una vez al día)","CARDIOVASCULAR AGENTS Calcium Channel Blockers Diltiazem/ Efavirenz (240 mg once daily/ 600 mg once daily)",15,15
"869","es","en","Dióxido de titanio (E 171) Polisorbato 80 Hipromelosa Macrogol 400 Cera carnauba.","Titanium dioxide (E 171) Polysorbate 80 Hypromellose Macrogol 400 Carnauba wax",11,12
"870","es","en","Disgeusia (G3/ 4: < 1%); Parestesia (G3/ 4: < 1%)","Dysgeusia (G3/ 4: < 1%); Paraesthesia (G3/ 4: < 1%)",10,10
"871","es","en","Disminución de la agudeza visual, visión borrosa, aumento del lagrimeo","Visual acuity reduced, Vision blurred, Lacrimation increased",7,10
"872","es","en","Disnea, epistaxis, tos Derrame pleural3, dolor faringolaringeo, faringitis Dolor pleural, fibrosis pulmonar, hipertensión pulmonar, hemorragia pulmonar","Dyspnoea, epistaxis, cough Pleural effusion3, pharyngolaryngeal pain, pharyngitis Pleuritic pain, pulmonary fibrosis, pulmonary hypertension, pulmonary haemorrhage",16,16
"873","es","en","disolvente para la reconstitución (solución de cloruro sódico al 0,234%)","chloride solution) is also supplied for reconstitution.",7,10
"874","es","en","Disolvente para Metalyse 10.000 U Disolvente para uso parenteral","Solvent for Metalyse 10,000 U Solvent for parenteral use",9,9
"875","es","en","Disolvente para Zypadhera IM","Solvent for ZYPADHERA IM",4,4
"876","es","en","Disolvente: solución transparente e incolora.","Solvent: clear and colourless solution.",5,5
"877","es","en","Disolver el granulado efervescente (bicarbonato sódico) en un vaso de agua fría (aprox.","Dissolve the effervescent granules (sodium hydrogen carbonate) in a glass of cool water (approx.",14,13
"878","es","en","Distorsiones visuales de colores","Common ≥ 1/100 to <",5,4
"879","es","en","Distribución El volumen de distribución del fenilbutirato es de 0,2 l/ kg.","Distribution The volume of distribution of phenylbutyrate is 0.2 l/ kg.",11,12
"880","es","en","Distribución El volumen de distribución del icatibant (Vss) es de unos 20-25 litros.","Distribution Icatibant volume of distribution (Vss) is about 20-25 L.",10,13
"881","es","en","Disuria, trastorno en la micción, alteración en la frecuencia de micción","Dysuria, micturition disorder, altered micturition frequency",6,11
"882","es","en","Diverticulitis Sangrado rectal leve (ver sección 4.4)","Diverticulitis Mild rectal bleeding (see section 4.4)",7,7
"883","es","en","DK-2880 Bagsvaerd Dinamarca au","Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd Denmark",9,4
"884","es","en","DK-2900 Hellerup Tlf: +45-35 25 35 50","DK-2900 Hellerup Tlf: +45-35 25 35 50",7,7
"885","es","en","DMO: diferencia media a los 3 años con respecto al valor basal de toda la cadera","BMD – mean change relative to baseline total hip at year 3",12,16
"886","es","en","DNA vaccines non-amplifiable in eukaryotic cells for veterinary use Adoptada en marzo de 2000","Note for guidance on quality of herbal medicinal products Released for consultation November 2000",14,14
"887","es","en","Docetaxel Winthrop es un medicamento anticancerígeno.","Docetaxel Winthrop is an anticancer medicine.",6,6
"888","es","en","Doctora en medicina por la Universidad de Grenoble, Francia.","Qualified medical doctor from the University of Grenoble, France.",9,9
"889","es","en","Dolor abdominal superior, ulceración en la boca, boca seca, disfagia, estomatitis aftosa","Upper abdominal pain, mouth ulceration, dry mouth, dysphagia, aphthous stomatitis",10,12
"890","es","en","Dolor abdominal y síntomas gastrointestinales, tales como náuseas, vómitos, diarrea, retortijones y distensión abdominal.","Abdominal pain and gastrointestinal symptoms such as nausea, vomiting, diarrhoea, abdominal cramps and bloating",14,14
"891","es","en","Dolor abdominal, diarrea, dispepsia, náuseas.","Abdominal pain, diarrhoea, dyspepsia, nausea.",5,5
"892","es","en","dolor de cabeza (cefaleas), dificultad para dormir (insomnio), intranquilidad (agitación), confusión.","difficulty in sleeping (insomnia), restlessness (agitation), confusion",7,11
"893","es","en","Dolor de cabeza Trastornos de la piel","Fatigue Nervous System disorders",4,7
"894","es","en","dolor de cabeza. agitación, somnolencia, vértigo.","headache. agitation, somnolence, dizziness.",4,6
"895","es","en","Dolor de garganta, dispepsia,","Skin and subcutaneous tissue disorders Very rare Sweating, rash",9,4
"896","es","en","Dolor de pecho, astenia, edema, dolor en el punto de inyección","Chest pain, asthenia, oedema, injection site pain",7,11
"897","es","en","Dolor faringolaríngeo Sequedad de garganta Alteración amigdalar Trastornos Sequedad de boca n","ra Disorders and Administration Site Conditions",6,12
"898","es","en","Dolor musculoesquelético Osteoporosis Hematuria, proteinuria","Musculoskeletal pain Osteoporosis Haematuria, proteinuria",5,5
"899","es","en","Dolor tumoral, Síndrome mielodisplásico/ Leucemia mieloide aguda*","Tumour pain, Myelodysplastic syndrome / Acute myeloid leukaemia *",9,7
"900","es","en","Domaniewska 50 C PL – 02 672 Warszawa Tel.: + 48-22 549 15 00","Domaniewska 50 C PL – 02 672 Warszawa Tel.: + 48-22 549 15 00",14,14
"901","es","en","Dompé Biotec S. p. A.","or Dompé Biotec S. p. A.",6,5
"902","es","en","Doripenem ejerce su actividad bactericida mediante la inhibición de la biosíntesis de la pared celular bacteriana.","Doripenem exerts its bactericidal activity by inhibiting bacterial cell wall biosynthesis.",11,16
"903","es","en","DOSIFICACIÓN PARA CADA ESPECIE","DOSAGE FOR EACH SPECIES",4,4
"904","es","en","DOSIFICACIÓN PARA CADA ESPECIE, VÍA Y FORMA DE ADMINISTRACIÓN","DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION",9,9
"905","es","en","dosis de acido ibandrónico","ibandronic ac id dos e",5,4
"906","es","en","Dosis de iloprost en la","Dose of iloprost at mouthpiece",5,5
"907","es","en","Dosis de mantenimiento La dosis diaria recomendada es de 20 mg una vez al día.","Maintenance dose The recommended daily dose is 20 mg once a day.",12,15
"908","es","en","Dosis inicial La dosis deberá ser determinada por el médico según las necesidades del paciente.","Initial dose The dosage should be determined by the physician, according to the patient’ s requirements.",16,15
"909","es","en","Dosis más altas no fueron más efectivas.","Higher dosages were not more effective.",6,7
"910","es","en","Dosis única diaria por la noche (mg de base)","Once Daily Evening Dose (mg of base)",7,9
"911","es","en","Dosis únicas de antiácido (hidróxido magnésico/ hidróxido de aluminio) no afectaron la biodisponibilidad de sildenafilo.","Single doses of antacid (magnesium hydroxide/ aluminium hydroxide) did not affect the bioavailability of sildenafil.",15,15
"912","es","en","Dotación inicial de equipos informáticos para el normal funcionamiento de la Agencia","Purchases of new hardware for the operation of the Agency",10,12
"913","es","en","Doxastad 4 mg comprimidos de liberación prolongada y denominaciones asociadas se pueden tomar con o sin alimentos.","Doxastad 4 mg prolonged release tablets and associated names can be taken with or without food.",16,17
"914","es","en","Doxazosin-ratiopharm retard 4 mg","Doxazosin-ratiopharm 4 mg retard 4 mg",6,4
"915","es","en","Drammensveien 288 NO-0283 Oslo Tlf: + 47 24 12 65 00 38","Drammensveien 288 NO-0283 Oslo Tlf: + 47 24 12 65 00",11,12
"916","es","en","Dráž ní 7, 627 00 Brno","Dráž ní 7, 627 00 Brno Czech Republic",8,6
"917","es","en","Duloxetina se une tanto a la albúmina como a la alfa-1 glicoproteína ácida.","Duloxetine binds to both albumin and alpha-l acid glycoprotein.",9,13
"918","es","en","Duración del tratamiento – Pacientes no tratados previamente Previsibilidad de respuesta virológica sostenida:","Duration of treatment – Naïve patients Predictability of sustained virological response:",11,13
"919","es","en","Duración total del tratamiento","Total duration of treatment (potentially including initial parenteral treatment with ciprofloxacin)",11,4
"920","es","en","Durante el periodo de randomización del estudio EUROPA, sólo se recogieron reacciones adversas graves.","During the randomised period of the EUROPA study, only serious adverse events were collected.",14,14
"921","es","en","Durante el tratamiento a largo plazo no aumentó la frecuencia de reacciones adversas de hipersensibilidad.","Over long term treatment, the frequency of hypersensitivity-related adverse events did not increase.",13,15
"922","es","en","Durante el tratamiento con EXJADE pueden aparecer erupciones cutáneas.","Skin rashes may appear during EXJADE treatment.",7,9
"923","es","en","Durante el uso: no refrigerar. No conservar a temperatura superior a 30°C.","During use: do not refrigerate.",5,12
"924","es","en","Durante la administración de ProMeris el usuario no debe fumar, comer ni beber.","When administering ProMeris, the user should not smoke, eat or drink.",11,13
"925","es","en","Durante la experiencia post-comercialización se han notificado casos de pancreatitis en pacientes pediátricos.","There have been post-marketing reports of pancreatitis in paediatric patients.",10,13
"926","es","en","Durante su uso concomitante, puede ser necesario aumentar la dosis de Calcichew-D3 (y nombres asociados).","During concomitant use, it may be necessary to increase the dose of Calcichew-D3 (and associated names).",16,15
"927","es","en","Durapirox 20mg Tabs 9627.01.01","Durapirox 20mg Tabs 9627.01.01",4,4
"928","es","en","Dynastat 40 mg polvo y diolvente para solución inyectable","Dynastat 40 mg Powder and solvent for solution for injection",10,9
"929","es","en","Dynastat debe ser reconstituido antes de ser utilizado.","Dynastat must be reconstituted before use.",6,8
"930","es","en","Dynepo 4.000 UI/ 0,4 ml Inyectable","Dynepo 4,000 IU/ 0.4ml Injection Epoetin delta",7,6
"931","es","en","e EU/ 1/ 01/ 184/ 071","ris EU/ 1/ 01/ 184/ 071",6,6
"932","es","en","E_Mail: mail@emea. eudra. org","E_Mail: mail@emea. eudra. org",4,4
"933","es","en","Ebixa 5 mg comprimidos recubiertos con película.","Ebixa 5 mg film-coated tablets.",5,7
"934","es","en","ECALTA debe administrase una vez al día, mediante perfusión intravenosa (en goteo).","ECALTA should be given to you once a day, by slow infusion (a drip) into your vein.",17,12
"935","es","en","ECO Animal Health Ltd.","ECO Animal Health Ltd.",4,4
"936","es","en","Econor 50% Hipromelosa Talco Sílice coloidal anhidra Miristato de isopropilo Lactosa","Econor 50% Hypromellose Talc",4,11
"937","es","en","ed e nd sp","ed e nd sp",4,4
"938","es","en","Edema en el lugar de aplicación","Rigors Application site dermatitis",4,6
"939","es","en","Edema, edema depresible, edema facial, edema periférico, fatiga, rubefacción, astenia, sofoco","Oedema, pitting oedema, facial oedema, oedema peripheral, fatigue, flushing, 30",10,11
"940","es","en","Edifício Cinema Rua José Fontana, n. °1, 1°Andar P-2770− 101 Paço de Arcos Tel: + 351 21 4401320","Edifício Cinema Rua José Fontana, n. °1, 1°Andar P-2770− 101 Paço de Arcos Tel: + 351 21 4401320",18,18
"941","es","en","EDSS basal, mediana (intervalo)","median (range) EDSS-baseline, median (range)",5,4
"942","es","en","Eesti Boehringer Ingelheim Pharma GmbH Eesti Filiaal Tel: +372 60 80 940","Eesti Boehringer Ingelheim Pharma GmbH Eesti Filiaal Tel: +372 60 80 940",12,12
"943","es","en","Eesti BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.","Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.",6,5
"944","es","en","Eesti filiaal Tel: + 372 617 7410","Eesti filiaal Tel: + 372 617 7410",7,7
"945","es","en","Eesti JANSSEN-CILAG Polska Sp. z o. o.","Eesti JANSSEN-CILAG Polska Sp. z o. o.",7,7
"946","es","en","Eesti Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck. com","Eesti Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck. com",12,12
"947","es","en","Eesti Nycomed SEFA AS Tel: +372 6112 569","Eesti Österreich Nycomed SEFA AS Tel: +372 6112 569",9,8
"948","es","en","Eesti Österreich Takeda Global Research and Development Centre (Europe) Ltd., Ühendkuningriik Tel: +44 (0)20 3116 8000","Eesti Takeda Global Research and Development Centre (Europe) Ltd., Ühendkuningriik Tel: +44 (0)20 3116 8000",15,16
"949","es","en","Eesti Pfizer Animal Health Tel: +370 5 269 17 96","Eesti Pfizer Animal Health Tel: +370 5 269 17 96",10,10
"950","es","en","Eesti Sandoz d. d.","Eesti Sandoz d. d.",4,4
"951","es","en","Efavirenz 600 mg 750 mg TID QD","Efavirenz 600 mg 750 mg TID QD",7,7
"952","es","en","efecto adverso no mencionado en este prospecto, informe a su médico o farmacéutico.","tell your doctor or pharmacist.",5,13
"953","es","en","Efecto de etoricoxib sobre fármacos metabolizados por sulfotransferasas","Effect of etoricoxib on drugs metabolised by sulfotransferases",8,8
"954","es","en","Efecto de los alimentos en la absorción oral:","Common (Grade 3 or 4)",5,8
"955","es","en","Efectos adversos antes o después de recibir un trasplante hepático","Side effects before or after having a liver transplant",9,10
"956","es","en","Efectos adversos muy frecuentes (observados en más de 1 de cada 10 personas tratadas con Nplate): • cefalea.","Very common side effects (seen in more than 1 in 10 people taking Nplate): • headache.",16,18
"957","es","en","Efectos adversos poco frecuentes (es probable que los sufran entre 1 y 10 de cada 1.000 personas los):","Uncommon side effects (between 1 and 10 in every 1,000 people are likely to get these):",16,18
"958","es","en","Efectos adversos que pueden ocurrir en entre 1 y 10 de cada 1000 pacientes; • Raros:","Side effects that may occur in 1 to 10 out of 1,000 patients; • Rare:",15,16
"959","es","en","Efectos adversos raros (al menos 1 de cada 1.000 pacientes):","Rare side effects (likely to affect between 1 in 1,000 and 1 in 10,000 patients):",15,10
"960","es","en","Efectos de otros medicamentos sobre posaconazol:","Effects of other medicinal products on posaconazole:",7,6
"961","es","en","Efectos farmacodinámicos Efectos clínicos:","Pharmacodynamic effects Clinical effects:",4,4
"962","es","en","Efectos hepáticos No se ha estudiado el cambio de ácido nicotínico de liberación inmediata (cristalino) a Tredaptive.","Hepatic effects Switching from immediate-release (crystalline) nicotinic acid to Tredaptive has not been studied.",14,17
"963","es","en","Efectos que se dan cuando se interrumpe el tratamiento con NutropinAq","If you stop using NutropinAq",5,11
"964","es","en","Efectos sobre la capacidad para conducir y utilizar máquinas","Effects on ability to drive and use machines",8,9
"965","es","en","efectos terapéuticos o adversos de estos medicamentos se pueden ver aumentados.","or unwanted side effects of these medicines might be increased.",10,11
"966","es","en","Efexor Depot y nombres asociados (ver anexo 1) 150 mg cápsulas de liberación prolongada, duras.","Efexor depot and associated names (see Annex I) 150 mg prolonged-release capsules, hard",13,15
"967","es","en","Effentora 400 microgramos comprimidos bucales","Effentora 400 micrograms buccal tablets",5,5
"968","es","en","Efficib 50 mg/ 850 mg comprimidos sitagliptina/ metformina clorhidrato","Efficib 50 mg/ 850 mg tablets sitagliptin/ metformin HCl",9,9
"969","es","en","Eficacia en individuos con y sin infección o enfermedad previa debida a VPH 6, 11, 16 ó 18","Efficacy in subjects with and without prior infection or disease due to HPV 6, 11, 16, or 18",18,18
"970","es","en","EID Población por protocolo (PP)","RIE PP (per protocol) Population",5,5
"971","es","en","Einsteinweg 101 2333 CB Leiden Países Bajos","Einsteinweg 101 2333 CB Leiden The Netherlands",7,7
"972","es","en","Ej. usando un preservativo) o contaminación con sangre.","Your doctor can explain these symptoms to you.",8,8
"973","es","en","El 16 de noviembre de 2006 se emitió un dictamen positivo por consenso.","A positive opinion was adopted by consensus on 16 November 2006.",11,13
"974","es","en","El 95,5% de la dosis administrada de capecitabina se recoge en orina.","Faecal excretion is minimal (2.6%).",5,12
"975","es","en","El aclaramiento de la GL-3 también se consiguió en otros tipos de células renales.","Clearance of GL-3 was also achieved in several other cell types from the kidney.",14,14
"976","es","en","El aclaramiento en plasma total del fentanilo después de la administración intravenosa es aproximadamente de 42 l/ h.","The total plasma clearance of fentanyl following intravenous administration is approximately 42 L/ h.",14,18
"977","es","en","El aclaramiento renal representa el 30% del aclaramiento total de ViraferonPeg.","Renal clearance appears to account for 30% of total clearance of ViraferonPeg.",12,11
"978","es","en","El ajuste de la dosis en pacientes de edad avanzada debe realizarse con prudencia (ver sección 4.4).","Dose titration in elderly patients should be exercised with caution (see section 4.4).",13,17
"979","es","en","El alendronato pertenece a un grupo de medicamentos no hormonales denominados bisfosfonatos.","Alendronate belongs to a group of non-hormonal medicines called bisphosphonates.",10,12
"980","es","en","El aspartamo es una fuente de fenilalanina, que puede ser perjudicial para las personas con fenilcetonuria.","Aspartame is a source of phenylalanine, which may be harmful for people with phenylketonuria.",14,16
"981","es","en","El aumento de los niveles de fexofenadina puede disminuir con el tiempo por el desarrollo de la inducción.","Increased fexofenadine levels may lessen over time as induction develops.",10,18
"982","es","en","El aumento progresivo de la creatina cinasa es poco frecuente.","Progressive elevation of the creatine kinase is uncommon.",8,10
"983","es","en","El blister interior estéril debe abrirse en un entorno esterilizado.","The inner sterile blister must be opened in a sterile operating room area.",13,10
"984","es","en","El botón de inyección no se puede presionar","The injection button cannot be pressed in.",7,8
"985","es","en","El cambio del color del iris se produce lentamente y puede no ser apreciable durante meses o años.","The change in iris colour occurs slowly and may not be noticeable for months to years.",16,18
"986","es","en","El cartucho Penfill que no se esté utilizando debe conservarse en nevera (entre 2°C y 8°C).","The Penfill that is not being used is to be stored in a refrigerator (2°C - 8°C).",17,16
"987","es","en","El cartucho se encuentra sellado en una pluma precargada desechable.","The cartridge is sealed in a disposable pre-filled pen.",9,10
"988","es","en","El CHMP concluyó que el riesgo absoluto se consideraba muy bajo.","The CHMP concluded, that the absolute risk was considered to be very small.",13,11
"989","es","en","El ciprofloxacino inhibe la DNA-girasa, lo cual causa la inhibición de la síntesis de ADN.","Ciprofloxacin inhibits DNA-gyrase, resulting in inhibition of DNA synthesis.",9,15
"990","es","en","El color de la pluma en la ilustración difiere del de su FlexPen.","The colour of the pen in the illustrations differs from your FlexPen.",12,13
"991","es","en","El comienzo de la protección se produce a las 2 semanas. ic","The onset of protection is 2 weeks.",7,12
"992","es","en","El Comité recomendó que se autorizara su comercialización.","The Committee recommended that TORISEL be given marketing authorisation.",9,8
"993","es","en","El COMP se reunió 11 veces en 2002.","The COMP met 11 times in 2002.",7,8
"994","es","en","El comprimido se puede dividir en mitades iguales.","The tablet can be divided into equal halves.",8,8
"995","es","en","El concentrado reconstituido y la solución diluida para perfusión deben utilizarse inmediatamente.","The reconstituted concentrate and the diluted infusion solution should be used immediately.",12,12
"996","es","en","El conocimiento sobre el mecanismo es incompleto.","Knowledge about the mechanism is incomplete.",6,7
"997","es","en","El contenido debe removerse suavemente durante la disolución.","The contents should be swirled gently during dissolution.",8,8
"998","es","en","El criterio principal de eficacia fue la producción de anticuerpos frente al virus de la PPC.","The main measure of effectiveness was the production of antibodies to the CSF virus.",14,16
"999","es","en","El CVMP aprobó una lista de preguntas que envío al solicitante el 12 de diciembre de 2007.","A List of Questions was adopted by CVMP and sent to the applicant on 12 December 2007.",17,17
"1000","es","en","El CVMP observó que Equibactin vet.","CVMP noted that Equibactin vet.",5,6
"1001","es","en","El CYP2C19 es el principal responsable de la formación del metabolito O-desmetilado.","CYP2C19 is mainly responsible for the formation of the O-desmethyl metabolite.",11,12
"1002","es","en","El desarrollo de neurotoxicidad periférica grave requiere una reducción de la dosis (ver secciones 4.2 y 4.4).","The development of severe peripheral neurotoxicity requires a reduction of dose (see sections 4.2 and 4.4).",16,17
"1003","es","en","El deterioro de la función renal o hepática no afecta a la respuesta glucodinámica a la insulina lispro.","The glucodynamic response to insulin lispro is not affected by renal or hepatic function impairment.",15,18
"1004","es","en","El dexrazoxano ha mostrado poseer actividad mutagénica.","Dexrazoxane has been shown to possess mutagenic activity.",8,7
"1005","es","en","El difumarato de emedastina no resultó ser carcinogénico en estudios en ratas y ratones.","Emedastine difumarate was not found to be carcinogenic in studies in mice and rats.",14,14
"1006","es","en","El disolvente es un líquido turbio con un depósito blanco y un sobrenadante incoloro.","The solvent is a turbid liquid with a slow settling white deposit and a colourless supernatant.",16,14
"1007","es","en","El disolvente se presenta en viales de vidrio neutro hidrolítico tipo I.","The solvent comes in vials of neutral glass of hydrolytic type I.",12,12
"1008","es","en","El docetaxel alcanza altas concentraciones intracelulares con un prolongado tiempo de permanencia celular.","Docetaxel achieves high intracellular concentrations with a long cell residence time.",11,13
"1009","es","en","El efecto adelgazante fue relativamente moderado (del orden del 6-7% del peso antes del tratamiento).","The weight lowering effect was relatively moderate (in the range of 6-7% of the weight before treatment).",17,15
"1010","es","en","El efecto de Enbrel sobre la farmacocinética humana del metotrexato, no ha sido investigado.","The effect of Enbrel on the human pharmacokinetics of methotrexate has not been investigated.",14,14
"1011","es","en","El efecto de la insulina será más rápido si se realiza la inyección en el abdomen.","quickly if you inject it around the waist.",8,16
"1012","es","en","El efecto depletor de potasio de hidroclorotiazida está atenuado por el efecto ahorrador de potasio de aliskiren.","The potassium-depleting effect of hydrochlorothiazide is attenuated by the potassium-sparing effect of aliskiren.",13,17
"1013","es","en","El efecto en algunos pacientes fue evidente en la primera semana de tratamiento.","The effect in some patients was apparent in the first week of treatment.",13,13
"1014","es","en","El efecto fue de pequeño a moderado.","The effect was modest to moderate.",6,7
"1015","es","en","El efecto máximo se presenta entre 1 y 3 horas después de la inyección.","The maximum effect is exerted between 1 and 3 hours after the injection.",13,14
"1016","es","en","El empleo concomitante de agentes inmunosupresores pareció reducir la frecuencia de reacciones relacionadas con la perfusión.","Use of concomitant immunosuppressant agents appeared to reduce the frequency of infusion-related reactions.",13,16
"1017","es","en","El empleo de betabloqueantes puede potenciar la reacción hipertensiva por retirada súbita de clonidina.","The hypertensive reaction to sudden withdrawal of clonidine can be potentiated when taking beta-blockers.",14,14
"1018","es","en","El enalaprilato alcanza concentraciones máximas en el suero 4 horas después de una dosis oral de enalapril.","Peak serum concentrations of enalaprilat occur about 4 hours after an oral dose of enalapril tablet.",16,17
"1019","es","en","El episodio puede ser limitado, pero se debe interrumpir la administración de ziconotida hasta que se resuelva.","The event may be self limited, but ziconotide should be discontinued until the event resolves.",15,17
"1020","es","en","El esquema de tratamiento también se indica en el envase de tratamiento de inicio.","The treatment scheme is also indicated on the treatment initiation pack.",11,14
"1021","es","en","El estado estable se consigue después de cuatro a siete días de dosificación.","Steady state is achieved after 4– 7 days of dosing.",10,13
"1022","es","en","El estudio de carcinogenicidad en rata, no detectó ningún efecto que pueda ser relevante en humanos.","The carcinogenicity study in the rat did not reveal any effect which may be relevant for humans.",17,16
"1023","es","en","El estudio se realizó en 705 pacientes anémicos con tumores no mieloides que recibían múltiples ciclos de quimioterapia.","This study was conducted in 705 anaemic patients with",9,18
"1024","es","en","El factor IX es un constitutivo normal de la sangre humana.","Factor IX is a normal constituent of human blood.",9,11
"1025","es","en","El fentanilo, principio activo de IONSYS, puede crear dependencia.","Fentanyl, the active substance in IONSYS, can be abused.",9,9
"1026","es","en","El firocoxib se metaboliza predominantemente por desalquilación y glucuronización en el hígado.","Firocoxib is metabolised predominantly by dealkylation and glucuronidation in the liver.",11,12
"1027","es","en","El gadolinio se utiliza como medio de contraste para obtener mejores imágenes en las resonancias.","Gadolinium is used as a ‘ contrast enhancer’ to help obtain better images with MRI scans.",16,15
"1028","es","en","El grado de biodisponibilidad es similar cuando la cetirizina se administra como solución, cápsula o comprimido.","The extent of bioavailability is similar when cetirizine is given as solutions, capsules or tablets.",15,16
"1029","es","en","El grado de unión proteica en el plasma humano es de aproximadamente el 78%.","Protein binding in human plasma is approximately 78%.",8,14
"1030","es","en","El Grupo de trabajo concluyó también las directrices sobre excipientes utilizados en medicamentos veterinarios.","The Working Party also finalised the guideline on excipients used in veterinary medicinal products.",14,14
"1031","es","en","El ibuprofeno es un inhibidor no selectivo de la ciclooxigenasa, produciendo una reducción de la síntesis de prostaglandinas.","Ibuprofen is a non selective inhibitor of cyclo- oxygenase, leading to reduced synthesis of prostaglandins.",15,18
"1032","es","en","El inicio de tratamiento con epoprostenol puede haber influido en las estimaciones de 43/235 pacientes.","The estimates may have been influenced by the initiation of epoprostenol treatment in 43/235 patients.",15,15
"1033","es","en","El inicio del tratamiento está contraindicado durante el embarazo (ver sección 4.3).","Initiation of treatment is contraindicated during pregnancy (see section 4.3).",10,12
"1034","es","en","El intento de autolesión también se ha comunicado en adultos, niños y adolescentes.","The attempt to harm yourself has also been reported in adults, children, and adolescents.",14,13
"1035","es","en","El laboratorio que fabrica Eucreas ha aceptado que sus datos científicos puedan utilizarse para Icandra.","The company that makes Eucreas has agreed that its scientific data can be used for Icandra.",16,15
"1036","es","en","El líquido en el vaso tendrá un aspecto turbio. • Beber todo el contenido del vaso.","The liquid in the glass will look cloudy. • Drink everything in the glass.",14,16
"1037","es","en","El mecanismo de acción de la ranolazina es prácticamente desconocido.","The mechanism of action of ranolazine is largely unknown.",9,10
"1038","es","en","El medicamento de referencia de Ratiograstim es Neupogen.","The reference medicine for Ratiograstim is Neupogen.",7,8
"1039","es","en","El medicamento debe administrarse con precaución a los pacientes que se estén sometiendo a algún tratamiento odontológico.","Care is needed in patients who receive the medicine and are having dental treatment.",14,17
"1040","es","en","El medicamento no debe administrarse a mujeres en periodo de lactancia (ver sección 4.3).","The medicinal product must not be administered to breast feeding mothers (see section 4.3).",14,14
"1041","es","en","El medicamento se presenta en forma de comprimidos de liberación modificada.","The medicine comes as a modified-release tablet.",7,11
"1042","es","en","El medicamento se produce con calostro recogido de vacas mantenidas en condiciones de campo.","The product is produced from colostrum collected from cows kept under field conditions.",13,14
"1043","es","en","El medicamento sólo debe dispensarse con receta médica.","The medicine can only be obtained with a prescription.",9,8
"1044","es","en","El médico deberá observar las directrices nacionales para la vacunación contra la gripe.","Prescribers should refer to national guidelines for influenza vaccination.",9,13
"1045","es","en","El médico le aconsejará si debe tomar suplementos de calcio o vitamina D, además de PROTELOS.","Your doctor may advise you to take calcium and vitamin D supplements in addition to PROTELOS.",16,16
"1046","es","en","El médico le ha prescrito Fuzeon para controlar mejor la infección por el VIH.","Your doctor has prescribed Fuzeon to help control your HIV infection.",11,14
"1047","es","en","El metabolismo de atorvastatina es menos dependiente del CYP3A.","Atorvastatin is less dependent on CYP3A for metabolism.",8,9
"1048","es","en","El metabolismo de paroxetina no compromete su acción selectiva sobre la recaptación neuronal de la 5-HT.","Metabolism does not compromise paroxetine's selective action on neuronal 5-HT uptake.",11,16
"1049","es","en","El metabolito activo 3-AT presenta una concentración media de 57,9 ng/g y de 441 ng/g, respectivamente.","The active metabolite 3-AT has a mean concentration of 57.9 ng/g and 441 ng/g, respectively.",15,16
"1050","es","en","El MPA y el MPAG no se eliminan por hemodiálisis a las concentraciones encontradas a nivel clínico.","At clinically encountered concentrations, MPA and MPAG are not removed by haemodialysis.",12,17
"1051","es","en","El niño debe estar sentado en posición reclinada.","The child should be seated in a reclining position.",9,8
"1052","es","en","El nivel de dosis más alto evaluado ha sido dosis intravenosas múltiples de 10 mg/ kg.","The highest dose level evaluated has been multiple intravenous doses of 10 mg/ kg. na",15,16
"1053","es","en","El nivel de fibrinógeno se normaliza en un plazo de 2 días.","The fibrinogen level normalises within 2 days.",7,12
"1054","es","en","El número de cápsulas de ribavirina que tiene que tomar depende de su peso.","The number of ribavirin capsules you take depends on your weight.",11,14
"1055","es","en","El objetivo primario en la semana 24 fue la proporción de pacientes que alcanzaron respuesta ACR20.","The primary endpoint at week 24 was the proportion of patients who achieved an ACR 20 response.",17,16
"1056","es","en","El otro vial contiene el excipiente carmelosa.","The other vial contains the excipient carmellose.",7,7
"1057","es","en","El paciente bebe el líquido de examen","Note time patient drinks test meal",6,7
"1058","es","en","El paciente debe beber inmediatamente esta solución del test.","The patient should drink this test solution immediately.",8,9
"1059","es","en","El paciente debe ser estrechamente vigilado y el tratamiento debe ser sintomático y de soporte.","The patient should be closely monitored, and the treatment should be symptomatic and supportive.",14,15
"1060","es","en","El paciente presentó diarrea, irritabilidad y acidosis metabólica con hipopotasemia.","The patient developed diarrhoea, irritability and metabolic acidosis with hypokalaemia.",10,10
"1061","es","en","El papel de desecho y las torundas utilizadas se pueden tirar a la basura general.","Waste paper and used wipes can be put in an ordinary rubbish bin.",13,15
"1062","es","en","El perfil de seguridad sistémica de INTANZA es similar en comparación con la vacuna de administración intramuscular.","Systemic safety profile of INTANZA is similar to the comparator vaccine administered intramuscularly.",13,17
"1063","es","en","El perfil farmacocinético del icatibant en pacientes con AEH es parecido al observado en los voluntarios sanos.","The pharmacokinetic profile of icatibant in patients with HAE is similar to that in healthy volunteers.",16,17
"1064","es","en","El perindopril está contraindicado durante el segundo y tercer trimestres del embarazo.","Perindopril is contraindicated during the second and third trimesters of pregnancy.",11,12
"1065","es","en","El peso no tuvo ninguna influencia en el aclaramiento de agalsidasa en esta población.","Agalsidase clearance was not influenced by weight in this population.",10,14
"1066","es","en","El peso vivo y la dosis deben determinarse con exactitud para evitar sobredosificaciones.","Bodyweight and dosage rate must be accurately determined to avoid overdosing.",11,13
"1067","es","en","El pH de la solución reconstituida es 4,0 – 6,0.","The pH of the reconstituted solution is 4.0 – 6.0",10,10
"1068","es","en","El pimecrolimus es un inhibidor de la calcineurina autorizado como formulación en crema con una concentración del 1%.","Pimecrolimus is a calcineurin inhibitor approved as cream formulation at a 1% concentration.",13,18
"1069","es","en","El polvo debe disolverse en agua estéril antes de inyectarse en una vena.","The powder needs to be dissolved in sterile water before being injected into a vein.",15,13
"1070","es","en","El polvo es una masa compacta de color blanco a blanquecino.","The powder is a white to off-white cake.",8,11
"1071","es","en","El ponente fue el Dr.","The Rapporteur was Dr.",4,5
"1072","es","en","El pramipexol muestra una cinética lineal y una variabilidad inter-individual limitada de los niveles en plasma.","Pramipexole shows linear kinetics and a small inter-patient variation of plasma levels.",12,16
"1073","es","en","El primer parche se aplica el día 1 y se cambia el día 8.","The first patch is applied on day 1, and then changed on day 8.",14,14
"1074","es","en","El principal objetivo de esta intervención es mantener la perfusión renal.","The key aim of intervention is to maintain renal perfusion.",10,11
"1075","es","en","El principal producto de degradación de pravastatina es el metabolito 3-α-hidroxi isomérico.","The major degradation product of pravastatin is the 3-α- hydroxy isomeric metabolite.",12,12
"1076","es","en","El principio activo de Bondronat, el ácido ibandrónico, es un bisfosfonato.","The active substance in Bondronat, ibandronic acid, is a bisphosphonate.",10,11
"1077","es","en","El principio activo de Exelon, la rivastigmina, es un medicamento contra la demencia.","The active substance in Exelon, rivastigmine, is an antidementia medicine.",10,13
"1078","es","en","El principio activo de Jalra, la vildagliptina, es un inhibidor de la dipeptidil peptidasa 4 (DPP-4).","The active substance in Jalra, vildagliptin, is a dipeptidyl peptidase 4 (DPP-4) inhibitor.",13,16
"1079","es","en","El principio activo de Mixtard es la insulina humana (ADNr).","Mixtard contains the active substance insulin human (rDNA).",8,10
"1080","es","en","El principio activo de Pidolma comprimidos, derivado de dihidropiridina amlodipino, es un derivado quinozolítico compuesto de racemato.","The active substance in Pidolma tablets, the dihydropyridine derivative amlodipine, is a chiral substance, composed of a racemate.",18,17
"1081","es","en","El principio activo de TESAVEL, sitagliptina, es un inhibidor de la dipeptidil peptidasa4 (DPP-4).","The active substance in TESAVEL, sitagliptin, is a dipeptidyl peptidase 4 (DPP-4) inhibitor.",13,14
"1082","es","en","El principio activo es febuxostat.","The active substance is febuxostat.",5,5
"1083","es","en","El principio activo es un conjugado covalente de interferón alfa-2b* recombinante con monometoxipolietilenglicol.","The active substance is a covalent conjugate of recombinant interferon alfa-2b* with monomethoxy polyethylene glycol.",15,13
"1084","es","en","El principio activo es: interferón beta-1a 30 microgramos/0,5 ml.","Interferon-beta 1a 30 micrograms/0.5 ml The other ingredients are:",9,9
"1085","es","en","El principio activo, pregabalina, es un análogo del ácido gamma-aminobutírico (ácido (S)-3- (aminometil)-5-metilhexanoico).","The active substance, pregabalin, is a gamma-aminobutyric acid analogue ((S)-3-(aminomethyl)-5- methylhexanoic acid).",12,13
"1086","es","en","El procedimiento de la prueba Pylobactell en el aliento incluye la administración de una ración de prueba adecuada.","The Pylobactell breath test procedure includes the administering of a suitable test meal.",13,18
"1087","es","en","El producto debe inspeccionarse visualmente antes de su administración para verificar la ausencia de partículas y decoloración.","The product should be inspected visually for particulate matter and discolouration prior to administration.",14,17
"1088","es","en","El producto diluido no debe usarse si se observan partículas extrañas o cambios de color.","Do not use if it is discoloured or if foreign particles are seen.",13,15
"1089","es","en","El producto presentado permite tratar un perro que padezca otitis en ambos oídos.","The product as presented allows treating a dog suffering from bilateral otitis.",12,13
"1090","es","en","El producto reconstituido debe utilizarse inmediatamente o en un plazo de 3 horas.","Use the reconstituted solution immediately or within 3 hours.",9,13
"1091","es","en","El protector de seguridad para la aguja cubrirá ésta una vez que se suelte el émbolo.","The needle safety guard will cover the needle when releasing the plunger.",12,16
"1092","es","en","El resumen del dictamen del Comité de Medicamentos Huérfanos sobre Evoltra puede consultarse aquí.","The summary of opinion of the Committee for Orphan Medicinal Products for Evoltra is available here.",16,14
"1093","es","en","El riesgo de problemas de ritmo cardiaco puede verse aumentado con la utilización de FIRMAGON. − Diabetes mellitus.","The risk of heart rhythm problems may be increased when using FIRMAGON. − Diabetes mellitus.",15,18
"1094","es","en","El riesgo parece ser mayor durante los primeros 5 meses del tratamiento.","The risk appears to be greatest during the first 5 months of therapy.",13,12
"1095","es","en","El ritonavir es otro inhibidor de la proteasa que se utiliza como “ potenciador”.","Ritonavir is another protease inhibitor that is used as a ‘ booster’.",12,14
"1096","es","en","El Sector desempeña también un papel activo en la vigilancia de los productos autorizados en la Comunidad.","The Sector also plays an active role in monitoring products authorised within the Community.",14,17
"1097","es","en","El sexo no tiene un efecto clínicamente significativo sobre la farmacocinética de laropiprant.","Gender had no clinically meaningful effect on the pharmacokinetics of laropiprant.",11,13
"1098","es","en","El significado de los términos utilizados para describir la frecuencia de los efectos adversos es el siguiente:","The meaning of the terms used to describe the frequency of side effects is as follows:",16,17
"1099","es","en","El signo más común de sobredosis es la dificultad en la respiración.","The most common sign of overdose is reduced ability to breathe.",11,12
"1100","es","en","El síntoma aislado de una reacción de hipersensibilidad más frecuente fue una erupción cutánea.","The most common isolated symptom of a hypersensitivity reaction was a skin rash.",13,14
"1101","es","en","El sistema de ventilación del gallinero no debe estar en funcionamiento durante la pulverización","The ventilation system of the poultry house should be inoperative during the spray administration.",14,14
"1102","es","en","El solicitante presentó asimismo datos extraídos de la literatura científica.","The applicant also presented data from the scientific literature.",9,10
"1103","es","en","El TAC implantará un Programa de Prevención de Embarazo (PPE) en cada Estado Miembro.","The MAH shall implement a pregnancy prevention programme (PPP) in each Member State.",13,14
"1104","es","en","El tenofovir es un inhibidor de la transcriptasa inversa análogo de nucleótidos.","Tenofovir is a nucleotide reverse transcriptase inhibitor.",7,12
"1105","es","en","El texto completo del EPAR de ACOMPLIA puede encontrarse aquí.","The full EPAR for ACOMPLIA can be found here.",9,10
"1106","es","en","El texto completo del EPAR de Avandia puede encontrarse aquí.","The full EPAR for Avandia can be found here.",9,10
"1107","es","en","El texto completo del EPAR de Ebixa puede encontrarse aquí.","The full EPAR for Ebixa can be found here.",9,10
"1108","es","en","El texto completo del EPAR de Firazyr puede encontrarse aquí.","The full EPAR for Firazyr can be found here.",9,10
"1109","es","en","El texto completo del EPAR de Infanrix Hexa puede encontrarse aquí.","The full EPAR for Infanrix Hexa can be found here.",10,11
"1110","es","en","El texto completo del EPAR de Keppra puede encontrarse aquí.","The full EPAR for Keppra is available here.",8,10
"1111","es","en","El texto completo del EPAR de Mixtard puede encontrarse aquí.","The full EPAR for Mixtard can be found here.",9,10
"1112","es","en","El texto completo del EPAR de OPATANOL puede encontrarse aquí.","The full EPAR for OPATANOL is available here.",8,10
"1113","es","en","El texto completo del EPAR de Prezista puede encontrarse aquí.","The full EPAR for Prezista can be found here.",9,10
"1114","es","en","El texto completo del EPAR de Remicade puede encontrarse aquí.","The full EPAR for Remicade can be found here.",9,10
"1115","es","en","El texto completo del EPAR de Tredaptive puede encontrarse aquí.","The full EPAR for Tredaptive can be found here.",9,10
"1116","es","en","El texto completo del EPAR de Volibris puede encontrarse aquí.","The full EPAR for Volibris can be found here.",9,10
"1117","es","en","El texto era correcto en ese momento.","The text was valid at that time.",7,7
"1118","es","en","El tiempo de perfusión recomendado para la dosis inicial es de 120 minutos.","For the initial dose, the recommended infusion period is 120 minutes.",11,13
"1119","es","en","El tiempo hasta alcanzar la concentración máxima es de aproximadamente 0,5 horas.","The time to maximum concentration is approximately 0.5 hours.",9,12
"1120","es","en","El titular de la autorización de comercialización es Celgene Europe Ltd.","The marketing authorisation holder is Celgene Europe Ltd.",8,11
"1121","es","en","El titular de la Autorización de Comercialización es Eli Lilly Nederland B.V., Grootslag 1-5, 3991 RA Houten, Holanda.","Eli Lilly Nederland B.V., Grootslag 1-5, 3991 RA Houten, The Netherlands.",11,18
"1122","es","en","El titular de la Autorización de Comercialización es Pacira Limited.","The marketing authorisation holder is Pacira Limited",7,10
"1123","es","en","El titular de la autorización de comercialización presentó explicaciones por escrito el 15 de enero de 2007.","The Marketing Authorisation Holder provided written explanations on 15 January 2007.",11,17
"1124","es","en","El tratamiento con Adenuric no debe suspenderse si se produce una crisis de gota.","Adenuric treatment should not be stopped if an attack happens.",10,14
"1125","es","en","El tratamiento con Advate debe iniciarlo un médico con experiencia en el tratamiento de la hemofilia.","Advate should be started by a doctor who has experience in the treatment of haemophilia.",15,16
"1126","es","en","El tratamiento con Extavia no debe iniciarse durante el embarazo.","Extavia treatment should not be started during pregnancy.",8,10
"1127","es","en","El tratamiento con Filgrastim HEXAL se prolongará durante 4 - 5 días consecutivos.","Filgrastim HEXAL treatment will last for 4 - 5 consecutive days.",11,13
"1128","es","en","El tratamiento con Glivec puede entonces continuarse a la dosis diaria reducida.","Treatment with Glivec may then be continued at a reduced daily dose.",12,12
"1129","es","en","El tratamiento con Herceptin debe ser iniciado por un médico con experiencia en el uso de medicamentos anticancerosos.","Herceptin treatment should only be started by a doctor who has experience in the use of anticancer medicines.",18,18
"1130","es","en","El tratamiento con Micofenolato mofetilo Teva debe ser iniciado y mantenido por especialistas en trasplantes.","Mycophenolate mofetil Teva treatment should be initiated and maintained by a qualified transplant specialist.",14,15
"1131","es","en","El tratamiento con NeoRecormon se divide en dos fases:","Treatment with NeoRecormon is divided into two stages:",8,9
"1132","es","en","El tratamiento con Nespo debe iniciarlo un médico con experiencia en las indicaciones arriba n","Nespo treatment should be initiated by physicians experienced in the above mentioned indications. du",14,15
"1133","es","en","El tratamiento con Protopy debe ser prescrito únicamente por médicos con","A statement to highlight that tacrolimus should not be applied to lesions, wh ich",14,11
"1134","es","en","El tratamiento con Ratiograstim durará entre 4 y 5 días.","Ratiograstim treatment will last for 4 to 5 days.",9,10
"1135","es","en","El tratamiento con Seretide no debe suspenderse bruscamente.","Treatment with Seretide should not be stopped abruptly.",8,8
"1136","es","en","El tratamiento con Vidaza también se asoció a una disminución de las citopenias y de sus síntomas relacionados.","Vidaza treatment was also associated with a reduction in cytopenias, and their related symptoms.",14,18
"1137","es","en","El tratamiento con Xolair debe iniciarlo un médico experimentado en el diagnóstico y tratamiento del asma grave persistente.","Xolair treatment should be initiated by physicians experienced in the diagnosis and treatment of severe persistent asthma.",17,18
"1138","es","en","El tratamiento con Zerene debe ser tan corto como sea posible con una duración máxima de dos semanas.","Treatment with Zerene should be as short as possible and should last for no more than two weeks.",18,18
"1139","es","en","El tratamiento debe ser de apoyo y puede incluir la hemodiálisis (ver sección 5.2).","Treatment should be supportive and may include haemodialysis (see Section 5.2).",11,14
"1140","es","en","El tratamiento debe ser prescrito por un médico con experiencia en el manejo de las infecciones por VIH.","The therapy should be prescribed by a physician experienced in the management of HIV infection.",15,18
"1141","es","en","El tratamiento deberá suspenderse al cabo de 10 días como máximo, si no existe una mejora clínica aparente.","Treatment should be discontinued after 10 days if no clinical improvement is apparent.",13,18
"1142","es","en","El tratamiento dura generalmente de 5 a 21 días, pero puede durar más para las infecciones graves.","The treatment usually lasts from 5 to 21 days, but may take longer for severe infections.",16,17
"1143","es","en","El tratamiento en pacientes pediátricos menores de 1 año de edad no ha sido estudiado:","Treatment of paediatric patients younger than 1 year of age has not been studied:",14,15
"1144","es","en","El tratamiento es sintomático y de apoyo.","Treatment is symptomatic and supportive.",5,7
"1145","es","en","El tratamiento requiere una sola intervención quirúrgica.","Treatment requires a single surgery.",5,7
"1146","es","en","El tratamiento se divide en dos fases:","The treatment is divided into two stages:",7,7
"1147","es","en","El tratamiento suele durar 2 días, como mínimo, teniendo en cuenta la temperatura corporal.","The length of treatment is usually at least 2 days beyond the normalisation of body temperature.",16,14
"1148","es","en","El uso clínico de TESLASCAN ha sido investigado a intensidades de campo de 0,5 a 2,0 Tesla.","The clinical use of TESLASCAN has been investigated at field strengths from 0.5 to 2.0 Tesla.",16,17
"1149","es","en","El uso concomitante de antagonistas GPIIb/ IIIa aumenta el riesgo de hemorragia.","Concomitant use of GPIIb/ IIIa antagonists increases bleeding risk.",9,12
"1150","es","en","El uso concomitante de quinidina está contraindicada (ver sección 4.3).","The concomitant use of quinidine is contraindicated (see section 4.3).",10,10
"1151","es","en","El uso de anticonvulsivantes (carbamazepina, fenobarbital, fenitoína) debe realizarse con precaución.","Anticonvulsants (carbamazepine, phenobarbital, phenytoin) should be used with caution.",9,11
"1152","es","en","El uso de carbón activado puede ser beneficioso.","The use of activated charcoal may be beneficial.",8,8
"1153","es","en","El uso de IDflu debe basarse en las recomendaciones oficiales.","The use of IDflu should be based on official recommendations.",10,10
"1154","es","en","El uso de Neupro se ha asociado a somnolencia, incluyendo excesiva somnolencia diurna y episodios de sueño repentino.","Neupro has been associated with somnolence including excessive daytime somnolence and sudden sleep onset episodes.",15,18
"1155","es","en","El uso de Oxyglobin no requiere comprobar el tipo de sangre del receptor.","Use of Oxyglobin does not require typing or cross – matching of the recipient ’ s blood.",17,13
"1156","es","en","El uso de Rotarix deberá estar sujeto a las recomendaciones oficiales.","Rotarix is given according to official recommendations.",7,11
"1157","es","en","El uso de Thyrogen debe supervisarlo un médico experto en el cáncer de tiroides.","The use of Thyrogen should be supervised by a doctor with expertise in thyroid cancer.",15,14
"1158","es","en","El uso de VIAGRA no está indicado en mujeres.","VIAGRA is not indicated for use by women.",8,9
"1159","es","en","El valor de t1/ 2 está comprendido entre 3,2 y 6 horas.","T½ is between 3.2 and 6 hours.",7,12
"1160","es","en","El vial puede contener alta presión debido a radiólisis.","The vial may contain high pressure due to radiolysis.",9,9
"1161","es","en","El volumen de distribución en sangre es de alrededor de 150 ml/ Kg.","The volume of distribution in blood is approximately 150 ml/ kg.",11,13
"1162","es","en","El volumen de distribución fue de 0,5 l/ kg.","The volume of distribution was 0.5 l/ kg.",8,9
"1163","es","en","El volumen reconstituido es de 10,6 ml.","The reconstituted volume is 10.6 ml.",6,7
"1164","es","en","Elan Pharma International Ltd.","Elan Pharma International Ltd.",4,4
"1165","es","en","Elevación de ALT > 2x valor basal y > 10x LSN","ALT elevation > 2x baseline and > 10x ULN",9,11
"1166","es","en","Eli Lilly and Company Ltd Priestley Road, Basingstoke Hampshire RG24 9NL Reino Unido","Eli Lilly and Company Ltd Priestley Road, Basingstoke Hampshire RG24 9NL United Kingdom",13,13
"1167","es","en","Eli Lilly N. V.","Eli Lilly N. V.",4,4
"1168","es","en","Eli Lilly Nederland BV, Groostlag 1-5, NL-3991 RA Houten, Holanda.","Eli Lilly Nederland BV, Grootslag 1-5, NL-3991 RA Houten, The Netherlands.",11,10
"1169","es","en","Elija una hora que le resulte cómoda y tome sus comprimidos a esta hora cada día.","Choose a time that is convenient for you and take your tablets at this time each day.",17,16
"1170","es","en","Eliminación Metformina se elimina por excreción renal.","Elimination Metformin is eliminated by renal excretion.",7,7
"1171","es","en","Eliminación Valdecoxib se elimina por metabolismo hepático recuperándose menos del 5% de valdecoxib inalterado en la orina.","Elimination Valdecoxib is eliminated via hepatic metabolism with less than 5% unchanged valdecoxib recovered in the urine.",17,17
"1172","es","en","Eliminación: el perfil concentración– tiempo tras la administración intravenosa se describe adecuadamente mediante un modelo bicompartimental.","The concentration-time profile following intravenous administration is well described by a two-compartment model.",13,16
"1173","es","en","Elimine el aire del cartucho y aguja.","Expel air from the cartridge and needle.",7,7
"1174","es","en","Ello dependerá de su peso corporal y de la cantidad de IgE que tenga en la sangre.","This will depend on your body weight and the amount of IgE measured in your blood.",16,17
"1175","es","en","EMADINE 0,5 mg/ ml Colirio en solución en envase multidosis.","EMADINE 0.5 mg/ml Eye Drops, solution in multidose container.",9,10
"1176","es","en","EMBALAJE DEL COMPONENTE INDIVIDUAL (NO INCLUYE UNA BLUE BOX) SOLO PARA ENVASES MULTIPLES (112 COMPRIMIDOS)","INTERMEDIATE CARTON (WITHOUT BLUE BOX) MULTIPACKS ONLY (3x112 TABLETS)",9,15
"1177","es","en","EMBALAJE EXTERIOR {vial de 50 ml, vial de 100 ml y vial de 200 ml}","OUTER CARTON {50 ml vial, 100 ml and 200 ml vial}",11,15
"1178","es","en","EMBALAJE EXTERIOR Y ETIQUETA DEL FRASCO DE GRANULADO","OUTER CARTON AND BOTTLE LABEL FOR GRANULES",7,8
"1179","es","en","Embarazo No existen estudios adecuados y bien controlados sobre el uso de darunavir en mujeres embarazadas.","Pregnancy There are no adequate and well controlled studies with darunavir in pregnant women.",14,16
"1180","es","en","Embarazo Se dispone de datos clínicos limitados en el embarazo para tenofovir disoproxil fumarato.","Pregnancy For tenofovir disoproxil fumarate limited clinical data on exposed pregnancies are available.",13,14
"1181","es","en","Embarazo Si se puede quedar embarazada, use medidas anticonceptivas durante el tratamiento con Extavia.","Pregnancy Women at risk of becoming pregnant should use contraception during treatment with Extavia.",14,14
"1182","es","en","Embarazo y lactancia ADROVANCE sólo está destinado para el uso en mujeres postmenopáusicas.","Pregnancy and breast-feeding ADROVANCE is only intended for use in postmenopausal women.",12,13
"1183","es","en","Embarazo y lactancia Consulte a su médico o farmacéutico antes de utilizar cualquier medicamento.","Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine.",14,14
"1184","es","en","Embarazo y lactancia No debe usar Xolair cuando esté embarazada.","Pregnancy and breast-feeding You should not take Xolair when you are pregnant.",12,10
"1185","es","en","Embarazo y lactancia No tome Tekturna si está embarazada.","Pregnancy and breast-feeding Do not take Tekturna if you are pregnant.",11,9
"1186","es","en","Embarazo y lactancia SonoVue no ha sido estudiado en mujeres embarazadas.","Pregnancy and breast-feeding SonoVue has not been studied in pregnant women.",11,11
"1187","es","en","Embarazo: la experiencia sobre el uso de buprenorfina/ naloxona en mujeres embarazadas es muy limitada.","There is very limited experience with buprenorphine/ naloxone in pregnant women.",11,15
"1188","es","en","Emtricitabina tampoco inhibe la enzima responsable de la glucuronización.","Emtricitabine did not inhibit the enzyme responsible for glucuronidation.",9,9
"1189","es","en","Emtriva está también disponible en cápsulas duras.","Emtriva is also available as hard capsules.",7,7
"1190","es","en","En 1998 se designaron ponentes y ponentes adjuntos para solicitudes que representaban 32 principios activos.","Rapporteurs and co-rapporteurs were appointed for applications representing 32 active substances in 1998.",13,15
"1191","es","en","En 2003 se espera un aumento significativo de la carga de trabajo en esta área.","Working parties and ad hoc groups",6,15
"1192","es","en","En 61 de estos 117 pacientes se identificaron quinasas de fusión FIP1L1-PDGFRα.","In 61 of these 117 patients FIP1L1-PDGFRα fusion kinase was identified.",11,12
"1193","es","en","En adolescentes, el dolor de cabeza fue la reacción adversa comunicada más frecuentemente.","In adolescents, headache was the most commonly reported side effect.",10,13
"1194","es","en","En algunos casos muy graves, estos daños musculares podrían llegar a provocar insuficiencia renal.","In very severe cases this could lead to kidney failure.",10,14
"1195","es","en","En algunos casos puede producirse hipertermia hasta 2 días.","In some cases hyperthermia may occur for up to 2 days.",11,9
"1196","es","en","En algunos casos, los medicamentos pueden alterar la forma de actuar de otros medicamentos.","In some cases, medicines can affect the way other medicines work.",11,14
"1197","es","en","En algunos Estados miembros, la administración puede repetirse al cabo de cinco días en caso de problemas graves.","In some Member States this administration can be repeated after five days in the face of severe challenge.",18,18
"1198","es","en","En algunos varones tratados, se han notificado casos de impotencia, esterilidad, azoospermia, y atrofia testicular.","Impotence, sterility, azoospermia, and testicular atrophy have been reported in male patients.",12,15
"1199","es","en","En ambos ensayos, el resultado del tratamiento con Thelin fue un aumento significativo en la capacidad de ejercicio.","In both trials, treatment with Thelin resulted in a significant increase in exercise capacity.",14,18
"1200","es","en","En ambos estudios participaron pacientes adultos (≥ 18 años) que habían recibido Toxina Botulínica Tipo A con anterioridad.","Both studies enrolled adult patients (≥ 18 years) who had a history of receiving Botulinum Toxin Type A.",18,18
"1201","es","en","En animales, no se hallaron efectos adversos sobre la fertilidad en machos o hembras (ver sección 5.3).","In animals, no adverse effects on male or female fertility were found (see section 5.3).",15,17
"1202","es","en","En aquellos pacientes que desarrollan esta sintomatología, el aumento de la dosis puede ser perjudicial.","In patients who develop these symptoms, increasing the dose may be detrimental.",12,15
"1203","es","en","En aquellos pacientes que necesiten un mayor alivio de los síntomas, puede aumentarse la dosis hasta 15 mg.","For those patients requiring greater symptom relief, the dose may be increased to 15 mg.",15,18
"1204","es","en","En ausencia de estudios de compatibilidad, este medicamento no debe mezclarse con otros medicamentos.","In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.",17,14
"1205","es","en","En ausencia de toxicidad materna no se ha observado toxicidad fetal.","This means that patients usually may drive or perform tasks requiring concentration.",12,11
"1206","es","en","En cada banda de peso se debe aplicar todo el contenido de la pipeta del tamaño adecuado.","Within each weight band the entire contents of the correct size pipette should be used.",15,17
"1207","es","en","En caso contrario, el tratamiento debe iniciarse con 4,6 mg/ 24 h.","Otherwise treatment should be re-initiated with 4.6 mg/ 24 h.",10,12
"1208","es","en","En caso de administración concomitante se recomienda precaución.","Caution is recommended in case of co-administration.",7,8
"1209","es","en","En caso de apreciarse alguna de estas circunstancias, desechar el envase.","In the event of either being observed, discard the vaccine.",10,11
"1210","es","en","En caso de deterioro clínico, pese al tratamiento con Revatio, deberán considerarse terapias alternativas.","In case of clinical deterioration in spite of Revatio treatment, alternative therapies should be considered.",15,14
"1211","es","en","En caso de embarazo durante el uso de EVRA, se debe interrumpir el uso de EVRA de inmediato.","If pregnancy occurs during use of EVRA, EVRA should be stopped immediately.",12,18
"1212","es","en","En caso de exposición accidental al medicamento deberá lavarse la piel y aclararse los ojos con agua.","Wash the skin and rinse eyes with water, if accidental exposure occurs.",12,17
"1213","es","en","En caso de ingestión accidental, debe administrarse tratamiento sintomático.","In case of accidental oral uptake, symptomatic treatment should be administered.",11,9
"1214","es","en","En caso de insuficiencia renal severa, Neoclarityn deberá utilizarse con precaución (ver sección 5.2).","In the case of severe renal insufficiency, Neoclarityn should be used with caution (see section 5.2).",16,14
"1215","es","en","En caso de observar otros efectos adversos, por favor informe a su veterinario.","If you notice any other side effects, please inform your veterinary surgeon.",12,13
"1216","es","en","En caso de shock, debe emplearse el tratamiento médico habitual.","In case of shock, standard medical treatment for shock should be implemented.",12,10
"1217","es","en","En caso de sobredosificación discontinuar la terapia.","In the case of overdosage discontinue therapy.",7,7
"1218","es","en","En caso de sobredosificación puede haber mayor riesgo de hemorragia.","In the event of overdosage there may be an increased risk of bleeding.",13,10
"1219","es","en","En caso de sobredosis accidental, debe consultar inmediatamente con su veterinario y debe iniciarse un tratamiento sintomático.","In cases of accidental overdose your veterinary surgeon should be consulted immediately and symptomatic therapy should be initiated.",18,17
"1220","es","en","En caso de sobredosis consulte a su médico.","Consult your doctor if you have taken an overdose.",9,8
"1221","es","en","En caso de tener síntomas de cualquier infección, por ejemplo: fiebre, heridas,","r • If you have a severe infection, including active tuberculosis (see “Take special care with",16,12
"1222","es","en","En caso de volúmenes más grandes, debe elegirse más de un lugar para la inyección.","In case of larger volumes, more than one site should be chosen for the injection.",15,15
"1223","es","en","En caso necesario, en 1998 se creará un Sector específico para los arbitrajes.","If necessary, a dedicated Sector would have to be created in 1998 to deal with arbitrations.",16,13
"1224","es","en","En condiciones de laboratorio, se demostró que Purevax RCPCh confería protección frente a las enfermedades indicadas.","In laboratory conditions Purevax RCPCh was demonstrated to provide protection against the diseases listed above.",15,16
"1225","es","en","En condiciones normales, esta enzima descompone una sustancia grasa denominada globotriaosilceramida (GL3).","This enzyme normally breaks down a fatty substance called globotriaosylceramide (GL-3).",11,12
"1226","es","en","En consecuencia el CHMP decidió conceder a Actos la autorización de comercialización.","The committee recommended that Actos be given marketing authorisation.",9,12
"1227","es","en","En consecuencia, el CHMP acordó recomendar las siguientes dosis:","The CHMP therefore agreed to recommend the following dosage recommendation:",10,9
"1228","es","en","En consecuencia, el Comité recomendó que se aprobase la comercialización de Cubicin.","The Committee recommended that Cubicin be given marketing authorisation.",9,12
"1229","es","en","En consecuencia, el Comité recomendó que se autorizara su comercialización.","The Committee recommended that AZILECT be given marketing authorisation.",9,10
"1230","es","en","En consecuencia, el Comité recomendó que se autorizase la comercialización de Infanrix Hexa.","The Committee recommended that Infanrix Hexa be given marketing authorisation.",10,13
"1231","es","en","En consecuencia, el Comité recomendó que se autorizase su comercialización.","The Committee recommended that Levitra be given marketing authorisation.",9,10
"1232","es","en","En consecuencia, el CVMP recomienda una variación de la autorización de comercialización.","The CVMP therefore recommends a variation of the Marketing Authorisation.",10,12
"1233","es","en","En consecuencia, el flujo sanguíneo periférico se eleva y no se modifica la frecuencia cardíaca.","As a consequence, peripheral blood flow increases, with no effect on heart rate.",13,15
"1234","es","en","En consecuencia, el producto de factor IX utilizado resulta inactivado (véase Posibles efectos adversos).","As a result, the factor IX product used becomes inactivated (see Possible side effects).",14,14
"1235","es","en","En consecuencia, recomendó que se autorizase la comercialización de Preotact.","They recommended that Preotact be given marketing authorisation.",8,10
"1236","es","en","En consecuencia, recomendó que se autorizase su comercialización.","They recommended that Fevaxyn Pentofel should be given a marketing authorisation.",11,8
"1237","es","en","En cualquier momento del tratamiento podrá beber agua del grifo.","Plain water may be taken at any time during the course of Bondronat treatment.",14,10
"1238","es","en","En cualquiera de estos casos, deberá informar a su médico.","If any of these apply, you should inform your doctor.",10,10
"1239","es","en","En cuanto a los niños, el tratamiento debería continuar hasta finalizar la etapa de crecimiento.","For children, the treatment should be continued until the end of the growth has been reached.",16,15
"1240","es","en","En dos pacientes los anticuerpos indicaron efecto inhibitorio in vitro.","In two patients the antibodies showed inhibitory effect in vitro.",10,10
"1241","es","en","En el adulto, las tres indicaciones se tratan con dosis de 10 mg diarios de cetirizina.","In adults, all three indications are treated by a 10 mg daily dose of cetirizine.",15,16
"1242","es","en","En el anexo 4 se indica la composición de dicho Comité.","Membership of the Committee is given in Annex 4.",9,11
"1243","es","en","En el anexo 7 se facilitan más datos sobre las autorizaciones comunitarias de comercialización concedidas para medicamentos veterinarios.","Details of Community marketing authorisations granted for veterinary medicinal products are given in Annex 7.",15,18
"1244","es","en","En el ensayo de fase II (estudio 001/ 007) se incluyeron sólo mujeres que:","The phase II trial (study 001/ 007) enrolled only women who:",11,14
"1245","es","en","En el ensayo PEARL se observaron resultados similares para el pH vaginal y el IM.","Similar results for vaginal pH and MI were observed in the PEARL study.",13,15
"1246","es","en","En el envase exterior","On the outer package you",5,4
"1247","es","en","En el Estudio 2a (N = 99) la tasa de respuesta global aumentó hasta el 56,1%.","In Study 2a (N = 99), the overall response rate increased to 56.1%.",13,16
"1248","es","en","En el estudio con adultos, el 34% de ambos grupos de adultos presentaron respuesta favorable.","In the adult study, 34% of both groups of adults had a favourable response.",14,15
"1249","es","en","En el estudio con niños, Apidra e insulina lispro produjeron cambios similares del HbA1c pasados seis meses.","In the study in children, Apidra and insulin lispro produced similar changes in HbA1c after six months.",17,17
"1250","es","en","En el estudio no se comparó Evoltra con ningún otro tratamiento.","The study did not compare Evoltra with any other treatments.",10,11
"1251","es","en","En el etiquetado de la caja puede encontrarse información sobre las condiciones de administración de este medicamento.","Information on the prescription status of this product may be found on the outer package.",15,17
"1252","es","en","En el etiquetado de la caja puede encontrarse información sobre las condiciones de dispensación de este producto.","Information on the prescription status of this product may be found on the label/ outer package.",16,17
"1253","es","en","En el hombre, la FSH es necesaria para la producción de esperma.","In men, FSH is needed for the production of sperm.",10,12
"1254","es","en","En el muestreo angular no deben adquirirse menos de 120 imágenes en 360 grados preferentemente.","Angular sampling should preferably be not less than 120 views over 360 degrees.",13,15
"1255","es","en","En el ojo, la prostaglandina aumenta el drenaje del líquido acuoso (humor acuoso) fuera del globo ocular.","In the eye, prostaglandin increases the drainage of the watery fluid (aqueous humour) out of the eyeball.",17,17
"1256","es","en","En el otro, se comparó Insulin Human Winthrop Comb 25 con insulina humana semisintética.","In the other study, Insulin Human Winthrop Comb 25 was compared with semi-synthetic human insulin.",15,14
"1257","es","en","En el presente documento se resume el Informe Público Europeo de Evaluación (EPAR).","This document is a summary of the European Public Assessment Report (EPAR).",12,13
"1258","es","en","En el prospecto encontrará las instrucciones de uso completas.","See the Package Leaflet for full instructions for use.",9,9
"1259","es","en","en el recuento de plaquetas (puede aumentar su predisposición a los moratones y hemorragias)","in blood platelets (may make you more prone to bruising and bleeding)",12,14
"1260","es","en","En ese caso, continúe con la siguiente dosis del modo normal.","In that case carry on with the next dose as normal.",11,11
"1261","es","en","En esta situación, el balance beneficio/ riesgo del tratamiento con Trudexa debe ser cuidadosamente considerado. r uto","In this situation, the benefit/ risk balance of therapy with Trudexa should be very carefully considered.",16,17
"1262","es","en","En este caso, debe tomar los comprimidos solamente una o dos veces al día.","In this case, you will have to take the tablets only once or twice a day.",16,14
"1263","es","en","En este caso, Luveris debe reconstituirse primero y luego utilizarse para reconstituir el polvo de follitropina alfa.","In this case Luveris should be reconstituted first and then used to reconstitute the follitropin alfa powder.",17,17
"1264","es","en","En este momento, compruebe que la dosis es la correcta.","At that point check that you have the correct dose.",10,10
"1265","es","en","En este subgrupo, hubo una tasa de respuesta virológica sostenida del 92% (89/97).","In this subgroup, there was a 92% (89/97) sustained virological response rate.",12,13
"1266","es","en","En estos 46 pacientes, el porcentaje medio de reducción del colesterol LDL fue de aproximadamente el 21%.","From these 46 patients, the mean percent reduction in LDL-C was approximately 21%.",13,17
"1267","es","en","En estos casos, el tratamiento debe ser interrumpido de inmediato y permanentemente y debe iniciarse una terapia adecuada.","In such cases, treatment should immediately and permanently be discontinued and appropriate therapy initiated.",14,18
"1268","es","en","En estos casos, fue frecuente el tratamiento concomitante con otros fármacos hepatotóxicos.","Co- medication with other hepatotoxic medicinal products was frequently present.",10,12
"1269","es","en","En estos casos, se recomienda posponer la vacunación hasta el final de la enfermedad o del tratamiento.","In such cases it is recommended to postpone the vaccination until the end of the disease or treatment.",18,17
"1270","es","en","En estos pacientes deben controlarse los niveles séricos de calcio y monitorizarse la función renal.","In these patients serum calcium levels should be followed and renal function should be monitored.",15,15
"1271","es","en","En estos tres estudios de seis semanas, los resultados de eficacia al finalizar los ensayos, fueron los siguientes:","In these three 6-week studies, the efficacy results at endpoint were as follows:",13,18
"1272","es","en","En estudios in vitro, no se ha observado antagonismo entre tigeciclina y otras clases de antibióticos comúnmente utilizadas.","In in vitro studies, no antagonism has been observed between tigecycline and other commonly used antibiotic classes.",17,18
"1273","es","en","En función de su situación concreta, puede ser preferible recibir una transfusión sanguínea.","Depending on your individual situation a blood transfusion may be preferable.",11,13
"1274","es","en","En general, el tratamiento debe continuar durante al menos 7 días después de la desaparición de los síntomas.","In general, treatment should continue for at least 7 days after resolution of symptoms.",14,18
"1275","es","en","En la bandeja también se incluye otra aguja para administrar la inyección.","A separate needle to give the injection is also included in the tray.",13,12
"1276","es","en","En la candidiasis bucofaríngea, Posaconazole SP fue tan eficaz como el fluconazol.","In oropharyngeal candidiasis, Posaconazole SP was as effective as fluconazole.",10,12
"1277","es","en","En la mayoría de estos casos se administró Mabthera en combinación con quimioterapia.","In the majority of these cases, MabThera was administered with chemotherapy.",11,13
"1278","es","en","En la mayoría de los casos necesitará un médico.","In most cases you will need a doctor.",8,9
"1279","es","en","En la mayoría de los casos, las reacciones adversas generalmente no han requerido la interrupción del tratamiento.","The majority of adverse reactions have not usually required cessation of therapy.",12,17
"1280","es","en","En la tabla 5 se presentan los resultados de eficacia adicional.","Further efficacy results are reported in Table 5.",8,11
"1281","es","en","En la Tabla 9 se presentan los resultados.","Results are presented in Table 9.",6,8
"1282","es","en","En los caballos se pueden producir reacciones alérgicas (hipersensibilidad) que deben recibir tratamiento sintomático.","In horses, anaphylactoid (hypersentivity) reactions can occur and should be treated symptomatically.",12,14
"1283","es","en","En los cuatro ensayos controlados con placebo los hazard ratios (índice de riesgo) para la","In the four placebo-controlled studies the hazard in",8,15
"1284","es","en","En los ensayos clínicos se han empleado pautas posológicas alternativas.","Alternative dosing regimens have been used in clinical studies.",9,10
"1285","es","en","En los ensayos clínicos, el rango de dosis eficaz fue de 900 a 3600 mg/ día.","In clinical trials, the effective dosing range was 900 to 3600 mg/ day.",13,16
"1286","es","en","En los ensayos clínicos, los comprimidos se han estudiado durante hasta 14 días de tratamiento.","In clinical trials the tablets have been studied for up to 14 days treatment.",14,15
"1287","es","en","En los ensayos en artritis psoriásica se evaluaron los cambios radiográficos.","Radiographic changes were assessed in the psoriatic arthritis studies.",9,11
"1288","es","en","En los estudios clínicos no se ha observado inducción del metabolismo hepático.","Induction of hepatic metabolism has not been observed in clinical studies.",11,12
"1289","es","en","En los estudios de fase II-III aproximadamente 2.900 pacientes fueron tratados con ivabradina.","Approximately 2,900 patients have been treated with ivabradine in phase II-III studies.",12,13
"1290","es","en","En los niños se ha descrito que la artropatía se produce con frecuencia (ver sección 4.4).","In children, arthropathy is reported to occur commonly (see section 4.4).",11,16
"1291","es","en","En los pacientes con infecciones graves se puede proceder a un aumento más rápido de la dosis.","A faster schedule of dose escalation may be considered in patients presenting with severe infections.",15,17
"1292","es","en","En los pacientes con insuficiencia de la función hepática no se precisa un ajuste de la dosis.","In patients with impaired liver function no dose adjustment is required.",11,17
"1293","es","en","En mujeres con una dieta baja en calcio generalmente se recomienda administrar suplementos de calcio y vitamina D.","Generally calcium and vitamin D supplements are advised in women with a low dietary intake.",15,18
"1294","es","en","En muy raras ocasiones (< 1/ 100000) pueden observarse reacciones de hipersensibilidad.","In very rare cases (< 1/ 100000), hypersensitivity can be observed.",11,12
"1295","es","en","En niños prematuros o recién nacidos, ya que contiene alcohol bencílico.","In premature or newborn babies, because it contains benzyl alcohol.",10,11
"1296","es","en","En ocasiones puede producirse dolor en el punto de inyección.","Pain at the injection site can occur occasionally.",8,10
"1297","es","en","En pacientes coinfectados con VHC/VIH, la duración del tratamiento es de 48 semanas.","For HCV/HIV co-infected patients, the duration of treatment is 48 weeks.",11,13
"1298","es","en","En pacientes con anomalías hematológicas significativas confirmadas debe considerarse la interrupción del tratamiento con Trudexa.","Discontinuation of Trudexa therapy should be considered in patients with confirmed significant haematologic abnormalities. na",15,15
"1299","es","en","En pacientes con HAP, las concentraciones plasmáticas máximas se alcanzan habitualmente de 1 a 4 horas.","In PAH patients, peak plasma concentrations are generally achieved within 1-4 hours.",12,16
"1300","es","en","En pacientes con riesgo se recomienda monitorizar los niveles plasmáticos de potasio.","Adequate monitoring of serum potassium in patients at risk is recommended.",11,12
"1301","es","en","En pacientes con trasplante renal, la concentración de tacrolimus no pareció verse alterada por micofenolato mofetilo.","In renal transplant patients, the tacrolimus concentration did not appear to be altered by mycophenolate mofetil.",16,16
"1302","es","en","En pacientes diabéticos hipertensos, Riprazo en monoterapia demostró ser seguro y eficaz.","In diabetic hypertensive patients, Riprazo monotherapy was safe and effective.",10,12
"1303","es","en","En pacientes que además toman antidiabéticos por vía oral, un efecto secundario común son los signos de alergia.","In patients also taking oral anti-diabetes medicines, a common side effect is signs of allergy.",15,18
"1304","es","en","En pacientes recibiendo lumiracoxib, se han comunicado reacciones de hipersensibilidad graves (tales como anafilaxia y angioedema).","Serious hypersensitivity reactions (such as anaphylaxis and angioedema) have been reported in patients receiving lumiracoxib.",15,16
"1305","es","en","En pacientes sin factores de riesgo cardiacos, debe considerarse una evaluación basal de la fracción de eyección.","In patients without cardiac risk factors, a baseline evaluation of ejection fraction should be considered.",15,17
"1306","es","en","En pollos y pavos se han realizado nueve ensayos principales en aves con infecciones respiratorias.","In cattle, seven main studies were carried out.",8,15
"1307","es","en","En primer lugar, el virus se inactiva (se","The virus has first been inactivated (killed) so that it does not cause any disease.",15,8
"1308","es","en","En raras ocasiones pueden resultar mortales.","In rare cases these may be fatal.",7,6
"1309","es","en","En raras ocasiones se han notificado casos de SNM, asociados al tratamiento con olanzapina.","Rare cases reported as NMS have also been received in association with olanzapine.",13,14
"1310","es","en","En raras ocasiones, estos trastornos musculares pueden ser","On rare occasions, these muscle disorders have been",8,8
"1311","es","en","En raros casos, se han asociado tromboembolismos al tratamiento con menotropina/ hCG.","In rare instances, thromboembolisms have been associated with menotrophin/ hCG therapy.",11,12
"1312","es","en","En recién nacidos, niños y adolescentes (de 0 a 17 años):","In new-born infants, children and adolescents (0 to 17 years):",10,11
"1313","es","en","En su conjunto, los datos disponibles relativos al riesgo de isquemia miocárdica no son concluyentes.","In their entirety, the available data on the risk of myocardial ischaemia are inconclusive.",14,15
"1314","es","en","En todos los estudios, Kaletra redujo la carga viral.","In all of the studies, Kaletra reduced viral loads.",9,9
"1315","es","en","En un estudio de 64 pacientes con artritis reumatoide que fueron tratados con Trudexa, no se observó","In a study of 64 patients with rheumatoid arthritis that were treated with Trudexa, there was no",17,17
"1316","es","en","En un estudio de dos años de duración se comparó la deferiprona con la deferoxamina.","In one study of two-year duration deferiprone was compared to deferoxamine.",11,15
"1317","es","en","En una bolsa de perfusión: hasta 8 horas a una temperatura de hasta 25oC","In an infusion bag: up to 8 hours not above 25oC",11,14
"1318","es","en","En uno de cada 10 perros se han observado vómitos o diarrea.","Vomiting or diarrhoea has been observed in one out of 10 dogs.",12,12
"1319","es","en","En uno de estos estudios participaron únicamente hombres diabéticos.","One of these studies contained only diabetic men.",8,9
"1320","es","en","En uno de estos estudios se utilizó una pauta de dosificación abreviada de daclizumab.","An abbreviated dosing schedule of daclizumab was used in one of the studies.",13,14
"1321","es","en","En varias dosis de 2 - 5 días, junto con ácido acetilsalicílico.","in several doses for 2 – 5 days in association with acetylsalicylic acid",13,12
"1322","es","en","Enbrel 50 mg polvo para solución inyectable etanercept","Enbrel 50 mg powder for solution for injection etanercept",9,8
"1323","es","en","Enbrel se presenta como un polvo blanco y disolvente para solución inyectable para uso pediátrico.","Enbrel is supplied as a white powder and solvent for solution for injection for paediatric use.",16,15
"1324","es","en","Eneuresis, trastornos en la micción, incontinencia urinaria mama Femenino: amenorrea, menorragia, alteración menstrual, trastorno vaginal.","Female: amenorrhea, menorrhagia, menstrual disorder, vaginal disorder.",7,15
"1325","es","en","ENF no de novo","Not de novo ENF",4,4
"1326","es","en","Enfuvirtida y VIRAMUNE pueden administrarse conjuntamente sin ajustes de dosis.","Enfuvirtide and VIRAMUNE can be co-administered without dose adjustments.",9,10
"1327","es","en","ensayos compararon la eficacia de Viraferon utilizado solo o en combinación con ribavirina.","The trials compared the efficacy of Viraferon used alone or in combination with ribavirin.",14,13
"1328","es","en","Entre 1 de cada 10 y 1 de cada 100 pacientes experimenta","Between 1 in 10 and 1 in 100 patients experience",10,12
"1329","es","en","Envase con 1 ó 4 viales de 250 µg de romiplostim.","Carton containing 1 or 4 vials of 250 µg of romiplostim.",11,11
"1330","es","en","Envase con 1 pluma precargada y 14 agujas que deben utilizarse con la pluma para la administración.","Pack of one pre-filled pen and 14 needles to be used with the pen for administration.",16,17
"1331","es","en","Envase con 1 vial.","Pack size of 1.",4,4
"1332","es","en","Envase de 1 vial que contiene 16 ml.","Pack of 1 vial containing 16 ml.",7,8
"1333","es","en","Envase de comprimidos de polietileno de alta densidad Tamaños del envase:","High Density Polyethylene tablet containers Pack sizes:",7,11
"1334","es","en","Envase múltiple que contiene 2 envases, con 5 jeringas precargadas cada uno.","Multipack comprising 2 packs, each containing 5 pre-filled syringes.",9,12
"1335","es","en","Envases con 14, 28, 30, 50, 56, 84, 90 y 98 comprimidos, en plaquetas de aluminio/ aluminio.","Aluminium/ aluminium blisters, packs of 14, 28, 30, 50, 56, 84, 90 and 98 tablets",15,17
"1336","es","en","Envases de 1 y 10x.","Packs of 1 and 10.",5,5
"1337","es","en","Envases de 10, 30, 50, 56, 60, 90, 100 o 200 comprimidos dispersables/ masticables.","Packs of 10, 30, 50, 56, 60, 90, 100 or 200 dispersible/ chewable tablets.",14,14
"1338","es","en","Enviage pertenece a nueva clase de medicamentos llamados inhibidores de la renina.","Enviage belongs to a new class of medicines called renin inhibitors.",11,12
"1339","es","en","Epi/ CPA (75/ 600","Epi/ CPA (75/ 600",4,4
"1340","es","en","Epivir 150 mg comprimidos recubiertos con película","Epivir 150 mg film-coated tablets",5,7
"1341","es","en","Epoyetina alfa HEXAL 10.000 UI/ 1 ml solución inyectable en una jeringa precargada Epoyetina alfa","Epoetin alfa HEXAL 10 000 IU/ 1 ml solution for injection in a pre-filled syringe Epoetin alfa",17,15
"1342","es","en","Epoyetina alfa HEXAL 6000 UI/ 0,6 ml solución inyectable en una jeringa precargada","Epoetin alfa HEXAL 6000 IU/ 0.6 ml solution for injection in a pre-filled syringe",14,13
"1343","es","en","Epoyetina alfa IV/ subcutánea","Epoetin alfa IV/ SC",4,4
"1344","es","en","EQUIOXX 8,2 mg/ g de pasta oral para caballos.","EQUIOXX 8.2 mg/ g oral paste for horses",8,9
"1345","es","en","Erbitux se administra una vez a la semana.","Erbitux is given once a week.",6,8
"1346","es","en","Eritema, alteración en la pigmentación, aumento de la sudoración","Erythema, pigmentation abnormal, sweating increased",5,9
"1347","es","en","Erlotinib es sustrato de la P-glicoproteína (transportador de sustancias activas).","Erlotinib is a substrate for the P-glycoprotein active substance transporter.",10,10
"1348","es","en","erupciones, dermatitis, urticaria, síndrome de Stevens-Johnson papiloedema, lagrimeo anormal, hemorragia retiniana, sordera.","rash, dermatitis, urticaria, Stevens-Johnson syndrome papilloedema, abnormal lacrimation, retinal haemorrhage, deafness",11,12
"1349","es","en","Es aconsejable que los EMEA/ CHMP/ 123439/ 2006/ ES","EMEA/ CHMP/ 123439/ 2006/ EN Cleaning:",6,9
"1350","es","en","Es especialmente importante en estas situaciones una estrecha vigilancia en lo que a reacciones inmunológicas se refie re.","Close surveillance with regard to immunological reactions is especially important in such situations.",13,18
"1351","es","en","Es importante asegurar que las jeringas no contengan vestigios de ningún otro material.","It is important to ensure that syringes do not contain traces of any other material.",15,13
"1352","es","en","Es importante informar a su médico si está tomando:","It is important to tell your doctor if you are taking:",11,9
"1353","es","en","Es importante que continúe tomando este medicamento hasta que su médico le aconseje lo contrario.","It is important that you continue to take Irbesartan BMS until your doctor tells you otherwise.",16,15
"1354","es","en","Es importante que tome Kinzalmono cada día hasta que su médico le indique lo contrario.","It is important that you take Kinzalmono every day until your doctor tells you otherwise.",15,15
"1355","es","en","Es mejor que tome Avandamet con las comidas, o poco después de las comidas.","It is best to take Avandamet with food, or just after food.",12,14
"1356","es","en","Es normal que queden restos de espuma blanca en el vial.","Some white foam may remain in the vial – this is normal.",12,11
"1357","es","en","Es poco probable que la vacuna produzca algún efecto sobre la capacidad de conducir y usar maquinaria.","The vaccine is unlikely to affect your ability to drive or use machines.",13,17
"1358","es","en","Es posible la oclusión del sistema de diálisis si la heparinización no es óptima.","Occlusion of the dialysis system is possible if heparinisation is not optimum.",12,14
"1359","es","en","Es posible que el médico deba ajustar la dosis.","The doctor may have to adjust your dosage.",8,9
"1360","es","en","Es posible que no se comercialicen todas las presentaciones.","Not all pack sizes may be marketed",7,9
"1361","es","en","Es posible que sea necesario ajustar la dosis de amiodarona durante el tratamiento con alli.","The dose of amiodarone may need to be adjusted during treatment with alli.",13,15
"1362","es","en","Escherichia coli J5: > 50 RED60 * Staph. aureus (CP8): > 50 RED80 **","Escherichia coli J5: > 50 RED60 * Staph. aureus (CP8): > 50 RED80 **",14,14
"1363","es","en","Escriba la fecha de apertura en el envase de comprimidos.","Write the date of opening on the tablet container.",9,10
"1364","es","en","España Alexion Pharma Spain World Trade Center Edificio Sur - 2a Planta Muelle de Barcelona Barcelona 08039 España","España Alexion Pharma Spain World Trade Center Edificio Sur - 2a Planta Muelle de Barcelona Barcelona 08039 España",18,18
"1365","es","en","España Eisai Farmacéutica, S. A.","España Eisai Farmacéutica, S. A.",5,5
"1366","es","en","España GlaxoSmithKline, S. A.","España GlaxoSmithKline, S. A.",4,4
"1367","es","en","España Lilly S. A..","España Lilly S. A..",4,4
"1368","es","en","España Pfizer S. A.","España Pfizer S. A.",4,4
"1369","es","en","España sanofi-aventis, S. A.","España sanofi-aventis, S. A.",4,4
"1370","es","en","España Wyeth Farma S.A.","España Wyeth Farma S.A.",4,4
"1371","es","en","Especies a las que va destinado el medicamento","Pharmaceutical Target species Form",4,8
"1372","es","en","Especies para las que la resistencia adquirida puede suponer un problema Ninguna","Species for which acquired resistance may be a problem None",10,12
"1373","es","en","Esperar una semana y, si los síntomas mejoran, volver a dosificar con una reducción del 25%.","Wait one week and if symptoms improve redose at 25% dose reduction",12,16
"1374","es","en","Espere 30 minutos desde el momento en que bebió la solución.","Wait 30 minutes from the time of drinking the Pylobactell 13C-urea solution.",12,11
"1375","es","en","Est ablecimiento de límites máximos de residuos para nuevas sustancias","Establishment of maximum residue limits for new substances",8,10
"1376","es","en","Esta cepa lentogénica es naturalmente apatógena para la gallina.","The VG/ GA strain is lentogenic and naturally apathogenic for chickens.",11,9
"1377","es","en","Esta conclusión fue aceptada.","This conclusion was accepted.",4,4
"1378","es","en","Esta diferencia no fue estadísticamente significativa.","This difference was not statistically significant.",6,6
"1379","es","en","Está disponible en comprimidos ovales de color amarillo (600 mg) y como solución oral (20mg/ ml).","It is available as yellow, oval tablets (600 mg) and as an oral solution (20 mg/ ml).",17,16
"1380","es","en","Está disponible en envases de 10, 30, 50, 60 y 100 comprimidos recubiertos con película.","They are available as packs of 10, 30, 50, 60 and 100 film-coated tablets.",14,15
"1381","es","en","Esta dosis se libera mediante una activación de la bomba.","This dose is adequately delivered by one pump activation.",9,10
"1382","es","en","Esta es la causa más común de respuesta incompleta a un tratamiento con eritropoyetina.","This is the most common cause of an incomplete response to an erythropoietin therapy.",14,14
"1383","es","en","Esta gammagrafía mostrará exactamente la distribución del radiofármaco en un órgano determinado y en el cuerpo..","This scan will show exactly where the radioactivity is inside the organ and the body.",15,16
"1384","es","en","Esta hormona promueve el crecimiento durante la infancia y la adolescencia.","Growth hormone promotes growth during childhood and adolescence.",8,11
"1385","es","en","Esta indicación está aprobada en todos los Estados miembros de la UE, Islandia y Noruega.","This indication was approved in all EU Member States, Iceland and Norway.",12,15
"1386","es","en","Esta información está destinada únicamente a médicos o profesionales del sector sanitario:","The following information is intended for medical or healthcare professionals only:",11,12
"1387","es","en","Esta interferencia causa una prolongación del tiempo de protrombina y una elevación del INR aparentes.","This interference led to an apparent prolongation of PT and elevation of INR.",13,15
"1388","es","en","Esta nueva indicación fue aprobada por el CPMP.","The additional indication was approved by the CPMP.",8,8
"1389","es","en","Esta sensación suele desaparecer espontáneamente, pero si no ocurriera así, informe a su médico.","This will usually pass on its own but if it does not, tell your doctor.",15,14
"1390","es","en","Esta solución está preparada para su inyección en vena.","This solution is ready for injection into a vein.",9,9
"1391","es","en","Esta unión a la proteína plasmática depende de la concentración, indicativo de la saturación del enlace.","This protein binding is concentration dependent indicative for saturation of binding.",11,16
"1392","es","en","Esta vacuna cumple con las recomendaciones de la OMS y decisión de la UE para la pandemia.","decision for the pandemic.",4,17
"1393","es","en","Esta vacuna debe administrarse por vía intramuscular.","This vaccine should be administered intramuscularly.",6,7
"1394","es","en","Esta vacuna sólo podrá dispensarse con receta médica.","The vaccine can only be obtained with a prescription.",9,8
"1395","es","en","Estabilidad demostrada durante 3 horas, a 2-8 ºC.","In-use stability demonstrated for 3 hours at 2-8 °C.",9,8
"1396","es","en","Están disponibles dos presentaciones de BYETTA:","Two presentations of BYETTA are available:",6,6
"1397","es","en","Están disponibles las siguientes presentaciones para los comprimidos recubiertos con película de 45 mg en blisters:","The following pack sizes are available for the 45 mg film-coated tablets in blisters:",14,16
"1398","es","en","Están en marcha estudios de seguimiento a más largo plazo (ver sección 5.1).","Longer term follow-up studies are ongoing (see section 5.1).",9,13
"1399","es","en","Estan marcados con 20 por un lado y con PD 156 por el otro lado.","They are marked with 20 on one side and PD156 on the other side.",14,15
"1400","es","en","Estas dosis son adecuadas para personas con problemas leves de hígado o para personas con problemas de riñones.","These doses are suitable for people with mild liver problems or people with kidney problems.",15,18
"1401","es","en","Estas hormonas se liberan después de las comidas y estimulan al páncreas para que produzca insulina.","Sitagliptin does not work when the blood glucose is low.",10,16
"1402","es","en","Estas inyecciones están justificadas aun cuando no tenga la certeza de que padece hipoglucemia.","These injections are justified even if it is not certain that you have hypoglycaemia.",14,14
"1403","es","en","Estas notas son un recordatorio.","These notes are a reminder.",5,5
"1404","es","en","Estas publicaciones, así como los ejemplares del Diario Oficial, podrán obtenerse en la siguiente dirección:","These publications, along with copies of the Official Journal, are available from:",12,15
"1405","es","en","Estas reacciones adversas son raras (menos de 1 de cada 1.000 pacientes tratados).","These side effects are rare (fewer than 1 in every 1,000 patients treated).",13,13
"1406","es","en","Estas reacciones pueden producirse muy pronto en la primera perfusión, pero también pueden producirse con perfusiones posteriores.","These reactions can occur very early in the first infusion, but may also occur with subsequent infusions.",17,17
"1407","es","en","Estas reacciones son a menudo transitorios.","These events are often transitory.",5,6
"1408","es","en","Estas recomendaciones se aplican a menos que su médico le haya dado instrucciones diferentes de cómo usar Zyrtec.","These guidelines apply unless your Doctor has given you different instructions on how to use Zyrtec.",16,18
"1409","es","en","Estas solicitudes han sido presentadas al CPMP para que las remita a sus grupos de trabajo.","These requests have been put to the CPMP to be addressed by its Working Parties.",15,16
"1410","es","en","Estas sustituciones sólo se observaron en presencia de sustituciones LVDr (rtM204 y rtL180M).","These substitutions were observed only in the presence of LVDr substitutions (rtM204V and rtL180M).",14,13
"1411","es","en","Este cambio puede ser permanente.","This change may be permanent.",5,5
"1412","es","en","Este cartucho se debe utilizar sólo con OptiClik.","This cartridge is for use with OptiClik only.",8,8
"1413","es","en","Este ciclo se repite tres veces más, seguido de cinco ciclos de inyecciones una vez por semana.","This cycle is repeated three more times, followed by five cycles of once-weekly injections.",14,17
"1414","es","en","Éste desaparece normalmente en dos o cuatro semanas.","This usually disappears within one to four weeks.",8,8
"1415","es","en","Este efecto adverso puede tener lugar especialmente al comienzo del tratamiento o al cambiar desde otro medicamento.","This can happen especially at the start of treatment, or when changing over from other preparations.",16,17
"1416","es","en","Este efecto es previsible y generalmente no obliga a interrumpir el tratamiento.","This effect is anticipated, and usually is not a reason to discontinue treatment.",13,12
"1417","es","en","Este efecto se mantuvo durante un máximo de cuatro años.","This effect was maintained for up to four years.",9,10
"1418","es","en","Este efecto se produjo junto a un aumento del 24% en el aclaramiento plasmático aparente de erlotinib.","In a phase I dose escalation study in NSCLC patients who were",12,17
"1419","es","en","Este evento tuvo un desenlace fatal 2 Ver sección 4.4: pancreatitis y lípidos","See section 4.4: pancreatitis and lipids",6,13
"1420","es","en","Este hecho es característico de los antimicóticos azólicos.","This is typical of azole antimycotics.",6,8
"1421","es","en","Este hecho se deberá tener en cuenta en los pacientes afectados por formas graves de fenilcetonuria.","Therefore this should be taken into consideration in patients affected with severe forms of phenylketonuria.",15,16
"1422","es","en","Este medicamento contiene 2,4 mmol de sodio por vial.","This medicinal product contains 2.4 mmol sodium per vial.",9,9
"1423","es","en","Este medicamento contiene lactosa monohidrato.","This product contains lactose monohydrate.",5,5
"1424","es","en","Este medicamento contiene menos de 1mmol (23 mg) de sodio por dosis, esto es, esencialmente “exento de sodio”.","This medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially ‘sodium-free’.",18,18
"1425","es","en","Este medicamento contiene metacresol, el cual puede causar reacciones alérgicas.","This medicine contains metacresol which may cause allergic reactions.",9,10
"1426","es","en","Este medicamento es de un solo uso. to","This medicinal product is for single use only. lo no",10,8
"1427","es","en","Este medicamento es idéntico a Cialis, ya autorizado en la Unión Europea (UE).","This medicine is the same as Cialis, which is already authorised in the European Union (EU).",16,13
"1428","es","en","Este medicamento está autorizado en los Estados Miembros del EEE bajo los siguientes nombres:","This medicinal product is authorised in the Member States of the EEA under the following names:",16,14
"1429","es","en","Este medicamento está autorizado en los estados miembros del Espacio Económico Europeo con los siguientes nombres:","Fentanyl-ratiopharm 25 µg/ h transdermales Matrixpflaster Fentanyl-ratiopharm 25 µg/ h Matrixpflaster",11,16
"1430","es","en","Este medicamento no debe mezclarse con otros excepto con los mencionados en la sección 6.6.","This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.",17,15
"1431","es","en","Este medicamento no debe mezclarse con otros.","This medicinal product must not be mixed with other medicinal products.",11,7
"1432","es","en","Este medicamento no requiere condiciones especiales de conservación.","This medicinal product does not require any special storage conditions.",10,8
"1433","es","en","Este medicamento tienen un efecto óptimo si se toma con el estómago vacío.","This medicine has the best effect when taken into empty stomach.",11,13
"1434","es","en","Este medicamento veterinario es únicamente para unción dorsal puntual.","This veterinary medicinal product is for spot-on application only.",9,9
"1435","es","en","Este mensajero está implicado en la inflamación y se concentra a altos niveles en pacientes con artritis reumatoide.","This messenger is involved in causing inflammation and is found at high levels in patients with rheumatoid arthritis.",18,18
"1436","es","en","Este paciente pudo continuar el tratamiento con BeneFIX sin aumento del inhibidor ni anafilaxis.","This patient was able to continue treatment with BeneFIX with no rise in inhibitor or anaphylaxis.",16,14
"1437","es","en","Este procedimiento de variación presentado por reconocimiento mutuo se inició el 7 de diciembre de 2006.","This Mutual Recognition variation procedure was started on 7 December 2006.",11,16
"1438","es","en","Este prospecto fue aprobado en","This leaflet was last approved in",6,5
"1439","es","en","Este prospecto fue aprobado en {Mes/ año}","This leaflet was last approved in {MM/ YYYY}",8,7
"1440","es","en","Este prospecto fue aprobado en {Mes/ año}.","This leaflet was last approved in {MM/ YYYY}.",8,7
"1441","es","en","Este prospecto fue aprobado en {mes/año}","This leaflet was last approved on {date}",7,6
"1442","es","en","Este prospecto fue aprobado en.","This leaflet was last approved.",5,5
"1443","es","en","Este prospecto ha sido","This leaflet was last approved in {MM/YYYY}",7,4
"1444","es","en","Este prospecto ha sido aprobado en","Lietuva Boehringer Ingelheim Pharma Ges mbH Tel.: +370 37 47 39 22",12,6
"1445","es","en","Este prospecto ha sido aprobado en {Mes/año}.","This leaflet was last approved in {MM/YYYY}.",7,7
"1446","es","en","Este prospecto ha sido aprobado en: ---------------------------------------------------------------------------------------------------------------------------- Esta información está destinada únicamente a médicos o profesionales sanitarios:","This leaflet was last approved in: ------------------------------------------------------------------------------------------------------------------------ The following information is intended for medical or healthcare professionals only:",18,17
"1447","es","en","Este síndrome se asoció temporalmente al comienzo de la terapia con rufinamida y en la población pediátrica.","This syndrome occurred in close temporal association to the initiation of rufinamide therapy and in the paediatric population.",18,17
"1448","es","en","Este sustituto actúa de la misma forma que el interferón alfa natural.","The replacement acts in same way as naturally produced interferon alpha.",11,12
"1449","es","en","Este tipo de administración de denomina perfusión intravenosa.","This is known as intravenous infusion.",6,8
"1450","es","en","Este último efecto clínico fue observado después de más de un año de tratamiento.","This latter clinical effect was observed after more than one year of treatment.",13,14
"1451","es","en","Este volumen de distribución relativamente alto indica una penetración eficaz en los líquidos y en los tejidos.","This relatively high distribution volume indicates an effective tissue and fluid penetration.",12,17
"1452","es","en","estimarse a partir de datos disponibles)*","Dizziness, headache, disturbance of taste",5,6
"1453","es","en","Esto aplica a bilis, riñón, vesícula biliar y tejido hepático.","This applies to gall, kidney, gall bladder and liver tissue.",10,10
"1454","es","en","Esto ayuda a su médico a diagnosticar y evaluar el grado de su enfermedad.","This helps your doctor make a diagnosis and evaluate the extent of your illness.",14,14
"1455","es","en","Esto da lugar a efectos nocivos como la inflamación y lesiones en los tejidos.","This results in harmful effects such as swelling and tissue damage.",11,14
"1456","es","en","Esto despolariza las células ß, produciendo una apertura de los canales de calcio.","The resulting increased calcium influx induces insulin secretion from the β -cell.",12,13
"1457","es","en","Esto es algo habitual con medicamentos como DaTSCAN.","This is normal practice with medicines like DaTSCAN.",8,8
"1458","es","en","Esto es aplicable también a los virus desconocidos o emergentes y a otros patógenos.","This also applies to unknown or emerging viruses and other pathogens.",11,14
"1459","es","en","Esto evitará la obstrucción de los tubos del sistema de diálisis.","This should avoid a blockage in the tubing of the dialysis system.",12,11
"1460","es","en","Esto impide que el virus se adhiera a la superficie de las células humanas y las infecte.","This prevents the virus from attaching to the surface of human cells and infecting them.",15,17
"1461","es","en","Esto incluye a la tuberculosis (TB).","This includes tuberculosis (TB).",4,6
"1462","es","en","Esto incluye, clamidia, herpes genital, verrugas genitales, gonorrea, hepatitis B, sífilis.","These include chlamydia, genital herpes, genital warts, gonorrhoea, hepatitis B, syphilis.",11,11
"1463","es","en","Esto mismo puede aplicarse a pacientes con la función hepática alterada.","The same applies to patients with altered hepatic function.",9,11
"1464","es","en","Esto no afecta al funcionamiento normal de la jeringa, que se puede girar dentro del dispositivo.","This does not affect normal operation of the syringe and the syringe can be rotated in the device..",18,16
"1465","es","en","Esto puede interferir con el resultado de los ensayos cruzados de comparación con sangre (ver sección 4.8.).","This may interfere with the performance of cross matching tests with blood (see section 4.8).",15,17
"1466","es","en","Esto puede prolongarse a 2 horas en pacientes que no están en ayunas.","This may be extended to 2 hours in fed patients.",10,13
"1467","es","en","Esto puede requerir la administración separada de la","This may require separate administration of hepatitis B vaccine and should follow official recommendations.",14,8
"1468","es","en","Esto se debe tener en cuenta en los pacientes con una dieta con sodio controlado.","This has to be taken into consideration for patients on a controlled sodium diet.",14,15
"1469","es","en","Esto se denomina Eliminación de Aire.","This is called performing the Air- Shot.",7,6
"1470","es","en","Esto se refleja en los hallazgos obtenidos en el estudio de fertilidad.","This is reflected by the findings from the fertility study.",10,12
"1471","es","en","Esto significa tomar 4 cápsulas por la mañana y otras 4 cápsulas por la noche.","This means taking 4 capsules in the morning then 4 capsules in the evening.",14,15
"1472","es","en","Esto suma en total un ciclo de tratamiento de 28 días.","This adds up to a 28- day treatment cycle.",9,11
"1473","es","en","Estos coágulos pueden ser peligrosos si se desplazan a otros lugares del organismo como los pulmones.","These clots can be dangerous if they move to another part of the body such as the lungs.",18,16
"1474","es","en","Estos datos no se consideran clínicamente significativos.","These data are not considered clinically significant.",7,7
"1475","es","en","Estos efectos adversos pueden ser intensos y pueden necesitar atención inmediata.","Such side effects may be serious and need immediate attention.",10,11
"1476","es","en","Estos efectos secundarios suelen desparecer en 1 a 2 días sin tratamiento.","These side effects usually disappear within one to two days without treatment.",12,12
"1477","es","en","Estos factores incluyen la mayor edad, sexo masculino, obesidad, fumar, vía de administración, y algunas enfermedades crónicas subyacentes.","These factors include older age, male gender, obesity, smoking, route of administration, and some chronic underlying diseases.",17,18
"1478","es","en","Estos fueron dependientes de la dosis.","These were dose- dependent.",4,6
"1479","es","en","Estos incrementos se encuentran posiblemente relacionados con los efectos sobre la musculatura esquelética.","These transaminase increases were likely to be related to the skeletal muscle effects.",13,13
"1480","es","en","Estos medicamentos pueden interferir con el efecto de Thelin.","These medicines may interfere with the effect of Thelin.",9,9
"1481","es","en","Estos pacientes se han tratado anteriormente con plasma humano y/ o factor VII de origen plasmático.","These patients have previously been treated with human plasma and/ or plasma-derived factor VII.",14,16
"1482","es","en","Estos pacientes ya estaban recibiendo una combinación de levodopa y entacapone (otro fármaco inhibidor de la COMT).","These patients were already receiving a combination of levodopa and entacapone (another medicine that blocks COMT).",16,17
"1483","es","en","Estos pueden indicar efectos adversos graves que pueden requerir atención médica urgente.","These may signal serious side effects that may need ur gent medical attention.",13,12
"1484","es","en","Estos pueden ser signos de una reacción alérgica.","may be the signs of an allergic reaction.",8,8
"1485","es","en","Estos síntomas pueden evitarse dejando el tratamiento gradualmente.","These symptoms can be avoided by stopping gradually.",8,8
"1486","es","en","Estos síntomas pueden indicar problemas con su hígado.","These symptoms may suggest problems with your liver.",8,8
"1487","es","en","Estos tres primeros meses constituyen el periodo mas crítico post-trasplante.","This first three months, is the most critical period post-transplantation. na",11,10
"1488","es","en","Estrada Consiglieri Pedroso, 69 A Queluz de Baixo PT-2734-503 Barcarena Tel: +351 21 43 68 835","Estrada Consiglieri Pedroso, 69 A Queluz de Baixo PT-2734-503 Barcarena Tel: +351 21 43 68 835",16,16
"1489","es","en","Estradiol (como hemihidrato) 0.5 mg + Noretisterona acetato 0.1 mg","Estradiol (as hemihydrate) 0.5 mg Film-coated tablets Oral use + Norethisterone acetate 0.1 mg",14,10
"1490","es","en","Estreñimiento, diarrea, náuseas, aumento y disminución del peso Frecuentes:","Constipation, diarrhoea, nausea, increase and decrease in weight Common:",9,9
"1491","es","en","ESTUCHE (ENVASE 14 DÍAS, ENVASE ÚNICO)","OUTER CARTON (14 DAY, SINGLE PACK)",6,6
"1492","es","en","ESTUCHE FRASCO X 30 COMPRIMIDOS RECUBIERTOS CON PELÍCULA (300 mg)","BOTTLE CARTON X 30 FILM-COATED TABLETS (300 mg)",8,10
"1493","es","en","Estudio H0648g: subgrupo de pacientes IHC3+ 3.","IHC3+ patient subset 3.",4,7
"1494","es","en","Estudios de negocios e idiomas en la Politécnica Loughborough Trayectoria profesional hasta la fecha:","Business studies and languages at Loughborough Polytechnic Career to date:",10,14
"1495","es","en","Estudios de posgrado en pediatría y doctorado en nutrición.","Post- graduate degree in paediatrics and a PhD in nutrition.",10,9
"1496","es","en","Estudios en conejos han mostrado toxicidad reproductiva (ver sección 5.3.).","Studies in rabbits have shown reproductive toxicity (see section 5.3).",10,10
"1497","es","en","Estudios farmacocinéticos preclínicos realizados en ratas evidencian la afinidad de vigabatrina por la melanina.","Preclinical pharmacokinetic studies in rats provide evidence of melanin binding of vigabatrin.",12,14
"1498","es","en","Estudios in vitro demuestran que rosiglitazona se metaboliza fundamentalmente por el CYP2C8, con una contribución menor del CYP2C9.","In vitro studies demonstrate that rosiglitazone is predominantly metabolised by CYP2C8, with a minor contribution by CYP2C9.",17,18
"1499","es","en","Estudios sobre el desarrollo en animales han demostrado efectos adversos (ver sección 5.3).","Developmental studies in animals have shown adverse effects (see section 5.3).",11,13
"1500","es","en","ETIQUETA 60 mg (todos los tamaños)","FOIL LABEL, 60 mg (ALL PACK SIZES)",7,6
"1501","es","en","ETIQUETA DEL FRASCO x 60 COMPRIMIDOS","BOTTLE LABEL x 60 FILM-COATED TABLETS",6,6
"1502","es","en","ETIQUETA DEL SOBRE - SEMANA 3","SACHET LABEL - WEEK 3",5,6
"1503","es","en","ETIQUETA DEL VIAL DE POLVO","VIAL LABEL FOR THE POWDER",5,5
"1504","es","en","ETIQUETA PARA FRASCOS QUE CONTIENEN 5 O 20 CAPSULAS DURAS DE TEMODAL 5 mg","LABEL FOR BOTTLES CONTAINING 5 OR 20 HARD CAPSULES OF TEMODAL 5 mg",13,14
"1505","es","en","ETIQUETADO Y PROSPECTO na co to en am dic Me","LABELLING AND PACKAGE LEAFLET tn uc rod lp ina dic Me",11,10
"1506","es","en","Etoricoxib no es dializable por hemodiálisis; se desconoce si puede serlo por diálisis peritoneal.","Etoricoxib is not dialysable by haemodialysis; it is not known whether etoricoxib is dialysable by peritoneal dialysis.",17,14
"1507","es","en","EU/ 2/ 99/ 015/ 002 Oxyglobin 130 mg/ ml","EU/ 2/ 99/ 015/ 002 Oxyglobin",6,9
"1508","es","en","EU/1/00/132/001 EU/1/00/132/002 EU/1/00/132/003 EU/1/00/132/004 EU/1/00/132/005 EU/1/00/132/026","EU/1/00/132/001 EU/1/00/132/002 EU/1/00/132/003 EU/1/00/132/004 EU/1/00/132/005 EU/1/00/132/026",6,6
"1509","es","en","EU/1/02/207/005- 2 jeringas precargadas EU/1/02/207/006- 7 jeringas precargadas","ut EU/ 1/ 02/ 207/ 005- 2 pre-filled syringes",9,8
"1510","es","en","EU/2/04/044/007 – 40 g EU/2/04/044/008 – 400 g","EU/2/04/044/007 - 40 g EU/2/04/044/008 - 400 g",8,8
"1511","es","en","EudraVigilance – Medicamentos veterinarios – Cuenta atrás en 2002","EudraVigilance – Veterinary – Countdown during",6,9
"1512","es","en","European Medicines Agency Evaluation of Medicines for Human Use","European Medicines Agency Evaluation of Medicines for Human Use",9,9
"1513","es","en","European Medicines Agency Veterinary Medicines","European Medicines Agency Veterinary Medicines",5,5
"1514","es","en","European Medicines Agency Veterinary Medicines and Inspections","European Medicines Agency Veterinary Medicines and Inspections",7,7
"1515","es","en","Evaluación en 60 días o menos Evaluación en 60-90 días","s Evaluation in 30-60 days",5,10
"1516","es","en","Evento(s) adverso(s) a partir de vigilancia post-comercialización con la vacuna pandémica: no procede.","Adverse event(s) from post-marketing surveillance with the pandemic vaccine: not applicable.",11,13
"1517","es","en","Evista está pensado para una utilización prolongada.","Evista is intended for long-term use.",6,7
"1518","es","en","Evitar la introducción de contaminación durante el uso.","Avoid introduction of contamination during use.",6,8
"1519","es","en","Evitar su uso en animales deshidratados, hipovolémicos o hipotensos ya que existe un riesgo potencial de toxicidad renal.","Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.",18,18
"1520","es","en","Evite el contacto directo con piel, ojos o boca.","Avoid direct contact with skin, eyes or mouth.",8,9
"1521","es","en","Evite situaciones en las que OptiSet puede estropearse.","Avoid situations where OptiSet might be damaged.",7,8
"1522","es","en","Exacerbación de una artritis reumatoide previa y de los síntomas de artritis Exploraciones complementarias","Rheumatoid arthritis and arthritic symptoms exacerbation Investigations",7,14
"1523","es","en","Exacerbación o empeoramiento del asma","Exacerbation or worsening of asthma",5,5
"1524","es","en","Exantema MedDRA versión 7.0","Rash MedDRA version 7.0",4,4
"1525","es","en","Excepcionalmente puede notar un ligero aumento del dolor óseo unos días después de la inyección de QUADRAMET.","You may exceptionally feel a slight increase in bone pain a few days after QUADRAMET injection.",16,17
"1526","es","en","Excepcionalmente, en pacientes con trombocitopenia o trastornos de la coagulación, la vacuna debe administrarse por vía subcutánea.","Exceptionally the vaccine may be administered subcutaneously in patients with thrombocytopenia or bleeding disorders.",14,17
"1527","es","en","Excipiente: cada cápsula de 400 mg contiene 149,6 mg de lactosa.","Each 400 mg capsule contains 149.6 mg of lactose.",9,11
"1528","es","en","Excipiente: cada comprimido contiene 0,834 mg de amarillo ocaso FCF (E110).","Each tablet contains 0.834 mg sunset yellow FCF (E110).",9,11
"1529","es","en","Excipientes con actividad reconocida: sorbitol (E420), acetato sódico.","Excipients known to have a recognised action: sorbitol (E420), sodium acetate.",11,8
"1530","es","en","Excipientes: la vacuna contiene 5 microgramos de tiomersal","It contains 5 micrograms thiomersal",5,8
"1531","es","en","Excipientes: maltosa, dihidrógeno fosfato sódico monohidrato y cloruro sódico","Excipients: maltose, sodium dihydrogen phosphate monohydrate and sodium chloride",9,9
"1532","es","en","Exelon 3,0 mg cápsulas duras","Exelon 3.0 mg hard capsules",5,5
"1533","es","en","Exelon no deberá administrarse al mismo tiempo que otros medicamentos con efectos similares a los suyos.","Exelon should not be given at the same time as other medicines with similar effects to Exelon.",17,16
"1534","es","en","Exforge 5 mg/ 80 mg","Exforge 5 mg/ 80 mg",5,5
"1535","es","en","Existen al menos dos mecanismos de resistencia a las tetraciclinas.","At least two mechanisms of resistance to tetracyclines exist.",9,10
"1536","es","en","Éxito global de tratamiento combinado para adultos y niños según la especie de Candida","Adults and Children Combined, Overall Treatment Success by Candida Species",10,14
"1537","es","en","Éxito global del tratamiento en el grupo de tratamiento por protocolo, estudio de candidiasis invasiva","Overall Treatment Success in the Per Protocol Set, Invasive Candidiasis Study",11,15
"1538","es","en","EXP (dd/ mm/ aa) Usar inmediatamente después de reconstitución.","EXP {month/ year} Use immediately after reconstitution.",7,9
"1539","es","en","Exponga esa pequeña área de piel a la luz solar durante 10 minutos.","Expose a small area of skin to sunlight for 10 minutes.",11,13
"1540","es","en","Extracción y eliminación de la aguja","Remove and discard the needle",5,6
"1541","es","en","Extraer la solución de Enbrel del vial","Withdrawing the Enbrel solution from the vial",7,7
"1542","es","en","Extraíga la dosis de insulina recetada en la jeringa","Draw the right dose of insulin into the syringe 5.",10,9
"1543","es","en","Eλλάδα Boehringer Ingelheim Ellas A. E.","Eλλάδα Boehringer Ingelheim Ellas A. E.",6,6
"1544","es","en","Fabbroni, 6 I-00191 Roma Italia","Fabbroni, 6 I-00191 Roma Italy",5,5
"1545","es","en","Fabrazyme es una solución para perfusión (goteo en vena) que contiene el principio activo agalsidase beta.","Fabrazyme is a solution for infusion (drip into a vein) containing the active substance agalsidase beta.",16,16
"1546","es","en","Fabricante que libera el lote:","Manufacturer for the batch release:",5,5
"1547","es","en","Fabricante responsable de la liberación de lote:","or Manufacturer responsible for batch release:",6,7
"1548","es","en","Factor VIII de coagulación de origen recombinante, 250 UI/ vial.","Recombinant Coagulation factor VIII, 250 IU/ vial.",7,10
"1549","es","en","Fareston es un medicamento que contiene el principio activo toremifeno.","Fareston is a medicine that contains the active substance toremifene.",10,10
"1550","es","en","Farmacocinética en poblaciones especiales de pacientes:","Pharmacokinetics in special patient populations:",5,6
"1551","es","en","Farmacocinética y metabolismo de los medicamentos:","Pharmacokinetics and Drug Metabolism:",4,6
"1552","es","en","farmacocinéticos no cambiaron tras dosificaciones múltiples durante 12 semanas (dosificación cada 1 ó 2 semanas).","change on multiple dosing over 12 weeks (dosing every week or every two weeks).",14,15
"1553","es","en","Fase 3, 26 semanas de tratamiento comparado con el placebo","Phase 3, 26 weeks of treatment compared to placebo",9,10
"1554","es","en","Fase crónica, diagnóstico reciente:","Chronic phase, newly diagnosed:",4,4
"1555","es","en","Faslodex está contraindicado durante el embarazo (ver sección 4.3).","Faslodex is contraindicated in pregnancy (see section 4.3).",8,9
"1556","es","en","Fasturtec funciona facilitando la eliminación del ácido úrico del cuerpo a través de los riñones.","Fasturtec works by allowing uric acid to more easily be removed from the body by the kidneys.",17,15
"1557","es","en","Fatiga Enfermedad pseudogripal Pirexia","Hydronephrosis Renal failure Urine abnormality",5,4
"1558","es","en","FECHA DE LA PRIMERA AUTORIZACIÓN / RENOVACIÓN DE LA AUTORIZACIÓN to","DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION",9,11
"1559","es","en","Fecha de la primera autorización:","Date of first authorisation:",4,5
"1560","es","en","FECHA DE LA REVISIÓN DEL TEXTO","Date of revision of the text",6,6
"1561","es","en","FECHA DE LA REVISIÓN DEL TEXTO n","DATE OF REVISION OF THE TEXT a in ic",9,7
"1562","es","en","Fecha de la última actualización del presente resumen: septiembre de 2008.","This summary was last updated in September 2008.",8,11
"1563","es","en","Fecha de la última renovación:","Date of last renewal:",4,5
"1564","es","en","FECHA EN QUE FUE APROBADO EL PROSPECTO POR ÚLTIMA VEZ","DATE ON WHICH PACKAGE LEAFLET WAS LAST APPROVED",8,10
"1565","es","en","Fecha: ____ SEMANA 2.","Date: ____ WEEK 2.",4,4
"1566","es","en","Feldene Dispersible 20 Mg, Comprimé Sécable","Feldene Dispersible 20 Mg, Comprimé Sécable",6,6
"1567","es","en","Femenino: amenorrea, menorragia, alteraciones menstruales,","General disorders and administration site conditions",6,5
"1568","es","en","Fentanilo Matrix ratiopharm 25 microgramos/ h parches transdérmicos EFG","Fentanilo Matrix ratiopharm 25 microgramos/ h parches transdérmicos EFG",9,9
"1569","es","en","Fentanyl ratiopharm 75 µg/ uur, pleister voor transdermaal gebruik","Fentanyl ratiopharm 75 µg/ uur, pleister voor transdermaal gebruik",9,9
"1570","es","en","Ferriprox se presenta en frascos de 100 comprimidos.","Ferriprox is packaged in bottles of 100 tablets.",8,8
"1571","es","en","Fertavid 600 UI/ 0,72 ml solución inyectable folitropina beta","Fertavid 600 IU/ 0.72 ml solution for injection follitropin beta",10,9
"1572","es","en","Fertilidad En estudios de fertilidad con gemcitabina se produjo hipoespermatogénesis en ratones macho (ver sección 5.3).","Fertility In fertility studies gemcitabine caused hypospermatogenesis in male mice (see section 5.3).",13,16
"1573","es","en","Fibrilación atrial, Isquemia cardiaca/infarto","Flushing, Hypotension, Hypertensive crisis",4,4
"1574","es","en","FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO","SUMMARY OF PRODUCT CHARACTERISTICS",4,9
"1575","es","en","FICHA TÉCNICA O RESUMEN DE LAS CARACTERISTICAS DEL PRODUCTO, ETIQUETADO Y PROSPECTO","SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET",8,12
"1576","es","en","Ficha Técnica o Resumen de las Características del Producto, sección 4.2)","Summary of Product Characteristics, section 4.2)",6,11
"1577","es","en","Ficha técnica o Resumen de las Características del Producto, sección 4.2).","Summary of Product Characteristics, section 4.2).",6,11
"1578","es","en","Filgrastim HEXAL se puede diluir, si es necesario, en una solución glucosa de 50 mg/ ml (al 5%).","If required, Filgrastim HEXAL may be diluted in glucose 50 mg/ ml (5%) solution.",14,18
"1579","es","en","Final EU recommendations for the Influenza vaccine composition for the season 2000/2001 Adoptada en abril de 2000","Final EU recommendations for the Influenza vaccine composition for the season 2000/2001 Adopted April 2000",15,17
"1580","es","en","Firazyr siempre debe ser inyectado por personal médico o de enfermería.","Firazyr will always be injected by your doctor or nurse.",10,11
"1581","es","en","Fleming, 2 37135 Verona – Italia","Fleming, 2 37135 Verona Italy",5,6
"1582","es","en","Fluoxetina tiene un perfil farmacocinético no lineal con efecto hepático de primer paso.","Fluoxetine is well absorbed from the gastrointestinal tract after oral administration.",11,13
"1583","es","en","Focetria es una vacuna “ de prueba”.","Focetria is a ‘ mock-up’ vaccine.",6,7
"1584","es","en","folletos o prospectos de los envases de dichos medicamentos;","leaflets or inserts for these medicinal products;",7,9
"1585","es","en","Fondaparinux no se une significativamente a otras proteínas plasmáticas, incluyendo el factor 4 plaquetario (FP4).","Fondaparinux does not bind significantly to other plasma proteins, including platelet factor 4 (PF4).",14,15
"1586","es","en","FORMA DE ADMINISTRACIÓN am","METHOD OF ADMINISTRATION ct",4,4
"1587","es","en","Forma de administración Raptiva se administra por vía subcutánea.","Method of administration Raptiva is for subcutaneous injection.",8,9
"1588","es","en","FORMA FARMACÉUTICA Y CONTENIDO DEL ENVASE","PHARMACEUTICAL FORM AND CONTENTS",4,6
"1589","es","en","FORMA FARMACÉUTICA Y VÍA(S) DE ADMINISTRACIÓN","METHOD AND ROUTE(S) OF ADMINISTRATION",5,6
"1590","es","en","Forma parte de un tratamiento que reduce la cantidad de virus en la sangre.","It is part of a treatment reducing the amount of virus in the blood.",14,14
"1591","es","en","FORMA Y VÍA(S) DE ADMINISTRACIÓN","METHOD AND ROUTE OF ADMINISTRATION",5,5
"1592","es","en","FORMA Y VÍA(S) DE ADMINISTRACIÓN co","METHOD AND ROUTE(S) OF ADMINISTRATION t uc",7,6
"1593","es","en","Formistin, Virlix, Zirtec 10 mg compresse rivestite con film Letonia:","Formistin, Virlix, Zirtec 10 mg compresse rivestite con film Latvia:",10,10
"1594","es","en","Fort Dodge Animal Health","Fort Dodge Animal Health",4,4
"1595","es","en","Fort Dodge Animal Health Holland C. J. van Houtenlaan 36 NL-1381 CP Weesp Países Bajos","Marketing authorisation holder Fort Dodge Animal Health Holland C. J. van Houtenlaan 36 NL-1381 CP Weesp The Netherlands",18,15
"1596","es","en","Fort Dodge Laboratories (Ireland) Finisklin Industrial Estate Sligo Irlanda","Fort Dodge Laboratories (Ireland) Finisklin Industrial Estate Sligo Ireland",9,9
"1597","es","en","FORTZAAR Cozaar Comp Cozaar Comp Forte Fortzaar 100 mg/ 25 mg film-coated tablets","FORTZAAR Cozaar Comp Cozaar Comp Forte Fortzaar 100 mg/ 25 mg film-coated tablets",13,13
"1598","es","en","Fosavance Fosavance Fosavance Fosavance Fosavance Fosavance Fosavance Fosavance Fosavance","Fosavance Fosavance Fosavance Fosavance Fosavance Fosavance Fosavance Fosavance Fosavance",9,9
"1599","es","en","Fosfato cálcico dibásico anhidro Celulosa microcristalina Sílice coloidal anhidra Estearato de magnesio Croscarmelosa sódica.","Dibasic calcium phosphate, anhydrous Micro crystalline cellulose Colloidal silica, anhydrous Magnesium stearate Croscarmellose sodium",14,14
"1600","es","en","Fosfato sódico monobásico, monohidratado polisorbato 20 cloruro sódico hidróxido de sodio agua para inyecciones","Sodium phosphate monobasic, monohydrate polysorbate 20 sodium chloride sodium hydroxide water for injections",13,14
"1601","es","en","France 92 rue Baudin F-92300 Levallois-Perret to","ge France 92 rue Baudin",5,7
"1602","es","en","France Bayer Santé Tél. +33 3 20 20 80 80","France Bayer Santé Tél. +33 3 20 20 80 80",10,10
"1603","es","en","France Laboratoires Merck Sharp & Dohme – Chibret Tél: +33 (0) 1 47 54 87 00 contact@msd-france. com","France Laboratoires Merck Sharp & Dohme – Chibret Tél: +33 (0) 1 47 54 87 00 contact@msd-france. com",18,18
"1604","es","en","France UCB Pharma S. A.","France UCB Pharma S.A.",4,5
"1605","es","en","Frances NUTTALL Gerard O’MALLEY","Andreas POTT* Frances NUTTALL Gerard O’MALLEY",6,4
"1606","es","en","Francia Laboratoire GlaxoSmithKline 100 route de Versailles 78163 Marly- le- roi Cedex, Francia","France Laboratoire GlaxoSmithKline 100 route de Versailles 78163 Marly- le- roi Cedex France",13,13
"1607","es","en","Frasco (vidrio o PET) Frasco (vidrio o PET) Vial (vidrio)","Bottle (glass or PET) Bottle (glass or PET) Vial (glass)",10,10
"1608","es","en","Frasco contiene 45 mg de 13C-urea","Jar contains 45 mg 13C-Urea",5,6
"1609","es","en","Frasco de HDPE con cierre de seguridad para niños.","HDPE bottles with a child resistant closure.",7,9
"1610","es","en","Frecuencia desconocida • Depresión de la médula ósea (granulocitopenia, agranulocitosis, anemia aplásica y trombocitopenia) • Eosinofilia","Bone marrow depression (granulocytopenia, agranulocytosis, aplastic anemia thrombocytopenia) Eosinophilia",9,16
"1611","es","en","Frecuencia no conocida: dolor abdominal, hematoquecia, úlcera bucal.","Not known: abdominal pain, haematochezia, mouth ulcer.",7,8
"1612","es","en","Frecuencias de las reacciones adversas identificadas en los datos bibliográficos.","Frequency of adverse reactions identified from literature data Adverse reaction",10,10
"1613","es","en","Frecuente (≥ 1/ 100, < 1/ 10) Frecuente (≥ 1/ 100, < 1/ 10)","Common (> 1% ,< 10%) Common (> 1% ,< 10%)",10,14
"1614","es","en","Frecuente: diarrea, sequedad de boca, nausea Poco frecuente: dolor abdominal","common: dry mouth, nausea, diarrhoea uncommon:, abdominal pain",8,10
"1615","es","en","Frecuentes (≥ 1/ 100 a < 1/ 10) • Hipotensión ortostática","Vascular disorders General disorders and administration site conditions",8,11
"1616","es","en","Frecuentes (≥ 1/ 100, < 1/ 10)","Common (≥ 1/ 100 to < 1/ 10)",8,7
"1617","es","en","frecuentes (≥ 1/100, < 1/10) en ensayos clínicos en pacientes tratados con PegIntron en","These adverse reactions were common (≥1/100 to < 1/10) in clinical trials in patients treated with PegIntron monotherapy.",18,14
"1618","es","en","Frecuentes Cansancio, edema (hinchazón), náuseas, vómitos, erupción cutánea, picor, mareo, depresión, sangrado uterino, secreción vaginal de fluido blanco.","Common side effects Fatigue, oedema (swelling), nausea (feeling sick), vomiting, rash, itching, dizziness, depression, uterine bleeding, white discharge.",18,18
"1619","es","en","Frecuentes: - hipoestesia, problemas de atención, temblores.","Common: -hypoaesthesia, disturbance in attention, tremor.",6,7
"1620","es","en","Frecuentes: § Ver sección 4.4","ori Injury and poisoning Common: §",6,5
"1621","es","en","Frecuentes: bronquitis Poco frecuentes trastornos respiratorios","Respiratory, thoracic and mediastinal disorders: common: bronchitis uncommon: respiratory disorder",10,6
"1622","es","en","Frecuentes: hiperlactatemia asintomática; Desconocida: acidosis láctica","Common: asymptomatic hyperlactatemia, Not known: lactic acidosis",7,6
"1623","es","en","Frecuentes: hipomagnesemia, hiperpotasemia, hiperglucemia.","Common: hypomagnesaemia, hyperkalaemia, hyperglycaemia.",4,4
"1624","es","en","Frecuentes: manchas en la piel, picor, sudoración","Common: rash, itching, sweating",4,7
"1625","es","en","Frecuentes: sueño anormales, trastornos del sueño 5 * Ver más abajo información adicional.","abnormal dreams, sleep disorder",4,13
"1626","es","en","Frecuentes: tinnitus Muy raras: pérdida de audición sensorineural, vértigo","Very rare*: sensorineural hearing loss, vertigo",6,9
"1627","es","en","Fresenius Kabi 2 mg/ ml, Solución para perfusión","Solution for infusion Intravenous use",5,8
"1628","es","en","Fresenius Kabi Austria GmbH, Hafnerstraße 36, A-8055 Graz, Austria Tel-No.:","Fresenius Kabi Austria GmbH, Hafnerstraße 36, A-8055 Graz, Austria Tel-No.:",10,10
"1629","es","en","Frote la parte superior del frasco con un algodón impregnado en alcohol.","Wipe the top of the vial with an alcohol swab.",10,12
"1630","es","en","Fue nombrado Jefe de Sector el 1 de mayo de 2002.","Chapter 1 EMEA in the European system",7,11
"1631","es","en","Fue nombrado presidente del Comité de Medicamentos Huérfanos en mayo de 2000.","He was elected Chairperson of the Committee for Orphan Medicinal Products in May 2000.",14,12
"1632","es","en","Fuera del ámbito de aplicación del Reglamento (EC) 2377/ 90","Not within the scope of Council Regulation (EC) 2377/ 90",10,10
"1633","es","en","Fujisawa GmbH Neumarkter Str.","Fujisawa GmbH** Neumarkter Str.",4,4
"1634","es","en","Fulvestrant es un antagonista competitivo del receptor estrogénico (RE) con una afinidad comparable a estradiol.","Mechanism of action Fulvestrant is a competitive estrogen receptor (ER) antagonist with an affinity comparable to estradiol.",17,15
"1635","es","en","Fuzeon no está recomendado en niños menores de seis años.","Fuzeon is not recommended for use in children under six years of age.",13,10
"1636","es","en","G04B E Disfunción de la erección","G04B E Erectile dysfunction",4,6
"1637","es","en","Gabriel Beechinor es su sucesor.","He is succeeded by Mr Gabriel Beechinor.",7,5
"1638","es","en","Galvus redujo la concentración de HbA1c en todos los estudios.","Galvus reduced levels of HbA1c in all studies.",8,10
"1639","es","en","Ganancia de ≥ 15 letras de agudeza visual (%)a","Gain of ≥ 15 letters in visual acuity (%)a",9,9
"1640","es","en","Gap Ae Agisilaou 46 Agios Dimitrios 17341 Grecia","Gap Ae Agisilaou 46 Agios Dimitrios 17341 Greece",8,8
"1641","es","en","Gatos: tratamiento de vermes redondos intestinales adultos (Toxocara cati) y adultos de vermes intestinales con ganchos (Ancylostoma tubaeforme).","Cats: treatment of adult roundworms (Toxocara cati) and adult intestinal hookworms (Ancylostoma tubaeforme).",13,18
"1642","es","en","Gelatina Laurilsulfato de sodio Dióxido de titanio (E171) Indigo carmín (E132) Tinta verde comestible.","Gelatin Sodium Lauryl Sulfate Titanium Dioxide (E171) Indigo Carmine (E132) Edible Green Ink",13,14
"1643","es","en","Gemcitabina más cisplatino (N=200)","Gemcitabine plus cisplatin arm (N=200)",5,4
"1644","es","en","Gemzar 1.000 mg polvo para solución para perfusión","Gemzar 1000 mg powder for solution for infusion",8,8
"1645","es","en","General approach to testing","General approach to testing",4,4
"1646","es","en","General considerations for clinical trials","General considerations for clinical trials",5,5
"1647","es","en","Generales Galvus no es un sustituto de la insulina en pacientes que requieran insulina.","General Galvus is not a substitute for insulin in insulin-requiring patients.",11,14
"1648","es","en","Generalmente remiten en 4 días.","In general this disappears within 4 days.",7,5
"1649","es","en","Generalmente son de leves a moderados y más frecuentes al inicio del tratamiento.","This is generally mild to moderate and is more common at the start of your treatment.",16,13
"1650","es","en","Generalmente, estas reacciones se produjeron durante la perfusión o en el curso de la hora siguiente.","These reactions usually occurred during the infusion or up to 1 hour after completion of the infusion.",17,16
"1651","es","en","Generalmente, estos síntomas son de leves a moderados; sin embargo, en algunos pacientes pueden ser de intensidad grave.","Generally, these symptoms are mild to moderate; however, in some patients they may be severe in intensity.",17,18
"1652","es","en","Genotipo 2/ 3/ 4 (n=26)","Genotype 2/ 3/ 4 (n=26)",5,5
"1653","es","en","Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland","Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland",11,11
"1654","es","en","Gestión y divulgación de documentos","Document management and dissemination",4,5
"1655","es","en","Gilead Sciences Internati onal Limited Cambridge CB21 6GT Reino Unido","Gilead Sciences International Limited Cambridge CB21 6GT United Kingdom",9,10
"1656","es","en","Girando el selector de dosis no inyectará insulina.","Turning the dose selector will not inject insulin.",8,8
"1657","es","en","Girar el capuchón 1 vuelta completa hasta que el indicador de dosis vuelva a marcar 0.","Turn the cap round 1 full turn, so 0 is opposite the dosage indicator again.",15,16
"1658","es","en","Girar suavemente el vial unas cuantas veces, hasta que el contenido esté completamente disuelto.","Gently swirl the vial a few times until the content is completely dissolved.",13,14
"1659","es","en","Gire la aguja para acoplarla al conector Luer.","Twist to lock the needle to the Luer connector.",9,8
"1660","es","en","Glivec 100 mg comprimidos recubiertos con película Imatinib","Glivec 100 mg film-coated tablets Imatinib",6,8
"1661","es","en","global = 6. 0 meses","Median OS = 6.4 months",5,5
"1662","es","en","glucémico inadecuado independientemente de la dosis máxima tolerada de metformina en monoterapia.","despite maximal tolerated dose of monotherapy with metformin",8,12
"1663","es","en","GLUCOPHAGE 500 mg, comprimido con cubierta pelicular.","GLUCOPHAGE 500 mg film-coated tablet.",5,7
"1664","es","en","Glustin 30 mg comprimidos Pioglitazona (como HCl)","Glustin 30 mg tablets Pioglitazone (as HCl)",7,7
"1665","es","en","Goma laca, Propilenglicol, Hidróxido de amonio, Agente colorante (E 132).","Shellac, Propylene glycol, Ammonium hydroxide, Colouring agent (E 132).",9,10
"1666","es","en","GONAL-f 1050 UI/ 1,75 ml (77 microgramos/ 1,75 ml) polvo y disolvente para solución inyectable.","GONAL-f 1050 IU/ 1.75 ml (77 micrograms/ 1.75 ml) powder and solvent for solution for injection.",16,15
"1667","es","en","GONAL-f 450 UI/ 0,75 ml (33 microgramos/ 0,75 ml) solución inyectable en pluma precargada.","GONAL-f 450 IU/ 0.75 ml (33 micrograms/ 0.75 ml) solution for injection in a pre-filled pen.",16,14
"1668","es","en","GONAL-f no está indicado si está embarazada o está dando de mamar.","GONAL-f is not indicated if you are pregnant or are breast-feeding.",11,12
"1669","es","en","Gonazon contiene azagly-nafarelina, que es un análogo de una hormona natural llamada hormona liberadora de gonadotropinas (GnRH).","Gonazon contains azagly-nafarelin, which is an analogue of a natural hormone called gonadotrophin- releasing hormone (GnRH).",16,17
"1670","es","en","GOSCIKOVA Schurmanova 15 SK-949 010 Nitra Tel:","GOSCIKOVA Schurmanova 15 SK-949 010 Nitra Tel:",7,7
"1671","es","en","Gran via de les Cortes Catalanes, 649 Despacho, n°1 E-08010 Barcelona Espanha Tel: +34 93 342 51 20","Gran via de les Cortes Catalanes, 649 Despacho, n°1 E-08010 Barcelona Espanha Tel: +34 93 342 51 20",18,18
"1672","es","en","Granulado para administración en agua de bebida para pollos (sobre de 400 g)","Granules for use in drinking water for chickens (400 g sachet)",11,13
"1673","es","en","Grootslag 1-5, Nl-3991 RA Houten, Holanda","Grootslag 1-5, NL-3991 RA, Houten The Netherlands",7,6
"1674","es","en","Grupo de trabajo ""Biotecnología"" (BWP)","Biotechnology Working Party (BWP)",4,5
"1675","es","en","Grupo de trabajo « Seguridad »","Safety Working Party 2 The Safety Working Party (SWP), chaired by Dr P.",13,6
"1676","es","en","Grupo de trabajo «Medicamentos veterinarios inmunológicos» (IWP)","s Very dissatisfied s Satisfied",5,7
"1677","es","en","Grupo de trabajo del CPMP “ Biotecnología”","CPMP Biotechnology Working Party",4,7
"1678","es","en","Grupo de trabajo del CPMP “ Seguridad” Número de referencia CPMP/ SWP/ 2600/ 01","CPMP Safety Working Party",4,14
"1679","es","en","Grupo farmacoterapéutico: antibacterianos para uso sistémico (cefalosporinas).","Antibacterials for systemic use (cephalosporins).",5,7
"1680","es","en","Grupo farmacoterapéutico: factor VIII de la coagulación (Código ATC B02B D02).","Pharmacotherapeutic group: blood coagulation factor VIII (ATC-Code B02B D02).",9,11
"1681","es","en","Grupo farmacoterapéutico: insulina y análogos, de acción rápida.","Pharmacotherapeutic group: insulin and analogues, fast-acting.",6,8
"1682","es","en","Grupo farmacoterapéutico: medicamento antidiabético.","Pharmacotherapeutic group: antidiabetic agent.",4,4
"1683","es","en","Grupo farmacoterapéutico: medicamentos para el tratamiento de enfermedades óseas, bifosfonatos.","Drugs for treatment of bone diseases, bisphosphonates.",7,10
"1684","es","en","Grupo farmacoterapéutico: otros preparados cardíacos, código ATC:","Pharmacotherapeutic group: other cardiac preparations, ATC code:",7,7
"1685","es","en","Grupo farmacoterapéutico: vacunas virales Código ATC:","Pharmacotherapeutic group: viral vaccines ATC code:",6,6
"1686","es","en","GSK d. o. o., Ljubljana, Knezov stradon 90, 1000 Ljubljana, Slovenia","GSK d. o. o., Ljubljana, Knezov stradon 90, 1000 Ljubljana, Slovenia",11,11
"1687","es","en","Guarde los medicamentos donde los niños no puedan verlos ni cogerlos.","Keep out of the reach and sight of children.",9,11
"1688","es","en","Guárdela en un lugar seguro, preferentemente en la caja original.","Store the GONAL-f pre- filled pen in a safe place, preferably in the original package.",15,10
"1689","es","en","H-1113 Budapest Tel: +36-1-463-8100","H-1113 Budapest Tel: +36-1-463-8100",4,4
"1690","es","en","H-2045 Törökbálint, Tó Park Tel.: +36 23 513-800","H-2045 Törökbálint, Tó Park Tel.: +36 23 513-800",8,8
"1691","es","en","Habitualmente, el SHO se resuelve espontáneamente al comenzar la menstruación.","Usually, OHSS resolves spontaneously with the onset of menses.",9,10
"1692","es","en","Hable con su médico y su enfermera responsables del tratamiento de su diabetes sobre su requerimiento de insulina.","Talk about your insulin needs with your doctor and diabetes nurse.",11,18
"1693","es","en","Hacer una incisión, de aproximadamente 5 mm de longitud, a lo largo del extremo elevado del implante.","Make a stab incision, approximately 5 mm long, along the elevated near end of the implant.",16,17
"1694","es","en","Haga descender lentamente el émbolo para inyectar todo el disolvente en el vial de BeneFIX.","Slowly depress the plunger rod to inject all the solvent into the BeneFIX vial",14,15
"1695","es","en","Hasta 0,05 mg/ kg de peso corporal administrados diariamente por inyección subcutánea.","Up to 0.05 mg/ kg bodyweight given as a daily subcutaneous injection.",12,12
"1696","es","en","Hay cuatro presentaciones distintas (frascos que contienen 30, 60, 100 ó 500 comprimidos).","There are four different pack sizes (bottles containing 30, 60, 100 or 500 tablets).",14,13
"1697","es","en","Hay pocos datos disponibles acerca de la sobredosis con RoActemra.","There are limited data available on overdose with RoActemra.",9,10
"1698","es","en","Hay que tener cuidado cuando empiece a tomar otro medicamento y también, cuando deje de tomarlo.","Be careful when you start or stop taking another medicine.",10,16
"1699","es","en","Hay-on-Wye HR3 5PG Reino Unido","Hay-on-Wye HR3 5PG United Kingdom",5,5
"1700","es","en","Helicobacter Test INFAI 75 mg","Helicobacter Test INFAI 75 mg",5,5
"1701","es","en","Helixate NexGen 500 UI debe administrarse únicamente por vía intravenosa, inmediatamente después de su reconstitución.","Helixate NexGen 500 IU is intended for intravenous administration only and must be administered immediately after reconstitution.",17,15
"1702","es","en","Hematoma en el lugar de punción del vaso Hemorragia en el lugar de punción","Vessel puncture site haematoma Puncture site haemorrhage",7,14
"1703","es","en","Hemiplejía, ataxia, alteración en la coordinación, trastorno de la marcha, hiperestesia, trastorno sensorial","Hemiplegia, ataxia, coordination abnormal, gait abnormal, hyperesthesia, sensory disturbance",9,13
"1704","es","en","Hemorragia gastrointestinal y retroperitoneal que puede producir la muerte, pancreatitis, colitis (incluyendo colitis ulcerosa o linfocítica), estomatitis.","Gastrointestinal and retroperitoneal haemorrhage with fatal outcome, pancreatitis,",8,17
"1705","es","en","Hemorragia rectal, gastritis, vómitos, dispepsia, distensión abdominal, estreñimiento.","rectal haemorrhage, gastritis, vomiting, dyspepsia, abdominal bloating, constipation,",8,8
"1706","es","en","Hemorragia retiniana, trastornos oculares NOS, visión borrosa, fotofobia, cromatopsia, cianopsia, irritación ocular, ojos inyectados de sangre/ ojos rojos","Retinal haemorrhage, visual disturbance NOS, blurred vision, photophobia, chromatopsia, cyanopsia, eye irritation, blood shot eyes/ red eyes",17,18
"1707","es","en","Hemorragia, edema, edema de piernas","Haemorrhage, oedema, oedema leg",4,5
"1708","es","en","Henrique de Barros - Edf.","Henrique de Barros - Edf.",5,5
"1709","es","en","Hepatitis, anomalías en la función hepática","Hepatitis, abnormal liver function",4,6
"1710","es","en","Hexal AG Industriestrasse 25 83607 Holzkirchen Germany","Hexal AG Industriestrasse 25 83607 Holzkirchen Germany",7,7
"1711","es","en","HEXAVAC - jeringa precargada monodosis con 2 agujas separadas - Envase de 1","HEXAVAC - single dose pre-filled syringe with 2 separate needles - Pack of 1",14,13
"1712","es","en","Hidroxibenzoato de metilo (E218) e hidroxibenzoato de propilo (E216) pueden producir reacciones alérgicas (posiblemente retardadas).","Methyl hydroxybenzoate (E218) and propyl hydroxybenzoate (E216) may cause allergic reactions (possibly delayed).",13,15
"1713","es","en","Hidróxido de sodio Todas las especies de alimentos","Ethanol8 Poloxamer 1889 Macrogol 300 Glycine10 Disodium edetate Sodium Hydroxide11 Hydrochloric acid Water for injection12 Nitrogen13",16,8
"1714","es","en","Hikma Farmacêutica (Portugal), Lda.","Hikma Farmacêutica (Portugal) Lda.",4,4
"1715","es","en","HIPERGLUCEMIA (niveles altos de azúcar en sangre)","HYPERGLYCAEMIA (high blood sugar levels)",5,7
"1716","es","en","Hiperhidrosis primaria de la axila","The lowest effective dose should be used.",7,5
"1717","es","en","Hiperpotasemia Se ha observado hiperpotasemia en algunos pacientes tratados con inhibidores de la ECA, incluido TRITAZIDE.","Hyperkalaemia Hyperkalaemia has been observed in some patients treated with ACE inhibitors including TRITAZIDE.",14,16
"1718","es","en","Hipersensibilidad a estavudina o a alguno de los excipientes.","Hypersensitivity to stavudine or to any of the excipients.",9,9
"1719","es","en","Hipersensibilidad a insulina lispro o a alguno de sus excipientes.","Hypersensitivity to insulin lispro or to any of the excipients.",10,10
"1720","es","en","Hipersensibilidad a lamotrigina o a cualquiera de los excipientes de la formulación.","Hypersensitivity to the active substance or to any of the excipients.",11,12
"1721","es","en","Hipersensibilidad a los principios activos o a alguno de los excipientes.","Hypersensitivity to the active substances, or to any of the excipients.",11,11
"1722","es","en","Hipersensibilidad al principio activo o a alguno de los excipientes (ver sección 6.1).","Hypersensitivity to the active substance or to any of the excipients (see section 6.1).",14,13
"1723","es","en","Hipersensibilidad al principio activo o a alguno de los excipientes o a loratadina.","Hypersensitivity to the active substance, to any of the excipients, or to loratadine.",13,13
"1724","es","en","Hipersensibilidad conocida a otros excipientes.","Hypersensitivity to any of the excipients.",6,5
"1725","es","en","Hipofosfatemia Aumento de la creatinina y urea sanguíneas, hipocalcemia","Hypophosphataemia Blood creatinine and blood urea increased, hypocalcaemia",8,9
"1726","es","en","HIPOGLUCEMIA (bajos niveles de azúcar en sangre)","HYPOGLYCAEMIA (low blood sugar levels)",5,7
"1727","es","en","Hipoxia Derrame pleural Disnea Rinorrea","Hypoxia Pleural effusion Dysphonia Rhinorrhoea",5,5
"1728","es","en","Hipromelosa Macrogol 400 Dióxido de titanio (E171) Óxido de hierro amarillo (E172) Óxido de hierro rojo (E172).","Hypromellose Macrogol 400 Titanium dioxide (E171) Iron oxide yellow (E172) Iron oxide red (E172).",14,17
"1729","es","en","Hoechst AG Brüningstrasse 50 D-65929 Frankfurt","Hoechst AG Brüningstrasse 50 D-65929 Frankfurt",6,6
"1730","es","en","Hoechst Pharma S. p. A Via R.","Hoechst Pharma S. p. A Via R.",7,7
"1731","es","en","Homburg v. d. H. ,Alemania. perfusión Tel-No.:","Homburg v. d. H. ,Germany infusion Tel-No.:",7,7
"1732","es","en","Hörgatúni 2 IS-210 Garðabær Tel: +354 535 7000","Hörgatúni 2 IS-210 Garðabær Tel: +354 535 7000",8,8
"1733","es","en","Howmedica International S. de R.","Howmedica International S. de R.",5,5
"1734","es","en","http: / /www. pheur. org","http: / /www. pheur. org",5,5
"1735","es","en","Humalog BASAL Pen 100 U/ml suspensión inyectable insulina lispro","Humalog BASAL 100 U/ml Pen suspension for injection (insulin lispro)",10,9
"1736","es","en","Humalog Mix es una mezcla de estas dos formulaciones.","Humalog Mix is a mixture between these both formulations.",9,9
"1737","es","en","Humalog Mix50 100 U/ml, suspensión para inyección en vial se presenta en un formato de 1 vial.","Humalog Mix50 100 U/ml suspension for injection in vial comes in a pack of 1 vial.",16,17
"1738","es","en","Humira también se encuentra disponible en jeringa precargada o en pluma precargada.","Humira is also available as a pre-filled syringe or a pre-filled pen.",12,12
"1739","es","en","Huntercombe Lane South Taplow, Maidenhead Berkshire, SL6 0PH United Kingdom","Huntercombe Lane South Taplow, Maidenhead Berkshire, SL6 0PH United Kingdom",10,10
"1740","es","en","HYCAMTIN 1 mg está disponible en envases que contienen 1 vial y 5 viales.","HYCAMTIN 1 mg is available in cartons containing 1 vial and 5 vials.",13,14
"1741","es","en","Ibaflin 900 mg 0,5 1","Ibaflin 900 mg 0.5 1",5,5
"1742","es","en","ic EU/ 1/ 99/ 128/ 011","al IU/ 0.5ml EU/ 1/ 99/ 128/ 011",8,6
"1743","es","en","IDflu 9 µg/ cepa Vacuna antigripal Suspensión inyectable Campaña 2006/ 2007 Vía intradérmica","IDflu 9 µg/ strain suspension for injection Influenza vaccine Strains 2006/ 2007 Intradermal use",14,13
"1744","es","en","IDV + ZDV + 3TC ª NC=F no completó b","Responder rates (NC = Fa) Plasma HIV-RNA",7,10
"1745","es","en","Igual que arriba Igual que arriba Igual que arriba","Frequency and route Recommended dose of administration",7,9
"1746","es","en","Incidencia de fracturas vertebrales clínicas DMO: diferencia media a los 3 años con respecto al valor lumbar basal","Incidence of clinical vertebral fracture BMD – mean change relative to baseline lumbar spine at year 3",17,18
"1747","es","en","Incidencia en pacientes Muy poco frecuentes (≤ 1/ 10,000):","Subject Incidence Very rare (≤ 1/ 10,000):",7,9
"1748","es","en","Incluso a niveles séricos muy elevados, no se han observado síntomas de sobredosis.","Even at very high serum levels, no symptoms of overdose have been observed.",13,13
"1749","es","en","Incontinencia urinaria, hematuria, poliuria, frecuencia de micción incrementada/ polaquiuria, alteraciones en la orina","Uncommon: urinary incontinence, haematuria, polyuria, urine frequency/ pollakiuria, abnormality",9,13
"1750","es","en","INCRELEX 10 mg/ml solución inyectable Mecasermina","INCRELEX 10 mg/ml solution for injection Mecasermin",7,6
"1751","es","en","Incremento FIX (UI/ d por UI/ kg)","FIX increase (IU/ dl per IU/ kg)",7,7
"1752","es","en","Indinavir 800 mg Q8H X 7 días","Indinavir 800 mg Q8H X 7 days",7,7
"1753","es","en","Indinavir se eliminó rápidamente, con una semivida de 1,8 horas.","Indinavir was rapidly eliminated with a half– life of 1.8 hours.",11,10
"1754","es","en","Industriepark 30 2220 Heist op den Berg Bélgica","Industriepark 30 2220 Heist op den Berg Belgium",8,8
"1755","es","en","INFAI, Institut für biomedizinische Analytik und NMR-Imaging GmbH Universitätsstr.","INFAI, Institut für biomedizinische Analytik und NMR-Imaging GmbH Universitätsstr.",9,9
"1756","es","en","Infección bacteriana (mucocutánea) por grampositivos","Gram positive (mucocutaneous) bacterial infection",5,5
"1757","es","en","Infección del tracto urinario incluyendo cistitis","Urinary tract infection including cystitis",5,6
"1758","es","en","Infecciones de la piel y de los tejidos blandos","Infections of the skin and soft tissue",7,9
"1759","es","en","Infecciones e infestaciones Frecuentes: - sinusitis, papiloma cutáneo, gripe, neumonía, infección de oído.","Infections and Infestations Common: - sinusitis, skin papilloma, influenza, pneumonia, ear infection.",12,13
"1760","es","en","Infecciones e infestaciones Trastornos vasculares","Infections and infestations Vascular disorders",5,5
"1761","es","en","Infecciones fúngicas Hipertensión Trombosis venosa/ tromboembolismo","Fungal infections Hypertension Venous thrombosis/ thromboembolism",6,6
"1762","es","en","Inflamación de los músculos Trastornos renales: fallo renal Lesiones traumáticas o intoxicaciones:","Inflammation of the muscles Renal disorders: renal failure Injury or poisoning:",11,12
"1763","es","en","Inflamación en la zona de inyección, reacción en el punto de inyección, síntomas pseudogripales,","Very common Injection site inflammation, injection site reaction, influenza-like symptoms",10,14
"1764","es","en","Información adicional sobre las interacciones con irbesartan: en estudios clínicos, la hidroclorotiazida no modifica la farmacocinética de irbesartan.","Additional information on irbesartan interactions: in clinical studies, the pharmacokinetic of irbesartan is not affected by hydrochlorothiazide.",17,18
"1765","es","en","Información de estudios no clínicos:","Information from non-clinical studies:",4,5
"1766","es","en","Información del Producto Información sobre Exjade para el médico (folleto y tarjeta de bolsillo) Información para el paciente","Product information Physician information about Exjade (brochure and pocket card) Patient information pack",13,18
"1767","es","en","Información importante sobre algunos de los componenetes de Glustin 45 mg comprimidos:","Important information about some of the ingredients of Glustin 45 mg tablets:",12,12
"1768","es","en","Información importante sobre algunos de los componentes de Aprovel Aprovel contiene lactosa.","Important information about some of the ingredients of Aprovel Aprovel contains lactose.",12,12
"1769","es","en","Información importante sobre algunos de los componentes de CoAprovel CoAprovel contiene lactosa.","Important information about some of the ingredients of CoAprovel CoAprovel contains lactose.",12,12
"1770","es","en","Información importante sobre algunos de los componentes de este medicamento","Important information about some of the ingredients of this medicine",10,10
"1771","es","en","Información importante sobre algunos de los componentes de Invirase Cada comprimido recubierto contiene 38,5 mg de lactosa (monohidrato).","Important information about an ingredient of Invirase Each film-coated tablet contains lactose (monohydrate) 38.5 mg.",15,18
"1772","es","en","Información importante sobre algunos de los componentes de Nifedipine Pharmamatch retard Nifedipine Pharmamatch retard contiene lactosa.","Important information about some of the ingredients of Nifedipine Pharmamatch retard 36/ 44 Nifedipine Pharmamatch retard contains lactose.",18,16
"1773","es","en","Información importante sobre algunos de los componentes de Remeron Remeron solución oral contiene maltitol líquido.","Important information about some of the ingredients of Remeron Remeron oral solution contains maltitol liquid.",15,15
"1774","es","en","Información importante sobre algunos de los componentes de VFEND Los comprimidos de VFEND contienen lactosa.","VFEND tablets contain lactose.",4,15
"1775","es","en","INFORMACIÓN PARA EL USARIO","INFORMATION FOR THE USER",4,4
"1776","es","en","INFORMACIÓN PARA EL USUARIO Arava 10 mg comprimidos recubiertos con película Leflunomida","Arava 10 mg film-coated tablets Leflunomide",6,12
"1777","es","en","INFORMACIÓN PARA EL USUARIO Irbesartan BMS 300 mg comprimidos recubiertos con película Irbesartan","INFORMATION FOR THE USER Irbesartan BMS 300 mg film-coated tablets irbesartan",11,13
"1778","es","en","INFORMACIÓN PARA EL USUARIO Karvezide 300 mg/ 25 mg comprimidos recubiertos con película Irbesartan / hidroclorotiazida","INFORMATION FOR THE USER Karvezide 300 mg/ 25 mg film-coated tablets irbesartan/ hydrochlorothiazide",13,16
"1779","es","en","INFORMACIÓN PARA EL USUARIO Myfenax 500 mg comprimidos recubiertos con película Micofenolato mofetilo","Myfenax 500mg film-coated tablets Mycophenolate mofetil",6,13
"1780","es","en","INFORMACIÓN QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR","PARTICULARS TO APPEAR ON THE OUTER PACKAGING",7,8
"1781","es","en","Informe a su médico de que olvidó una dosis.","Do tell your doctor that you missed a dose.",9,9
"1782","es","en","Informe a su médico inmediatamente o acuda al Servicio de Urgencias del hospital más cercano.","Tell your doctor immediately, or go to the casualty department at your nearest hospital.",14,15
"1783","es","en","Informe a su médico si está embarazada o tiene intención de quedarse embarazada.","Always tell your doctor if you are pregnant or planning to become pregnant.",13,13
"1784","es","en","Informe a su médico si está embarazada o tiene planeado quedarse embarazada.","Tell your doctor if you are pregnant or planning to become pregnant.",12,12
"1785","es","en","Informe a su médico si está tomando los siguientes medicamentos.","Please tell your doctor if you are taking the following medicines.",11,10
"1786","es","en","Informe a su médico si experimenta efectos adversos frecuentes como mareos, náuseas o vómitos.","Tell your doctor if you experience common side effects such as dizziness or feeling sick or vomiting.",17,14
"1787","es","en","Informe a su médico si presenta fístulas de las que sale pus.","If you have fistulas that are leaking pus, please inform your doctor.",12,12
"1788","es","en","Informe a su médico si se encuentra en periodo de lactancia.","Treatment with Dafiro is not recommended during breast- feeding.",9,11
"1789","es","en","Informe a su médico si tiene problemas de riñón.","Inform your doctor whether you suffer from problems with your kidney.",11,9
"1790","es","en","Informe a su médico, ya que podrá ser necesario controlarlo.","Tell your doctor as this may need to be monitored.",10,10
"1791","es","en","Informe inmediatamente a su médico si está dando el pecho; él decidirá si debe tomar Vimpat.","If you are breast-feeding, please inform your doctor immediately; he/ she will decide if you should take Vimpat.",18,16
"1792","es","en","INFORME PÚBLICO EUROPEO DE EVALUACIÓN (EPAR)","EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR)",5,6
"1793","es","en","Informes Periódicos de Seguridad (IPSs): el Titular de Autorización de comercialización continuará presentando IPSs cada dos años.","The Marketing Authorisation Holder will continue to submit Periodic Safety Update Reports on a 2 years basis.",17,17
"1794","es","en","Ingelvac CircoFLEX suspensión inyectable para cerdos","Ingelvac CircoFLEX suspension for injection for pigs",7,6
"1795","es","en","Inhibe la captación neuronal de la serotonina, con lo que facilita la transmisión serotoninérgica.","Paroxetine inhibits the neuronal uptake of serotonin and thereby facilitates serotonergic transmission.",12,14
"1796","es","en","Inhibidores de la ECA, simples, código ATC C09AA05.","ACE Inhibitors, plain, ATC code C09AA05.",6,8
"1797","es","en","Inhibidores de la fosfodiesterasa 5 (PDE-5) Sildenafilo Vardenafilo Tadalafilo","PDE-5 inhibitors Sildenafil Vardenafil Tadalafil Rifamycines",6,9
"1798","es","en","Inhibidores de la transcriptasa inversa no nucleósidos (INNTI’ s) Efavirenz 600 mg QD","Non-nucleoside reverse transcriptase inhibitors (NNRTIs) Efavirenz 600 mg QD",9,13
"1799","es","en","Inmediatamente antes de extraer insulina del vial para pasarla a la jeringa para inyección, debe resuspenderse la insulina.","Immediately before withdrawal from the vial into the injection syringe, the insulin must be re- suspended.",16,18
"1800","es","en","Inmunoestimulantes, Interferones, código ATC:","Immunostimulants, Interferon, ATC code:",4,4
"1801","es","en","Innovation House 70 Norden Road Maidenhead Berkshire SL6 4AY Reino Unido","Innovation House 70 Norden Road Maidenhead Berkshire SL6 4AY United Kingdom",11,11
"1802","es","en","Inovelon se administra por vía oral.","Inovelon is for oral use.",5,6
"1803","es","en","Inserte la aguja como le enseñó el médico.","Insert the needle in the way the doctor showed you.",10,8
"1804","es","en","Inserte la aguja en la piel.","Insert the needle into the skin.",6,6
"1805","es","en","Insomnio Depresión Disminución de la fracción de eyección","Insomnia Depression Ejection fraction decrease",5,8
"1806","es","en","Inspecciones de BPF realizadas Inspecciones de BPL realizadas","Inspections of pharmacovigilance compliance activities are also expected to increase.",10,8
"1807","es","en","Instrucciones de uso ¡En primer lugar lávese las manos!","Instructions for use First wash your hands!",7,9
"1808","es","en","INSTRUCCIONES PARA INYECTARSE CEPLENE","INSTRUCTIONS FOR SELF-INJECTION OF CEPLENE",5,4
"1809","es","en","Instrucciones para preparar la suspensión Se recomienda que su farmacéutico prepare la suspensión de VFEND antes de dársela.","It is recommended that your pharmacist constitutes VFEND suspension before giving it to you.",14,18
"1810","es","en","Instrucciones previas a la inyección","Setting up for an injection",5,5
"1811","es","en","Instrucciones sobre el tratamiento de la hipoglucemia.","Instructions on the treatment of hypoglycaemia.",6,7
"1812","es","en","Insuficiencia hepática (es decir, cirrosis o enfermedad hepática activa) (ver sección 4.2 y 4.4).","Hepatic impairment (i. e. cirrhosis or active liver disease) (see sections 4.2 and 4.4).",14,14
"1813","es","en","Insuficiencia hepática grave, cirrosis biliar o colestasis.","Severe hepatic impairment, biliary cirrhosis or cholestasis.",7,7
"1814","es","en","Insuficiencia hepática La farmacocinética de Pegasys fue similar entre individuos sanos y pacientes con hepatitis B o C.","Hepatic impairment The pharmacokinetics of Pegasys were similar between healthy subjects and patients with hepatitis B or C.",18,18
"1815","es","en","Insuficiencia hepática, cola esteatosis","Vomiting, dyspepsia, dysphagia, mouth ulceration, gingival bleeding, glossitis, stomatitis, flatulence, dry mouth",12,4
"1816","es","en","Insuficiencia hepática: no se ha estudiado EVRA en mujeres con insuficiencia hepática.","EVRA has not been studied in women with hepatic impairment.",10,12
"1817","es","en","Insuficiencia renal Fondaparinux se excreta principalmente por vía renal.","Fondaparinux is known to be mainly excreted by the kidney. lP",11,9
"1818","es","en","Insuficiencia renal grave (aclaramiento de creatinina < 30 ml/ minuto) (ver secciones 4.2 y 5.2).","Severe renal impairment (creatinine clearance < 30 ml/ min) (see sections 4.2 and 5.2).",14,15
"1819","es","en","Insuficiencia Renal Las propiedades farmacocinéticas de la insulina glulisina generalmente se mantienen en pacientes con insuficiencia renal.","Renal impairment The pharmacokinetic properties of insulin glulisine are generally maintained in patients with renal impairment.",16,17
"1820","es","en","Insuficiencia renal leve (aclaramiento de creatinina 50-80 ml/ min):","Mild renal impairment (creatinine clearance 50-80 ml/ min):",8,9
"1821","es","en","Insuficiencia renal o hepática:","Renal or hepatic impairment:",4,4
"1822","es","en","Insuficiencia renal y hepática ORENCIA no se ha estudiado en estas poblaciones de pacientes.","Renal and hepatic impairment ORENCIA has not been studied in these patient populations.",13,14
"1823","es","en","Insuficiencia renal: no se han realizado estudios formales en pacientes con insuficiencia renal.","Renal insufficiency: no formal studies have been conducted in patients with renal insufficiency.",13,13
"1824","es","en","Insuficiencia suprarrenal Hipertiroidismo, hipotiroidismo y de la nutrición Hipoglucemia, hipopotasemia","Adrenal insufficiency Hyperthyroidism, hypothyroidism",4,10
"1825","es","en","Insulatard es una insulina de acción prolongada.","Insulatard is a long-acting insulin.",5,7
"1826","es","en","Insulatard Penfill 100 UI/ ml suspensión inyectable en un cartucho","Insulatard Penfill 100 IU/ ml suspension for injection in a cartridge.",11,10
"1827","es","en","Insulin Human Winthrop Basal 100 UI/ ml suspensión inyectable en pluma precargada.","Insulin Human Winthrop Basal 100 IU/ ml suspension for injection in a pre-filled pen",14,12
"1828","es","en","Insulin Human Winthrop Basal se inyecta por vía subcutánea 45 – 60 minutos antes de la comida.","Insulin Human Winthrop Basal is injected subcutaneously 45 to 60 minutes before a meal.",14,17
"1829","es","en","Insulin Human Winthrop Comb 15 100 UI/ ml suspensión inyectable en pluma precargada.","Insulin Human Winthrop Comb 15 100 IU/ ml suspension for injection in a pre-filled pen.",15,13
"1830","es","en","Insulin Human Winthrop Comb 15 se inyecta por víasubcutánea 30 - 45 minutos antes de la comida.","Insulin Human Winthrop Comb 15 is injected subcutaneously 30 to 45 minutes before a meal.",15,17
"1831","es","en","Insulin Human Winthrop Comb 25 40 UI/ ml suspensión inyectable en un vial","Insulin Human Winthrop Comb 25 40 IU/ ml suspension for injection in a vial",14,13
"1832","es","en","Insulin Human Winthrop Comb 50","Insulin Human Winthrop Comb 50",5,5
"1833","es","en","Insulin Human Winthrop Comb 50 en cartuchos para OptiClik se ha desarrollado para utilizar sólo con OptiClik.","Insulin Human Winthrop Comb 50 in cartridges for OptiClik has been developed for use with OptiClik only.",17,17
"1834","es","en","Insulin Human Winthrop Infusat está especialmente concebido para uso con bombas de infusión.","Insulin Human Winthrop Infusat is specially prepared ready to be used in infusion pumps.",14,13
"1835","es","en","Insulin Human Winthrop Rapid 100 UI/ ml solución inyectable en un vial","Insulin Human Winthrop Rapid 100 IU/ ml solution for injection in a vial",13,12
"1836","es","en","Insulin Human Winthrop Rapid se presenta en plumas precargadas, SoloStar, que contienen 3 ml de solución (300 UI).","Insulin Human Winthrop Rapid is supplied in pre-filled pens, SoloStar, containing 3 ml solution (300 IU).",16,18
"1837","es","en","Insulin Human WinthropSi usa más Insulin Human Winthrop Basal del que debiera","If you use more Insulin Human Winthrop Basal than you should",11,12
"1838","es","en","Insulina lispro (origen rDNA)","Liprolog 100 U/ ml solution for injection in vial Insulin lispro (rDNA origin)",13,4
"1839","es","en","Insulinas y análogos para inyección, insulina (humana) de acción intermedia combinada con insulina de acción rápida.","Insulins and analogues for injection, intermediate-acting combined with fast-acting, insulin (human).",11,16
"1840","es","en","Insuman Basal 100 UI/ml suspensión inyectable en un cartucho para OptiClik Insulina humana","Insuman Basal 100 IU/ml suspension for injection in a cartridge for OptiClik Insulin human",14,13
"1841","es","en","Insuman Basal se inyecta bajo la piel 45 a 60 minutos antes de la comida.","Insuman Basal is injected under the skin 45 to 60 minutes before a meal.",14,15
"1842","es","en","Insuman Comb 15 100 UI/ml suspensión inyectable en un vial Insulina humana","Insuman Comb 15 100 IU/ml suspension for injection in a vial Insulin human",13,12
"1843","es","en","Insuman Comb 15 se presenta en viales que contienen 10 ml de suspensión (400 UI).","Insuman Comb 15 is supplied in vials containing 10 ml suspension (400 IU).",13,15
"1844","es","en","Insuman Comb 25 40 UI/ ml suspensión inyectable en un vial","Insuman Comb 25 40 IU/ ml suspension for injection in a vial",12,11
"1845","es","en","Insuman Comb 50 100 UI/ ml","Insuman Comb 50 100 IU/ ml",6,6
"1846","es","en","Insuman Comb 50 en cartuchos para OptiClik se ha desarrollado para utilizar sólo con OptiClik.","Insuman Comb 50 in cartridges for OptiClik has been developed for use with OptiClik only.",15,15
"1847","es","en","Insuman Infusat 100 UI/ml solución inyectable en un vial Insulina humana","Insuman Infusat 100 IU/ml solution for injection in a vial Insulin human",12,11
"1848","es","en","Insuman Rapid 100 UI/ ml solución inyectable en un cartucho","Insuman Rapid 100 IU/ ml solution for injection in a cartridge",11,10
"1849","es","en","Insuman Rapid es una solución para inyección bajo la piel.","Insuman Rapid is a solution for injection under the skin.",10,10
"1850","es","en","INTEGRILIN 2 mg/ ml, solución inyectable","INTEGRILIN 2 mg/ ml, solution for injection",7,6
"1851","es","en","INTELENCE se puede administrar con antagonistas del receptor H2 sin ajuste de dosis.","INTELENCE can be co-administered with H2-receptor antagonists without dose adjustments.",10,13
"1852","es","en","Intente tomar un comprimido cada día a la misma hora.","Try to take the tablet at the same time each day.",11,10
"1853","es","en","Interacción con otros medicamentos y otras formas de interacción","Interaction with Other Medicinal Products and Other Forms of Interaction",10,9
"1854","es","en","Interacciones entre el medicamento y análisis de laboratorio:","Medicinal product / laboratory test interactions:",6,8
"1855","es","en","Interacciones relativas a lamivudina","Interactions relevant to lamivudine",4,4
"1856","es","en","Interface International Consultancy Ltd","Interface International Consultancy Ltd",4,4
"1857","es","en","Interferencias observadas in vitro de hidroxicobalamina con los análisis de laboratorio","Observed in vitro interferences of hydroxocobalamin with laboratory tests",9,11
"1858","es","en","Interferón beta-1a Envase para iniciar el tratamiento","Interferon beta-1a Initiation pack",4,7
"1859","es","en","Interferón Omega recombinante de origen felino 10 MU */ vial","Recombinant Omega interferon of feline origin 10 MU*/ vial",9,10
"1860","es","en","Interrumpir Glivec hasta que RAN ≥ 1,5 x 109/ l y plaquetas ≥ 75 x 109/ l.","Stop Glivec until ANC ≥ 1.5 x 109/ l and platelets ≥ 75 x 109/ l.",16,17
"1861","es","en","Intervet International B. V.","Intervet International B. V.",4,4
"1862","es","en","intramuscular o subcutánea recomendada de 2 millones de UI/ m2).","recommended intramuscular or subcutaneous dose of 2 million IU/ m2).",10,10
"1863","es","en","Intravenous conditioning treatment - prior to hematopoietic progenitor cell transplantation","Intravenous conditioning treatment prior to hematopoietic progenitor cell transplantation",9,10
"1864","es","en","Introduzca la jeringa usada en el recipiente especial de desecho.","Put the used syringe in the disposal container.",8,10
"1865","es","en","IntronA 1 millón de UI/ ml polvo y disolvente para solución inyectable o para perfusión interferón alfa-2b","IntronA 1 million IU/ml powder and solvent for solution for injection or infusion interferon alfa-2b",15,17
"1866","es","en","IntronA 25 millones de UI/ 2,5 ml solución inyectable o para perfusión interferón alfa-2b","IntronA 25 million IU/2.5 ml solution for injection or infusion interferon alfa-2b",12,14
"1867","es","en","IntronA 5 millones de UI/ ml polvo y disolvente para solución inyectable o para perfusión Interferón alfa-2b","IntronA 5 million IU/ml powder and solvent for solution for injection or infusion Interferon alfa-2b",15,17
"1868","es","en","IntronA se utiliza después de la cirugía en pacientes cuyo melanoma podría reaparecer.","IntronA is used after surgery in patients whose melanoma could come back.",12,13
"1869","es","en","INVEGA se debe utilizar con precaución en pacientes ancianos con demencia que presenten factores de riesgo de apoplejía.","INVEGA should be used with caution in elderly patients with dementia who have risk factors for stroke.",17,18
"1870","es","en","Invertir el frasco / jeringa (ver e sq ue m a).","syringe onto the food or directly into the m outh.",10,11
"1871","es","en","Invertir el sistema (el vial con la solución reconstituida en la parte superior).","Invert the system (the vial with the reconstituted solution has to be on top).",14,13
"1872","es","en","Invertir el vial y la jeringa • Extraer la dosis prescrita de Ultratard en la jeringa.","Then turn the vial and syringe upside down • Draw the right dose of Ultratard into the syringe.",18,16
"1873","es","en","Invierta el frasco y la jeringa.","Turn the vial and syringe upside down.",7,6
"1874","es","en","Invirase se receta en combinación con ritonavir y otros medicamentos antirretrovirales.","Invirase is prescribed for use in combination with ritonavir and other antiretroviral medicines.",13,11
"1875","es","en","inyección (que consistieron en dolor, hinchazón, enrojecimiento o prurito [picor]).","respiratory infection (colds) and injection site reactions (including pain, swelling, redness or pruritus [itching]).",14,10
"1876","es","en","Inyección i. m. de 2 ml Antes de su uso, deberá leer el prospecto.","i. m. injection of 2 ml Read the package leaflet before use.",12,14
"1877","es","en","Inyección IM de 2 ml.","IM injection of 2 ml",5,5
"1878","es","en","Inyección por vía subcutánea o intravenosa.","Cattle: subcutaneous or intravenous injection.",5,6
"1879","es","en","Inyecciones posteriores • Cada vez que use una pluma debe emplear una nueva aguja.","Further injections • Every time you use a Pen you must use a new needle.",15,14
"1880","es","en","Inyectar el líquido lenta y regularmente, manteniendo siempre la piel pellizcada.","Inject the liquid slowly and evenly, always keeping your skin pinched.",11,11
"1881","es","en","Inyectar el líquido, mezclar vigorosamente hasta que la pastilla se disuelva completamente.","Inject the contents of the syringe into the vial.",9,12
"1882","es","en","Inyectar la solución de Enbrel","Injecting the Enbrel solution",4,5
"1883","es","en","Inyecte el agua en el vial empujando lentamente el émbolo de la jeringa.","Inject the water into the vial by slowly pushing the plunger of the syringe.",14,13
"1884","es","en","Inyéctese la IL-2 tal y como le han explicado.","Inject IL-2 as you have been instructed.",7,9
"1885","es","en","ió 6 ULI EU/ 1/ 05/ 327/ 018","EU/ 1/ 05/ 327/ 018",5,8
"1886","es","en","ió Conservar en nevera (entre 2°C y 8°C).","Do not freeze. lp",4,8
"1887","es","en","ió La incidencia de reacciones adversas consideradas relacionadas con el tratamiento con Nespo en los","discomfort was generally mild and transient in nature and occurred predominantly after the first injection. ro",16,15
"1888","es","en","ió Peso corporal - El aclaramiento plasmático de fondaparinux se incrementa con el peso corporal (9%","Body weight - Plasma clearance of fondaparinux increases with body weight (9% increase per 10 kg). du",17,16
"1889","es","en","ió recomendaciones del CVMP, le aconsejamos que lea el Debate Científico (también incluido en el EPAR).","er Discussion (also part of the EPAR).",7,16
"1890","es","en","ión calcitonina de salmón) una vez al día, administradas mediante inyección subcutánea o intramuscular.","au calcitonin) once daily by subcutaneous or intramuscular injection.",9,14
"1891","es","en","ión facial, somnolencia, alteraciones en el gusto Muy raras:","somnolence, taste perversion Very rarely:",5,9
"1892","es","en","ión Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636","Hertfordshire AL7 1TW Tel: + 44-(0)1 707 363 636",9,9
"1893","es","en","ión Shire Park Welwyn Garden City Hertfordshire AL7 1TW","ed Shire Park Welwyn Garden City Hertfordshire AL7 1TW",9,9
"1894","es","en","IONSYS 40 microgramos por dosis, sistemas transdérmicos iontoforéticos.","IONSYS 40 micrograms per dose iontophoretic transdermal system.",8,8
"1895","es","en","IPSEN PHARMA BIOTECH, SAS Parc d’ Activités du Plateau de Signes Chemin Départemental no 402 83870 Signes Francia","Ipsen Pharma Biotech SAS Parc d’ Activités du Plateau de Signes Chemin Départemental no 402 83870 Signes France",18,18
"1896","es","en","Irbesartan BMS no debe utilizarse en pacientes menores de 18 años.","Irbesartan BMS is not recommended for use in patients below 18 years of age.",14,11
"1897","es","en","Irbesartan Krka 300 mg comprimidos recubiertos con película Irbesartan","Irbesartan Krka 300 mg film-coated tablets Irbesartan",7,9
"1898","es","en","Irbesartan Winthrop 75 mg comprimidos recubiertos con película irbesartan","Irbesartan Winthrop 75 mg film-coated tablets irbesartan",7,9
"1899","es","en","Ireland Baxter Healthcare Ltd Unit 7 Deansgrange Industrial Estate IRL-Blackrock, Dublin Tel: +353 1 2065500","Ireland Baxter Healthcare Ltd Unit 7 Deansgrange Industrial Estate IRL-Blackrock, Dublin Tel: +353 1 2065500",15,15
"1900","es","en","Ireland ECO Animal Health Ltd, The Grange, 100 The High Street, London, N14 6BN, UNITED KINGDOM.","Ireland ECO Animal Health Ltd, The Grange, 100 The High Street, London, N14 6BN, UNITED KINGDOM.",16,16
"1901","es","en","Ireland EXUBERA Customer Care Centre Tel:","ed Ireland EXUBERA Customer Care Centre",6,6
"1902","es","en","Ireland GlaxoSmithKline (Ireland) Ltd Tel: + 353 (0)1 4955000","Ireland GlaxoSmithKline (Ireland) Ltd Tel: + 353 (0)1 4955000",9,9
"1903","es","en","Ireland Pfizer Healthcare Ireland Tel:","Ireland Pfizer Healthcare Ireland Tel:",5,5
"1904","es","en","Ireland sanofi-aventis Ireland Ltd.","Ireland sanofi-aventis Ireland Ltd.",4,4
"1905","es","en","Ireland Tom MOONEY Seamus HEALY (5)","Ireland Tom MOONEY Seamus HEALY (5)",6,6
"1906","es","en","Isis House, 43 Station road Henley-on-Thames Oxfordshire RG9 1AT, UK Tel: +44 1491 414333","Isis House, 43 Station road Henley-on-Thames Oxfordshire RG9 1AT, UK Tel: +44 1491 414333",14,14
"1907","es","en","Ísland JANSSEN-CILAG, c/ o Vistor Hf Sími: +354 535 7000","Ísland JANSSEN-CILAG, c/o Vistor Hf",5,10
"1908","es","en","Ísland Roche a/ s c/ o Icepharma hf Tel: +354 540 8000","Ísland Roche a/s c/o Icepharma hf Tel: +354 540 8000",10,12
"1909","es","en","Italia Bayer S. p. A.","Italia Bayer S. p. A.",5,5
"1910","es","en","Italia Eisai S. r. l.","Italia Eisai S. r. l.",5,5
"1911","es","en","Italia Pfizer Italia s. r. l., Tel: +39 06 3318 2933","Italia Pfizer Italia s. r. l., Tel: +39 06 3318 2933",11,11
"1912","es","en","Italia The Medicines Company UK Ltd Tel: + 800 843 633 26 o +41 61 564 1320 Email:","Italia The Medicines Company UK Ltd Tel: + 800 843 633 26 o +41 61 564 1320 Email:",18,18
"1913","es","en","Italia Wyeth Lederle S.p.A.","Italia Wyeth Lederle S.p.A.",4,4
"1914","es","en","Itraconazol, al igual que ketoconazol, es un inhibidor potente así como sustrato de CYP3A4.","Itraconazole, like ketoconazole, is a potent inhibitor as well as substrate of CYP3A4.",13,14
"1915","es","en","IV/ SC 0,5 ml","IV/ SC 0.5 ml",4,4
"1916","es","en","IVEMEND no se debe utilizar durante el embarazo a menos que sea claramente necesario.","IVEMEND should not be used during pregnancy unless clearly necessary.",10,14
"1917","es","en","Jalra 50 mg comprimidos Vildagliptina","Jalra 50 mg tablets vildagliptin",5,5
"1918","es","en","Janssen Cilag N. V.","Janssen Cilag N. V.",4,4
"1919","es","en","Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse, Belgium","Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse, Belgium",8,8
"1920","es","en","JANSSEN-CILAG INTERNATIONAL N. V.","JANSSEN-CILAG INTERNATIONAL N. V.",4,4
"1921","es","en","Janssen-Cilag Pharmaceutical S. A. C. I 56 Eirinis Avenue 56 Pefki, 15121 Grecia","Janssen-Cilag Pharmaceutical S. A. C. I 56 Eirinis Avenue 56 Pefki, 15121 Greece",13,13
"1922","es","en","Janumet se administra dos veces al día.","Janumet is taken twice a day.",6,7
"1923","es","en","Jefe de unidad Personal y servicios de apoyo Contabilidad","Head of Unit Personnel & support Accounts Total",8,9
"1924","es","en","Jeneweinova 51a, 617 00 Brno, República Checa","Jeneweinova 51a, 617 00 Brno, Czech Republic",7,7
"1925","es","en","jeringa precargada (vidrio) provistas de un sistema manual de seguridad","pre-filled syringe (glass) with a manual safety system",8,10
"1926","es","en","Jeringas precargadas (vidrio de tipo I), con émbolo (goma con lado de Teflon), selladas en un blister.","Pre-filled syringes (glass type I) with plunger (Teflon-faced rubber) sealed in a blister.",13,17
"1927","es","en","João I – Piso 0 Ala A P-2770-203 Paço d’ Arcos Tel: +351 21 00 45 900","João I – Piso 0 Ala A P-2770-203 Paço d’Arcos Tel: +351 21 00 45 900",16,17
"1928","es","en","Johnson & Johnson d. o. o., Š martinska 53, Ljubljana, Eslovenia","Johnson & Johnson d. o. o., Š martinska 53, Ljubljana, Slovenia",11,11
"1929","es","en","José GUIMARÃES MORAIS Dr Henrique LUZ-RODRIGUES","José GUIMARAES MORAIS Dr Henrique LUZ-RODRIGUES",6,6
"1930","es","en","Jytte LYNGVIG Direktør Lægemiddelstyrelsen Frederikssundvej 378 DK – 2700 Brønshøj Tel.","DENMARK Jytte LYNGVIG Direktør Lægemiddelstyrelsen Frederikssundvej 378 DK - 2700 Brønshøj",11,11
"1931","es","en","Kaletra contiene lopinavir y ritonavir, inhibidores ambos de la isoforma CYP3A del P450.","Kaletra contains lopinavir and ritonavir, both of which are inhibitors of the P450 isoform CYP3A.",15,13
"1932","es","en","Kaletra deber prescribirse por médicos con experiencia en el tratamiento de la infección por VIH.","Kaletra should be prescribed by physicians who are experienced in the treatment of HIV infection.",15,15
"1933","es","en","Karla Engliš e 3201/ 6, 15000 Praha 5, República Checa","Karla Engliš e 3201/ 6, 15000 Praha 5, Czech Republic",10,10
"1934","es","en","Karvezide, 150 mg/ 12,5 mg, comprimidos.","Karvezide 150 mg/ 12.5 mg tablets.",6,6
"1935","es","en","Kedrion S. p. A.","Kedrion S. p. A.",4,4
"1936","es","en","Kent CT13 9NJ en","CT13 9NJ United Kingdom al in",6,4
"1937","es","en","Kent ME11 5EL Reino Unido dic","Queenborough Kent ME11 5EL United Kingdom",6,6
"1938","es","en","Kentera mejoró invariablemente los síntomas de vejiga hiperactiva comparado con placebo.","Kentera led to consistent improvements in overactive bladder symptoms compared with placebo.",12,11
"1939","es","en","Keppra 100 mg/ ml solución oral Levetiracetam","Keppra 100 mg/ ml oral solution Levetiracetam",7,7
"1940","es","en","Képviselet Tel: +36 1 310 7440","Képviselet Tel: +36 1 310 7440",6,6
"1941","es","en","Ketoconazol 400 mg cada día","Ketoconazole 400 mg QD",4,5
"1942","es","en","KG Birkendorfer Strasse 65 D-88397 Biberach/ Riss Alemania","KG Birkendorfer Strasse 65 D-88397 Biberach/ Riss Germany",8,8
"1943","es","en","KG Teichweg 3 35396 Giessen Germany","KG Teichweg 3 35396 Giessen Germany",6,6
"1944","es","en","KG Tel.: + 49 (0)89 36044 8701 produkt. info@gsk. com","KG Tel.: + 49 (0)89 36044 8701 produkt. info@gsk. com",10,10
"1945","es","en","KG, Teichweg 3, 35396 Giessen, Alemania","KG, Teichweg 3, 35396 Giessen, Germany.",6,6
"1946","es","en","Kineret se inyecta debajo de la piel (inyección subcutánea) una vez al día.","Kineret must be injected under your skin (subcutaneous) once daily.",10,13
"1947","es","en","Kinzalmono 40 mg son comprimidos blancos, oblongos y con el código “ 51H” grabado.","Kinzalmono 40 mg tablets are white, oblong-shaped and engraved with the code number '51H 'on one side.",17,14
"1948","es","en","Kit – Conservar en nevera (entre 2 y 8ºC).","Kit - Store in a refrigerator (2ºC - 8ºC).",9,9
"1949","es","en","Kit de emergencia para extravasación de antraciclina","Emergency kit for Anthracycline Extravasation",5,7
"1950","es","en","Kobaltweg 49 NL-3542 CE Utrecht Tel: +31 30 2488911","Kobaltweg 49 NL-3542 CE Utrecht Tel: +31 30 2488911",9,9
"1951","es","en","KOGENATE Bayer 500 UI no debe mezclarse con otras soluciones para perfusión.","KOGENATE Bayer 500 IU must not be mixed with other infusion solutions.",12,12
"1952","es","en","Krka d. d., Novo mesto, Š marješ ka cesta 6, 8501 Novo mesto, Eslovenia","Krka d. d., Novo mesto, Š marješ ka cesta 6, 8501 Novo mesto, Slovenia",14,14
"1953","es","en","Kuvan es un medicamento que contiene el principio activo dihidrocloruro de sapropterina.","Kuvan is a medicine that contains the active substance sapropterin dihydrochloride.",11,12
"1954","es","en","Kύπρος Wyeth Hellas (Cyprus Branch) AEBE Tηλ:+357 22 817690 Φαξ:+357 22 751855","Kύπρος Wyeth Hellas (Cyprus Branch) AEBE Tηλ: +357 22 817690 Φαξ: +357 22 751855",14,12
"1955","es","en","L 226 of 07.09.96","L 226 of 07.09.96",4,4
"1956","es","en","L-histidina hidrocloruro, L-histidina, polisorbato 20, α,α-trehalosa dihidrato.","L-histidine hydrochloride, L-histidine, polysorbate 20, α ,α -trehalose dehydrate.",9,7
"1957","es","en","La {forma farmacéutica} debe tragarse entera (sin triturarla, romperla o masticarla).","The {pharmaceutical form} must be swallowed entirely (without crushing, breaking or chewing it).",13,11
"1958","es","en","La absorción y eliminación se completan aproximadamente seis a ocho meses después de la última inyección.","The absorption and elimination are complete approximately six to eight months after the last injection.",15,16
"1959","es","en","La actividad antimuscarínica reside principalmente en el isómero R.","Antimuscarinic activity resides predominantly in the R-isomer.",7,9
"1960","es","en","La administración concomitante de voriconazol y rifampicina está contraindicada (ver sección 4.3.).","Coadministration of voriconazole and rifampicin is contraindicated (see section 4.3).",10,12
"1961","es","en","La administración conjunta de litio y losartán debe realizarse con precaución.","Co-administration of lithium and losartan should be undertaken with caution.",10,11
"1962","es","en","La administración de Ariclaim combinada con la rehabilitación muscular del suelo pélvico puede proporcionar un beneficio adicional.","Combining Ariclaim with pelvic floor muscle training may provide additional benefit.",11,17
"1963","es","en","La administración de BeneFIX podrá ser diferente a la de los productos de factor IX derivados de plasma.","Dosing of BeneFIX may differ from that of plasma-derived factor IX products.",12,18
"1964","es","en","La administración de lamotrigina dio lugar a un aumento de la concentración de topiramato del 15%.","Administration of lamotrigine resulted in a 15% increase in topiramate concentrations.",11,16
"1965","es","en","La administración de SOMAVERT debe suspenderse si persisten los síntomas de la enfermedad hepática.","Administration of SOMAVERT should be discontinued if signs of liver disease persist.",12,14
"1966","es","en","La administración intramuscular y subcutánea da lugar a una respuesta totalmente superponible.","Intramuscular and subcutaneous administrations produce fully superimposable responses.",8,12
"1967","es","en","La administración lenta de la infusión evita que se produzcan las reacciones adversas inmediatas.","Administering the infusion slowly helps prevent immediate side effects occurring.",10,14
"1968","es","en","La administración subcutánea se realiza del mismo modo que con una jeringa clásica. am","The subcutaneous injection is administered in the same way as with a classical syringe.",14,14
"1969","es","en","la Agencia Europea para la Evaluación de Medicamentos (""la Agencia"")","Between National competent authority and The European Agency for the Evaluation of Medicinal Products (‘ the Agency’)",17,10
"1970","es","en","La angiotensina es un poderoso vasoconstrictor (una sustancia que contrae los vasos sanguíneos).","Angiotensin II is a powerful vasoconstrictor (a substance that narrows blood vessels).",12,13
"1971","es","en","La aplasia medular fue la principal toxicidad limitante de la dosis de Paxene.","Bone marrow suppression was the major dose-limiting toxicity of Paxene.",10,13
"1972","es","en","La autorización de comercialización fue renovada el 17 de mayo de 2006.","The marketing authorisation was renewed on 17 May 2006.",9,12
"1973","es","en","La autorización de comercialización fue renovada el 22 de marzo de 2007.","The marketing authorisation was renewed on 22 March 2007.",9,12
"1974","es","en","La autorización de comercialización fue renovada el 28 de agosto de 2005.","The marketing authorisation was renewed on 28 August 2005.",9,12
"1975","es","en","La autorización de comercialización fue renovada el 7 de mayo de 2004.","The marketing authorisation was renewed on 7 May 2004.",9,12
"1976","es","en","La Autorización de Comercialización fue renovada en el 11 de julio de 2006.","The marketing authorisation was renewed on 11 July 2006.",9,13
"1977","es","en","La azacitidina está contraindicada en los pacientes con tumores hepáticos malignos avanzados (ver sección 4.3).","Azacitidine is contraindicated in patients with advanced malignant hepatic tumours (see section 4.3).",13,15
"1978","es","en","La bacteria también libera una toxina (veneno), que puede causar daño","The bacteria also release a toxin (poison), which can cause nerve damage, heart problems, and even",16,11
"1979","es","en","La bandeja está sellada en una bolsa de aluminio laminado con un desecante.","The tray is sealed in a foil laminate pouch with a desiccant.",12,13
"1980","es","en","La base de datos contribuirá a mejorar la coherencia de las evaluaciones científicas.","The database will contribute towards improved consistency of scientific assessments;",10,13
"1981","es","en","La biodisponibilidad absoluta de dabigatrán tras la administración oral de Pradaxa fue del 6,5%, aproximadamente.","The absolute bioavailability of dabigatran following oral administration of Pradaxa was approximately 6.5%.",13,15
"1982","es","en","La biodisponibilidad absoluta del riluzol es del 60% ± 18%.","About 90% of the dose is absorbed and the absolute bioavailability is 60 ± 18%.",15,10
"1983","es","en","La biodisponibilidad de digoxina puede reducirse ligeramente con Tekturna.","In experimental animals, it has been shown that P-gp is a major determinant of Tekturna bioavailability.",16,9
"1984","es","en","La biodisponibilidad del principio activo en terneros tras una administración oral única es de alrededor del 80%.","The bioavailability of the drug in the calf, following single oral administration, is about 80%.",15,17
"1985","es","en","La biodisponibilidad tras la administración subcutánea es del 96%.","After subcutaneous administration the bioavailability is 96%.",7,9
"1986","es","en","La bleomicina se administra casi siempre en combinación con otros fármacos citostáticos, con radioterapia o con ambos.","The administration of bleomycin almost always takes place in combination with other cytostatic drugs and/ or radiation therapy.",18,17
"1987","es","en","La bomba sin aire permite administrar el producto sea cual sea la posición del frasco.","The airless pump allows the product to be administered whatever the position of the bottle is.",16,15
"1988","es","en","La bradicardia podrá remitir con la administración de anticolinérgicos.","Bradycardia can be reversed by the administration of anticholinergics.",9,9
"1989","es","en","La calcitonina de salmón está desprovista de potencial embriotóxico, teratogénico y mutagénico.","Salmon calcitonin is devoid of embryotoxic, teratogenic and mutagenic potential.",10,12
"1990","es","en","La calcitonina también está contraindicada en pacientes con hipocalcemia.","Calcitonin is also contra-indicated in patients with hypocalcaemia.",8,9
"1991","es","en","La cantidad de alcohol de este medicamento puede afectar a su capacidad para conducir o utilizar máquinas.","The amount of alcohol in this product may impair your ability to drive or use machines.",16,17
"1992","es","en","La capacidad de concentración y de reacción de los pacientes diabéticos puede verse afectada por una hipoglucemia.","The patient’ s ability to concentrate and react may be impaired as a result of hypoglycaemia.",16,17
"1993","es","en","La captación en hígado disminuye hasta 8,4% 24 horas después de la inyección.","Liver uptake decreases then to 8.4% 24 hours after injection.",10,13
"1994","es","en","La cianocobalamina es un compuesto estable y no tóxico que se excreta por la orina.","Cyanocobalamin is a stable, non-toxic compound that is excreted in the urine.",12,15
"1995","es","en","La ciclooxigenasa es responsable de la síntesis de prostaglandinas.","Cyclooxygenase is responsible for generation of prostaglandins.",7,9
"1996","es","en","La ciclosporina (microemulsión) y otros productos medicinales o no medicinales pueden interaccionar con sirolimus (ver sección 4.5).","Ciclosporin (microemulsion) and other medicinal or non-medicinal products may interact with sirolimus (see section 4.5).",15,17
"1997","es","en","La Cmax no cambió significativamente.","Cmax was not significantly changed.",5,5
"1998","es","en","La coadministración con bepridil está contraindicada (ver sección 4.3).","Co-administration with bepridil is contraindicated (see section 4.3)",8,9
"1999","es","en","La coadministración con Norvir puede causar un gran aumento de la concentración de esta benzodiazepina.","Co-administration with Norvir may cause a large increase in the concentration of this benzodiazepine.",14,15
"2000","es","en","La colocación de los tubos de timpanostomía fue reducida un 24% (95% IC:","Tympanostomy tube placement was reduced by 24% (95% CI:",9,13
"2001","es","en","La combinación de rifampicina y Telzir junto con dosis bajas de ritonavir está contraindicada (ver sección 4.3).","The combination of rifampicin and Telzir with concomitant low-dose ritonavir is contraindicated (see section 4.3).",15,17
"2002","es","en","La combinación fue eficaz durante un máximo de dos años.","The combination was effective for up to two years.",9,10
"2003","es","en","La combinación Trudexa/ metotrexato era clínica y estadísticamente superior a la monoterapia con dic","Trudexa/ methotrexate combination therapy was clinically and statistically superior to methotrexate (p < 0.001) and Trudexa monotherapy",17,14
"2004","es","en","La Comisión Europea convirtió el dictamen final en una Decisión el 25.06.03.","The final opinion was converted into a decision by the European Commission on 25 June 2003.",16,12
"2005","es","en","La concentración en plasma deseada se suele alcanzar dentro de un plazo de 3 a 5 meses.","The target plasma concentration is usually reached within a period of 3 to 5 months.",15,17
"2006","es","en","La concentración plasmática total de pioglitazona no se modifica, pero aumenta el volumen de distribución.","Patients with hepatic impairment Total plasma concentration of pioglitazone is unchanged, but with an increased volume of distribution.",18,15
"2007","es","en","La conclusión fue que el producto es bien tolerado por caballos de distintas edades.","It was concluded that the product is well tolerated by horses of different age.",14,14
"2008","es","en","La coriogonadotropina alfa se produce por tecnología del ADN recombinante en células de ovario de hámster chino.","Choriogonadotropin alfa is produced by recombinant DNA technology in Chinese Hamster Ovary cells.",13,17
"2009","es","en","La COX es una enzima clave en el metabolismo del ácido araquidónico.","COX is a key enzyme in pathways of arachidonic acid metabolism.",11,12
"2010","es","en","La cubierta de la aguja de la jeringa precargada contiene caucho natural (un derivado del látex).","The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex).",15,16
"2011","es","en","La darifenacina se metaboliza mediante CYP3A4 y CYP2D6.","Darifenacin is metabolised by CYP3A4 and CYP2D6.",7,8
"2012","es","en","La desintegración del comprimido ocurre rápidamente con la saliva.","Tablet disintegration occurs rapidly in saliva.",6,9
"2013","es","en","La diarrea responde bien al tratamiento proactivo (ver sección 4.4).","Diarrhoea responds well to proactive management (see section 4.4).",9,10
"2014","es","en","La dieta y el ejercicio pueden ayudar al organismo a utilizar mejor el azúcar.","Diet and exercise can help your body use its blood sugar better.",12,14
"2015","es","en","La diferencia entre los grupos de Enbrel solo y de metotrexato solo también fue significativa (p < 0,05).","The difference between Enbrel alone and methotrexate alone was also significant (p < 0.05).",14,18
"2016","es","en","La dispensación de talidomida debe realizarse en un plazo máximo de 7 días después de la prescripción.","Dispensing of thalidomide should occur within a maximum of 7 days of the prescription.",14,17
"2017","es","en","La distancia entre cada señal del indicador viene a corresponder a 20 unidades.","The distance between each mark on the gauge is about 20 units.",12,13
"2018","es","en","La distribución y consumo hepáticos de oxígeno no cambiaron significativamente a concentraciones de CAM de hasta 2,0.","Hepatic oxygen delivery and consumption were not significantly altered at concentrations up to 2.0 MAC.",15,17
"2019","es","en","La dosis acumulativa osciló de 20 mg a 60 mg.","Cumulative doses ranged from 20 mg up to 60 mg.",10,10
"2020","es","en","La dosis de Ceplene debe inyectarse entre 1 y 3 minutos después de la dosis de IL-2.","Ceplene must be injected 1 to 3 minutes after IL-2.",10,17
"2021","es","en","La dosis de comprimido bucodispersable se introduce en la boca y se dispersa inmediatamente.","The dose of orodispersible tablet is placed in the mouth where it will disperse immediately.",15,14
"2022","es","en","La dosis de inicio habitual es de 1 MU por kilogramo de peso corporal al día.","The usual starting dose is 1 MU per kg bodyweight each day.",12,16
"2023","es","en","La dosis diaria de rifabutina debe aumentarse un 50% cuando se administre concomitantemente con Atripla.","The daily dose of rifabutin should be increased by 50% when given with Atripla.",14,15
"2024","es","en","La dosis diaria máxima de buprenorfina no deberá ser superior a 24 mg.","The dose should not be higher than 24 mg buprenorphine per day.",12,13
"2025","es","en","La dosis diaria máxima es de 9 g.","The maximum daily dose is 9 g.",7,8
"2026","es","en","La dosis diaria recomendada es de 8 cápsulas (2 g de sustancia activa), administrada en 2 tomas separadas.","The recommended daily dose is 8 capsules (2 g of the active ingredient) taken as 2 separate doses.",18,18
"2027","es","en","La dosis es de 1 MU/ kg de peso corporal.","The dose is 1 MU/ kg bodyweight.",7,10
"2028","es","en","La dosis final rara vez supera 1,0 mg/ día.","The final dose seldom exceeds 1.0 mg/ day.",8,9
"2029","es","en","La dosis habitual es:","The usual dose is:",4,4
"2030","es","en","La dosis inicial de TOVIAZ que se recomienda es de 4 mg una vez al día.","The recommended starting dose of TOVIAZ is 4 mg once a day.",12,16
"2031","es","en","La dosis inicial debe de ser de 2 mg/ día de risperidona.","Patients should start with 2 mg/ day risperidone.",8,12
"2032","es","en","La dosis inicial es de 150 UI/ kg administrada por vía subcutánea 3 veces por semana.","The initial dose is 150 IU/ kg given subcutaneously 3 times per week.",13,16
"2033","es","en","La dosis inicial recomendada de Ranexa es de 375 mg dos veces al día.","The recommended initial dose of Ranexa is 375 mg twice daily.",11,14
"2034","es","en","La dosis inicial recomendada es de 0,5 mg.","The recommended starting dose is 0.5 mg.",7,8
"2035","es","en","La dosis máxima es de 80 mg una vez al día.","Special populations − Geriatric:",4,11
"2036","es","en","La dosis máxima recomendada es de 8 mg de doxazosina cada 24 horas.","The maximum recommended dose is 8 mg doxazosin once daily.",10,13
"2037","es","en","La dosis no afectó de forma consistente al volumen de distribución en ninguno de los ensayos.","Dose level has no consistent effect on the volume of distribution in any of the studies.",16,16
"2038","es","en","La dosis normal es de 400 mg dos veces al día.","The usual dose is 400 mg twice a day.",9,11
"2039","es","en","La dosis óptima para la mayoría de los pacientes es de 0,5 mg dos veces al día.","The optimum dose is 0.5 mg twice daily for most patients.",11,17
"2040","es","en","La dosis puede inhalarse a continuación y cerrarse el dispositivo.","The dose can then be inhaled and the device closed.",10,10
"2041","es","en","La dosis puede reducirse tras la mejoría del estado del paciente.","The dose may be reduced after the condition of the patient has improved.",13,11
"2042","es","en","La dosis recomendada de Copalia es un comprimido al día.","The recommended dose of Copalia is one tablet per day.",10,10
"2043","es","en","La dosis recomendada de Lucentis es 0,5 mg (0,05 ml).","The recommended dose for Lucentis is 0.5 mg (0.05 ml).",10,10
"2044","es","en","La dosis recomendada de Revlimid es de 25 mg al día.","The recommended dose of Revlimid is 25 mg a day.",10,11
"2045","es","en","La dosis recomendada se retira directamente de la ampolla con una jeringa y se inyecta sin diluir.","The recommended dose is directly withdrawn by a syringe and injected without dilution.",13,17
"2046","es","en","La dosis se titulará segun sea necesario para mantener los niveles objetivo de hemoglobina. en","Dosing should be titrated as necessary to maintain the haemoglobin target. ct",12,15
"2047","es","en","La dosis usual de Trazec para empezar es de 60 mg antes de las tres comidas principales.","The usual dose of Trazec to start with is 60 mg before the three main meals.",16,17
"2048","es","en","La duración de la acción es de aproximadamente 6 horas. ic","The duration of action lasts approximately 6 hours. od",9,11
"2049","es","en","La duración del tratamiento no debe superar las 48 horas.","The duration of the treatment should not exceed 48 hours.",10,10
"2050","es","en","La duración del tratamiento no deberá au","The duration of treatment should not exceed that evaluated during clinical trial (mean 7 days)",15,7
"2051","es","en","La duración media de la disfunción orgánica anterior al tratamiento fue de 25 horas.","The median duration of organ dysfunction prior to treatment was 25 hours.",12,14
"2052","es","en","La duración media del tratamiento fue de 29 días para posaconazol y 25 días para fluconazol/ itraconazol.","The mean duration of therapy was 29 days for posaconazole and 25 days for fluconazole/ itraconazole.",16,17
"2053","es","en","La duración recomendada del tratamiento es de 24 semanas.","The recommended duration of treatment is 24 weeks.",8,9
"2054","es","en","La edad gestacional media (DE) en el momento del parto fue igual en ambos grupos:","Mean (SD) gestational age at delivery was the same in the two groups:",13,15
"2055","es","en","La edad media (intervalo) de los pacientes que fallecieron fue de 86 años (intervalo de 67 a 100).","The mean age (range) of patients who died was 86 years (range 67-100).",13,18
"2056","es","en","La eficacia de < Marca de fantasía > se mantuvo en el tiempo.","The efficacy of < Invented Name > was maintained over time.",11,13
"2057","es","en","La eficacia de la dosis de 12,5 mg no ha sido investigada en ensayos clínicos.","The efficacy of the 12.5 mg dose has not been investigated in clinical trials.",14,15
"2058","es","en","La eficacia de Thalidomide Celgene se examinó en un estudio principal de 447 pacientes con mieloma múltiple.","The effectiveness of Thalidomide Celgene was studied in one main study involving 447 patients with multiple myeloma.",17,17
"2059","es","en","La eficacia tendría que haberse investigado con la dosis más baja recomendada.","Efficacy should have been investigated at the lowest dose recommended.",10,12
"2060","es","en","La eficacia y seguridad fue similar para ambos regímenes.","Efficacy and safety were similar for both regimens.",8,9
"2061","es","en","La elección de la formulación se basa en las características individuales del paciente (ver sección 4.1).","Safety and effectiveness of Ribavirin",5,16
"2062","es","en","La eliminación del pramipexol depende de la función renal.","The elimination of pramipexole is dependent on renal function.",9,9
"2063","es","en","La eliminación del producto no utilizado o del material desechable se establecerá de acuerdo con los requisitos locales.","Any unused product or waste material should be disposed of in accordance with local requirements.",15,18
"2064","es","en","La eliminación hepática de IgG incluye una degradación en el sistema reticuloendotelial y células endoteliales.","Liver elimination of IgG includes degradation in the reticuloendothelial system and endothelial cells.",13,15
"2065","es","en","La EMEA interviene en ambas:","The EMEA plays a role in both procedures:",8,5
"2066","es","en","La enfermedad pulmonar intersticial es una alteración potencialmente fatal, que puede aparecer de forma aguda durante la terapia.","Interstitial lung disease is a potentially fatal disorder, which may occur acutely during therapy.",14,18
"2067","es","en","La eritropoyetina es producida por los riñones.","Erythropoietin is produced by the kidneys.",6,7
"2068","es","en","La especificidad de eculizumab por C5 en el suero humano se evaluó en dos estudios in vitro.","The specificity of eculizumab for C5 in human serum was evaluated in two in vitro studies.",16,17
"2069","es","en","La espondiloartritis anquilosante es una enfermedad inflamatoria de la columna vertebral y de las articulaciones largas.","Ankylosing spondylitis is an inflammatory disease of the spine and large joints.",12,16
"2070","es","en","La excreción biliar, principalmente como conjugado glucurónido, representa un 10 a 20% de la dosis administrada.","Biliary excretion, mainly as the glucuronide conjugate, accounts for 10-20% of the administered dose.",14,16
"2071","es","en","La excreción es rápida y se realiza principalmente en las heces.","Excretion is rapid and mainly via the faeces.",8,11
"2072","es","en","La excreción renal de pramipexol inalterado constituye la vía principal de eliminación.","Renal excretion of unchanged pramipexole is the major route of elimination.",11,12
"2073","es","en","La experiencia clínica con insulina aspart en casos de embarazo es limitada","There is limited clinical experience with insulin aspart in pregnancy.",10,12
"2074","es","en","La experiencia clínica en mujeres embarazadas es limitada.","Clinical experience in pregnant women is limited.",7,8
"2075","es","en","La experiencia de OPTISON en pacientes gravemente enfermos es limitada.","The experience of OPTISON in severely ill patients is limited.",10,10
"2076","es","en","La experiencia fue limitada en pacientes mayores de 75 años y en las razas oriental/ asiática.","Experience in patients over 75 years and ina",8,16
"2077","es","en","La experiencia referente a la sobredosis de SPRYCEL en los ensayos clínicos está limitada a casos aislados.","Experience with overdose of SPRYCEL in clinical studies is limited to isolated cases.",13,17
"2078","es","en","La farmacocinética de aprepitant es no lineal en el intervalo de la dosis clínica.","The pharmacokinetics of aprepitant is non-linear across the clinical dose range.",11,14
"2079","es","en","La farmacocinética de Liprolog Mix50 Pen es representativa de las propiedades farmacocinéticas individuales de los dos componentes.","The pharmacokinetics of Liprolog Mix50 are representative of the individual pharmacokinetic properties of the two components.",16,17
"2080","es","en","La farmacocinética de telmisartán no difiere entre los pacientes de edad avanzada y los menores de 65 años.","The pharmacokinetics of telmisartan do not differ between the elderly and those younger than 65 years.",16,18
"2081","es","en","La fecha de caducidad es el último día del mes que se indica.","The expiry date refers to the last day of that month.",11,13
"2082","es","en","La fenilalanina puede ser perjudicial para personas con fenilcetonuria.","Phenylalanine may be harmful for people with phenylketonuria.",8,9
"2083","es","en","La folitropina alfa se produce en células de ovario de hámster chino (CHO), modificadas por ingeniería genética.","Follitropin alfa is made from genetically engineered Chinese Hamster Ovary (CHO) cells.",12,17
"2084","es","en","La formulación intravenosa produjo irritación local en el lugar de la inyección en conejos y ratas.","The intravenous formulation produced local irritation at the site of injection in both rabbits and rats.",16,16
"2085","es","en","La fracción de bortezomib unido a las proteínas del plasma no fue proporcional a la concentración.","The fraction of bortezomib bound to plasma proteins was not concentration- dependent.",12,16
"2086","es","en","La frecuencia del descenso en hemoglobina (anemia) fue mayor con Volibris 10 mg.","The frequency of decreased haemoglobin (anaemia) was higher with 10 mg Volibris.",12,13
"2087","es","en","La frecuencia registrada para","In post-marketing experience from January 2003, predominately in patients with rheumatoid arthritis, Me",13,4
"2088","es","en","La función tiroidea es normal.","Thyroid function is normal.",4,5
"2089","es","en","La gravedad de las reacciones adversas fue generalmente de leve a moderada.","The severity of the adverse events was generally mild to moderate.",11,12
"2090","es","en","La gravedad fue generalmente de leve a moderada.","Severity was generally mild to moderate.",6,8
"2091","es","en","La hemodiálisis contribuye de manera insignificante a la eliminación de tadalafilo.","Haemodialysis contributes negligibly to tadalafil elimination.",6,11
"2092","es","en","La hemoglobina se medirá cada una o dos semanas hasta que se estabilice.","er The haemoglobin should be measured every one or two weeks until it is stable.",15,13
"2093","es","en","La hiperpirexia puede requerir, especialmente en niños, el tratamiento con compresas de agua tibia o una manta hipotérmica.","Hyperpyrexia, especially in children, may require treatment with tepid water sponge baths or hypothermia blanket.",15,18
"2094","es","en","La hipoglucemia puede estar asociada con apatía, confusión, palpitaciones, dolor de cabeza, sudoración y vómitos.","Hypoglycaemia may be associated with listlessness, confusion, palpitations, headache, sweating and vomiting.",12,15
"2095","es","en","La hipotensión también fue poco frecuente (< 1%) durante el tratamiento de combinación con otros agentes antihipertensivos.","Hypotension was also uncommon (< 1%) during combination therapy with other antihypertensive agents.",13,17
"2096","es","en","La IgG inalterada también se excreta en la bilis.","Intact IgG is also excreted in bile.",7,9
"2097","es","en","La importancia clínica de esta reducida susceptibilidad no se ha estudiado en profundidad.","The clinical relevance of this reduced susceptibility is not fully explored.",11,13
"2098","es","en","La incidencia clínica de factores neutralizantes en pacientes que recibieron 0,5 microgramos/kg de PegIntron es de 1,1%.","The clinical incidence of neutralising factors in patients who received PegIntron 0.5 micrograms/kg is 1.1%.",15,17
"2099","es","en","La incidencia de artropatía, mencionada más arriba, se refiere a la información recogida en estudios realizados con adultos.","The incidence of arthropathy, mentioned above, is referring to data collected in studies with adults.",15,18
"2100","es","en","La incidencia de EPP fue similar en los dos brazos de tratamiento, lapatinib más capecitabina y capecitabina sola.","The incidence of PPE was similar in both lapatinib plus capecitabine and capecitabine alone treatment arms.",16,18
"2101","es","en","La indicación para tratar las infecciones urinarias del gato no se aceptó.","The indication for treatment of urinary infections in cats was not accepted.",12,12
"2102","es","en","La infección por el virus de la hepatitis B puede causar inflamación del hígado.","Infection with the hepatitis B virus may cause the liver to become swollen (inflamed).",14,14
"2103","es","en","La influencia de Cholestagel sobre la capacidad para conducir y utilizar máquinas es nula o insignificante.","Cholestagel has no or negligible influence on the ability to drive and use machines.",14,16
"2104","es","en","La influencia de clopidogrel sobre la capacidad para conducir y utilizar máquinas es nula o insignificante.","Clopidogrel has no or negligible influence on the ability to drive and use machines.",14,16
"2105","es","en","La influencia de Intrinsa sobre la capacidad para conducir y utilizar máquinas es nula.","Intrinsa has no influence on the ability to drive and use machines.",12,14
"2106","es","en","La influencia de la administración de esta combinación no ha sido investigada sistemáticamente.","The influence of this combined administration has not yet been investigated systemically.",12,13
"2107","es","en","La información acerca del efecto del alcohol se encuentra en la sección 3.","Information on the effect of alcohol is in section 3.",10,13
"2108","es","en","La información disponible de sobredosis con telmisartán en humanos es limitada.","There is limited information available for telmisartan with regard to overdose in humans.",13,11
"2109","es","en","La ingesta de alimentos retrasa ligeramente y disminuye la magnitud de la absorción de metformina.","Food slightly delays and decreases the extent of the absorption of metformin.",12,15
"2110","es","en","La inhibición del proteosoma provoca la detención del ciclo celular y la apoptosis.","Inhibition of the proteasome results in cell cycle arrest and apoptosis.",11,13
"2111","es","en","La insuficiencia cardiaca debe controlarse adecuadamente antes de iniciar el tratamiento con timolol.","Cardiac failure should be adequately controlled before beginning therapy with timolol.",11,13
"2112","es","en","La insuficiencia renal alterada contribuyó al aumento de la exposición a entecavir en estos pacientes (ver sección 4.4).","Altered renal function contributed to the increase in entecavir exposure in these patients (see section 4.4).",16,18
"2113","es","en","La insulina de acción rápida y la de acción retardada siempre deben mezclarse en este orden.","Always mix fast-acting and long-acting insulin in this order.",9,16
"2114","es","en","La insulina detemir se distribuye más lentamente a los tejidos periféricos diana que la insulina NPH.","Insulin detemir is distributed more slowly to peripheral target tissues compared to NPH insulin.",14,16
"2115","es","en","La interrupción permanente de palivizumab por RAM fue rara (0,2%).","Permanent discontinuation of palivizumab due to ADRs was rare (0.2%).",10,10
"2116","es","en","La inyección accidental es peligrosa – léase el prospecto antes de usarlo.","Accidental injection is dangerous – see package insert before use",10,12
"2117","es","en","La inyección será preparada por su médico, enfermera o farmacéutico.","Your doctor, nurse or pharmacist will prepare the injection for you.",11,10
"2118","es","en","La isotretinoína está contraindicada en mujeres embarazadas o en la lactancia.","Isotretinoin is contraindicated in women who are pregnant or breastfeeding.",10,11
"2119","es","en","La jeringa dosificadora debe usarse para extraer la cantidad prescrita de Rapamune de la botella.","The dosing syringe should be used to withdraw the prescribed amount of Rapamune from the bottle.",16,15
"2120","es","en","La jeringa está ahora lista para utilizarla.","The syringe is now ready for use.",7,7
"2121","es","en","La jeringa precargadoa está lista para su uso y contiene 10,5 ml de solución.","The pre-filled syringe is ready for use and contains 0.5 ml of solution.",13,14
"2122","es","en","La lactancia materna no es una contraindicación.","Breast-feeding is not a contraindication.",5,7
"2123","es","en","La lamivudina impide que el virus fabrique ADN, lo que evita su multiplicación y diseminación.","Lamivudine stops the virus making DNA and prevents it from multiplying and spreading.",13,15
"2124","es","en","La leche materna debe desecharse durante las primeras 24 horas después del tratamiento trombolítico.","Breast milk should be discarded within the first 24 hours after thrombolytic therapy.",13,14
"2125","es","en","La lista completa de efectos secundarios comunicados sobre Aclasta puede consultarse en el prospecto.","For the full list of all side effects reported with Aclasta, see the Package Leaflet.",15,14
"2126","es","en","La lista completa de efectos secundarios comunicados sobre Avastin puede consultarse en el prospecto.","For the full list of all side effects reported with Avastin, see the Package Leaflet.",15,14
"2127","es","en","La lista completa de efectos secundarios comunicados sobre Circovac puede consultarse en el prospecto.","For a full list of all side effects reported with Circovac, see the Package Leaflet.",15,14
"2128","es","en","La lista completa de efectos secundarios comunicados sobre Combivir puede consultarse en el prospecto.","For the full list of all side effects reported with Combivir, see the Package Leaflet.",15,14
"2129","es","en","La lista completa de efectos secundarios comunicados sobre Eucreas puede consultarse en el prospecto.","For the full list of all side effects reported with Eucreas, see the Package Leaflet.",15,14
"2130","es","en","La lista completa de efectos secundarios comunicados sobre Glustin puede consultarse en el prospecto.","For the full list of all side effects reported with Glustin, see the Package Leaflet.",15,14
"2131","es","en","La lista completa de efectos secundarios comunicados sobre Januvia puede consultarse en el prospecto.","For the full list of all side effects reported with Januvia, see the Package Leaflet.",15,14
"2132","es","en","La lista completa de efectos secundarios comunicados sobre Mirapexin puede consultarse en el prospecto.","For the full list of all side effects reported with Mirapexin, see the Package Leaflet.",15,14
"2133","es","en","La lista completa de efectos secundarios comunicados sobre Pandemrix puede consultarse en el prospecto.","For the full list of all side effects reported with Pandemrix, see the Package Leaflet.",15,14
"2134","es","en","La lista completa de efectos secundarios comunicados sobre Rebetol puede consultarse en el prospecto.","For the full list of all side effects reported with Rebetol, see the Package Leaflet.",15,14
"2135","es","en","La lista completa de efectos secundarios comunicados sobre Suboxone puede consultarse en el prospecto.","For the full list of all side effects reported with Suboxone, see the Package Leaflet.",15,14
"2136","es","en","La lista completa de efectos secundarios comunicados sobre TRISENOX puede consultarse en el prospecto.","For the full list of all side effects reported with TRISENOX, see the Package Leaflet.",15,14
"2137","es","en","La lista completa de efectos secundarios comunicados sobre Xiliarx puede consultarse en el prospecto.","For the full list of all side effects reported with Xiliarx, see the Package Leaflet.",15,14
"2138","es","en","La lista completa de estos medicamentos puede consultarse en el prospecto.","See the Package Leaflet for the full list of these medicines.",11,11
"2139","es","en","La lista completa de restricciones puede consultarse en el prospecto.","For the full list of restrictions, see the Package Leaflet.",10,10
"2140","es","en","La lista de expertos europeos está disponible para su consulta previa petición a las oficinas de la EMEA.","Certificates of a medicinal product The EMEA issues certificates of a medicinal product in",14,18
"2141","es","en","La lista de nombres del producto concernidos figura en el Anexo I.","The list of product names concerned is given in Annex I.",11,12
"2142","es","en","La manera habitual de tomar Myfenax es la siguiente:","The usual way to take Myfenax is as follows:",9,9
"2143","es","en","La mayor parte de datos derivan del uso ilícito de GHB.","Most data derives from the illicit use of GHB.",9,11
"2144","es","en","La mayor parte de la dosis se excretó en un período de 96 horas.","The majority of the dose was excreted within 96 hours.",10,14
"2145","es","en","La mayoría de estos signos son debidos a los efectos agonistas del receptor alfa-2-adrenérgico.","Most of these signs are due to alpha-2- adreno-receptor agonist effects.",11,14
"2146","es","en","La mayoría de los pacientes con erupción leve o moderada pueden continuar con Agenerase.","Most patients with mild or moderate rash can continue Agenerase.",10,14
"2147","es","en","La mayoría de los pacientes con hiperplasia de la próstata son controlados con la dosis inicial.","Most of the patients with prostatic hyperplasia are controlled with the initial dose.",13,16
"2148","es","en","La mayoría de los pacientes en estos ensayos clínicos fueron tratados durante un año.","The majority of patients in these clinical trials were treated for one year.",13,14
"2149","es","en","La mayoría fueron de gravedad grado 1/ 2 y no necesitaron intervención.","Most were Grade 1/ 2 in severity and manageable without intervention.",11,12
"2150","es","en","La mediana del tiempo hasta la aparicición de diarrea Grado 2 o peor fue de 9 días.","The median time to onset of grade 2 or worse diarrhoea was 9 days.",14,17
"2151","es","en","LA MENCIÓN “ ÚNICAMENTE PARA USO VETERINARIO”","THE WORDS “ FOR ANIMAL TREATMENT ONLY”",7,7
"2152","es","en","LA MENCIÓN “ ÚNICAMENTE PARA USO VETERINARIO”, Y LAS CONDICIONES O RESTRICCIONES DE DISPENSACIÓN Y USO, si procede","THE WORDS “ FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable",17,18
"2153","es","en","LA MENCIÓN ” ÚNICAMENTE PARA USO VETERINARIO”","THE WORDS ""FOR ANIMAL TREATMENT ONLY""",6,7
"2154","es","en","La mezcla se debe remover, debiéndose administrar todo el contenido al paciente.","The mixture should be stirred and the entire contents given to the patient.",13,12
"2155","es","en","La mortalidad fue menor del 1%, pero puede incrementarse como consecuencia de infecciones secundarias.","Mortality was less than 1%, but might be increased as a result of secondary infections.",15,14
"2156","es","en","La neuropatía periférica, caracterizada por parestesia/ disestesia, es un efecto frecuente y muy conocido del arsénico medioambiental.","Peripheral neuropathy, characterised by paresthesia/ dysesthesia, is a common and well known effect of environmental arsenic.",16,17
"2157","es","en","La neutropenia grave duró más de 7 días en el 11% de los ciclos.","Severe neutropenia lasted beyond 7 days in 11% of courses overall.",11,14
"2158","es","en","La neutropenia inducida por topotecan puede ocasionar colitis neutropénica.","Topotecan-induced neutropenia can cause neutropenic colitis.",6,9
"2159","es","en","La neutropenia rara vez afecta a los pacientes con función renal normal y sin ninguna complicación.","The dose adjustment should be based on the clinical response of the individual patient.",14,16
"2160","es","en","La octreotida/ lanreotida puede tanto reducir como aumentar los requerimientos de insulina. am","Octreotide/ lanreotide may both decrease and increase insulin requirement. lo",10,13
"2161","es","en","La olanzapina no mostró interacción cuando se administró conjuntamente con litio o biperideno.","Olanzapine showed no interaction when co-administered with lithium or biperiden.",10,13
"2162","es","en","La olanzapina se metaboliza en el hígado a través de reacciones de conjugación y oxidación.","Olanzapine is metabolized in the liver by conjugative and oxidative pathways.",11,15
"2163","es","en","La omisión de una comida y el ejercicio físico intenso no previsto pueden producir hipoglucemia.","Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycaemia.",13,15
"2164","es","en","La OMS ha concluido que hay una relación causal entre la exposición al busulfano y el cáncer.","WHO has concluded that there is a causal relationship between busulfan exposure and cancer.",14,17
"2165","es","en","La paliperidona puede antagonizar el efecto de la levodopa y de otros agonistas de la dopamina.","Paliperidone may antagonise the effect of levodopa and other dopamine agonists.",11,16
"2166","es","en","La parte corporal no debe haber sido irradiada mediante radioterapia.","The body part must not have been irradiated in connection with radiation therapy.",13,10
"2167","es","en","La parte exterior de Actraphane 30 InnoLet puede limpiarse con un algodón humedecido con alcohol.","You can clean your Actraphane 30 InnoLet by wiping it with a medicinal swab.",14,15
"2168","es","en","La participación de la Comisión en las reuniones del MRFG fue muy valiosa.","The participation of the Commission during the MRFG meetings was very valuable.",12,13
"2169","es","en","La perfusión debe realizarse según la práctica clínica habitual.","The infusion must be conducted according to standard medical practice.",10,9
"2170","es","en","La perfusión durará aproximadamente una hora durante la cual estará en el hospital.","The infusion will last approximately one hour during which you will be in the hospital.",15,13
"2171","es","en","La piel debe estar completamente seca antes de aplicar el parche.","The skin must be completely dry before applying the patch.",10,11
"2172","es","en","La pioderma es principalmente secundaria a enfermedades subyacentes.","Pyoderma is mostly secondary to an underlying disease.",8,8
"2173","es","en","La pioglitazona no afecta la capacidad para conducir o utilizar máquinas.","Pioglitazone will not affect your ability to drive or operate machinery.",11,11
"2174","es","en","La pluma va acompañada de un manual de instrucciones para su uso.","The pen has a user manual.",6,12
"2175","es","en","La población incluida estaba constituída principalmente por niños con hepatitis C de leve a moderada.","The population enrolled mainly consisted in children with mild to moderate hepatitis C.",13,15
"2176","es","en","La pregabalina no fue teratógena ni en ratones ni en ratas ni en conejos.","Pregabalin was not teratogenic in mice, rats or rabbits.",9,14
"2177","es","en","La preparación de la solución del test se hace de la siguiente manera:","Now the preparation of the test solution follows:",8,13
"2178","es","en","La presencia de una infección leve no es una contraindicación. to","The presence of a minor infection, such as a cold, is not a contraindication for vaccination. rod",17,11
"2179","es","en","La prevalencia de DCV en esta cohorte era 30,2%.","The prevalence of VFD in this cohort was 30.2%.",9,9
"2180","es","en","La primera dosis se administrará en una fecha acordada con su médico.","The first dose will be given on a date agreed with your doctor.",13,12
"2181","es","en","La producción de eritropoyetina tiene lugar y","The production of erythropoietin primarily occurs in and is regulated by the M",13,7
"2182","es","en","La prolongación del intervalo QT puede provocar un aumento del riesgo de arritmias ventriculares, incluyendo Torsade de pointes.","QT interval prolongation may lead to an increased risk of ventricular arrhythmias including Torsade de pointes.",16,18
"2183","es","en","La prueba no tiene efectos secundarios conocidos.","There are no known side effects of the test.",9,7
"2184","es","en","La razón de probabilidades (intervalo de confianza exacto del 95%) fue de 1,21 (0,7, 2,1).","The odds ratio (95% exact confidence interval) was 1.21 (0.7, 2.1).",11,15
"2185","es","en","La reacción adversa más frecuente es la diarrea.","The most common adverse drug reaction is diarrhoea.",8,8
"2186","es","en","La recuperación media de 2-amino-5, 6-dicloro-3, 4-dihidroquinazolina en orina equivale aproximadamente al 18-35% de la dosis administrada.","The mean recovery of 2-amino-5, 6-dichloro-3, 4-dihydroquinazoline in urine is approximately 18-35% of the administered dose.",16,17
"2187","es","en","La reducción del riesgo relativo alcanzó el 61% al cabo de 2 años (p=0,0006) de tratamiento.","A relative risk reduction of 61% was observed after 2 years (p=0.0006).",12,16
"2188","es","en","La reforma de las tasas pagaderas a la EMEA tendría que finalizar en 1998.","The reform of fees payable to the EMEA should be completed in 1998.",13,14
"2189","es","en","La relación de nombres del producto figura en el Anexo I.","The list of the product names concerned is given in Annex I.",12,11
"2190","es","en","La relación entre beneficio y riesgo puede consultarse en el módulo 6 de este EPAR.","The benefit-risk balance may be found in module 6 of this EPAR.",12,15
"2191","es","en","La relevancia clínica de esta disminución se desconoce.","The clinical relevance of this decrease is unknown.",8,8
"2192","es","en","La repaglinida se metaboliza casi totalmente y no se ha identificado ningún metabolito con efecto hipoglucemiante clínicamente relevante.","Repaglinide is almost completely metabolised, and no metabolites with clinically relevant hypoglycaemic effect have been identified.",16,18
"2193","es","en","La respuesta de anticuerpos en pacientes con inmunodeficiencia endógena o iatrogénica puede ser insuficiente.","Antibody response in patients with endogenous or iatrogenic immunosuppression may be insufficient.",12,14
"2194","es","en","La respuesta inmunológica puede verse disminuida si el paciente está bajo tratamiento inmunosupresor.","The immunological response may be diminished if the patient is undergoing immunosuppressant treatment.",13,13
"2195","es","en","La ribavirina no inhibe las enzimas del citocromo P450.","Ribavirin does not inhibit cytochrome P450 enzymes.",7,9
"2196","es","en","La segunda dosis se debe administrar no después de 6 semanas antes del comienzo de la puesta.","The second dose should be administered no later than 6 weeks before the onset of lay.",16,17
"2197","es","en","La seguridad de la administración concomitante de ácido nicotínico y laropiprant se evaluó en perros y en ratas.","The safety of concomitant administration of nicotinic acid and laropiprant was assessed in dogs and rats.",16,18
"2198","es","en","La seguridad y eficacia de Enbrel en pacientes con inmunosupresión o infecciones crónicas no han sido evaluadas.","The safety and efficacy of Enbrel in patients with immunosuppression or chronic infections have not been evaluated.",17,17
"2199","es","en","La semivida de eliminación de ceftriaxona es unas 2 – 3 veces superior comparada con adultos jóvenes.","The plasma elimination half-life of ceftriaxone is about 2 - 3 fold increased compared to young adults.",17,17
"2200","es","en","La semivida de eliminación de lamivudina observada es de 5 a 7 horas.","The observed lamivudine half-life of elimination is 5 to 7 hours.",11,13
"2201","es","en","La semivida de eliminación del fármaco es de 1,0 a 2,0 horas.","The elimination half-life of lansoprazole is 1.0-2.0 hours.",8,12
"2202","es","en","La semivida de eliminación terminal de irbesartan es de 11-15 horas.","The terminal elimination half-life of irbesartan is 11-15 hours.",9,11
"2203","es","en","La semivida de timolol en plasma es de aproximadamente 4 a 6 horas.","The half-life of timolol in plasma is about 4 to 6 hours.",12,13
"2204","es","en","La semolina se usa como transportador.","Semoline is employed as carrier.",5,6
"2205","es","en","La sobredosis aguda puede conducir inicialmente a hipoglucemia y posteriormente a hiperglucemia.","Acute overdose could lead initially to hypoglycaemia and subsequently to hyperglycaemia.",11,12
"2206","es","en","La sobredosis de Efient puede provocar prolongación del tiempo de sangría y posteriores complicaciones hemorrágicas.","Overdose of Efient may lead to prolonged bleeding time and subsequent bleeding complications.",13,15
"2207","es","en","La sobredosis masiva puede provocar una hipotensión marcada que requerirá soporte cardiovascular activo.","Massive overdose may result in pronounced hypotension requiring active cardiovascular support.",11,13
"2208","es","en","La sobredosis puede causar náuseas y vómitos.","Overdosage may cause nausea or vomiting.",6,7
"2209","es","en","La solicitud estaba en su “ día 174” cuando fue retirada por la empresa.","The application was at day 174 when the company withdrew.",10,14
"2210","es","en","La solución contiene 10'000 UI de epoetina dseta por ml.","The solution contains 10000 IU Epoetin zeta per ml.",9,10
"2211","es","en","La solución de Enbrel no debería mezclarse con ningún otro medicamento.","Do not mix the Enbrel solution with any other medicine.",10,11
"2212","es","en","La solución de MabCampath se presenta en una ampolla de vidrio.","MabCampath is contained in solution in a glass ampoule.",9,11
"2213","es","en","La solución de rasburicasa debe perfundirse durante 30 minutos.","Rasburicase solution should be infused over 30 minutes.",8,9
"2214","es","en","La solución de transparente a ligeramente opalescente y de incolora a amarilla pálida no debe tener partículas visibles.","The clear to slightly opalescent and colourless to pale yellow solution should be free of visible particles.",17,18
"2215","es","en","La solución debe ser clara e incolora.","The solution should be clear and colourless.",7,7
"2216","es","en","La solución debe utilizarse inmediatamente tras la reconstitución.","The solution should be used immediately after reconstitution.",8,8
"2217","es","en","La solución es transparente e incolora.","The solution is clear and colourless.",6,6
"2218","es","en","La solución intravenosa de CellCept nunca se debe administrar mediante inyección intravenosa rápida o en bolus.","CellCept IV solution should never be administered by rapid or bolus intravenous injection.",13,16
"2219","es","en","La solución inyectable diluida debe utilizarse inmediatamente.","The diluted solution for injection should be used immediately.",9,7
"2220","es","en","La solución inyectable en uncartucho precargado está lista para su uso con el dispositivo de autoinyección RebiSmart.","The solution for injection in a pre-filled cartridge is ready for use with the RebiSmart autoinjector device.",17,17
"2221","es","en","La solución no utilizada debe desecharse (ver sección 3).","Any unused solution should be discarded (see section 3).",9,9
"2222","es","en","La solución no utilizada, los viales vacíos y las agujas y jeringas utilizadas deben ser eliminados adecuadamente.","All unused solution, empty vials and used needles and syringes must be discarded appropriately.",14,17
"2223","es","en","La solución oral está indicada para pacientes que no pueden tomar los comprimidos o las cápsulas.","The oral solution is for patients who cannot take the tablets or capsules.",13,16
"2224","es","en","La solución premezcla debe utilizarse inmediatamente después de su preparación.","The premix solution should be used immediately after preparation.",9,10
"2225","es","en","La solución reconstituida contiene 150 UI/ ml.","The reconstituted solution contains 150 IU/ ml.",7,7
"2226","es","en","La solución reconstituida es transparente e incolora.","The reconstituted solution is clear and colourless.",7,7
"2227","es","en","La solución se mezclará suavemente antes de la perfusión.","The solution is to be mixed gently before infusion.",9,9
"2228","es","en","La solución, si se ha refrigerado, debe alcanzar la temperatura ambiente antes de la administración.","Allow the refrigerated solution to reach room temperature before administration.",10,15
"2229","es","en","La supervivencia del páncreas en 1 año fue significativamente superior con tacrolimus:","Pancreas survival at 1 year was significantly superior with tacrolimus:",10,12
"2230","es","en","La sustancia activa es cloruro de (90Y) itrio.","The active substance is Yttrium (90Y) Chloride.",7,8
"2231","es","en","La tapa lleva impreso “ Temodal”.","The cap is imprinted with “Temodal”.",6,6
"2232","es","en","La tasa de respuesta global fue 14,1%.","The overall response rate was 14.1%.",6,7
"2233","es","en","La tasa de supervivencia, del 41%, dependió mucho de la situación clínica.","The survival rate of 41% depended very much on the clinical situation.",12,12
"2234","es","en","La telitromicina se distribuye ampliamente por el organismo.","Telithromycin is widely distributed throughout the body.",7,8
"2235","es","en","La tinta de impresión está compuesta por rojo óxido de hierro (E172), shellac, lecitina de soja.","The printing ink is composed of red iron oxide (E172), shellac, soya lecithin.",13,16
"2236","es","en","La toxina botulínica de tipo B es una sustancia tóxica producida por la bacteria Clostridium botulinum.","Botulinum toxin type B is a toxic substance produced by the bacterium Clostridium botulinum.",14,16
"2237","es","en","La trabectedina no debe utilizarse durante el embarazo salvo que fuera claramente necesario.","Trabectedin should not be used during pregnancy unless clearly necessary.",10,13
"2238","es","en","La unión de ciprofloxacino a las proteínas es baja (20 al 30%).","Pprotein binding of ciprofloxacin is low (20-30%).",7,12
"2239","es","en","La unión es de larga duración.","The binding is long-lasting.",4,6
"2240","es","en","La utilización de este procedimiento en 1998 fue la siquiente:","The mutual recognition procedure has made considerable progress during 1998.",10,10
"2241","es","en","La vacuna fue inmunogénica en ratones y conejos.","The vaccine was immunogenic in mice and rabbits.",8,8
"2242","es","en","La vacuna reduce los síntomas de la gripe y la excreción (eliminación) del virus por las aves infectadas.","The vaccine reduces the signs of flu and the excretion (shedding) of the virus by the infected birds.",18,18
"2243","es","en","La vacuna se administra mediante inyección en un músculo del cuello, detrás de la oreja.","The vaccine is given by injection into a muscle in the neck, in the area behind the ear.",18,15
"2244","es","en","La valoración rutinaria de este acontecimiento debe incluir recuentos sanguíneos completos y un reconocimiento físico.","Routine assessment of this event should include complete blood counts and physical examination.",13,15
"2245","es","en","La variabilidad farmacocinética interindividual de pregabalina es baja (< 20%).","Inter-subject pharmacokinetic variability for pregabalin is low (< 20%).",9,10
"2246","es","en","La variabilidad interindividual en la exposición a celecoxib es de unas 10 veces.","The inter-subject variability in the exposure of celecoxib is about 10-fold.",11,13
"2247","es","en","La velocidad de administración se determinará en función del grado de bienestar del paciente (velocidad máxima de inyección:","The rate of administration should be determined by the patient’ s comfort level (maximal rate of injection:",17,18
"2248","es","en","La versión completa del EPAR de Cetrotide puede consultarse en el sitio web dela Agencia Europea de Medicamentos.","The full EPAR for Cetrotide is available here.",8,18
"2249","es","en","La versión completa del EPAR de Suboxone puede encontrarse aquí.","The full EPAR for Suboxone can be found here.",9,10
"2250","es","en","La versión completa del EPAR puede consultarse aquí.","The full EPAR summary can be found here.",8,8
"2251","es","en","La vía sublingual es la única vía de administración eficaz para este medicamento.","Sublingual route is the only efficacious administration route for this product.",11,13
"2252","es","en","La vildagliptina no actúa cuando la concentración de glucosa en la sangre es baja.","Vildagliptin does not work when the blood glucose is low.",10,14
"2253","es","en","Laboratoire GlaxoSmithKline 100, route de Versailles 78163 Marly-le-Roi Cedex Francia Tel. +33 1 39 178000","Laboratoire GlaxoSmithKline 100, route de Versailles 78163 Marly-le-Roi Cedex France tel +33 1 39 178000",15,15
"2254","es","en","Laboratoires Janssen Cilag 1 rue Desmoulins TSA 91003 92787 Issy les Moulineaux Cedex 9, Francia","Laboratoires Janssen Cilag 1 rue Desmoulins TSA 91003 92787 Issy les Moulineaux Cedex 9, France",15,15
"2255","es","en","Laboratorios Abelló S. A.","Laboratorios Abelló S. A.",4,4
"2256","es","en","Laboratorios Inkeysa S. A.","Laboratorios Inkeysa S. A.",4,4
"2257","es","en","Lactancia Debeevitar amamantar a su hijo si toma Wilzin.","Breast-feeding Breast-feeding should be avoided if you are on Wilzin therapy.",11,9
"2258","es","en","Lactancia Indique inmediatamente a su médico si está en periodo de lactancia.","Breast-feeding Tell your doctor at once if you are breast-feeding.",10,12
"2259","es","en","Lactancia Se desconoce si el interferón beta-1b se excreta en la leche materna.","Lactation It is not known whether interferon beta-1b is excreted in human milk.",13,13
"2260","es","en","Lactancia Se desconoce si infliximab se excreta en la leche materna.","Breast-feeding It is not known if infliximab is excreted in human milk.",12,11
"2261","es","en","Lactancia Timolol se excreta en la leche materna.","Lactation Timolol is excreted in breast milk.",7,8
"2262","es","en","Lactosa Este medicamento contiene 299,2 mg de lactosa en cada dosis de 800 mg (dosis máxima única).","Lactose This medicinal product contains 299.2 mg of lactose in each 800-mg dose (maximum single dose).",16,17
"2263","es","en","Lactosa Estearato de magnesio Celulosa microcristalina Almidón glicolato sódico","Lactose Magnesium stearate Microcrystalline cellulose Sodium starch glycolate",8,9
"2264","es","en","Lactosa monohidrato Almidón de maíz Celulosa microcristalina Hidroxipropilcelulosa Estearato de magnesio","Lactose monohydrate Maize starch Microcrystalline cellulose Hydroxypropyl cellulose Magnesium stearate",10,11
"2265","es","en","lad CAD {MM/ YYYY}","ed EXP {MM/ YYYY}",4,4
"2266","es","en","lad LEVVIAX Denominación Común Internacional (DCI):","ris International Nonproprietary Name (INN):",5,6
"2267","es","en","lad titular de la autorización de comercialización.","For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.",17,7
"2268","es","en","Lagoas Park, Edifício 1, Piso 3, 2740-264 Porto Salvo Portugal","Box 217, 3640 AE Mijdrecht, The Netherlands,",7,10
"2269","es","en","Lansoprazol no debe administrarse con atazanavir (ver sección 4.5).","Lansoprazole should not be administered with atazanavir (see section 4.5).",10,9
"2270","es","en","Lansoprazol-AbZ 15 mg debe ingerirse con el estómago vacío (antes de las comidas).","Lansoprazol AbZ should be taken on an empty stomach (before meals).",11,13
"2271","es","en","Lansoprazolo ratiopharm 30 mg capsule di gelatina dura","capsule di gelatina dura",4,8
"2272","es","en","LansoTEVA 15 mg 15 mg kapsulka dojelitowa twarda","Lansoprazole 15 mg 15 mg Gastro-resistant Capsules",7,8
"2273","es","en","Lantus en cartuchos para OptiClik ha sido diseñado para utilizar sólo OptiClik.","Lantus in cartridge for OptiClik has been developed for use in OptiClik only.",13,12
"2274","es","en","Laropiprant suprime los sofocos mediados por la PGD2","Laropiprant suppresses PGD2 mediated flushing associated with administration of nicotinic acid.",11,8
"2275","es","en","Las 18 primeras semanas de tratamiento, constituyen un período crítico que requiere una estrecha monitorización (ver sección 4.4).","The first 18 weeks of treatment is a critical period which requires close monitoring (see section 4.4).",17,18
"2276","es","en","Las aberraciones cromosómicas se clasificaron de acuerdo con el modelo jerárquico de Döhner.","Chromosomal aberrations were categorized according to Döhner’ s hierarchical model.",10,13
"2277","es","en","Las agujas para inyección no están incluidas.","Injection needles are not included.",5,7
"2278","es","en","Las alteraciones de las pruebas de función hepática pueden estar asociadas con mayores concentraciones plasmáticas y/ o dosis.","Liver function test abnormalities may be associated with higher plasma concentrations and/ or doses.",14,18
"2279","es","en","Las ampollas están destinadas a un solo uso, deberá desecharse cualquier parte sin utilizar.","Ampoules are intended for single use only, any unused portions must be discarded.",13,14
"2280","es","en","Las autoridades competentes de los Estados miembros efectuarán controles regulares del producto.","The competent authorities of the Member States will continue to keep the product under regular review.",16,12
"2281","es","en","Las bacterias entéricas como E. coli son intrínsecamente resistentes a la pirlimicina.","Enteric bacteria such as E. coli are intrinsically resistant to pirlimycin.",11,12
"2282","es","en","Las bacterias pueden ser responsables del 60-70% de episodios clínicos de OMA.","Bacteria can be responsible for 60-70% of clinical episodes of AOM.",11,12
"2283","es","en","Las cápsulas de Emend debe tragarse enteras, con o sin alimento.","Emend capsules should be swallowed whole, with or without food.",10,11
"2284","es","en","Las cápsulas no se deben abrir.","Capsules should not be opened.",5,6
"2285","es","en","Las cápsulas se presentan en frascos de 100 cápsulas duras.","The capsules are provided in bottles containing 100 hard capsules.",10,10
"2286","es","en","Las cápsulas tienen que tragarse enteras.","The capsules should be swallowed whole.",6,6
"2287","es","en","Las características basales se muestran en la tabla 2.","Baseline characteristics are shown in Table 2.",7,9
"2288","es","en","Las cifras correspondientes a una reducción del dolor de al menos 50% fueron 50% y 26%, respectivamente.","The corresponding figures for at least 50% pain reduction were 50% and 26% respectively.",14,17
"2289","es","en","Las combinaciones de lansoprazol con uno o dos antibióticos determinaron una erradicación equivalente de H. pylori.","Combinations of lansoprazole with one or two antibiotics produced equivalent eradication of H. pylori.",14,16
"2290","es","en","Las concentraciones de estos medicamentos aumentan cuando se administran junto con Invirase/ritonavir.","Concentrations of these medicinal products increase several fold when co-administered with Invirase/ ritonavir.",13,12
"2291","es","en","Las concentraciones de HAMA deben ser determinadas antes de readministrar LeukoScan.","HAMA titers should be determined before repeated administration of LeukoScan.",10,11
"2292","es","en","Las concentraciones de warfarina pueden verse afectadas.","Concentrations of warfarin may be affected.",6,7
"2293","es","en","Las concentraciones en plasma cayeron en más del 95% en las 6 horas posteriores a la administración intravenosa.","Plasma concentrations fell by more than 95% within 6 hours following intravenous administration.",13,18
"2294","es","en","Las concentraciones máximas de vareniclina ocurren generalmente a las 3-4 horas después de la administración.","Maximum plasma concentrations of varenicline occur typically within 3-4 hours after oral administration.",13,15
"2295","es","en","Las concentraciones plasmáticas de lacosamida no se vieron afectadas por carbamazepina ni por ácido valproico.","Lacosamide plasma concentrations were not affected by carbamazepine and by",10,15
"2296","es","en","Las concentraciones plasmáticas máximas de rosiglitazona se alcanzan aproximadamente 1 h después de la ingesta.","Rosiglitazone plasma concentrations peak at around 1 h after dosing.",10,15
"2297","es","en","Las conclusiones científicas figuran como Anexo II y el Resumen de Características del Producto como Anexo III.","The scientific conclusions are provided in Annex II, together with the Summary of Product Characteristics in Annex III.",18,17
"2298","es","en","Las conclusiones relativas a las Autorizaciones de Comercialización figuran en el Anexo IV.","Conditions of the Marketing Authorisation are set out in Annex IV.",11,13
"2299","es","en","Las diferencias fueron estadísticamente significativas (diferencia -0,7%, IC95% -0,80; -0,5, p < au","Differences were statistically significant (Difference -0.7%, CI95% -0.80; -0.5, p < 0.001).",12,13
"2300","es","en","Las directrices publicadas para consulta en 1996 son las siguientes:","Guidelines released for consultation in 1996 include:",7,10
"2301","es","en","Las dos vacunas deberán administrarse como inyecciones separadas en diferentes sitios del cuerpo.","The two vaccines should be given as separate injections at different body sites.",13,13
"2302","es","en","Las dosis altas pueden causar parálisis en los músculos distantes al punto de inyección.","Large doses may cause paralysis in muscles distant to the injection site.",12,14
"2303","es","en","Las dosis recomendadas son las que se indican a continuación.","The recommended doses are given below.",6,10
"2304","es","en","Las dosis siguientes deben administrarse mensualmente durante la estación del VRS.","Subsequent doses should be administered monthly throughout the RSV season.",10,11
"2305","es","en","Las dosis superiores a 10 μ g dos veces al día no están recomendadas.","Doses higher than 10µg BID are not recommended.",8,14
"2306","es","en","Las enfermedades concomitantes, especialmente las infecciones, suelen aumentar la necesidad de insulina del paciente.","Concomitant illness, especially infections, usually increases the patient’ s insulin requirements.",11,14
"2307","es","en","Las frecuencias de las reacciones adversas se expresan en pacientes-año, de acuerdo con las siguientes categorías:","The frequencies of adverse reactions are expressed in patient-years, according to the following categories:",14,16
"2308","es","en","Las frecuencias están basadas en los datos de los ensayos clínicos.","The incidences are based on clinical trial data.",8,11
"2309","es","en","Las frecuencias se definen como frecuentes (≥ 1/ 100, < 1/ 10).","Frequencies are defined as common (≥ 1/ 100, < 1/ 10).",11,12
"2310","es","en","Las instrucciones de uso de la pluma de insulina se proporcionan con su pluma de insulina.","The instructions for using the insulin pen are provided with your insulin pen.",13,16
"2311","es","en","Las instrucciones para el uso adecuado de Keppra se proporcionan en la sección 3.","Direction for the proper use of Keppra is provided in section 3.",12,14
"2312","es","en","Las instrucciones para la autoadministración se mencionan en el prospecto del producto.","Instruction for self-administration is mentioned in the Package Leaflet.",9,12
"2313","es","en","Las jeringas contienen 0,7 ml (7000 UI) de solución.","The syringes contain 0.7 ml (7000 IU) of solution.",9,9
"2314","es","en","Las jeringas para inyección no deben contener ningún otro principio activo ni residuo (p. ej., trazas de heparina).","The injection syringes must not contain any other medicinal product or residue (e. g. traces of heparin).",17,18
"2315","es","en","Las lesiones de la piel son complicaciones frecuentes de la diabetes.","Diabetic skin lesions are a common complication of diabetes.",9,11
"2316","es","en","Las listas de expertos europeos están disponibles para su inspección previa petición a las oficinas de la EMEA.","European experts lists The list of European experts is available for examination on request at the EMEA offices.",18,18
"2317","es","en","Las mujeres con posibilidad de quedar embarazadas deben adoptar medidas anticonceptivas eficaces.","Effective contraceptive measures must be taken by women of child-bearing potential.",11,12
"2318","es","en","Las mujeres en edad de riesgo de embarazo tienen que utilizar medidas anticonceptivas eficaces durante el tratamiento.","Women of childbearing potential have to use effective contraception during treatment.",11,17
"2319","es","en","Las mujeres que reciban Myocet, no deben amamantar.","Women receiving Myocet should not breastfeed.",6,8
"2320","es","en","Las mutaciones V82A, I54V y M46I fueron las que aparecieron con mayor frecuencia.","Cholecystitis, hepatitis, hepatomegaly, liver fatty deposit, liver tenderness",8,13
"2321","es","en","Las otras 2 dosis se administrarán 7 y 21 días después de la primera dosis.","The remaining 2 doses will be given 7 days and 21 days after the first dose.",16,15
"2322","es","en","Las pacientes que han interrumpido su tratamiento por reacciones de hipersensibilidad no deben re-iniciar el tratamiento con PROTELOS.","Patients who have stopped treatment due to hypersensitivity reactions should not re-start therapy with PROTELOS.",15,18
"2323","es","en","Las personas con hipersensibilidad (alergia) conocida al meloxicam deberán evitar el contacto con el medicamento.","People with known hypersensitivity (allergic) to meloxicam should avoid contact with the product.",13,15
"2324","es","en","Las personas inmunocomprometidas/ inmunosuprimidas no pueden ser autorizadas a manipular esta vacuna.","Immunocompromised/ immunosuppressed individuals must not be allowed to handle this vaccine.",11,12
"2325","es","en","Las personas que manipulen y distribuyan esta vacuna deben ser vacunadas contra la rabia.","People handling and distributing this vaccine should be vaccinated against rabies.",11,14
"2326","es","en","Las plumas en uso no deben guardarse en la nevera.","Pens in use must not be stored in the refrigerator.",10,10
"2327","es","en","Las plumas vacías no deben rellenarse y se deben desechar de forma segura.","Empty pens must not be re-filled and must be properly discarded.",11,13
"2328","es","en","Las prioridades para 2001-2002 son:","the whole process for product information.",6,5
"2329","es","en","Las propuestas son aceptables, con algunas mejoras.","The proposals are acceptable with some improvements.",7,7
"2330","es","en","Las pruebas de seguimiento de inhibidores en este paciente tras abandonar el ensayo fueron negativas.","Follow-up inhibitor tests in this patient after withdrawal from the study were negative.",13,15
"2331","es","en","Las RA fueron de intensidad leve y fueron valoradas como reacciones asociadas a la perfusión.","The ADRs were mild in intensity and assessed as an IAR.",11,15
"2332","es","en","Las RAMs en cuanto a su gravedad fueron en su mayoría leves o moderadas:","ADRs were mostly mild to moderate in severity:",8,14
"2333","es","en","Las reacciones adversas (RAs) notificadas con más frecuencia (incidencia ≥ 1/ 10) son:","The most frequently reported adverse drug reactions (ADRs) (incidence ≥ 1/ 10) are:",13,13
"2334","es","en","Las reacciones adversas a nivel del sistema nervioso aparecen en aproximadamente el 40% de los pacientes.","Nervous system undesirable effects occur in approximately 40% of patients.",10,16
"2335","es","en","Las reacciones adversas fueron normalmente de leve a moderadas y aparecieron en las dos primeras semanas de tratamiento.","Adverse reactions were usually mild or moderate and occurred within the first two weeks of treatment.",16,18
"2336","es","en","Las reacciones adversas más frecuentes se detallan en la sección 4.8.","The most commonly reported reactions are listed in section 4.8.",10,11
"2337","es","en","Las reacciones adversas más relevantes asociadas a efavirenz son erupción y síntomas del sistema nervioso (ver sección 4.4).","The most notable adverse reactions associated with efavirenz are rash and nervous system symptoms (see section 4.4).",17,18
"2338","es","en","Las reacciones adversas se citan según la frecuencia absoluta y clasificación por órganos y sistemas de MedDRA.","Adverse reactions are listed by MedDRA system organ class and absolute frequency.",12,17
"2339","es","en","Las reacciones adversas se enumeran en orden decreciente de gravedad dentro de cada intervalo de frecuencia.","Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.",13,16
"2340","es","en","Las reacciones adversas se presentan en orden decreciente de gravedad dentro de cada intervalo de frecuencia.","Within each frequency grouping, adverse reactions are ranked in order of decreasing seriousness.",13,16
"2341","es","en","Las reacciones alérgicas a estas sustancias pueden ser graves en ciertos casos.","Allergic reactions to these substances may occasionally be serious.",9,12
"2342","es","en","Las reacciones asociadas con la perfusión consistieron sobre todo en fiebre y escalofríos.","Infusion associated reactions consisted most often of fever and chills.",10,13
"2343","es","en","Las reacciones de frecuencia no conocida notificadas con la administración de telmisartán sólo incluyen:","Adverse reactions of unknown frequency reported with the use of telmisartan alone include:",13,14
"2344","es","en","Las reacciones normalmente desaparecen en unos pocos días eincluso semanas.","Reactions usually resolve in a few days to a few weeks.",11,10
"2345","es","en","Las recomendaciones en cuanto a dosis son las mismas que las de los adultos tratados con quimioterapia.","The dose recommendations are the same as those for adults receiving chemotherapy.",12,17
"2346","es","en","Las respuestas ACR se mantuvieron en el ensayo de extensión abierto hasta la semana 136.","ACR responses were maintained in the open-label extension study for up to 136 weeks.",14,15
"2347","es","en","Las respuestas observadas durante el periodo abierto son similares a las observadas en el periodo doble ciego.","Responses observed during the open-label period were similar to those observed in the double-blind period.",15,17
"2348","es","en","Las siguientes instrucciones explican cómo inyectarse IntronA usted mismo.","The following instructions explain how to inject IntronA yourself.",9,9
"2349","es","en","Las siguientes reacciones adversas adicionales se han observado con Exelon parches transdérmicos: confusión grave, ansiedad, fiebre (frecuente).","Additional side effects which have been reported with Exelon transdermal patches: severe confusion, anxiety, fever (common).",16,17
"2350","es","en","Las siguientes reacciones adversas relacionadas con el tratamiento se notificaron durante la terapia con PegIntron.","The following treatment-related adverse reactions were reported during therapy with PegIntron.",11,15
"2351","es","en","Las soluciones de gemcitabina reconstituidas no se deben refrigerar porque puede producirse cristalización.","Solutions of reconstituted gemcitabine should not be refrigerated, as crystallisation may occur.",12,13
"2352","es","en","Las soluciones refrigeradas deben dejarse atemperar a temperatura ambiente antes de usarlas.","Refrigerated infusion bags should be allowed to warm to room temperature prior to use.",14,12
"2353","es","en","Las tasas de respuesta en el mes 6 fueron comparables con los resultados a 3 meses. t en","The response rates at month 6 were comparable to the 3-month results.",12,18
"2354","es","en","Las tiazidas deben utilizarse con precaución en pacientes con alteración de la función hepática.","Thiazides should be used with caution in patients with impaired hepatic function.",12,14
"2355","es","en","Las UDP-glucuronil transferasas han sido identificadas como las enzimas responsables del metabolismo de lamotrigina.","UDP-glucuronyl transferases have been identified as the enzymes responsible for metabolism of lamotrigine.",13,14
"2356","es","en","Las zonas para la auto-administración incluyen las nalgas, el muslo, el abdomen o la parte superior del brazo.","Sites for self-injection include the buttocks, thigh, abdomen or upper arm.",11,18
"2357","es","en","Latvija Bauskas 58a -401 Rī ga, LV-1004 Tel: + 371-7 21 38 25","Latvija Bauskas 58a -401 Rī ga, LV-1004 Tel: + 371-7 21 38 25",13,13
"2358","es","en","Latvija Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820","Latvija Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820",12,12
"2359","es","en","Latvija JANSSEN-CILAG Polska Sp. z o. o. filiā le Latvijā Talr. +371 6789 3561","Latvija JANSSEN-CILAG Polska Sp. z o. o. filiā le Latvijā Tel. +371 6789 3561",14,14
"2360","es","en","Latvija Pfizer Animal Health Tel: +370 5 269 17 96","Latvija Pfizer Animal Health Tel: +370 5 269 17 96",10,10
"2361","es","en","Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51","Latvija sanofi -aventis Latvia SIA Tel: +371 67 33 24 51",11,10
"2362","es","en","Latvija SIA Nycomed Latvia Duntes iela 6 Rī ga, LV 1013 Tel: +371 784 0082 nycomed@nycomed. lv","Latvija SIA Nycomed Latvia Duntes iela 6 Rī ga, LV 1013 Tel: +371 784 0082 nycomed@nycomed. lv",17,17
"2363","es","en","Lavarse las manos después de su uso.","Wash hands after use.",4,7
"2364","es","en","Lávese bien las manos con agua y jabón y séqueselas.","Wash your hands thoroughly with soap and water and dry them.",11,10
"2365","es","en","Le rogamos comente esto con su médico después de recibir una inyección de Foscan.","Please speak to your doctor about this before you go home after being injected with Foscan.",16,14
"2366","es","en","Lea cuidadosamente las “Instrucciones de Uso de SoloStar” incluidas en este prospecto.","Read carefully the ""SoloStar Instructions for Use"" included in this package leaflet.",12,12
"2367","es","en","Lea cuidadosamente las instrucciones siguientes antes de utilizar Actrapid FlexPen.","Please read the following instructions carefully before using your Actrapid FlexPen.",11,10
"2368","es","en","Lea el prospecto antes de usar el medicamento","Read the package leaflet before use",6,8
"2369","es","en","Leer el prospecto del envase para consultar las precauciones especiales de manipulación y eliminación.","Read package leaflet for special precautions for handling and disposal.",10,14
"2370","es","en","Leflunomida no fue mutagénica.","Leflunomide was not mutagenic.",4,4
"2371","es","en","Lerchenfelder Guertel 9-11 A-1164 Wien","Lerchenfelder Guertel 9-11 A-1164 Wien",5,5
"2372","es","en","Lesiones traumáticas e intoxicaciones","Investigations Injury, poisoning *Cross refer to Section 4.4.",8,4
"2373","es","en","Lesiones traumáticas, intoxicaciones y complicaciones de procedimientos terapéuticos a","Injury, poisoning and procedural complications a",6,9
"2374","es","en","Leucopenia Trombocitopenia, linfadenopatía, linfopenia Anemia aplásica Aplasia pura de la serie roja, púrpura trombocitopénica idiopática, púrpura trombocitopénica trombótica","Thrombocytopaenia, lymphadenopathy, lymphopenia Aplastic anaemia Pure red cell aplasia, idiopathic thrombocytopenic purpura, lon thrombotic thrombocytopenic purpura",16,18
"2375","es","en","LeukoScan está contraindicado durante el embarazo.","LeukoScan is contraindicated in pregnancy.",5,6
"2376","es","en","Levemir 100 U/ ml solución inyectable en una pluma precargada Insulina detemir, InnoLet","Levemir 100 U/ ml solution for injection in a pre-filled pen InnoLet insulin detemir",14,13
"2377","es","en","Levetiracetam provocó una leve inducción del CYP2B6 y del CYP3A4.","The in vitro data and in",6,10
"2378","es","en","Levitra permite obtener una erección con una duración suficiente para mantener una relación sexual satisfactoria.","LEVITRA allows an erection to last long enough for you to satisfactorily complete sexual activity.",15,15
"2379","es","en","Levviax no debe administrarse concomitantemente con simvastatina, atorvastatina y lovastatina.","Levviax should not be used concomitantly with simvastatin, atorvastatin and lovastastin.",11,10
"2380","es","en","Liberación transdérmica de fentanilo (microgramos/ h)","Transdermal fentanyl release (micrograms/ h)",5,6
"2381","es","en","Libere la dosis presionando el botón de inyección por completo.","Deliver the dose by pressing the injection button in all the way.",12,10
"2382","es","en","Licenciada en medicina y cirugía por la Universidad de Roma.","Degree in medicine and surgery from the University of Rome.",10,10
"2383","es","en","Licenciado en Derecho por la Universidad de Dundee del Reino Unido.","Law degree from the University of Dundee, UK.",8,11
"2384","es","en","Lietuva Abbott Laboratories Baltics","Lietuva Abbott Laboratories Baltics Vienibas 87h LV-1004 Rīga Latvia Tel: + 371 7605580",13,4
"2385","es","en","Lietuva GlaxoSmithKline Lietuva UAB Tel: + 370 5 264 90 00 info. lt@gsk. com","Lietuva GlaxoSmithKline Lietuva UAB Tel: + 370 5 264 90 00 info. lt@gsk. com",14,14
"2386","es","en","Lietuva Merck Serono Atstovybė C/o Ares Trading SA Baltic States Zamenhofo 11-3, LT-44287 Kaunas Tel: +370 37320603","Lietuva Merck Serono Atstovybė C/ o Ares Trading SA Baltic States Zamenhofo 11-3, LT-44287 Kaunas Tel: +370 37320603",18,17
"2387","es","en","Lietuva Pfizer Luxembourg SARL filialas Lietuvoje Tel. + 370 52 51 4000","Lietuva Pfizer Luxembourg SARL filialas Lietuvoje Tel. + 370 52 51 4000",12,12
"2388","es","en","Lietuva UAB “ GlaxoSmithKline Lietuva” Tel: +370 5 264 90 00","Lietuva UAB “ GlaxoSmithKline Lietuva” Tel: +370 5 264 90 00",11,11
"2389","es","en","Lietuva UAB “ Sicor Biotech” Telephone: +370 5 211 35 00.","Lietuva UAB “Sicor Biotech” Telephone: +370 5 211 35 00.",10,11
"2390","es","en","Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224","Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224",8,8
"2391","es","en","Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 en","au Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224",9,9
"2392","es","en","Lilly France S. A. S., Rue du Colonel Lilly, 67640 Fegersheim, Francia.","Lilly France S. A. S., Rue du Colonel Lilly, 67640 Fegersheim, France.",12,12
"2393","es","en","Lilly S.A., Avda. de la Industria 30, 28108 Alcobendas, Madrid, España.","Lilly S.A., Avda. de la Industria 30, 28108 Alcobendas, Madrid, Spain.",11,11
"2394","es","en","Limpiar las zonas afectadas y cortar el pelo que cubre las lesiones antes de la administración.","Clean the affected areas and clip the hair covering the lesions before application.",13,16
"2395","es","en","Limpie la piel y luego pellizquela con el dedo pulgar y el dedo índice, sin apretarla.","Clean your skin and then pinch the skin between your thumb and forefinger, without squeezing it.",16,16
"2396","es","en","Liofilizado y disolvente para suspensión para inyectables","Lyophilisate and solvent for suspension for injection",7,7
"2397","es","en","Liprolog contiene el principio activo insulina lispro.","Liprolog contains the active substance insulin lispro.",7,7
"2398","es","en","Liprolog Mix25 es una suspensión blanca y estéril.","Liprolog Mix25 is a white, sterile suspension",7,8
"2399","es","en","Liprolog Pen es una solución estéril, clara, incolora y acuosa de insulina lispro.","Liprolog Pen is a sterile, clear, colourless, aqueous solution.",9,13
"2400","es","en","Lisonorm puede influir en la capacidad de conducir y utilizar máquinas (especialmente durante el periodo inicial del tratamiento).","Lisonorm may influence the ability to drive and operate machines (particularly during the initial period of treatment).",17,18
"2401","es","en","Lista de expertos en medicamentos de uso humano","Human medicines’ experts list human_experts@emea.eudra.org",5,8
"2402","es","en","LITAK 2 mg/ ml solución de cladribina inyectable","LITAK 2 mg/ ml solution for injection cladribine",8,8
"2403","es","en","Litio: los AINEs disminuyen la excreción renal de litio y por tanto aumentan los niveles plasmáticos de litio.","NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels.",11,18
"2404","es","en","Litio: no se recomienda la combinación de litio y Karvezide (ver sección 4.5).","Lithium: the combination of lithium and Karvezide is not recommended (see section 4.5).",13,13
"2405","es","en","Livensa 300 microgramos/ 24 horas, parche transdérmico Testosterona Vía transdérmica","Livensa 300 micrograms/ 24 hours transdermal patch Testosterone Transdermal use",10,10
"2406","es","en","Llame a un médico inmediatamente.","Call a doctor immediately.",4,5
"2407","es","en","Llame inmediatamente a su médico o acuda al servicios de urgencias más cercano.","You should contact your doctor immediately or go to the nearest casualty department.",13,13
"2408","es","en","Lleve consigo alguna información que indique que es diabético.","Carry some information with you to show you are diabetic.",10,9
"2409","es","en","LMC fase acelerada y crisis blástica y LLA Ph+ (dosis inicial","Accelerated phase CML and blast crisis and Ph+",8,11
"2410","es","en","LMC pediátrica fase acelerada y crisis blástica (dosis inicial 340 mg/ m2)","crisis (starting dose 340 mg/ m2)",6,12
"2411","es","en","Lo que debe ser tenido en cuenta en pacientes con dietas pobres en sodio.","To be taken into consideration by patients on a sodium controlled diet.",12,14
"2412","es","en","Lo que sigue es una descripción general del proceso de administración.","The following is a general description of the administration process.",10,11
"2413","es","en","Loc Ai Conti 55051 Castelvecchio Pascoli, Barga (Lucca) - ITALIA","Loc Ai Conti 55051 Castelvecchio Pascoli, Barga (Lucca) - ITALY",10,10
"2414","es","en","Londres, 1 Octubre 2007 EMEA/ CHMP/ 432352/ 2007","London, 1 October 2007 EMEA/ CHMP/ 432352/ 2007",8,8
"2415","es","en","Londres, 26 de abril de 2007 Doc.","London, 26 April 2007 Doc.",5,7
"2416","es","en","Londres, a 19 de diciembre de 1995.","London, 19 December 1995",4,7
"2417","es","en","Lopid no debe utilizarse durante el embarazo a menos que sea claramente necesario.","Lopid should not be used during pregnancy unless it is clearly necessary.",12,13
"2418","es","en","Lopinavir/ Ritonavir (400 c/ 12 h/ 100 c/ 12 h/ 300 c/ 24 h)","Lopinavir/ Ritonavir (400 b. i. d. / 100 b. i. d. / 300 q. d.)",15,14
"2419","es","en","Loratadin- ratiopharm (10 mg Tabletten) bei Allergien","Loratadin- ratiopharm (10 mg Tabletten) bei Allergien",7,7
"2420","es","en","loratadina Denominación Común Internacional (DCI): loratadine","loratadine International Non-Proprietary Name (INN): loratadine",6,6
"2421","es","en","Los 9 pacientes restantes murieron (5 pacientes) o dependían de ventilación invasiva (4 pacientes).","The 9 remaining patients either died (5 patients) or became invasive-ventilator dependent (4 patients).",14,14
"2422","es","en","Los acontecimientos tromboembólicos incluyen trombosis venosa profunda, tromboflebitis y embolismo pulmonar (ver también sección 4.4).","Thromboembolic events include deep venous thrombosis, thrombophlebitis and pulmonary embolism (see also section 4.4).",14,15
"2423","es","en","Los ajustes de dosis, si son necesarios, deberán realizarse como se ha especificado anteriormente.","Adjustments of dosage, if required, should be made as specified above.",11,14
"2424","es","en","Los alimentos retrasaron la absorción y disminuyeron la Cmax, pero no afectaron las concentraciones globales en plasma (AUC).","Food delayed absorption and decreased Cmax but did not affect overall plasma concentrations (AUC).",14,18
"2425","es","en","Los alimentos y bebidas normales no afectan a su tratamiento con Foscan.","Your normal food and drink will not affect your treatment with Foscan",12,12
"2426","es","en","Los análisis también pueden mostrar:","Tests may also show:",4,5
"2427","es","en","Los animales pueden bañarse 2 horas después del tratamiento sin pérdida de eficacia.","Animals may be bathed 2 hours after treatment without loss of efficacy.",12,13
"2428","es","en","Los animales tratados no deben usarse para reproducción hasta 12 semanas después del tratamiento.","Treated animals should not be used for breeding for 12 weeks after the last administration.",15,14
"2429","es","en","Los antiácidos pueden interferir en la absorción gastrointestinal.","Antacids may interfere with gastro-intestinal absorption.",6,8
"2430","es","en","Los anticuerpos ayudarán a proteger el organismo contra las enfermedades causadas por esos virus.","The antibodies will help to protect against the diseases caused by these viruses.",13,14
"2431","es","en","Los anticuerpos monoclonales son proteínas que reconocen y se unen a otras proteínas de forma selectiva.","Adalimumab binds to a specific protein uc",7,16
"2432","es","en","Los anticuerpos pueden reducir la efectividad terapéutica del producto.","Antibodies may reduce the therapeutic effectiveness of the product.",9,9
"2433","es","en","Los betabloqueantes pueden atenuar los síntomas de aviso de una reacción hipoglucémica o suprimirlos n","Alcohol may increase the action of insulin and cause low blood sugar levels.",13,15
"2434","es","en","Los betabloqueantes pueden enmascarar los signos y síntomas de hipoglucemia (ver sección 4.4).","Beta-blockers can mask the signs and symptoms of hypoglycaemia (see section 4.4).",12,13
"2435","es","en","Los blisters unidosis de EXUBERA sólo deben utilizarse con el inhalador de insulina","EXUBERA unit dose blisters must only be used with the insulin inhaler.",12,13
"2436","es","en","Los cambios en el HDL-C y TG en esta población fueron similares a los de la población no-diabética.","Changes in HDL-C and TG in this population were similar to that of the non-diabetic population.",16,18
"2437","es","en","Los cartuchos de 3 ml van incorporados en una pluma desechable, llamada “ KwikPen”.","The 3 ml cartridges are sealed in a disposable pen injector.",11,14
"2438","es","en","Los casos de comportamiento suicida fueron más comunes en los hombres.","Behavioural events were more common in males.",7,11
"2439","es","en","Los casos severos pueden, potencialmente, dar origen a discapacidad para el paciente.","Severe cases are potentially disabling.",5,12
"2440","es","en","Los coágulos de sangre (episodios trombóticos) pueden ser un riesgo.","Blood clots (thrombotic events)",4,10
"2441","es","en","Los componentes de tos ferina acelular (toxina pertussis:","The acellular pertussis components (pertussis toxin:",6,8
"2442","es","en","Los comprimidos de Activelle 0,5 mg/ 0,1 mg no están indicados durante la lactancia.","Lactation Activelle is not indicated during lactation",7,14
"2443","es","en","Los comprimidos de Activelle 0,5 mg/ 0,1mg mg no están indicados durante el embarazo.","Activelle is not indicated during pregnancy.",6,14
"2444","es","en","Los comprimidos de Arava deben ingerirse enteros con suficiente líquido.","Arava tablets should be swallowed whole with sufficient amounts of liquid.",11,10
"2445","es","en","Los comprimidos de Cozaar 50 mg también contienen cera de carnauba (E903), dióxido de titanio (E171).","The Cozaar 50 mg tablets also may contain Carnauba wax (E903), Titanium dioxide (E171).",14,16
"2446","es","en","Los comprimidos de Lamictal se deben tragar enteros, no se deben masticar ni machacar.","Lamictal tablets should be swallowed whole, and should not be chewed or crushed.",13,14
"2447","es","en","Los comprimidos deben ingerirse enteros y sin fraccionar.","Tablets should be taken whole and not divided.",8,8
"2448","es","en","Los comprimidos deben tragarse con agua.","Swallow the tablets with water.",5,6
"2449","es","en","Los comprimidos deben tragarse con un vaso de agua.","The tablets should be swallowed with a drink of water.",10,9
"2450","es","en","Los comprimidos dispersables/ masticables de Lamictal 25 mg son cuadrados con las esquinas redondeadas.","Lamictal 25 mg dispersible/chewable tablets are square with rounded corners.",10,14
"2451","es","en","Los comprimidos masticables Metacam se presentan en:","Metacam chewable tablets are supplied in:",6,7
"2452","es","en","Los comprimidos pueden presentarse en envases con el diseño de un calendario.","The tablets may come in calendar packs.",7,12
"2453","es","en","Los comprimidos se pueden dividir a lo largo de la línea marcada en el comprimido.","Tablets are breakable along the score line on the tablet.",10,15
"2454","es","en","Los comprimidos también contienen lactosa","The tablets also contain lactose",5,5
"2455","es","en","Los datos clínicos disponibles son insuficientes para excluir un riesgo.","The available clinical data is insufficient to exclude a risk.",10,10
"2456","es","en","Los datos clínicos preliminares sugieren que CRIXIVAN","Preliminary clinical data suggest that CRIXIVAN 400 mg in",9,7
"2457","es","en","Los datos de los ensayos clínicos con Retacrit coinciden con el perfil de inocuidad de otras eritropoyetinas autorizadas.","Data from clinical studies with Retacrit are in line with the safety profile of other authorized erythropoietins.",17,18
"2458","es","en","Los datos de reacciones adversas en pacientes mayores de 75 años son limitados.","Adverse reaction data are limited in patients over 75 years of age.",12,13
"2459","es","en","Los datos disponibles indican que puede existir un aumento del riesgo de aborto espontáneo.","Available data indicates that there may be an increased risk of spontaneous abortion.",13,14
"2460","es","en","Los datos farmacocinéticos de duloxetina son escasos en pacientes con insuficiencia renal de leve a moderada.","Pharmacokinetic data on duloxetine is limited in patients with mild or moderate renal impairment.",14,16
"2461","es","en","Los datos postcomercialización mostraron casos de eritema multiforme en una frecuencia muy rara.","Post-marketing data revealed very rare cases of erythema multiforme.",9,13
"2462","es","en","Los datos siguientes son resultados de los estudios realizados con pioglitazona o glimepirida individualmente.","The following data are findings in studies performed with pioglitazone or glimepiride individually.",13,14
"2463","es","en","Los datos sobre la sobredosis en humanos son limitados.","Limited data are available with regard to overdose of rosiglitazone in humans.",12,9
"2464","es","en","Los datos sobre la toxicidad reproductiva para la combinación de norelgestromina con etinilestradiol no están disponibles.","Data on reproductive toxicity of the combination of norelgestromin with ethinyl estradiol are not available.",15,16
"2465","es","en","Los demás componentes son cloruro sódico, borato sódico y agua para inyectables.","The other ingredients are sodium chloride, borax and water for injections.",11,12
"2466","es","en","Los demás componentes son: lactosa monohidrato, hiprolosa, carmelosa de calcio y estearato de magnesio.","The other ingredients are lactose monohydrate, hyprolose, carmellose calcium and magnesium stearate.",12,14
"2467","es","en","Los demás componentes son: macrogol 4000, distearoilfosfatidilcolina, dipalmitoilfosfatidilglicerol sódico, ácido palmítico.","The other ingredients are: macrogol 4000, distearoylphosphatidylcholine, dipalmitoylphosphatidylglycerol sodium, palmitic acid.",11,11
"2468","es","en","Los demás componentes son: manitol, almidón de maíz, sílice coloidal anhidra, povidona K 25, estearato de magnesio.","Mannitol, Maize starch, anhydrous colloidal silica, Povidone K 25, Magnesium stearate.",11,17
"2469","es","en","Los detalles del programa de trabajo de la Unión se recogen en el Capítulo 5.","Details of the Unit’ s work programme can be found in Chapter 5.",13,15
"2470","es","en","Los dispositivos necesarios para la reconstitución y administración se proporcionan en cada envase de KOGENATE Bayer 500 UI.","Medical devices for reconstitution and administration are provided with each package of KOGENATE Bayer 500 IU.",16,18
"2471","es","en","Los efectos adversos comunicados en los estudios clínicos para los pacientes tratados con Karvezide fueron:","Side effects reported in clinical studies for patients treated with Karvezide were:",12,15
"2472","es","en","Los efectos adversos descritos a continuación se han presentado en pacientes a los que se administró VIRAMUNE:","The side effects described below have been experienced by patients given VIRAMUNE:",12,17
"2473","es","en","Los efectos adversos poco frecuentes pueden incluir:","Uncommon side effects may include:",5,7
"2474","es","en","Los efectos adversos pueden aparecer con cierta frecuencia, tal y como se define a continuación:","Side effects may occur with certain frequencies, which are defined as follows:",12,15
"2475","es","en","Los efectos adversos raros, que afectan entre 1 por cada 1000 y 1 por cada 10.000 pacientes, incluyen:","Rare side-effects, reported in between 1 in 1000 and 1 in 10,000 people include:",14,18
"2476","es","en","Los efectos de Diractin se probaron en modelos de laboratorio antes de ser estudiados en seres humanos.","The effects of Diractin were first tested in experimental models before being studied in humans.",15,17
"2477","es","en","Los efectos de INVANZ se comprobaron primero en modelos experimentales, antes de estudiarse en seres humanos.","The effects of INVANZ were first tested in experimental models before being studied in humans.",15,16
"2478","es","en","Los efectos de la pioglitazona pueden estar mediados por una reducción de la resistencia a la insulina.","Pioglitazone effects may be mediated by a reduction of insulin resistance.",11,17
"2479","es","en","Los efectos de sobredosis que pueden esperarse incluyen hipercalcemia retardada, náuseas, vómitos, mareos y cefalea.","The effects of overdose that might be expected include delayed hypercalcemia, nausea, vomiting, dizziness and headache.",16,15
"2480","es","en","Los efectos de Thelin se probaron primero en modelos de laboratorio antes de estudiarse en seres humanos.","The safety and efficacy of Thelin were first tested in experimental models before being studied in humans.",17,17
"2481","es","en","Los efectos de una sobredosis de Pergoveris son desconocidos.","The effects of an overdose of Pergoveris are unknown.",9,9
"2482","es","en","Los efectos de Xelevia se probaron en modelos de laboratorio antes de estudiarse en seres humanos.","The effects of Xelevia were first tested in experimental models before being studied in humans.",15,16
"2483","es","en","Los efectos farmacodinámicos de bivalirudina pueden valorarse con medidas de anticoagulación como el TCA.","The pharmacodynamic effects of bivalirudin may be assessed using measures of anticoagulation including the ACT.",15,14
"2484","es","en","Los ensayos de carcinogénesis en ratas no han revelado hallazgos tumorogénicos.","Carcinogenicity studies in rats revealed no tumourigenic findings.",8,11
"2485","es","en","Los envases contienen 14 (sólo para la dosis de 62,5 mg), 56 ó 112 comprimidos recubiertos con película.","Cartons contain 56 or 112 film-coated tablets.",7,18
"2486","es","en","Los envases de blisters contienen 7, 10, 14 ó 20 comprimidos por cada tira de blister (Alu/ PP).","Blister packs containing either 7, 10, 14 or 20 tablets per blister strip (Alu/ PP).",15,18
"2487","es","en","Los envases se presentan en tamaños de 14, 28, 30, 49, 56 y 98 comprimidos de liberación prolongada.","Pack sizes of 14, 28, 30, 49, 56, and 98 prolonged-release tablets.",12,18
"2488","es","en","Los estafilococos resistentes a meticilina (MRS) son resistentes a todos los antibióticos β -lactámicos actualmente disponibles, incluyendo cefuroxima.","Methicillin-resistant staphylococci (MRS) are resistant to all currently available β -lactam antibiotics including cefuroxime.",14,18
"2489","es","en","Los estudios atendieron al número de mujeres que desarrollaban lesiones genitales o verrugas producidas por infección del VPH.","The studies looked at how many women developed genital lesions or warts that were due to HPV infection.",18,18
"2490","es","en","Los estudios con otros interferones han demostrado dicha especificidad de","Studies with other interferons have demonstrated species specificity.",8,10
"2491","es","en","Los estudios de interacciones se han realizado sólo en adultos.","Interaction studies have only been performed in adults.",8,10
"2492","es","en","Los estudios de laboratorio efectuados en ratas y ratones han demostrado evidencias de efectos embriotóxicos.","Laboratory studies in mice and rats have shown evidence of embryotoxic effects.",12,15
"2493","es","en","Los estudios efectuados han demostrado que el tratamiento mensual de los perros previene infestaciones causadas por Uncinaria stenocephala.","Studies have shown that monthly treatment of dogs will prevent infections caused by Uncinaria stenocephala.",15,18
"2494","es","en","Los estudios en animales han demostrado la excreción de vildagliptina en la leche materna.","Animal studies have shown excretion of vildagliptin in milk.",9,14
"2495","es","en","Los estudios en animales han mostrado cierta toxicidad reproductiva a dosis tóxicas para la madre (ver sección 5.3).","Studies in animals have shown some reproductive toxicity at maternally toxic doses (see section 5.3).",15,18
"2496","es","en","Los estudios en animales han mostrado que clopidogrel se excreta en la leche materna.","Animal studies have shown excretion of clopidogrel in breast milk.",10,14
"2497","es","en","Los estudios en animales han mostrado toxicidad reproductiva (ver sección 5.3).","Studies in animals have shown reproductive toxicity (see section 5.3).",10,11
"2498","es","en","Los estudios en animales no muestran efectos dañinos directos ni indirectos sobre la toxicidad para la reproducción.","Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity.",15,17
"2499","es","en","Los estudios en animales sobre la toxicidad reproductiva son incompletos (ver sección 5.3).","Animal studies of reproductive toxicity are incomplete (see section 5.3).",10,13
"2500","es","en","Los frascos están sellados con precinto de aluminio.","The bottles are sealed with an aluminium seal.",8,8
"2501","es","en","Los glóbulos rojos muy probablemente representen un compartimento secundario de distribución.","The red blood cells most likely represent a secondary compartment of distribution.",12,11
"2502","es","en","Los individuos deben recibir una dosis única administrada subcutáneamente.","Individuals should receive a single dose administered subcutaneously.",8,9
"2503","es","en","Los inhibidores raramente se forman después de los primeros 100 días de tratamiento.","Rarely, inhibitors may develop after the first 100 exposure days.",10,13
"2504","es","en","Los medicamentos como Emtriva pueden causar acidosis láctica (exceso de ácido láctico en la sangre).","Medicines like Emtriva can cause lactic acidosis (excess lactic acid in the blood).",13,15
"2505","es","en","Los medicamentos no se deben tirar a las aguas residuales o a la basura.","Medicines should not be disposed of via wastewater or household waste.",11,14
"2506","es","en","Los medicamentos no se deben tirar por los desagües ni a la basura.","Ask your pharmacist how to dispose of medicines no longer required.",11,13
"2507","es","en","Los medicamentos que afectan al sistema inmunitario, incluído ORENCIA, pueden atenuar la efectividad de algunas inmunizaciones.","Medicinal products that affect the immune system, including ORENCIA, may blunt the effectiveness of some immunisations.",16,16
"2508","es","en","Los miembros del MRFG participaron a su vez en conferencias y seminarios en el campo farmacéutico.","EMEA Annual Report 2001 23",5,16
"2509","es","en","los mismos síntomas, ya que puede perjudicarles.","Do not pass it on to others.",7,7
"2510","es","en","Los motivos fueron los siguientes:","The reasons being the following:",5,5
"2511","es","en","Los neurotransmisores son sustancias que transmiten las señales químicas de una célula nerviosa a otra.","Neurotransmitters are substances that transfer chemical signals from one nerve cell to another one.",14,15
"2512","es","en","Los niños no deben tomar CoAprovel CoAprovel no debe darse a niños menores de 18 años de edad.","Children should not take CoAprovel CoAprovel should not be given to children under 18 years of age.",17,18
"2513","es","en","Los niños son particularmente propensos a desarrollar depresión cuando son tratados con IntronA y ribavirina.","Children are particularly prone to develop depression when being treated with IntronA and ribavirin.",14,15
"2514","es","en","Los niveles de ciclosporina A (CsA) aumentan notablemente en pacientes en tratamiento con IPs, incluyendo indinavir.","Cyclosporine A (CsA) levels markedly increase in patients on PIs, including indinavir.",12,16
"2515","es","en","Los niveles de colesterol deben monitorizarse periódicamente.","Cholesterol levels should be periodically monitored.",6,7
"2516","es","en","Los niveles plasmáticos de buprenorfina aumentaron con la dosis sublingual de Suboxone.","Plasma levels of buprenorphine increased with the sublingual dose of Suboxone.",11,12
"2517","es","en","Los objetivos básicos conseguidos en 2001 fueron:","EMEA staff members by nationality in 2002",7,7
"2518","es","en","Los operarios deberán lavarse las manos tras el uso del producto.","Operators should wash their hands after use of the product.",10,11
"2519","es","en","Los pacientes con alteración renal grave (aclaramiento de creatinina < 30 ml/ min) deben ser tratados con precaución.","Patients with severe renal impairment (creatinine clearance < 30 ml/ min) should be treated with caution.",16,18
"2520","es","en","Los pacientes con depresión deben tratarse durante un periodo de tiempo de al menos 6 meses.","Patients with depression should be treated for a period of at least 6 months. • Bulimia nervosa:",17,16
"2521","es","en","Los pacientes con dermatitis atópica presentan predisposición a sufrir infecciones superficiales de la piel.","Patients with atopic dermatitis are predisposed to superficial skin infections.",10,14
"2522","es","en","Los pacientes con hemofilia B (enfermedad de Christmas) sufren un déficit de factor IX de la coagulación.","Patients with haemophilia B (Christmas disease) are deficient in coagulation factor IX.",12,17
"2523","es","en","Los pacientes con historial reciente de infiltrados pulmonares o neumonía pueden to","Patients with a recent history of pulmonary infiltrates or er pneumonia may be at higher risk. ng",17,12
"2524","es","en","Los pacientes con neuropatía severa preexistente, sólo podrán ser tratados con VELCADE tras una cuidadosa evaluación del riesgo-beneficio.","Patients with pre-existing severe neuropathy may be treated with VELCADE only after careful risk/ benefit assessment.",16,18
"2525","es","en","Los pacientes de 12 años o más deben tomar el contenido de 1 frasco con 75 mg..","Patients from the age of 12 must take the content of 1 jar with 75 mg.",16,17
"2526","es","en","Los pacientes de edades comprendidas entre 3 y 11 años deben tomar una dosis de 45 mg.","Children from the age of 3 to 11 must take the content of 1 jar with 45 mg.",18,17
"2527","es","en","Los pacientes deben lavarse las manos cuidadosamente antes y después de la aplicación de la crema.","Hands should be washed carefully before and after application of cream.",11,16
"2528","es","en","Los pacientes deben mantenerse bien hidratados antes y después de la administración de Zometa.","Patients must be maintained well hydrated prior to and following administration of Zometa.",13,14
"2529","es","en","Los pacientes deben ser advertidos sobre estos posibles efectos adversos.","Patients should be warned about these possible side effects.",9,10
"2530","es","en","Los pacientes en hemodiálisis necesitarán una dosis suplementaria de cefuroxima al final de cada tratamiento de diálisis.","Patients undergoing haemodialysis will require a supplementary dose of cefuroxime at the end of each dialysis treatment.",17,17
"2531","es","en","Los pacientes en tratamiento con fluoxetina pueden experimentar pérdida de peso que normalmente es proporcional al peso basal.","Weight loss may occur in patients taking fluoxetine but it is usually proportional to baseline body weight.",17,18
"2532","es","en","Los pacientes en tratamiento con Humira pueden ser vacunados, excepto con vacunas vivas.","No data are available on the secondary transmission of infection by live vaccines in patients receiving Humira.",17,13
"2533","es","en","Los pacientes fueron tratados durante 23 meses.","The patients were treated for up to 23 months.",9,7
"2534","es","en","Los pacientes fueron tratados hasta la progresión de la enfermedad o toxicidad inaceptable.","Patients were treated until disease progression or unacceptable toxicity occurred.",10,13
"2535","es","en","Los pacientes no deben mojar el sistema IONSYS.","Patients should not get the IONSYS system wet.",8,8
"2536","es","en","Los pacientes no sabían si habían recibido Lucentis o el procedimiento simulado.","The patients cannot tell whether they received Lucentis or the sham procedure.",12,12
"2537","es","en","Los pacientes no-respondedores primarios fueron excluidos de los ensayos y por tanto no fueron evaluados.","The primary non-responders were excluded from the studies and therefore these patients were not further evaluated. t uc",18,15
"2538","es","en","Los pacientes predispuestos al desarrollo de trastornos autoinmunes pueden presentar un mayor riesgo.","Patients predisposed to the development of autoimmune disorders may be at increased risk.",13,13
"2539","es","en","Los pacientes pueden presentar síntomas clínicos predominantemente hepáticos, neurológicos o psiquiátricos.","Patients may present clinically with predominantly hepatic, neurologic, or psychiatric symptoms.",11,11
"2540","es","en","Los pacientes que no fueron evaluados 12 semanas después del EOT se contabilizaron como fallos.","Patients who did not have an assessment 12 weeks after EOT were counted as failures.",15,15
"2541","es","en","Los pacientes tratados con Avastin tienen un mayor riesgo de hemorragia, especialmente hemorragia asociada al tumor.","Patients treated with Avastin have an increased risk of haemorrhage, especially tumour-associated haemorrhage.",13,16
"2542","es","en","Los pacientes tratados con memantina mostraron un efecto superior a placebo estadísticamente significativo, en las variables principales:","Memantine-treated patients showed a statistically significantly better effect than placebo-treated patients on the primary endpoints:",15,17
"2543","es","en","Los pacientes varones deberán mantener una anticoncepción eficaz mientras dure el tratamiento con Zavesca.","Male patients should maintain reliable contraceptive methods while taking Zavesca.",10,14
"2544","es","en","Los pacientes y cuidadores deben tener precaución hasta que estén familiarizados con los posibles efectos de este medicamento.","Patients and carers should exercise caution until they are familiar with the potential effects of this medicinal product.",18,18
"2545","es","en","Los perfiles metabólicos tras la inyección de olanzapina son similares a los de la administración por vía oral.","The metabolic profiles following intramuscular and oral use are similar.",10,18
"2546","es","en","Los preparados de insulina que se hayan congelado no deben utilizarse.","Insulin preparations which have been frozen must not be used.",10,11
"2547","es","en","Los primeros síntomas de bajada del nivel de azúcar suelen presentarse de improviso y están acompañados de:","The first symptoms of low blood sugar usually come on quickly and include the following: •",16,17
"2548","es","en","Los principales acontecimientos adversos notificadas son trastornos hematológicos (anemia, neutropenia), trastornos metabólicos (hiperlactatemia, hiperlipasemia).","The main adverse events reported are haematological disorders (anaemia, neutropenia), metabolic disorders (hyperlactatemia, hyperlipasemia).",14,14
"2549","es","en","Los principales problemas de seguridad debatidos fueron el riesgo de suicidio y el riesgo de reacciones de retirada.","The main safety issues discussed were the risk of suicide and the risk of withdrawal reactions.",16,18
"2550","es","en","Los rashes pasajeros no precisan la interrupción del tratamiento.","Transient rashes do not necessitate interruption of treatment.",8,9
"2551","es","en","Los recién nacidos, lactantes y embarazadas no deben ser expuestos a Ventavis en el aire ambiental.","Newborns, infants, and pregnant women should not be subjected to Ventavis in the room air.",15,16
"2552","es","en","Los resultados de eficacia se muestran en la Tabla 2.","Efficacy results are provided in Table 2.",7,10
"2553","es","en","Los resultados de estudios realizados en ratas con tigeciclina han demostrado cambios en la coloración del hueso.","Results of studies in rats with tigecycline have shown bone discolouration.",11,17
"2554","es","en","Los resultados indican que XELOX es equivalente a FOLFOX-4 en términos de supervivencia global (ver Tabla 7).","The results indicate that XELOX is equivalent to FOLFOX-4 in terms of overall survival (see Table 7).",17,17
"2555","es","en","Los resultados limitados de los estudios abiertos mostraron una respuesta aceptable frente a SRP y varicela.","Limited results from open label studies showed an acceptable response to MMR and varicella.",14,16
"2556","es","en","Los riesgos previsibles se asocian a la administración inadvertida de un exceso de radiactividad.","The risks to be expected are associated with the inadvertent administration of excess radioactivity.",14,14
"2557","es","en","Los siguientes acontecimientos adversos adicionales han sido notificados espontáneamente durante la experiencia post-comercialización:","During post-marketing experience, the following additional adverse events have been reported spontaneously:",12,13
"2558","es","en","Los siguientes efectos han sido notificados durante la experiencia post-comercialización:","The following events have been reported in post-marketing experience:",9,10
"2559","es","en","Los síntomas casi siempre pueden controlarse rápidamente con la ingestión inmediata de carbohidratos (azúcar).","Symptoms can almost always be promptly controlled by immediate intake of carbohydrates (sugar).",13,14
"2560","es","en","Los síntomas de aviso habituales pueden desaparecer en los pacientes con diabetes de larga evolución.","Usual warning symptoms may disappear in patients with longstanding diabetes.",10,15
"2561","es","en","Los síntomas de la hipoglucemia generalmente se","Symptoms of hypoglycaemia usually occur suddenly.",6,7
"2562","es","en","Los trastornos lipídicos deben tratarse como se considere clínicamente apropiado (ver sección 4.8).","Lipid disorders should be managed as clinically appropriate (see section 4.8).",11,13
"2563","es","en","Los tres metabolitos identificacados en plasma son: la sulfona, 5-hidroxilansoprazol y el sulfihidrilo.","Three metabolites have been identified in the plasma: the sulphone, 5-hydroxy lansoprazole and the sulphide.",15,13
"2564","es","en","Los valores de hemoglobina no deben superar los 12 g/dl.","The haemoglobin values should not exceed a value of 12 g/dl.",11,10
"2565","es","en","Los viales deben reconstituirse con 1 ml de agua para preparaciones inyectables.","Vials must be reconstituted with 1 ml of water for injections.",11,12
"2566","es","en","Los viales deben utilizarse con jeringas de insulina graduadas con una escala de unidades correspondiente.","The vials are for use with insulin syringes with a corresponding unit scale. no",14,15
"2567","es","en","Lote/ CAD: ver envase individual (etiqueta adhesiva solo para los envases clínicos)","Batch / EXP: see individual pack (label for sticker for hospital packs only)",13,12
"2568","es","en","Loxicom 1,5 mg/ ml suspensión oral para perros.","Loxicom 1.5 mg/ ml oral suspension for dogs.",8,8
"2569","es","en","Ltd Tel: +356 21232175","Ltd Tel: +356 21232175",4,4
"2570","es","en","lugar de la inyección; acumulación de líquido en el cuerpo","fluid in your body",4,10
"2571","es","en","LUMIGAN es un medicamento para el glaucoma.","LUMIGAN is an antiglaucoma preparation.",5,7
"2572","es","en","LUN MAR MIE JUE VIE SAB DOM","MON TUE WED THU FRI SAT SUN",7,7
"2573","es","en","Lundbeck A/ S Ottiliavej 9, DK-2500 Valby Dinamarca","Lundbeck A/ S Ottiliavej 9 DK-2500 Valby DENMARK",8,8
"2574","es","en","Luxembourg/ Luxemburg Eli Lilly Benelux S. A. / N. V.","Luxembourg/ Luxemburg Eli Lilly Benelux S. A. / N. V.",10,10
"2575","es","en","Luxembourg/ Luxemburg Merck Sharp & Dohme B. V.","Luxembourg/ Luxemburg Merck Sharp & Dohme B. V.",8,8
"2576","es","en","Luxembourg/ Luxemburg Rue de Stalle 73 B-1180 Bruxelles/ Brüssel Belgique/ Belgien Tél/ Tel: + 32-(0)2 370 92 11","B-1180 Bruxelles/Brüssel Belgique/Belgien Tél/Tel: + 32-(0)2 370 92 11 lon",10,18
"2577","es","en","Luxembourg/ Luxemburg S. A.","Luxembourg/ Luxemburg S. A.",4,4
"2578","es","en","Luxembourg/Luxemburg sanofi-aventis Belgium Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)","Luxembourg/Luxemburg sanofi-aventis Belgium Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)",10,10
"2579","es","en","Luxembourg/Luxemburg VIRBAC BELGIUM S.A.","Luxembourg/ Luxemburg VIRBAC BELGIUM S. A.",6,4
"2580","es","en","LYRICA 50 mg cápsulas duras Pregabalina","LYRICA 50 mg hard capsules Pregabalin",6,6
"2581","es","en","M abThera puede utilizarse para el tratamiento de tres enfermedades distintas.","M abThera may be used for the treatment of three different conditions.",12,11
"2582","es","en","m EU/ 1/ 02/ 207/ 020","r EU/ 1/ 02/ 207/ 020",6,6
"2583","es","en","M-M-RVAXPRO Polvo para suspensión inyectable","M-M-RVAXPRO Powder for suspension for injection.",6,5
"2584","es","en","MabThera es un concentrado con el que se prepara una solución para perfusión (goteo en una vena).","MabThera is a concentrate to be made up into a solution for infusion (drip into a vein).",17,17
"2585","es","en","Macugen 0,3 mg solución inyectable","Macugen 0.3 mg solution for injection",6,5
"2586","es","en","Magyarország AVENTIS PASTEUR Representative Office Tel.:","Magyarország AVENTIS PASTEUR Representative Office Tel.:",6,6
"2587","es","en","Magyarország Cymedica Hungary Kft.","Magyarország Cymedica Hungary Kft.",4,4
"2588","es","en","Magyarország Lundbeck Hungaria Kft.","Magyarország Lundbeck Hungaria Kft.",4,4
"2589","es","en","Magyarország Pfizer KFT Tel: +361 488 3695","Magyarország Pfizer KFT Tel: +361 488 3695",7,7
"2590","es","en","Magyarország Takeda Global Research and Development Centre (Europe) Ltd., Nagy-Britannia Tel.: + 44 (0)203 116 8000","Magyarország Takeda Global Research and Development Centre (Europe) Ltd., Nagy-Britannia Tel.: + 44 (0)203 116 8000",16,16
"2591","es","en","Malta Agrimed Limited Tel: +356 21 465 797","Malta Agrimed Limited Tel: +356 21 465 797",8,8
"2592","es","en","Malta BioPartners GmbH Eisenstrasse 3 D-65428 Rüsselsheim Ġ ermanja Tel: +49 (0) 6142 70 8000","Malta BioPartners GmbH Eisenstrasse 3 D-65428 Rüsselsheim Ġ ermanja Tel: +49 (0) 6142 70 8000",15,15
"2593","es","en","Malta GlaxoSmithKline (Malta) Limited Tel: + 356 21 238131 www. alli. com. mt","Malta GlaxoSmithKline (Malta) Limited Tel: + 356 21 238131 www.alli.com.mt",10,13
"2594","es","en","Malta OrionCorporation Orionintie 1 FIN-02200 Espoo Tel: +358 10 4261","Malta Orion Corporation Orionintie 1 FIN-02200 Espoo Tel: +358 10 4261",11,10
"2595","es","en","Malta Roche Products Ltd.Tel: +44 (0) 1707 366000","Malta (See United Kingdom)",4,8
"2596","es","en","Maltitol líquido Este medicamento contiene maltitol líquido.","Maltitol liquid This medicinal product contains maltitol liquid.",8,7
"2597","es","en","Manejar los comprimidos con cuidado.","OTHER SPECIAL WARNING(S), IF NECESSARY Handle tablets with care.",9,5
"2598","es","en","Mangion Building, Triq Ġdida fi Triq Valletta MT-Ħal-Luqa LQA 06 Tel: +356 2397 6000","Mangion Building, Triq Ġdida fi Triq Valletta MT-Ħal-Luqa LQA 06 Tel: +356 2397 6000",14,14
"2599","es","en","Manitol Hiprolosa (E 463) Estearato de magnesio.","Mannitol Hyprolose (E 463) Magnesium stearate",6,7
"2600","es","en","Mantener el cartucho en el embalaje exterior para protegerlo de la luz.","Keep the cartridge in the outer carton in order to protect from light.",13,12
"2601","es","en","Mantener el comprimido debajo de la lengua hasta que se disuelva.","Keep the tablet under your tongue until it dissolves.",9,11
"2602","es","en","Mantener el envase perfectamente cerrado para protegerlo de la luz y de la humedad.","Keep the container tightly closed in order to protect from light and moisture.",13,14
"2603","es","en","Mantener el frasco herméticamente cerrado.","Keep the bottle tightly closed.",5,5
"2604","es","en","Mantener el vial en el embalaje exterior para protegerlo de la luz.","Keep the container in the outer carton in order to protect from light.",13,12
"2605","es","en","Mantener fuera del alcance y de la vista de los niños ic ed","Keep out of the reach and sight of children ed",10,13
"2606","es","en","Mantener fuera del alcance y de la vista de los niños.","HOW TO STORE OLANZAPINE NEOPHARMA COATED TABLETS 96 Keep out of the reach and sight of children.",17,11
"2607","es","en","Mantener fuera del alcance y de la vista de los niños. am","Keep out of the reach and sight of children. na",10,12
"2608","es","en","Mantener la jeringa y el dispositivo para el acceso al vial alineados.","Keep the syringe and the vial access device aligned.",9,12
"2609","es","en","Mantener la pluma en el embalaje exterior para preservarlo de la luz.","Keep the pen in the outer carton in order to protect from light.",13,12
"2610","es","en","Mantener la pluma precargada en el embalaje exterior para protegerla de la luz.","Keep the pre-filled pen in the outer carton in order to protect from light.",14,13
"2611","es","en","Mantenga el botón de inyección presionado por completo.","Keep the injection button pressed all the way in.",9,8
"2612","es","en","Mantenga IntronA, solución inyectable, pluma multidosis, con la punta de la aguja de inyección hacia arriba.","Hold the IntronA, solution for injection, multidose pen with the injection needle point upwards.",14,16
"2613","es","en","Mantenga los cilindros en la botella.","Keep the canisters in the bottle.",6,6
"2614","es","en","Manténgase fuera del alcance y la vista de los niños.","Keep out of reach and sight of children",8,10
"2615","es","en","Manteniendo el frasco en posición vertical, inserte en el cuello del frasco el adaptador a presión.","While holding the bottle in its upright position, insert the press-in-bottle-adaptor into the neck of the bottle.",17,16
"2616","es","en","Mantenimiento Su FlexPen está diseñado para trabajar de forma exacta y segura.","Maintenance Your FlexPen is designed to work accurately and safely.",10,12
"2617","es","en","Maraviroc es un sustrato para la P-glicoproteina transportadora de salida.","Maraviroc is a substrate for the efflux transporter P-glycoprotein.",9,10
"2618","es","en","Marca de fantasía Nombre","Marketing Authorisation Holder (Invented) name",5,4
"2619","es","en","Marcado con « NVR » en una cara y « FB » en la otra.","One side is debossed with “ NVR”, and the other side with “ FB”.",14,15
"2620","es","en","Marinopoulou Str., 174 56 Alimos, Athens, Grecia. co","Marinopoulou Str., 174 56 Alimos, Athens, Greece. uc",8,8
"2621","es","en","Marsa HMR 14, Malta.","Marsa HMR 14, Malta.",4,4
"2622","es","en","Más del 99% de los datos de eficacia y seguridad se han obtenido en población de raza blanca.","More than 99% of efficacy and safety data were generated in Caucasians.",12,18
"2623","es","en","Más información sobre Xagrid:","Other information about Xagrid:",4,4
"2624","es","en","Material de acondicionamiento secundario Los sobres se acondicionan en una caja.","Secondary packaging material The sachets are packed in a carton.",10,11
"2625","es","en","Meda Pharma 25, Boulevard de l’ Amiral Bruix 75016 Paris Francia","Meda Pharma 25, Boulevard de l’ Amiral Bruix 75016 Paris France",11,11
"2626","es","en","Media de variación en el recuento de linfocitos CD4+ a partir del valor basal (x 106/l)b","CD4+ cell count mean change from baseline (x 106/l)b",9,16
"2627","es","en","Media del cambio desde el valor inicial antes del tratamiento","Mean change from pre-treatment baseline",5,10
"2628","es","en","Mediana del tiempo hasta la progresión (semanas)","Median time to progression (weeks)",5,7
"2629","es","en","Medicamento sujeto a prescripción médica","Medicinal product subject to medical prescription",6,5
"2630","es","en","Medicamento sujeto a prescripción médica restringida (Véase anexo I: resumen de las características del producto, 4.2).","Summary of Product Characteristics, 4.2)",5,16
"2631","es","en","Medicamento sujeto a prescripción médica.","Medicinal product subject to medical prescription.",6,5
"2632","es","en","Medicamento sujeto a prescripción médica. co","Medicinal product subject to medical prescription. uc rod",8,6
"2633","es","en","Medicamento sujeto a receta médica (Ver Anexo I:","Medicinal product subject to restricted medical prescription (See Annex I:",10,8
"2634","es","en","Medicamentos antiinflamatorios y antirreumáticos, no esteroídicos.","Anti-inflammatory and anti-rheumatic products, non-steroids.",5,6
"2635","es","en","Medicamentos de uso humano y veterinario Se excluyen los medicamentos veterinarios inmunológicos y las vacunas","Human and veterinary medicinal products Official batch release excluded EC-Canada",10,15
"2636","es","en","Medicamentos para el tratamiento de las arritmias cardiacas, como por ejemplo, quinidina, procainamida, amiodarona o sotalol.","Nitrates, medicines for angina, or nitric oxide donors, such as amyl nitrite.",12,16
"2637","es","en","Medicamentos para tratar infecciones por hongos (antifúngicos):","Medicines used to treat fungal infections (antifungals):",7,7
"2638","es","en","Medicamentos por áreas terapéuticas (dosis)","Sertraline dose increases should",4,5
"2639","es","en","médicos deben tenerlo presente y asegurarse de que el medicamento se use adecuadamente y de co","However, doctors must ensure that the medicine is used appropriately. lo",11,16
"2640","es","en","MEDIDAS QUE SE HAN DE TOMAR EN CASO DE REACCIONES ADVERSAS","ACTIONS TO TAKE IN CASE OF SIDE EFFECTS",8,11
"2641","es","en","Medir 94 ml de agua purificada en una probeta.","Measure 94 ml of purified water in a graduated cylinder.",10,9
"2642","es","en","Medochemie Ltd, Limassol Constantinoupoleos St.","Medochemie Ltd, Limassol Constantinoupoleos St.",5,5
"2643","es","en","Mejor respuesta global (CR + PR) al tratamiento en estudio [quimioterapia +/ - quimioradioterapia] (%)","Best overall response (CR + PR) to study treatment [chemotherapy +/ - chemoradiotherapy] (%) (95%CI)",15,15
"2644","es","en","Mejoría 90% en la Evaluación Global por el 28,5% Médico","Improvement ≥ 90% in Physician’ s 28.5% Global Evaluation",9,10
"2645","es","en","mellitus con tendencia a la cetoacidosis.","pulmonary embolism) or severe myelosuppression.",5,6
"2646","es","en","Meloxicam 0,5 mg (equivalente a 0,017 mg por gota)","Meloxicam 0.5 mg (equivalent to 0.017 mg per drop)",9,9
"2647","es","en","Menitorix no debe administrarse en ninguna circunstancia mediante inyección intravenosa, intradérmica o subcutánea","Menitorix should under no circumstances be administered intravascularly, intradermally or subcutaneously.",11,13
"2648","es","en","Menos de 61,2 kg 61,3 kg a 65,7 kg 65,8 kg y superior","Below 61.2 kg 61.3 kg to 65.7 kg 65.8 kg and over",12,13
"2649","es","en","Menos de un 5% de la dosis se excreta de forma inalterada en la orina y las heces.","Less than 5% of the dose is excreted unchanged in the urine and faeces.",14,18
"2650","es","en","Menos del 1% de la dosis se elimina como ingrediente activo inalterado.","Less than 1% of the dose is excreted as unchanged active ingredient.",12,12
"2651","es","en","Menos del 1% de los pacientes modificó su rutina diaria o suspendió el tratamiento debido a los fosfenos.","Fewer than 1% of patients changed their daily routine or discontinued the treatment in relation with phosphenes.",17,18
"2652","es","en","Merck AB Strandvejen 102 B, 4th DK-2900 Hellerup Tlf: +45 35253550","Merck AB Strandvejen 102 B, 4th DK-2900 Hellerup Tlf: +45 35253550",11,11
"2653","es","en","Merck Genéricos – Produtos Farmacêuticos, Lda.","Portugal Merck Genéricos – Produtos",5,6
"2654","es","en","Merck n. v. / s. a.","Merck n. v. / s. a.",6,6
"2655","es","en","Merck Sharp & Dohme (Italia) S. p. A.","Merck Sharp & Dohme (Italia) S. p. A.",8,8
"2656","es","en","Merck Sharp & Dohme B. V.","Merck Sharp & Dohme B. V.",6,6
"2657","es","en","Merck Sharp & Dohme BV Waarderweg 39, 2031 BN Haarlem P. O.","Merck Sharp & Dohme BV Waarderweg 39, 2031 BN Haarlem P. O.",12,12
"2658","es","en","Merck Sharp & Dohme GmbH Donau-City-Straße 6, 1220 Viena, Austria","Merck Sharp & Dohme GmbH Donau-City-Straße 6 1220 Wien Austria",10,10
"2659","es","en","Merck Sharp & Dohme GmbH Tel: +43 (0) 1 26 044 msd-medizin@merck. com","Österreich Merck Sharp & Dohme GmbH Tel: +43 (0) 1 26 044 msd-medizin@merck. com",14,13
"2660","es","en","Merck Sharp & Dohme OÜ Peterburi tee 46 11415 Tallín, Estonia","Merck Sharp & Dohme OÜ Peterburi tee 46 11415 Tallinn Estonia",11,11
"2661","es","en","Merck Sharp & Dohme PO Box 581 2003 PC Haarlem Países Bajos","Merck Sharp & Dohme Limited Hertford Road, Hoddesdon, Herts EN11 9BU United Kingdom",13,12
"2662","es","en","Merck Sharp & Dohme, inovativna HYZAAR zdravila d. o. o., Smartinska cesta 140, 1000 Liubliana, Eslovenia","Merck Sharp & Dohme, inovativna zdravila d. o. o., Smartinska cesta 140, 1000 Ljubljana Slovenia",15,16
"2663","es","en","Merck Sharp Dohme Chibret 3 av.","Merck Sharp Dohme Chibret 3 av.",6,6
"2664","es","en","MERIAL 29 avenue Tony Garnier F-69007 Lyon Francia","MERIAL 29 avenue Tony Garnier F-69007 LYON FRANCE",8,8
"2665","es","en","Merial Laboratoire Porte des Alpes Rue de l'Aviation F-69800 SAINT PRIEST FRANCIA","MERIAL Laboratoire Porte des Alpes Rue de l’ Aviation F-69800 SAINT PRIEST FRANCE",13,12
"2666","es","en","MERIAL, Laboratory of Lyon Gerland 254, Avenue Marcel Mérieux, 69007 Lyon, Francia","Merial, Laboratory of Lyon Gerland 254, Avenue Marcel Mérieux, 69007 Lyon, France",12,12
"2667","es","en","Mes 12 Mes 24","Month 12 Month 24",4,4
"2668","es","en","meses en animales nacidos de vacas inmunizadas)","born to immune cattle).",4,7
"2669","es","en","Metabolismo Oseltamivir se convierte ampliamente en oseltamivir carboxilato por acción de las esterasas, principalmente en el hígado.","Metabolism Oseltamivir is extensively converted to oseltamivir carboxylate by esterases located predominantly in the liver.",15,17
"2670","es","en","Metabolismo Se han identificado tres metabolitos principales de la isotretinoína en el plasma después de su administración oral:","Metabolism After oral administration of isotretinoin, three major metabolites have been identified in plasma:",14,18
"2671","es","en","Metabolismo y alteraciones de la nutrición muy frecuentes: frecuentes:","Metabolism and nutrition disorders very common:",6,9
"2672","es","en","MetabolismoLa rufinamida se elimina de forma casi exclusiva a través del metabolismo.","Biotransformation Rufinamide is almost exclusively eliminated by metabolism.",8,12
"2673","es","en","Metacam 1 mg comprimidos masticables para perros Meloxicam","Metacam 1 mg chewable tablets for dogs",7,8
"2674","es","en","Metalyse 8.000 unidades 1 vial contiene 8.000 unidades (40 mg) de tenecteplasa.","Metalyse 8,000 units 1 vial contains 8,000 units (40 mg) tenecteplase.",11,12
"2675","es","en","Metformina se distribuye en los eritrocitos.","Metformin partitions into erythrocytes.",4,6
"2676","es","en","Metformina se excreta por vía renal; por ello, deben monitorizarse regularmente las concentraciones séricas de creatinina:","Renal Function As metformin is excreted by the kidney, serum creatinine concentrations should be determined regularly:",16,16
"2677","es","en","metilo (E 218), 4-hidroxibenzoato de propilo (E 216), acetato de sodio, ácido acético, agua purificada.","stearate, hypromellose, colloidal silicon dioxide, titanium dioxide (E 171).",9,15
"2678","es","en","Mezclar con el vial B antes de la administración.","To be mixed with Vial B before administration",8,9
"2679","es","en","Mezclar suavemente la solución para perfusión.","Mix the infusion solution gently.",5,6
"2680","es","en","Mezclar suavemente, sin agitar el vial, hasta que se haya disuelto todo el medicamento (E).","Swirl vial gently until all material is dissolved (E).",9,15
"2681","es","en","mg/ día); la dosis diaria máxima es de 10 mg;","the maximal daily dose is 10 mg;",7,10
"2682","es","en","Mialgia, raramente miolisis, artralgia, creatina fosfoquinasa elevada","Myalgia, rarely myolysis, arthralgia, elevated creatine phosphokinase",7,7
"2683","es","en","Micardis pertenece a una clase de medicamentos conocidos como antagonistas de los receptores de la angiotensina II.","Micardis belongs to a class of medicines known as angiotensin II receptor antagonists.",13,17
"2684","es","en","Michel CHOJNOWSKI Danmark Ib VALSBORG Ib Bo LUMHOLTZ","Michel CHOJNOWSKI Danmark Ib VALSBORG Ib Bo LUMHOLTZ",8,8
"2685","es","en","Midazolam y otras benzodiacepinas metabolizadas por CYP3A4:","Midazolam and other benzodiazepines metabolised by CYP3A4:",7,7
"2686","es","en","Mientras esté tomando este medicamento requerirá revisiones extra, incluyendo análisis sanguíneo.","You will need extra check-ups, including blood tests, while you ’ re taking your medication.",15,11
"2687","es","en","Mientras tome Siklos se le harán análisis de sangre periódicos, y se evaluarán las funciones hepática y renal.","When taking Siklos you will have regular blood tests and tests on your liver and kidney functions.",17,18
"2688","es","en","Mimpara 30 mg comprimido Cinacalcet","Mimpara 30 mg tablet Cinacalcet",5,5
"2689","es","en","Minervum 7061 4817 ZK Breda Holanda","Minervum 7061 4817 ZK Breda The Netherlands",7,6
"2690","es","en","Mínimo 7 días, hasta 4 semanas","substance per kg feed with:",5,6
"2691","es","en","Miopatía, dolor de espalda, dolor musculoesquelético, mialgia","Reproductive system and breast disorders Uncommon:",6,7
"2692","es","en","MIRAPEXIN 0,7 mg comprimidos Pramipexol","MIRAPEXIN 0.7 mg tablets Pramipexole",5,5
"2693","es","en","MIRCERA 150 µg /0,3 ml inyectable metoxi-polietilenglicol epoetina beta SC/IV","MIRCERA 150 µg/0.3 ml injection methoxy polyethylene glycol-epoetin beta SC/IV",10,10
"2694","es","en","MIRCERA 50 microgramos/0,3 ml solución inyectable en jeringa precargada metoxi-polietilenglicol epoetina beta","MIRCERA 50 micrograms/0.3 ml solution for injection in pre-filled syringe methoxy polyethylene glycol-epoetin beta",14,12
"2695","es","en","MIRCERA se utiliza únicamente para tratar la anemia sintomática causada por la enfermedad renal crónica.","MIRCERA is used to treat only the symptomatic anaemia caused by your chronic kidney disease.",15,15
"2696","es","en","Mixtard 10 NovoLet no debe rellenarse.","Do not refill Mixtard 10 NovoLet.",6,6
"2697","es","en","Mixtard 20 Penfill 100 UI/ ml suspensión inyectable en un cartucho Insulina humana (ADNr)","Mixtard 20 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)",15,14
"2698","es","en","Mixtard 30 Penfill 100 UI/ ml suspensión inyectable en un cartucho Insulina humana, (ADNr)","Mixtard 30 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA),",15,14
"2699","es","en","momento para tomar Temodal hasta que el vómito esté bajo control.","If you vomit after taking your dose, do not take a second dose on the same day.",17,11
"2700","es","en","Mommaertslaan, 14 1831 Machelen (Diegem)","Mommaertslaan, 14 1831 Machelen (Diegem)",5,5
"2701","es","en","monitorizar el tratamiento con Enbrel en el caso de que la infección empeore.","Your doctor may wish to monitor the treatment with Enbrel in case the infection worsens.  Blood disorders:",18,13
"2702","es","en","monohidrato, edetato disódico, cloruro sódico, m-cresol, polisorbato 80 y agua para preparaciones inyectables.","monohydrate, edetate disodium, sodium chloride, m-cresol, polysorbate 80 and water for injections.",12,13
"2703","es","en","Monoterapia y combinación con otros antidiabéticos orales","Monotherapy and combination with other oral antidiabetic agents",8,7
"2704","es","en","MOTIVOS PARA LA MODIFICACIÓN DEL RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO, ETIQUETADO Y PROSPECTO","GROUNDS FOR AMENDMENT OF THE SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET",13,14
"2705","es","en","Moxidectina (mg/ kg p. v.)","Moxidectin [mg/ kg bw]",4,5
"2706","es","en","Msida MSD 1824 Tel: +356 21 320338","Msida MSD 1824 Tel: +356 21 320338",7,7
"2707","es","en","Muchos de estos pacientes comunicaron edema periférico concurrente.","Many of these patients reported concurrent peripheral oedema.",8,8
"2708","es","en","muestra algún signo de deterioro.","shows any sign of deterioration.",5,5
"2709","es","en","Muy frecuente > 10%; frecuente se define normalmente como > 1% y < 10%.","Very common ≥ 10%; Common is normally defined as ≥ 1% and < 10%.",14,14
"2710","es","en","Muy frecuentes (≥ 1/ 10)","Very common (≥ 1/ 10)",5,5
"2711","es","en","Muy frecuentes (al menos 1 de cada 10 personas)","Very common (at least 1 in 10 people) – Bleeding",10,9
"2712","es","en","Muy frecuentes Frecuentes Poco frecuentes","Very common Common Uncommon",4,5
"2713","es","en","Muy frecuentes: cefalea, mareos","Very common: headache, dizziness",4,4
"2714","es","en","Muy frecuentes: edema superficial, fatiga, fiebre Frecuentes: dolor, astenia, dolor torácico a","Very common: superficial oedemac, fatigue, pyrexia Common: pain, asthenia, chest pain a",12,12
"2715","es","en","Muy raras Poco frecuentes","Very rare Uncommon Rare Common",5,4
"2716","es","en","Muy raros (≤ 1/ 10.000) Trastornos vasculares:,","Very Rare (≤ 1/ 10 000) Vascular disorders:",8,7
"2717","es","en","Muy raros: anemia hemolítica, pancitopenia, agranulocitosis.","Very rare: haemolytic anaemia, pancytopenia, agranulocytosis.",6,6
"2718","es","en","Myocet tampón • carbonato sódico • agua para inyección","Myocet buffer • sodium carbonate • water for injections",9,9
"2719","es","en","Myozime es un polvo que se disuelve en una solución para infusión (goteo en vena).","Myozyme is a powder to be made up into a solution for infusion (drip into a vein).",17,15
"2720","es","en","n • CONDICIONES O RESTRICCIONES EN RELACIÓN CON LA UTILIZACIÓN SEGURA Y EFICAZ DEL MEDICAMENTO","au • CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT",17,15
"2721","es","en","n co EU/ 1/ 02/ 211/ 010","u EU/ 1/ 02/ 211/ 010",6,7
"2722","es","en","n debe abandonar la lactancia materna.","au you use Nespo.",4,6
"2723","es","en","n EU/ 1/ 02/ 207/ 012","o EU/ 1/ 02/ 207/ 012",6,6
"2724","es","en","n ió La dosis debe aumentarse en un 25%-50% si:","th Dose should be increased by 25% – 50% if:",10,10
"2725","es","en","N/ A N/ A N/ A N/ A","N/ A N/ A N/ A N/ A",8,8
"2726","es","en","N=Numero de pacientes desde el estado basal y durante las semanas 52, 104, +6 y +12 ic","Visit (weeks) N=Number of Subjects at Baseline, week 52, week 104, week +6, week +12. ed",16,17
"2727","es","en","N02BG08 Este medicamento se ha autorizado en “ Circunstancias excepcionales”.","This medicinal product has been authorised under “ Exceptional Circumstances”.",10,10
"2728","es","en","N06AX21 La duloxetina es un inhibidor de la recaptación de serotonina (5-HT) y de noradrenalina (NA).","Duloxetine is a combined serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor.",11,16
"2729","es","en","na ció iza tor au c on to en am dic Me","uth ra ge lon no ct du ro lp ina dic Me",12,12
"2730","es","en","na La insulina no tiene definiciones específicas de sobredosificación.","A specific overdose of insulin cannot be defined.",8,9
"2731","es","en","na Novo Nordisk A/S DK-2880 Bagsværd Dinamarca","au Novo Nordisk A/ S DK-2880 Bagsværd Denmark",8,7
"2732","es","en","na TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN","ra THE MARKETING AUTHORISATION HOLDER",5,7
"2733","es","en","NA-SALICYLAAT, 100%, polvo para solución para administración oral","NA-SALICYLAAT, 100%, powder for solution for oral administration",8,8
"2734","es","en","Náuseas, vómitos Diarrea, dispepsia, dolor abdominal, sequedad de boca","Nausea, vomiting Diarrhoea, dyspepsia, abdominal pain, dry mouth",8,9
"2735","es","en","Navamedic ASA Vollsveien 13 C 1327 Lysaker, Noruega","Navamedic ASA Vollsveien 13 C 1327 Lysaker, Norway",8,8
"2736","es","en","necesidad de dosis adicionales según las pautas de inmunización recomendadas.","given as in the recommended immunisation schedule.",7,10
"2737","es","en","necesidad de reducir la dosis.","th the dose should be reduced by approximately 25%.",9,5
"2738","es","en","Necesita más de una dosis, reconstituya la cantidad necesaria de medicamento repitiendo los pasos 2-9.","If you need more than one dose, reconstitute the desired amount of product repeating steps 2. - 9.",18,15
"2739","es","en","necesitándose una nueva prescripción para continuar el tratamiento.","treatment and continuation of treatment requires a new prescription.",9,8
"2740","es","en","Necesitará tomarlo cada día.","You will need to take it every day.",8,4
"2741","es","en","Nederland Baxter B. V.","Nederland Baxter B. V.",4,4
"2742","es","en","Nederland Eisai Europe Ltd.","Nederland Eisai Europe Ltd.",4,4
"2743","es","en","Nederland GlaxoSmithKline BV Tel: + 31 (0)30 69 38 100 nlinfo@gsk.com","Nederland GlaxoSmithKline BV Tel: + 31 (0)30 69 38 100 nlinfo@gsk. com",12,11
"2744","es","en","Nederland Menarini Benelux NV/SA Tel: +32 (0)2 721 4545","Nederland Menarini Benelux NV/SA Tel: +32 (0)2 721 4 545",10,9
"2745","es","en","Nederland Pfizer Animal Health B. V., Tel: +31 (0)10 4064 600","Nederland Pfizer Animal Health B.V., Tel: +31 (0)10 4064 600",10,11
"2746","es","en","Nederland sanofi-aventis Netherlands B.V.","Nederland sanofi-aventis Netherlands B. V.",5,4
"2747","es","en","Nederland Wyeth Pharmaceuticals B. V.","Nederland Wyeth Pharmaceuticals B. V.",5,5
"2748","es","en","Neisseria meningitidis OMPC (complejo proteico de la membrana externa de la cepa B11 de Neisseria meningitidis subgrupo B)","Neisseria meningitidis OMPC (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B)",16,18
"2749","es","en","Nelarabina mostró citotoxicidad in vitro en monocitos y macrófagos.","Nelarabine showed in vitro cytotoxicity to monocytes and macrophages.",9,9
"2750","es","en","Neoclarityn 2,5 mg comprimidos bucodispersables","Neoclarityn 2.5 mg orodispersible tablets",5,5
"2751","es","en","Neoclarityn comprimidos bucodispersables o a loratadina.","Neoclarityn orodispersible tablet, or to loratadine.",6,6
"2752","es","en","Neoplasias benignas, malignas y no especificadas (incl. quistes y pólipos) Poco frecuentes:","Bronchitis, nail fungal infection, sinusitis, skin infection malignant and unspecified (incl cysts and polyps)",14,12
"2753","es","en","Neoplasias benignas, malignas y no especificadas(incl quistes y pólipos)","Neoplasm benign, malignant and unspecified",5,9
"2754","es","en","NeoRecormon 3.000 UI solución inyectable en jeringa precargada","NeoRecormon 3000 IU solution for injection in pre-filled syringe",9,8
"2755","es","en","NeoRecormon jeringa precargada está lista para su uso.","The NeoRecormon pre-filled syringe is ready for use.",8,8
"2756","es","en","NeoRecormon se administra dos veces por semana durante 4 semanas.","NeoRecormon is administered twice weekly over 4 weeks.",8,10
"2757","es","en","Neots, Cambs PE19 3ET","Neots, Cambs PE19 3ET United Kingdom",6,4
"2758","es","en","Nespo 130 µg Darbepoetin alfa to","Nespo 130 µg Darbepoetin alfa IV/ SC",7,6
"2759","es","en","Nespo 20 µg inyectable to","Nespo 20 µg injection ro",5,5
"2760","es","en","Nespo 40 µg inyectable to","Nespo 40 µg injection ro",5,5
"2761","es","en","Nespo 80 microgramos solución inyectable en jeringa precargada.","Nespo 80 micrograms solution for injection in a pre-filled syringe.",10,8
"2762","es","en","Neulasta 6 mg solución inyectable en pluma precargada.","Neulasta 6 mg solution for injection in a pre-filled pen.",10,8
"2763","es","en","Neupro 2 mg/24 h parche transdérmico Rotigotina Vía transdérmica.","Neupro 2 mg/24 h transdermal patch Rotigotine Transdermal use.",9,9
"2764","es","en","Neuropatía óptica, edema de papila, alteración vascular de la retina, retinopatía, úlcera corneal","Optic neuropathy, papilloedema, retinal vascular disorder, retinopathy, corneal ulcer",9,13
"2765","es","en","Neutropenia de la nutrición Aumento del apetito Anorexia Hipoglucemia","Appetite increased Anorexia Hypoglycaemia",4,9
"2766","es","en","neutropenia trombocitopenia, leucopenia, anemia, eosinofilia, linfadenopatía","neutropenia thrombocytopenia, leukopenia, anaemia, eosinophilia, lymphadenopathy",6,6
"2767","es","en","NEVANAC contiene cloruro de benzalconio, que puede decolorar las lentes de contacto blandas.","NEVANAC contains benzalkonium chloride, which is known to discolour soft contact lenses.",12,13
"2768","es","en","Nevirapina AUC ↓ 0,42 Nevirapina Cmin ↓ 0,32 Nevirapina Cmax ↓ 0,50 comparado con los controles históricos.","Nevirapine AUC ↓ 0.42 Nevirapine Cmin ↓ 0.32 Nevirapine Cmax ↓ 0.50 compared to historical controls.",16,17
"2769","es","en","Nicobrand Limited 189 Castleroe Road Coleraine Irlanda del Norte BT51 3RP","Nicobrand Limited 189 Castleroe Road Coleraine Northern Ireland BT51 3RP",10,11
"2770","es","en","Nifedipino puede incrementar falsamente los valores espectrofotométricos del ácido vanillilmandélico urinario.","Nifedipine may increase the spectrophotometric values of urinary vanillylmandelic acid falsely.",11,11
"2771","es","en","NIMESULIDA 100MG ó 200 MG SUPOSITORIOS","NIMESULIDE 100 MG OR 200 MG SUPPOSITORIES",7,6
"2772","es","en","Ningún paciente abandonó el estudio a consecuencia de reacciones adversas atribuibles a Busilvex.","No patients were discontinued from treatment due to adverse reactions related to Busilvex.",13,13
"2773","es","en","Ningún paciente presentaba anticuerpos neutralizadores 2 años después del tratamiento.","There were no patients with neutralizing antibodies 2 years following treatment.",11,10
"2774","es","en","Ningún procedimiento quirúrgico adicional llevado a cabo que fuera clasificado como “ fallo”.","No additional surgical procedure performed that was classified as a “failure”",11,13
"2775","es","en","Ninguna si se siguen estrictamente las indicaciones de uso.","None if used strictly as directed.",6,9
"2776","es","en","Niños (de 1 mes a 4 años)","Infants and children (1 month to 4 years)",8,7
"2777","es","en","Niños (entre 2 y 18 años):","Children (aged 2 to 18 years):",6,6
"2778","es","en","Niños con SIDA Inmunomodulación:","Children with AIDS Immunomodulation:",4,4
"2779","es","en","Niños de 1 a 5 años:","Children 1 through 5 years of age:",7,6
"2780","es","en","Niños de 6 a 11 años:","Children 6 through 11 years of age:",7,6
"2781","es","en","Niños entre 6 y 12 años:","Children between 6 and 12 years old:",7,6
"2782","es","en","Niños mayores de 6 años:","Paediatric patients from 6 years of age",7,5
"2783","es","en","Niños mayores de 8 años y adolescentes:","Children and adolescents aged 8 years and above:",8,7
"2784","es","en","Niños menores de 16 años y adultos mayores de 60 años:","Children under the age of 16 and adults over 60 years:",11,11
"2785","es","en","Niños y adolescentes (< 18 años de edad):","Children and adolescents (< 18 years of age):",8,8
"2786","es","en","Niños y adolescentes (21 años o menos)","Children and adolescents (aged 21 years and younger)",8,7
"2787","es","en","Nivel de conciencia no deseado durante la anestesia","Anaesthetic complication (see section 4.4) Unwanted awareness during anaesthesia",9,8
"2788","es","en","Nivel de fosfato sérico en pacientes que no estén en tratamiento con quelantes del fosfato","Serum phosphate level in patients not on phosphate binders",9,15
"2789","es","en","Niveles de colesterol elevados11 Trastornos del sistema nervioso Muy frecuentes:","Elevated cholesterol levels Nervous system disorders Very common:",8,10
"2790","es","en","No abra el sobre y no administre así el sistema IONSYS a un paciente.","Do not open the sachet and do not dispense such an IONSYS system to a patient.",16,14
"2791","es","en","No administrar a gatitos de menos de 8 semanas de edad.","Do not administer to kittens under 8 weeks of age.",10,11
"2792","es","en","No agite el envase que contiene la jeringa precargada.","Do not shake the packing containing the pre-filled syringe.",9,9
"2793","es","en","No agite el vial.","Do not shake vial.",4,4
"2794","es","en","No agregar agua a los frascos de VIRACEPT 50 mg/g polvo oral.","Do not add water to bottles of VIRACEPT 50 mg/g oral powder.",12,12
"2795","es","en","No amamante mientras esté en tratamiento con Noxafil.","Do not breast-feed while being treated with Noxafil.",8,8
"2796","es","en","No aplique < Marca de fantasía > en los senos durante la lactancia.","Do not apply < Invented Name > to the breasts if breast-feeding.",12,13
"2797","es","en","No aplique la crema en su nariz, ojos o boca.","Do not use it in your nose, eyes or mouth.",10,10
"2798","es","en","No aumente la dosis total de ADVATE que utiliza para controlar su hemorragia sin consultar a su médico.","Do not increase the total dose of ADVATE to control your bleeding without consulting your doctor.",16,18
"2799","es","en","No colocar Insuman Basal cerca del compartimento congelador del frigorífico o junto a un acumulador de frío.","Do not put Insuman Basal next to the freezer compartment or a freezer pack.",14,17
"2800","es","en","No colocar Lantus cerca del compartimento de congelación o junto a un acumulador de frío.","Do not put Lantus next the freezer compartment or a freezer pack.",12,15
"2801","es","en","No coma, beba o fume mientras manipule el producto.","Do not eat, drink, or smoke when handling the product.",10,9
"2802","es","en","No conduzca ni maneje herramientas o máquinas si se siente mareado.","Do not drive or use any tools or machines if you feel dizzy.",13,11
"2803","es","en","No conservar a temperatura superior a 25 º C.","Do not store above 25ºC.",5,9
"2804","es","en","No conservar a temperatura superior a 25°C Mantener el frasco perfectamente cerrado para protegerlo de la humedad.","Keep the bottle tightly closed in order to protect from moisture.",11,17
"2805","es","en","No conservar a temperatura superior a 25°C.","Do not store above 25°C.",5,7
"2806","es","en","No conservar a temperatura superior a 25ºC.","Do not store above 25°C",5,7
"2807","es","en","No conservar a temperatura superior a 30°C Conservar en el envase original","Do not store above 30°C Store in the original container",10,12
"2808","es","en","No conservar a temperatura superior a 30°C Conservar en el envase original para protegerlo de la humedad.","Do not store above 30oC Store in the original package in order to protect from moisture.",16,17
"2809","es","en","No conservar a temperatura superior a 30°C.","Do not store above 30°C.",5,7
"2810","es","en","No conservar las cápsulas por encima de 30 ºC.","Do not store above 30 °C.",6,9
"2811","es","en","No debe administrarse a pacientes con deterioro hepático grave.","They should not be used in patients with severe liver problems.",11,9
"2812","es","en","No debe donar sangre durante el tratamiento y 1 semana después del final del tratamiento.","You should not donate blood during treatment and for 1 week after the end of treatment.",16,15
"2813","es","en","No debe masticar los comprimidos porque su sabor no es agradable.","Do not chew the tablets because they do not taste nice. b.",12,11
"2814","es","en","No debe mezclarse con Bondronat concentrado para solución para perfusión las soluciones que contengan calcio.","Calcium containing solutions should not be mixed with Bondronat concentrate for solution for infusion.",14,15
"2815","es","en","No debe olvidarse que está prevista la participación de los países del EEE en el CPMP.","In addition the anticipated involvement of EEA countries at CPMP level has to be taken into account.",17,16
"2816","es","en","No debe ser tratada con Temodal durante el embarazo a menos que sea claramente indicado por su médico.","You must not be treated with Temodal during pregnancy unless clearly indicated by your doctor.",15,18
"2817","es","en","No debe tomar CHAMPIX si está embarazada.","You should not take CHAMPIX while you are pregnant.",9,7
"2818","es","en","No debe tomar el comprimido de 3 mg de INVEGA, porque contiene lactosa.","You should not take the 3 mg tablet of INVEGA because it contains lactose.",14,13
"2819","es","en","No debe tomar una dosis doble a la mañana siguiente.","A double dose should not be taken on the next morning.",11,10
"2820","es","en","No debe usar Enbrel junto con medicamentos que contengan los principios activos anakinra o abatacept","You should not use Enbrel with medicines that contain the active ingredients anakinra or abatacept.",15,15
"2821","es","en","No debe utilizar Thymanax si su hígado no funciona adecuadamente.","You must not use Thymanax if your liver does not work properly.",12,10
"2822","es","en","No debe utilizarse en pacientes con problemas raros de intolerancia hereditaria a la fructosa.","Patients with rare hereditary problems of fructose intolerance should not take this vaccine.",13,14
"2823","es","en","No debe utilizarse la solución reconstituida si contiene partículas o no es transparente.","The reconstituted solution should not be used if it contains particles or is not clear.",15,13
"2824","es","en","No debe utilizarse otro disolvente.","Do not use any other solvent.",6,5
"2825","es","en","No debe utilizarse para fijar la dosis.","It must not be used to set the dose.",9,7
"2826","es","en","No deberá utilizar ninguna otra vía de administración.","You should not administer it using a different administration route.",10,8
"2827","es","en","No deje de tomar el medicamento a menos que así se lo indique su médico.","Do not stop taking your medicine unless your doctor tells you to.",12,15
"2828","es","en","No diluir con soluciones acuosas","Do not dilute with aqueous solutions.",6,5
"2829","es","en","No es necesario ajustar la dosis en pacientes de edad avanzada.","No dose adjustment is necessary for the elderly.",8,11
"2830","es","en","No es necesario realizar un ajuste de dosis para efavirenz.","No dosage adjustment is necessary for efavirenz.",7,10
"2831","es","en","No es necesario realizar un ajuste de dosis para ninguno de","No dosage adjustment is necessary for either medicinal product.",9,11
"2832","es","en","No es necesario realizar un ajuste de la dosificación en pacientes ancianos.","No dosage adjustment is necessary in elderly patients.",8,12
"2833","es","en","No es necesario realizar un ajuste de la dosis en función de la edad.","Dosage adjustment based on age is not required.",8,14
"2834","es","en","No es posible descartar que sorafenib pueda aumentar las concentraciones de sustratos de CYP2C9, administrados de forma concomitante.","It cannot be excluded that sorafenib may increase the concentrations of concomitantly administered substrates of CYP2C9.",16,18
"2835","es","en","No está clara la significación clínica de estos hallazgos.","The clinical significance of these findings is unknown.",8,9
"2836","es","en","No está claro si el efecto de tacrolimus se debe a inmunosupresión sistémica o a un efecto local.","It is unclear whether the effect of tacrolimus is due to systemic immunosuppression or a local effect.",17,18
"2837","es","en","No está recomendado el uso de CHAMPIX en niños o adolescentes menores de 18 años.","CHAMPIX is not recommended for use in children or adolescents below 18 years.",13,15
"2838","es","en","No está recomendado el uso de Enviage en niños y adolescentes.","The use of Enviage in children and adolescents is not recommended.",11,11
"2839","es","en","No existe diferencia en la respuesta a Karvezide en relación a la edad o el sexo.","There is no difference in response to Karvezide, regardless of age or gender.",13,16
"2840","es","en","No existe experiencia con el uso concomitante de inmunosupresores o esteroides por vía sistémica.","There is no experience with concomitant use of systemic steroids or immunosuppressive agents.",13,14
"2841","es","en","No existe experiencia con pacientes con puntuaciones Child-Pugh superiores a 9.","There is no experience in subjects with Child-Pugh scores above 9.",11,11
"2842","es","en","No existe información disponible sobre la seguridad y eficacia del uso conjunto de esta vacuna con cualquier otra.","No information is available on the safety and efficacy from the use of this vaccine with any other.",18,18
"2843","es","en","No existe interacción farmacocinética con la folitropina alfa cuando se administran simultáneamente.","There is no pharmacokinetic interaction with follitropin alfa when administered simultaneously.",11,12
"2844","es","en","No existe ningún antídoto específico para el tratamiento de la sobredosificación con efavirenz.","There is no specific antidote for overdose with efavirenz.",9,13
"2845","es","en","No existe un tratamiento específico con antídoto.","No specific antidotal therapy exists.",5,7
"2846","es","en","No existen datos clínicos disponibles con relación a la excreción de QUADRAMET en leche humana.","There are no available clinical data relating to the excretion of QUADRAMET in human milk.",15,15
"2847","es","en","No existen datos sobre los pacientes sometidos a trasplante hepático con insuficiencia renal crónica grave.","No data are available for hepatic transplant patients with severe chronic renal impairment.",13,15
"2848","es","en","No existen datos suficientes sobre la utilización de doxazosina en mujeres embarazadas.","There are no adequate data from the use of doxazosin in pregnant women.",13,12
"2849","es","en","No existen datos suficientes sobre la utilización de Kinzalmono en mujeres embarazadas.","There are no adequate data from the use of Kinzalmono in pregnant women.",13,12
"2850","es","en","No existen pruebas de que Betaferon tenga un efecto sobre la duración de las recaídas.","There is no evidence of Betaferon having an effect on the duration of relapses.",14,15
"2851","es","en","No fue necesario un ajuste de la dosis en estos pacientes.","No dosage adjustment was necessary in these patients.",8,11
"2852","es","en","No fumar, comer o beber mientras manipula el medicamento veterinario.","Do not smoke, eat or drink during application.",8,10
"2853","es","en","No guardarlos nunca dentro o cerca del congelador, ni de elementos refrigerantes de la nevera.","Do not store them in or too near the freezer section or cooling element.",14,15
"2854","es","en","No guarde ninguna porción no utilizada para su administración posterior.","Do not save any unused portions for later administration.",9,10
"2855","es","en","No ha quedado demostrada la seguridad del medicamento veterinario durante la gestación y la lactancia.","The safety of the veterinary medicinal product has not been established during pregnancy and lactation.",15,15
"2856","es","en","No hay datos que revelen la cinética de eliminación ósea del estroncio después del tratamiento.","There are no data in patients to demonstrate elimination kinetics of strontium from bone off-therapy.",15,15
"2857","es","en","No hay estudios sobre interacciones con fármacos que influyen en el metabolismo hepático.","There are no studies concerning interactions with agents influencing hepatic metabolism.",11,13
"2858","es","en","No hay evidencia que sugiera que la hipercalemia pueda causar feocromocitomas en humanos.","There is no evidence to suggest that hypercalcemia might cause phaeochromocytomas in humans.",13,13
"2859","es","en","No hay información sobre el uso del docetaxel en mujeres embarazadas.","There is no information on the use of docetaxel in pregnant women.",12,11
"2860","es","en","No hay ningún estudio adecuado y bien controlado en mujeres embarazadas.","There are no adequate and well-controlled studies in pregnant women.",10,11
"2861","es","en","No hay preocupaciones relacionadas con el uso clínico del producto.","No concerns in relation to the clinical use of the product.",11,10
"2862","es","en","No hay secreción tubular.","No tubular secretion takes place.",5,4
"2863","es","en","No hubo cambio alguno del Tmáx o de la vida media.","There was no change to Tmax or half-life.",8,11
"2864","es","en","No hubo diferencias significativas en la tasa de acontecimientos complicados entre etoricoxib y diclofenaco.","There was no significant difference between etoricoxib and diclofenac in the rate of complicated events.",15,14
"2865","es","en","No hubo indicios de un exceso de mortalidad global.","There was no evidence of an overall excess mortality.",9,9
"2866","es","en","No importa si lo toma con o sin alimentos.","It does not matter whether you take it with or without food.",12,9
"2867","es","en","No incluido en el envase:","Not included in the pack:",5,5
"2868","es","en","No intente inyectarse usted mismo si no le han enseñado cómo hacerlo.","Do not try to inject yourself if you have not been trained.",12,12
"2869","es","en","No interrumpa su tratamiento con Optisulin sin consultar con su médico, el le dirá lo que debe hacer.","Do not stop Optisulin without speaking to a doctor, who will tell you what needs to be done.",18,18
"2870","es","en","No interrumpa su tratamiento sin consultar con su médico.","Do not stop your treatment without contacting your doctor.",9,9
"2871","es","en","No inyectar por vía intravascular.","Do not inject intravascularly.",4,5
"2872","es","en","No lo deje cerca de ninguna fuente de calor ni al sol.","Do not keep the pre-filled pen that you are using in the fridge.",13,12
"2873","es","en","No lo use tampoco en bombas peristálticas con tubos de silicona.","Also do not use it in peristaltic pumps with silicone tubing.",11,11
"2874","es","en","No los puede transmitir a nadie.","You can’t pass it on to anyone else.",8,6
"2875","es","en","No masajee el lugar de la inyección.","Do not massage the injection site.",6,7
"2876","es","en","No mezclar con ninguna otra vacuna o producto inmunológico.","Do not mix with any other vaccine or immunological product.",10,9
"2877","es","en","No mezcle la insulina con ningún otro medicamento.","Do not mix insulin with any other medicines.",8,8
"2878","es","en","No obstante algunos de estos efectos adversos pueden ser graves y pueden necesitar atención médica.","Some of these effects may be serious and may require medical attention.",12,15
"2879","es","en","No obstante, el grado de absorción de lamivudina (basándose en el AUC) no se ve afectado.","However, the extent (based on the AUC) of lamivudine absorbed is not influenced.",13,16
"2880","es","en","No obstante, en algunos casos aislados han aparecido mastitis bacterianas graves después del tratamiento.","However, in rare cases, serious bacterial udder infections have occurred after treatment.",12,14
"2881","es","en","No obstante, estas asociaciones no resultan suficientemente pronunciadas para garantizar un ajuste de la dosis.","However, these associations are not sufficiently pronounced to warrant dose adjustment.",11,15
"2882","es","en","No obstante, hable con su médico si los efectos empeoran o duran mucho tiempo.","Talk to your doctor if any effects become troublesome or last a long time.",14,14
"2883","es","en","No obstante, los posibles efectos adversos se pueden evitar al reducir la velocidad de perfusión.","However, possible side effects may be reduced by slowing the infusion rate.",12,15
"2884","es","en","No obstante, no se han realizado estudios formales de interacción.","However, formal interaction studies have not been performed.",8,10
"2885","es","en","No obstante, puede interrumpirse en cualquier momento en caso necesario.","However, it can be interrupted at any time, if necessary.",10,10
"2886","es","en","No obstante, si esto sucediera, su médico le proporcionará el tratamiento adecuado.","However, should this occur, you will receive appropriate treatment from your doctor.",12,12
"2887","es","en","No puede excluirse el riesgo para el bebé.","A risk to a suckling infant cannot be excluded.",9,8
"2888","es","en","No purgar el aire a través de la aguja","Do not purge air through the needle.",7,9
"2889","es","en","No reanudar la lactancia hasta que el médico le indique que es seguro hacerlo.","Do not restart breast-feeding until the doctor tells you it is safe to do so.",15,14
"2890","es","en","No refrigerar ni congelar los blisters unidosis.","Do not refrigerate or freeze the unit dose blisters.",9,7
"2891","es","en","No refrigerar o congelar.","Do not refrigerate or freeze.",5,4
"2892","es","en","No rellenar los cartuchos vacíos.","Empty cartridges must not be refilled.",6,5
"2893","es","en","No rellene ni reutilice los cartuchos vacíos.","Do not re-fill and re-use empty cartridges.",7,7
"2894","es","en","No requiere condiciones especiales de conservación.","This medicinal product does not require any special storage condition.",10,6
"2895","es","en","No retire la cubierta de la jeringa precargada hasta que esté preparado para la inyección.","Do not remove the cover from the pre-filled syringe until you are ready to inject.",15,15
"2896","es","en","No reutilizar contenedores abiertos de vacuna disuelta Destruir el resto de vacuna no utilizado.","Destroy unused vaccine contents.",4,14
"2897","es","en","No se administre insulina.","Do not take more insulin.",5,4
"2898","es","en","No se aplique más gotas hasta que sea la hora de la siguiente dosis.","Don’ t put in any more drops until it’ s time for your next regular dose.",16,14
"2899","es","en","No se comunicó ninguna reacción clínica adversa.","No clinical adverse reactions were reported.",6,7
"2900","es","en","No se conoce aún plenamente qué efectos pueden tener éstas sobre la seguridad y la eficacia del medicamento.","The effect of these on the safety and effectiveness of the medicine is not fully known.",16,18
"2901","es","en","No se conoce el metabolismo de la eflornitina, la cual se elimina fundamentalmente por la orina.","Eflornithine is not known to be metabolised and is eliminated primarily in the urine.",14,16
"2902","es","en","No se conoce ningún beneficio por inyectar en el lugar de la extravasación otra sustancia.","There is no known benefit from injecting the extravasation site with another substance.",13,15
"2903","es","en","No se consideró necesario interrumpir el medicamento debido a las reacciones en el lugar de administración.","Injection site reactions generally did not necessitate discontinuation of the medicinal product.",12,16
"2904","es","en","No se debe administrar a mujeres que pudieran quedar embarazadas.","Must not be used in women with child bearing potential.",10,10
"2905","es","en","No se debe administrar Humalog BASAL por vía intravenosa bajo ninguna circunstancia.","Under no circumstances should Humalog BASAL be given intravenously.",9,12
"2906","es","en","No se debe administrar Liprolog Mix50 por vía intravenosa bajo ninguna circunstancia.","Under no circumstances should Liprolog Mix50 be given intravenously.",9,12
"2907","es","en","No se debe mezclar ReFacto AF con otras soluciones para infusión.","ReFacto AF should not be mixed with other infusion solutions.",10,11
"2908","es","en","No se debe rellenar el envase.","The container must not be refilled.",6,6
"2909","es","en","No se detectaron diferencias significativas en la supervivencia global (OS).","No significant differences were detected in overall survival (OS).",9,10
"2910","es","en","No se detectaron signos del efecto del fármaco en estos niños.","Metabolism and nutrition disorders Common: decreased appetite.",7,11
"2911","es","en","No se dispone de datos adecuados sobre el uso del bromuro de metilnaltrexona en mujeres embarazadas.","Pregnancy There are no adequate data with the use of methylnaltrexone bromide in pregnant women.",15,16
"2912","es","en","No se dispone de datos clínicos sobre embarazos de riesgo para Valtropin.","For Valtropin no clinical data on exposed pregnancies are available.",10,12
"2913","es","en","No se dispone de datos clínicos sobre la utilización de Nespo en mujeres embarazadas. au","Therapy should be reinitiated at ic",6,15
"2914","es","en","No se dispone de datos de seguridad tras el tratamiento con Ziagen en niños menores de tres meses.","There are no safety data available following treatment with Ziagen in babies under three months of age.",17,18
"2915","es","en","No se dispone de datos relativos a la leche humana.","Very common, common and uncommon events were derived from clinical trial data.",12,10
"2916","es","en","No se dispone de datos relativos a sobredosis clínica.","Data on clinical overdose are not available.",7,9
"2917","es","en","No se dispone de datos sobre el uso de LITAK en pacientes con trastornos renales o hepáticos.","There are no data on the use of LITAK in patients with renal or hepatic impairment.",16,17
"2918","es","en","No se dispone de experiencia clínica en pacientes con insuficiencia hepática grave.","There is no clinical experience in patients with severe hepatic impairment.",11,12
"2919","es","en","No se dispone de información específica referente a la sobredosis con alendronato.","There is no specific information available with regard to overdosage with alendronate.",12,12
"2920","es","en","No se dispone de información fiable de la prevalencia de DCV atribuible a vigabatrina en niños.","No reliable information of the prevalence of VFD attributable to vigabatrin exists in children.",14,16
"2921","es","en","No se encontro excreción biliar de glimepirida o su metabolito M1 tras su admninitración intravenosa en pacientes.","After intravenous dosing in patients, no significant biliary excretion of glimepiride or its M1 metabolite was observed.",17,17
"2922","es","en","No se encuentra afectada la agudeza visual central.","Central visual acuity is not impaired.",6,8
"2923","es","en","No se espera que una sobredosis accidental cause problemas graves.","No serious problems are expected with accidental overdose.",8,10
"2924","es","en","No se esperan efectos genotóxicos ni carcinogénicos.","Genotoxic and carcinogenic potential are not expected.",7,7
"2925","es","en","No se excederán las dosis diarias de 2,7 mg.","Daily doses of 2.7 mg should not be exceeded.",9,9
"2926","es","en","No se ha demostrado ningún efecto sobre las fracturas no vertebrales.","An effect on non-vertebral fractures has not been demonstrated.",9,11
"2927","es","en","No se ha determinado la biodisponibilidad oral absoluta relacionada con la administración intravenosa.","Absolute oral bioavailability relative to intravenous",6,13
"2928","es","en","No se ha determinado la densidad ósea durante el tratamiento con degarelix.","Bone density has not been measured during treatment with degarelix.",10,12
"2929","es","en","No se ha establecido el grado en que hidroclorotiazida se elimina por hemodiálisis.","The degree to which hydrochlorothiazide is removed by haemodialysis has not been established.",13,13
"2930","es","en","No se ha establecido la farmacocinética de maraviroc en pacientes pediátricos (ver sección 4.2)","Children: the pharmacokinetics of maraviroc in paediatric patients have not been established (see section 4.2).",15,14
"2931","es","en","No se ha establecido la necesidad de una dosis de recuerdo después de estos calendarios de inmunización.","The need for a booster dose after these immunisation schedules has not been established.",14,17
"2932","es","en","No se ha establecido la seguridad de Protopic pomada en pacientes con eritrodermia generalizado.","The safety of Protopic ointment has not been established in patients with generalised erythroderma.",14,14
"2933","es","en","No se ha establecido la seguridad del medicamento durante el embarazo.","The safe use of the medicinal product during pregnancy has not been established.",13,11
"2934","es","en","No se ha estudiado el uso en pacientes que presentan insuficiencia hepática.","Use in patients with hepatic impairment has not been studied.",10,12
"2935","es","en","No se ha estudiado la excreción de pramipexol en la leche materna en mujeres.","The excretion of pramipexole into breast milk has not been studied in women.",13,14
"2936","es","en","No se ha estudiado la farmacocinética de fosamprenavir en esta población de pacientes (ver sección 5.2).","The pharmacokinetics of fosamprenavir have not been studied in this patient population (see section 5.2).",15,16
"2937","es","en","No se ha estudiado la mezcla de Liprolog Mix50 con otras insulinas.","Mixing Liprolog Mix50 with other insulins has not been studied.",10,12
"2938","es","en","No se ha estudiado la seguridad y eficacia de duloxetina en pacientes de estas edades.","Children and adolescents The safety and efficacy of duloxetine in these age groups have not been studied.",17,15
"2939","es","en","No se ha evaluado in vivo la administración concomitante de inhibidores de OAT3.","Concomitant administration of OAT3 inhibitors has not been evaluated in vivo.",11,13
"2940","es","en","No se ha evaluado que los órganos o tejidos absorban el bexaroteno.","The uptake of bexarotene by organs or tissues has not been evaluated.",12,12
"2941","es","en","No se ha identificado el uso potencial de tolcapone en pacientes pediátricos.","There is no identified potential use of tolcapone in paediatric patients.",11,12
"2942","es","en","No se ha investigado el uso de LITAK en niños.","The use of LITAK in children has not been investigated.",10,10
"2943","es","en","No se ha observado aumento sinérgico de la toxicidad.","No synergistic enhancement of toxicity has been observed.",8,9
"2944","es","en","No se ha realizado ningún ensayo específico de interacciones fármaco- fármaco.","No specific drug-drug interaction study has been performed.",8,11
"2945","es","en","No se han descrito casos de sobredosis.","No case of overdose has been reported.",7,7
"2946","es","en","No se han descrito otras interacciones con medicamentos clínicamente significativas durante el tratamiento con GONAL-f.","No other clinically significant drug interaction has been reported during Gonal-f therapy.",12,15
"2947","es","en","No se han establecido de forma clara las interacciones entre DepoCyte administrado por vía intratecal y otros medicamentos.","No definite interactions between DepoCyte delivered intrathecally and other medicinal products have been established.",14,18
"2948","es","en","No se han establecido dosis adecuadas para esta combinación con respecto a la seguridad y eficacia.","Appropriate doses for this combination, with respect to efficacy and safety, have not been established.",15,16
"2949","es","en","No se han evaluado de manera plena las posibles interacciones entre Viraferon y otros medicamentos.","Interactions between Viraferon and other medicinal products have not been fully evaluated.",12,15
"2950","es","en","No se han evaluado sistemáticamente dosis por encima de 80 mg/ día.","Doses above 80 mg/ day have not been systematically evaluated.",10,12
"2951","es","en","No se han generado datos con Daronrix en sujetos menores de 18 años de edad.","No data have been generated with Daronrix below 18 years of age.",12,15
"2952","es","en","No se han identificado","No similar changes have been identified in humans.",8,4
"2953","es","en","No se han identificado interacciones.","No interactions have been identified.",5,5
"2954","es","en","No se han identificado otros patrones de resistencia a emtricitabina o tenofovir.","No other pathways of resistance to emtricitabine or tenofovir have been identified.",12,12
"2955","es","en","No se han llevado a cabo estudios de los efectos sobre la capacidad para conducir y utilizar máquinas.","No studies on the effects on the ability to drive and use machines have been performed.",16,18
"2956","es","en","No se han llevado a cabo estudios de reproducción animal con KOGENATE Bayer.","Animal reproduction studies have not been conducted with KOGENATE Bayer.",10,13
"2957","es","en","No se han llevado a cabo estudios de toxicidad con Pegasys sobre la función reproductora.","Reproductive toxicity studies have not been performed with Pegasys.",9,15
"2958","es","en","No se han llevado a cabo estudios en niños con insuficiencia renal.","No studies have been conducted in children with renal impairment.",10,12
"2959","es","en","No se han notificado reacciones adversas alérgicas graves con la administración subcutánea de Humira durante los ensayos clínicos.","Serious allergic adverse reactions have not been reported with subcutaneous administration of Humira during clinical trials.",16,18
"2960","es","en","No se han notificado víctimas mortales asociadas con sobredosis.","No fatalities associated with overdose have been reported.",8,9
"2961","es","en","No se han observado efectos sobre la capacidad para conducir y utilizar máquinas.","No effects on ability to drive and use machines have been observed.",12,13
"2962","es","en","No se han observado efectos sobre la fertilidad.","Effects on fertility have not been determined.",7,8
"2963","es","en","No se han realizado ensayos clínicos de interacción con diazepam y medicamentos antiinflamatorios no esteroideos.","Clinical interaction studies with diazepam and non- steroidal anti-inflammatory medicinal products have not been carried out.",16,15
"2964","es","en","No se han realizado estudios con clofarabina sobre la capacidad para conducir y utilizar máquinas.","No studies on the effects of clofarabine on the ability to drive and use machines have been performed.",18,15
"2965","es","en","No se han realizado estudios de carcinogenicidad a largo plazo.","Long term carcinogenicity studies have not been performed.",8,10
"2966","es","en","No se han realizado estudios de carcinogenicidad con sorafenib.","Carcinogenicity studies have not been conducted with sorafenib.",8,9
"2967","es","en","No se han realizado estudios de carcinogenicidad.","No carcinogenicity studies were performed.",5,7
"2968","es","en","No se han realizado estudios de interacción de la coadministración de Norvir con benzodiazepinas.","No drug interaction study has been performed for the co-administration of Norvir with benzodiazepines.",14,14
"2969","es","en","No se han realizado estudios de interacciones en seres humanos.","No interaction studies have been performed in humans.",8,10
"2970","es","en","No se han realizado estudios de interacciones.","No interaction studies have been performed.",6,7
"2971","es","en","No se han realizado estudios de los efectos sobre la capacidad para conducir y utilizar máquinas.","No studies of the effects on the ability to drive and use machines have been performed.",16,16
"2972","es","en","No se han realizado estudios en animales con AVAGLIM.","No animal studies have been conducted with the combined products in AVAGLIM.",12,9
"2973","es","en","No se han realizado estudios específicos que permitan establecer la interacción clínica con otros fármacos.","Consequent to the dysphagia there is the potential for aspiration, dyspnoea and occasionally the need for tube feeding.",18,15
"2974","es","en","No se han realizado estudios específicos sobre interacciones (ver sección 5.2)","No specific interaction studies have been performed (see section 5.2)",10,11
"2975","es","en","No se han realizado estudios farmacocinéticos específicos en ancianos ni en pacientes con alteración renal o hepática.","Dedicated pharmacokinetic studies in the elderly and those with renal or hepatic impairment have not been carried out.",18,17
"2976","es","en","No se han realizado estudios formales de interacciones con Beromun.","No formal interaction studies have been performed with Beromun.",9,10
"2977","es","en","No se han realizado estudios que cubran la fertilidad y el desarrollo embrionario precoz.","No studies were performed that covered fertility and early embryonic development.",11,14
"2978","es","en","No se han realizado estudios sobre interacciones farmacocinéticas.","Studies on pharmacokinetic interactions have not been performed.",8,8
"2979","es","en","No se han realizado estudios sobre la capacidad para conducir y utilizar máquinas.","Candidiasis of the mouth and throat",6,13
"2980","es","en","No se inyecte Insulin Human Winthrop Comb 15 en una vena (vaso sanguíneo).","Do not inject Insulin Human Winthrop Comb 15 into a vein (blood vessel).",13,13
"2981","es","en","No se notificaron secuelas clínicas relacionadas con el recuento plaquetario elevado en ninguno de los 3 pacientes.","No clinical sequelae were reported in association with the elevated platelet counts in any of the 3 subjects.",18,17
"2982","es","en","No se observaron efectos clínicos significativos en el intervalo QT.","No clinically significant effect on the QT interval was observed.",10,10
"2983","es","en","No se observaron malformaciones en fetos de ratas y conejos tratados con efavirenz.","No malformations were observed in foetuses from efavirenz-treated rats and rabbits.",11,13
"2984","es","en","No se observó esto en monos, perros o ratones.","This was not seen in monkeys, dogs or mice.",9,9
"2985","es","en","No se observó genotoxicidad en los ensayos estándar realizados con memantina.","No genotoxicity has been observed following testing of memantine in standard assays.",12,11
"2986","es","en","No se observó interacción farmacocinética entre rivastigmina y digoxina, warfarina, diazepam o fluoxetina en estudios en voluntarios sanos.","No pharmacokinetic interaction was observed between rivastigmine and digoxin, warfarin, diazepam or fluoxetine in studies in healthy volunteers.",18,18
"2987","es","en","No se oye un “clic” durante la inyección","You don’t hear clicking while injecting.",6,8
"2988","es","en","No se poseen datos adecuados sobre el uso de temsirolimus en la mujer embarazada.","There are no adequate data from the use of temsirolimus in pregnant women.",13,14
"2989","es","en","No se puede establecer la dosis hasta que el botón de dosificación esté hacia afuera.","A dose cannot be dialled until the dose knob is pulled out.",12,15
"2990","es","en","No se puede excluir la interacción a través de las proteínas de transporte.","Interaction via effects on transport proteins cannot be excluded.",9,13
"2991","es","en","No se puede excluir la posibilidad de resistencia cruzada entre tilvalosina y otros macrólidos.","Cross-resistance between tylvalosin and other macrolides cannot be excluded.",9,14
"2992","es","en","No se puede excluir una interacción con otros fármacos eliminados a través de la secreción tubular renal.","An interaction with other drugs eliminated by renal tubular secretion cannot be excluded.",13,17
"2993","es","en","No se realizarán cambios de dosis con más frecuencia que una vez al mes.","Dose changes will not be made more often than once a month.",12,14
"2994","es","en","No se recomienda administrar conjuntamente rifampicina y VIRAMUNE (ver sección 4.4).","It is not recommended to co- administer rifampicin and VIRAMUNE (see section 4.4).",13,11
"2995","es","en","No se recomienda el uso de ORENCIA en mujeres embarazadas a menos que sea claramente necesario.","ORENCIA should not be used in pregnant women unless clearly necessary.",11,16
"2996","es","en","No se recomienda el uso de RILUTEK en niños dado que no","The use of RILUTEK is not recommended in children",9,12
"2997","es","en","No se recomienda la administración concomitante de EMEND con plantas medicinales que contienen hipérico (Hypericum perforatum).","John’ s Wort (Hypericum perforatum) is not recommended.",8,16
"2998","es","en","No se recomienda la administración de Axura a pacientes con insuficiencia hepática grave.","Administration of Axura in patients with severe hepatic impairment is not recommended.",12,13
"2999","es","en","No se recomienda la administración simultánea de fármacos con probabilidad de producir una hipotensión significativa.","Concurrent administration of agents likely to cause significant hypotension is not recommended.",12,15
"3000","es","en","No se recomienda la coadministración de REYATAZ con inhibidores de la bomba de protones (ver sección 4.5).","Co-administration of REYATAZ with proton pump inhibitors is not recommended (see section 4.5).",13,17
"3001","es","en","No se recomienda la lactancia durante el tratamiento con Baraclude.","Breastfeeding is not recommended during treatment with Baraclude.",8,10
"3002","es","en","No se recomienda la repetición.","Repetition is not recommended.",4,5
"3003","es","en","No se recomienda su uso durante los tres primeros meses del embarazo.","Its use during the first three months of pregnancy is not recommended.",12,12
"3004","es","en","No se requiere ajuste de dosis en estos pacientes.","No dose adjustment is warranted in these patients.",8,9
"3005","es","en","No se requiere ajuste del intervalo de dosis","No dose interval adjustment required",5,8
"3006","es","en","No se requiere el ajuste de dosis en pacientes de 65 años y mayores.","No dose adjustment is required in patients aged 65 years and older.",12,14
"3007","es","en","No se requiere ningún ajuste de la dosis (ver sección 5.2).","No dosage adjustment is required (see section 5.2).",8,11
"3008","es","en","No se sabe si Cerezyme atraviesa la placenta y pasa al feto en desarrollo.","It is not known whether Cerezyme passes via the placenta to the developing foetus.",14,14
"3009","es","en","No se sabe si el efecto será distinto en los pacientes con mieloma múltiple.","It is not known whether the effect will be different in multiple myeloma patients.",14,14
"3010","es","en","No se sabe si VISTIDE se excreta en la leche humana.","It is not known whether VISTIDE is excreted in human milk.",11,11
"3011","es","en","No se se recomienda la coadministración de Kaletra y rifampicina.","Co-administration of Kaletra with rifampicin is not recommended.",8,10
"3012","es","en","No se venden por separado.","No individual sale of single packs.",6,5
"3013","es","en","No se vieron afectadas las funciones del neurocomportamiento de la descendencia.","Neurobehavioural functions of offspring were not affected.",7,11
"3014","es","en","No sumergirlo en agua.","Do not submerge in water.",5,4
"3015","es","en","No tirar los parches usados o sin usar al inodoro.","Do not flush used or unused patches down the toilet.",10,10
"3016","es","en","No tome {NOMBRE DEL PRODUCTO} 80 mg","BEFORE YOU TAKE {PRODUCT NAME} 80 mg",7,7
"3017","es","en","No tome CellCept si está en periodo de lactancia.","Do not take CellCept if you are breastfeeding.",8,9
"3018","es","en","No tome dos dosis al mismo tiempo.","Do not take two doses at the same time.",9,7
"3019","es","en","No tome Rasilez HCT","Do not take Rasilez HCT",5,4
"3020","es","en","No tome una dosis doble para compensar la dosis olvidada.","Do not take a double dose to make up for a forgotten dose.",13,10
"3021","es","en","No toque el tapón con las manos.","Do not touch the stopper with your hands.",8,7
"3022","es","en","No toque ni sacuda el émbolo.","Do not touch or bump the plunger.",7,6
"3023","es","en","No usar después de la fecha de caducidad que figura en la caja y en el frasco.","Do not use after the expiry date stated on the carton and the bottle.",14,17
"3024","es","en","No usar en animales con hipersensibilidad al ketoprofeno o a otros antiinflamatorios no esteroideos (AINE).","Do not use for animals hypersensitive to ketoprofen or other non steroid anti-inflammatory (NSAID) drugs.",15,15
"3025","es","en","No usar en aves en puesta.","Oil adjuvanted vaccine Do not use for birds in lay.",10,6
"3026","es","en","No usar en caso de hipersensibilidad al principio activo o a alguno de los excipientes.","Do not use in case of hypersensitivity to the active substance or to any of the excipients.",17,15
"3027","es","en","No usar en gatitos de menos de 8 semanas de edad o de peso inferior a 0,5 kg.","Do not use in kittens under 8 weeks of age or weighing less than 0.5 kg.",16,18
"3028","es","en","No usar en gatos.","Do not use in cats.",5,4
"3029","es","en","No usar en perros con predisposición genética conocida o sospechada a hipertermia maligna.","Do not use in dogs with a known or suspected genetic susceptibility to malignant hyperthermia.",15,13
"3030","es","en","No use DaTSCAN si:","Do not use DaTSCAN if:",5,4
"3031","es","en","No use Humalog BASAL Pen","Do not use Humalog BASAL Pen",6,5
"3032","es","en","No use Liprolog Mix25 KwikPen","Do not use Liprolog Mix25 KwikPen",6,5
"3033","es","en","No use Omnitrope si se hubiese congelado o estuviese sometido a altas temperaturas..","Do not use Omnitrope if it was frozen or subject to high temperatures.",13,13
"3034","es","en","No use Plavix después de la fecha de caducidad que aparece en el cartón y en el blíster.","Do not use Plavix after the expiry date which is stated on the carton and on the blister.",18,18
"3035","es","en","NO USE su pluma si cualquier parte está rota o dañada.","DO NOT USE your Pen if any part appears broken or damaged.",12,11
"3036","es","en","No use una dosis doble para compensar las dosis olvidadas.","Do not use a double dose to make up for a forgotten dose.",13,10
"3037","es","en","No utilice Aerius después de la fecha de caducidad que aparece en el envase y blister.","Do not use Aerius after the expiry date which is stated on the carton and blister.",16,16
"3038","es","en","No utilice Avonex después de la fecha de caducidad que figura en. el envase.","Do not use after the expiry date stated on the label.",11,14
"3039","es","en","NO utilice AVONEX si nota que:","Do NOT use AVONEX if you notice:",7,6
"3040","es","en","No utilice CIALIS después de la fecha de caducidad que aparece en el envase y el blíster.","Do not use CIALIS after the expiry date stated on the carton and blister.",14,17
"3041","es","en","No utilice el vial después de este periodo de tiempo.","Do not use the vial after this time period.",9,10
"3042","es","en","No utilice Insulatard después de la fecha de caducidad que aparece en la etiqueta y en el cartón.","Do not use Insulatard after the expiry date which is stated on the label and the carton.",17,18
"3043","es","en","No utilice INVANZ después de la fecha de caducidad que aparece en el envase.","Do not use INVANZ after the expiry date which is stated on the container.",14,14
"3044","es","en","No utilice Naglazyme después de la fecha de caducidad que aparece en el vial después de EXP.","Do not use Naglazyme after the expiry date which is stated on the vial after EXP.",16,17
"3045","es","en","No utilice OSSEOR después de la fecha de caducidad que aparece en la caja y en el sobre.","Do not use after the expiry date which is stated on the box and the sachet.",16,18
"3046","es","en","No utilice Rasilez HCT después de la fecha de caducidad que aparece en el envase.","Do not use Rasilez HCT after the expiry date which is stated on the carton.",15,15
"3047","es","en","No utilice Savene si usted observa que el vial está dañado o muestra signos de manipulación.","Do not use Savene if you notice that the vial is damaged or show signs of tampering.",17,16
"3048","es","en","No utilice Sonata después de la fecha de caducidad que aparece en el envase después de CAD.","Do not use Sonata after the expiry date, which is stated on the carton after EXP.",16,17
"3049","es","en","No utilice Thyrogen después de la fecha de caducidad que aparece en.","Do not use Thyrogen after the expiry date which is stated on the label.",14,12
"3050","es","en","No utilizar después de esta fecha.","Do not use after this date.",6,6
"3051","es","en","No utilizar después de este periodo de tiempo.","Do not use the pen after this time period.",9,8
"3052","es","en","No utilizar en animales menores de 6 semanas de edad.","Do not use in animals under 6 weeks of age.",10,10
"3053","es","en","No utilizar en hembras gestantes.","Do not use in pregnant animals.",6,5
"3054","es","en","No utilizar EVRA después de la fecha de caducidad que aparece en el envase (después de “CAD”).","Do not use EVRA after the expiry date, which is stated on the label.",14,17
"3055","es","en","No utilizar los viales que contengan partículas extrañas, que presenten turbidez o alteración del color.","Do not use vials exhibiting foreign particles, cloudiness or discoloration.",10,15
"3056","es","en","No utilizarla si la solución inyectable está turbia o contiene partículas.","Do not use if the solution is cloudy or contains particles.",11,11
"3057","es","en","No vuelva NUNCA a ponerle el capuchón a la aguja.","NEVER recap the needle.",4,10
"3058","es","en","Nobilis IB 4-91, liofilizado para suspensión","Nobilis IB 4-91, lyophilisate for suspension",6,6
"3059","es","en","Nobilis OR Inac es una emulsión (mezcla de líquidos basados en aceite y agua) inyectable.","Nobilis OR Inac is an emulsion (a mixture of oil- and water-based liquids) for injection.",15,15
"3060","es","en","Nocivo para las personas que padecen alcoholismo.","Harmful for those suffering from alcoholism.",6,7
"3061","es","en","NOMBRE DEL MEDICAMENTO Y VIA(S) DE ADMINISTRACION","NAME OF THE MEDICINAL PRODUCT AND IF NECESSARY ROUTE(S) OF ADMINISTRATION",11,7
"3062","es","en","NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN","NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION",9,7
"3063","es","en","NOMBRE DEL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN","NAME OF THE MARKETING AUTHORISATION HOLDER",6,8
"3064","es","en","NOMBRE O DENOMINACIÓN COMERCIAL Y DIRECCIÓN O RAZÓN SOCIAL REGISTRADA DEL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN","NAME OR CORPORATE NAME AND ADDRESS OR REGISTERED PLACE OF BUSINESS OF THE MARKETING AUTHORISATION HOLDER",16,17
"3065","es","en","Nombre o dirección del (de los) fabricante(s) responsable de la liberación de los lotes","Name and address of the manufacturer responsible for batch release",10,14
"3066","es","en","Nombre o razón social del (de los) fabricante(s) responsable(s) de la liberación de los lotes","Name and address of the manufacturer(s) responsible for batch release",10,15
"3067","es","en","Nombre y dirección de los fabricantes de la substancia biológica activa","Name and address of the manufacturer(s)of the biological active substance(s)",10,11
"3068","es","en","Nombre y dirección del fabricante de las substancias activas biológicas","Name and address of the manufacturer of the biological active substances",11,10
"3069","es","en","Nombre y dirección del fabricante del principio activo biológico","Name and address of the manufacturer of the biological active substance",11,9
"3070","es","en","Nombre y dirección del fabricante responsable de la liberación de los lotes","Name and address of manufacturer responsible for batch release",9,12
"3071","es","en","Nombre y dirección del fabricante responsable de la liberación de los lotes U U","Name and address of the manufacturer responsible for batch release U U",12,14
"3072","es","en","Nombre y dirección del(de los) fabricante(s) del(de los) principio(s) activo(s) biológico(s)","Name and address of the manufacturer(s) of the biological active substance(s)",11,11
"3073","es","en","Norbrook Laboratories Limited 105 Armagh Road Newry Co.","Norbrook Laboratories Limited 105 Armagh Road Newry Co.",8,8
"3074","es","en","Norfloxacina Terapia 400 mg","Norfloxacina Terapia 400 mg",4,4
"3075","es","en","Norge Baxter AS Gjerdrumsvei 11 N-0486 Oslo Tlf.: +47-22 58 48 00","Norge Baxter AS Gjerdrumsvei 11 N-0486 Oslo Tlf.: +47-22 58 48 00",12,12
"3076","es","en","Norge Gilead Sciences Sweden AB Tlf: + 46 (0) 8 5057 1849","Norge Gilead Sciences Sweden AB Tlf: + 46 (0) 8 5057 1849",12,12
"3077","es","en","Norge GlaxoSmithKline AS Tlf: + 47 22 70 20 00 firmapost@gsk.no","Tlf: + 47 22 70 20 00 firmapost@gsk.no",8,11
"3078","es","en","Norge Merck Serono Norge Luhrtoppen 2 1470 Lørenskog Tlf: +47 67 90 35 90","Norge Merck Serono Norge Luhrtoppen 2 1470 Lørenskog Tlf: +47 67 90 35 90",14,14
"3079","es","en","Norge Nycomed Pharma AS Drammensveien 852 N-1372 Asker Tlf: +47 6676 3030 infonorge@nycomed. no","Norge Nycomed Pharma AS Drammensveien 852 N-1372 Asker Tlf: +47 6676 3030 infonorge@nycomed. no",14,14
"3080","es","en","Norge Roche Norge AS Tlf: +47 - 22 78 90 00","Norge Roche Norge AS Tlf: +47 - 22 78 90 00",11,11
"3081","es","en","Norge Takeda Global R & D Centre (Europe), Storbritannia Tlf: + 44 (0)20 3116 8950","Norge Takeda Global R & D Centre (Europe), Storbritannia Tlf: + 44 (0)20 3116 8950",15,15
"3082","es","en","Norma Hellas Ae Menandrou 54 Athens 10431 Grecia","Norma Hellas Ae Menandrou 54 Athens 10431 Greece",8,8
"3083","es","en","Normalmente esta reacción era debida a la incorrecta rotación de las inyecciones.","This reaction was generally associated with lack of proper rotation of injections.",12,12
"3084","es","en","Normalmente no debe usarse más de una vez en un mismo paciente.","It should not usually be used on more than one occasion in any one patient.",15,12
"3085","es","en","Normalmente se desencadenan por variaciones bruscas de la intensidad luminosa.","They are usually triggered by sudden variations in light intensity.",10,10
"3086","es","en","Normalmente se prepara a partir de mezclas de plasma de no menos de 1000 donaciones.","It is usually prepared from pooled plasma from not fewer than 1000 donations.",13,15
"3087","es","en","Normalmente, antes de que se quede embarazada, su médico sustituirá Irbesartan Krka por otro medicamento antihipertensivo adecuado.","Appropriate antihypertensive medicinal product must usually replace Irbesartan Krka before starting a pregnancy.",13,17
"3088","es","en","Normalmente, antes de que se quede embarazada, su médico sustituirá Karvezide por otro medicamento antihipertensivo adecuado.","Appropriate antihypertensive drug must usually replace Karvezide before starting a pregnancy.",11,16
"3089","es","en","Normalmente, los síntomas aparecen durante las primeras ocho semanas del tratamiento con NutropinAq.","Symptoms usually occur within the first eight weeks of the initiation of NutropinAq therapy.",14,13
"3090","es","en","Norton Healthcare Limited Albert Basin, Royal Docks London E16 2QJ Reino Unido","Norton Healthcare Limited Albert Basin Royal Docks London E16 2QJ United Kingdom",12,12
"3091","es","en","Norvir debe tomarse preferentemente con alimentos.","Norvir should preferably be taken with food.",7,6
"3092","es","en","Nota: imputaciones realizadas con arreglo al algoritmo TLOVR (tiempo hasta la pérdida de respuesta virológica).","Imputations according to the TLOVR algorithm (TLOVR = Time to Loss of Virologic Response)",14,15
"3093","es","en","Note for guidance on the clinical investigation of plasma derived fibrin sealants","EMEA/CPMP/BPWG/1089/00 Note for guidance on the clinical investigation of plasma derived fibrin sealants",13,12
"3094","es","en","Novartis Animal Health Austria GmbH Biochemiestraße 10 A-6250 Kundl Austria","Novartis Animal Health Austria GmbH Biochemiestraße 10 A-6250 Kundl Austria",10,10
"3095","es","en","Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB Reino Unido","Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB United Kingdom",12,12
"3096","es","en","Novartis Finland Oy, Metsänneidonkuja 10, 02130 Espoo, Finlandia","Novartis Finland Oy, Metsänneidonkuja 10, 02130 Espoo, Finland",8,8
"3097","es","en","Novartis Pharma GmbH Roonstrasse 25 D-90429 Nurenberg","Novartis Pharma GmbH Roonstrasse 25 D-90429 Nürnberg",7,7
"3098","es","en","Novartis Pharmaceuticals UK Ltd Frimley Business Park Frimley Camberley Surrey GU16 7SR Reino Unido","Novartis Pharmaceuticals UK Ltd Frimley Business Park Frimley Camberley Surrey GU16 7SR United Kingdom",14,14
"3099","es","en","Novartis Sverige AB Kemistvägen 1B","Novartis Sverige AB Kemistvägen 1B P. O.",7,5
"3100","es","en","NovoMix 30 tuvo resultados casi idénticos a los de la insulina humana al final del estudio.","NovoMix 30 gave almost identical results to human insulin at the end of the study.",15,16
"3101","es","en","NovoMix 50 FlexPen debe ser utilizado por una sola persona.","NovoMix 50 FlexPen is for use by one person only.",10,10
"3102","es","en","NovoMix 70 FlexPen 100 U/ ml Suspensión inyectable Insulina aspart Vía SC","NovoMix 70 FlexPen 100 U/ ml Suspension for injection Insulin aspart SC use",13,12
"3103","es","en","NovoMix se emplea para el tratamiento de pacientes diabéticos.","NovoMix is used to treat patients who have diabetes.",9,9
"3104","es","en","NovoRapid debe protegerse del calor y la luz solar excesivos.","NovoRapid must be protected from excessive heat and sunlight.",9,10
"3105","es","en","NovoRapid FlexPen 100 U/ ml, solución inyectable en una pluma precargada.","NovoRapid FlexPen 100 U/ ml, solution for injection in a pre-filled pen.",12,11
"3106","es","en","NovoSeven se puede utlizar en el período de lactancia.","NovoSeven can be used during breast-feeding.",6,9
"3107","es","en","Noxafil es una suspensión oral que contiene el principio activo posaconazol (40 mg/ ml).","Noxafil is an oral suspension that contains the active substance posaconazole (40 mg/ ml).",14,14
"3108","es","en","nu La vacuna nunca debe inyectarse en una vena.","The vaccine should never be given into a vein.",9,9
"3109","es","en","Núcleo del comprimido Celulosa microcristalina Sílice coloidal anhidra Crospovidona Estearato de magnesio","Tablet core Microcrystalline cellulose Colloidal anhydrous silica Crospovidone Magnesium stearate",10,12
"3110","es","en","Núcleo del comprimido: celulosa microcristalina, fosfato cálcico dibásico (anhidro), croscarmelosa sódica, estearato magnésico.","microcrystalline cellulose, calcium hydrogen phosphate (anhydrous), croscarmellose sodium, magnesium stearate,",10,13
"3111","es","en","Núcleo: estearato de magnesio celulosa microcristalina carboximetilalmidón sódico.","Core: magnesium stearate microcrystalline cellulose sodium starch glycollate.",8,8
"3112","es","en","Nuevas solicitudes mediante el","of recommendations and proposals on initiatives to",7,4
"3113","es","en","Número de la UE EU/ 1/ 00/ 165/ 001","EU/ 1/ 00/ 165/ 001",5,9
"3114","es","en","NÚMERO DE LOTE DEL FABRICANTE","MANUFACTURER’ S BATCH NUMBER",4,5
"3115","es","en","Número de Número de casos casos Número de Número de individuos* individuos *","Number of Number at 2 years Number Number",8,13
"3116","es","en","Número de páginas traducidas","Mail in Mail out Number of pages translated",8,4
"3117","es","en","NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓNriz EU/ 1/ 99/ 098/ 002 uto","EU/ 1/ 99/ 098/ 002 ge lon",7,11
"3118","es","en","NÚMERO(S) DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN","NUMBER(S) IN THE COMMUNITY REGISTER OF MEDICINAL PRODUCTS",8,6
"3119","es","en","NÚMEROS DE AUTORIZACIÓN DE COMERCIALIZACIÓN","MARKETING AUTHORISATION NUMBERS du",4,5
"3120","es","en","Nunca comparta ni las agujas ni las plumas.","Needles and pens must not be shared.",7,8
"3121","es","en","Nunca debe inyectar la insulina co","How to use this insulin",5,6
"3122","es","en","Nunca debe mojarlo, lavarlo ni lubricarlo, ya que podría dañar el mecanismo.","This may damage the mechanism.",5,12
"3123","es","en","Nunca tome una dosis doble de Janumet.","Do not take a double dose of Janumet.",8,7
"3124","es","en","NutropinAq 10 mg/ 2 ml SC","NutropinAq 10 mg/ 2 ml SC",6,6
"3125","es","en","Nycomed Bélgica N. V.","Nycomed Belgium N. V.",4,4
"3126","es","en","o disminución de las cantidades del factor de la coagulación de la sangre (trombocitos)","decreased amounts of a blood clotting factor (thrombocytes)",8,14
"3127","es","en","OBLIGACIONES ESPECÍFICAS DE LOS TITULARES DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN","SPECIFIC OBLIGATIONS OF THE MARKETING AUTHORISATION HOLDERS",7,10
"3128","es","en","OBLIGACIONES ESPECÍFICAS QUE DEBERÁ CUMPLIR EL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN","SPECIFIC OBLIGATIONS TO BE FULFILLED BY THE MARKETING AUTHORISATION HOLDER",10,12
"3129","es","en","Observaciones Otros inhibidores de la proteasa (IPs) Ritonavir 500 mg 750 dosis única","Comment Other Protease Inhibitors (PIs) Ritonavir 500 mg 750 mg TID single dose X 6 doses",16,13
"3130","es","en","ocupando sus puestos bajo la dependencia del Jefe de Unidad, el Profesor 2.4 Grupos de trabajo Rolf Bass.","Ad hoc EMEA working group on herbal medicinal products",9,18
"3131","es","en","Oftalmológico – agentes betabloqueantes – timolol, combinaciones, código ATC:","Ophthalmological – beta-blocking agents – timolol, combinations, ATC code:",9,9
"3132","es","en","Olanzapina puede administrarse con o sin comidas ya que los alimentos no modifican su absorción.","Olanzapine can be given without regards for meals as absorption is not affected by food.",15,15
"3133","es","en","Olanzapina Teva 20 mg comprimidos bucodispersables EFG","Olanzapine Teva 20 mg orodispersible tablets",6,7
"3134","es","en","oleoyl phosphatidylglyc- erol and palmitic acid (Surfaxin)","oleoyl phosphatidylglyc-erol and palmitic acid (Surfaxin)",6,7
"3135","es","en","Olor anormal de la orina","Angio- neurotic oedema Stevens- Johnson Syndrome",6,5
"3136","es","en","Omnitrope 6,7 mg/ ml solución inyectable Somatropina Vía subcutánea","Omnitrope 6.7 mg/ ml solution for injection Somatropin Subcutaneous use",10,9
"3137","es","en","ón EU/ 1/ 02/ 211/ 002","EU/ 1/ 02/ 211/ 002",5,6
"3138","es","en","Onsenal redujo también el número de pólipos en niños con PAF.","Onsenal also reduced the number of polyps in children with FAP.",11,11
"3139","es","en","Onsior no debe ser administrado junto con otros AINEs.","Onsior must not be administered in conjunction with other NSAIDs.",10,9
"3140","es","en","Optimark jeringas precargadas se suministra en los siguientes tamaños de envases:","Optimark pre-filled syringes are supplied in the following package sizes:",10,11
"3141","es","en","OPTISON es una dispersión inyectable.","OPTISON is a dispersion for injection.",6,5
"3142","es","en","OPTRUMA 60 mg comprimidos recubiertos con película.","OPTRUMA 60 mg film coated tablets",6,7
"3143","es","en","Orbifloxacino - Resumen Patógeno E. coli Enterococci Proteus mirabilis Pseudomonas aeruginosa Staphylococcus intermedius Streptococcus ß-haemolyticus G","Pathogen E coli Enterococci Proteus mirabilis Pseudomonas aeruginosa Staphylococcus intermedius Streptococcus ß-haemolyticus G",13,16
"3144","es","en","Organon Kloosterstraat 6 N5349 AB Oss Holanda","Organon Kloosterstraat 6 5349 AB Oss The Netherlands",8,7
"3145","es","en","Organon, Kloosterstraat 6, Postbus 20, 5340 BH Oss, Países Bajos","Organon, Kloosterstraat 6, Postbus 20, 5340 BH Oss, The Netherlands",10,10
"3146","es","en","Orion Corporation Orionintie 1 FIN-02200 Espoo Finlandia","Orion Corporation Orionintie 1 FIN-02200 Espoo Finland",7,7
"3147","es","en","Orphan Europe SARL Immeuble “ Le Wilson” 70 avenue du Général de Gaulle F-92800 Puteaux- Francia","Orphan Europe SARL Immeuble ""Le Wilson"" 70 avenue du Général de Gaulle F-92800 Puteaux France",15,16
"3148","es","en","Osigraft no debe utilizarse en personas que puedan ser hipersensibles (alérgicas) a la eptotermina alfa o al colágeno.","Osigraft should not be used in people who may be hypersensitive (allergic) to eptotermin alfa or to collagen.",18,18
"3149","es","en","Österreich Am Euro Platz 2 A-1120 Wien Tel: + 43-(0) 1 813 12 31","Österreich Am Euro Platz 2 A-1120 Wien Tel: + 43-(0) 1 813 12 31",14,14
"3150","es","en","Österreich Cephalon GmbH Fraunhoferstr.","Österreich Cephalon GmbH Fraunhoferstr.",4,4
"3151","es","en","Österreich GlaxoSmithKline Pharma GmbH Tel: + 43 (0)1 97075 0 at .info@gsk.com","Österreich GlaxoSmithKline Pharma GmbH Tel: + 43 (0)1 97075 0 at. info@gsk. com",13,12
"3152","es","en","Österreich Pfizer Corporation Austria Ges.m.b.H.","Österreich Pfizer Corporation Austria Ges. m. b. H.",8,5
"3153","es","en","Österreich The Medicines Company UK Ltd Tel: + 800 843 633 26 oder +41 61 564 1320 E-Mail:","The Medicines Company UK Ltd Tel: + 800 843 633 26 oder +41 61 564 1320 E-Mail:",17,18
"3154","es","en","Otitis media supurativa, crónica","Chronic suppurative otitis media",4,4
"3155","es","en","Otitis media, bronquitis, sinusitis, forunculosis, infección bacteriana, infección vírica","Otitis media, bronchitis, sinusitis, furunculosis, bacterial infection, viral infections",9,9
"3156","es","en","Otra posibilidad, es disolver el comprimido en agua y beber la suspensión resultante.","Alternatively, disperse the tablet in water and drink the resulting suspension.",11,13
"3157","es","en","OTRA(S) ADVERTENCIA(S) ESPECIAL(ES), SI ES NECESARIO","OTHER SPECIAL WARNING(S), IF NECESSARY",5,6
"3158","es","en","Otras aplicaciones de TI · Diversas mejoras, nuevos dispositivos y tecnolo","EMEA contact points and reference documents",6,11
"3159","es","en","Otras informaciones sobre Abilify:","Other information about Abilify:",4,4
"3160","es","en","Otras informaciones sobre Arava:","Other information about Arava:",4,4
"3161","es","en","Otras informaciones sobre DEXDOMITOR:","Other information about DEXDOMITOR:",4,4
"3162","es","en","Otras informaciones sobre Eucreas:","Other information about Eucreas:",4,4
"3163","es","en","Otras informaciones sobre Gardasil:","Other information about Gardasil:",4,4
"3164","es","en","Otras informaciones sobre IntronA:","Other information about IntronA:",4,4
"3165","es","en","Otras informaciones sobre Levemir:","Other information about Levemir:",4,4
"3166","es","en","Otras informaciones sobre Olanzapina Teva:","Other information about Olanzapine Teva:",5,5
"3167","es","en","Otras informaciones sobre Posatex:","Other information about Posatex:",4,4
"3168","es","en","Otras informaciones sobre Purevax RCCh:","Other information about Purevax RCCh:",5,5
"3169","es","en","Otras informaciones sobre Ribavirin Teva:","Other information about Ribavirin Teva:",5,5
"3170","es","en","Otras informaciones sobre Synagis:","Other information about Synagis:",4,4
"3171","es","en","Otras informaciones sobre Tritanrix HepB:","Other information about Tritanrix HepB:",5,5
"3172","es","en","Otras situaciones con estimulación del sistema renina-angiotensina-aldosterona:","Other conditions with stimulation of the renin-angiotensin-aldosterone system:",8,7
"3173","es","en","Otro 4% presentó una disminución transitoria por debajo del límite inferior de normalidad.","Another 4% had a transient decrease below the lower limit of normal.",12,13
"3174","es","en","Otro estudio examinó el efecto de añadir NovoNorm a metformina.","Another study looked at the effect of adding NovoNorm to metformin.",11,10
"3175","es","en","Otros efectos adversos poco frecuentes:","Other infrequently reported side effects:",5,5
"3176","es","en","Otros efectos secundarios son infrecuentes o raros.","Other side effects are uncommon or rare.",7,7
"3177","es","en","Otros gastos financieros Total del artículo 2 3 2 Gastos de contenciosos","Other financial charges Article 2 3 2 — Total Legal expenses",11,12
"3178","es","en","Otros inductores potentes del CYP3A (p. ej., fenobarbital, carbamazepina) también pueden reducir las concentraciones plasmáticas de nelfinavir.","Other potent inducers of CYP3A (e. g., phenobarbital, carbamazepine) may also reduce nelfinavir plasma concentrations.",15,17
"3179","es","en","Ovitrelle 250 microgramos/ 0,5 ml solución inyectable en jeringa precargada Coriogonadotropina alfa","Ovitrelle 250 micrograms/ 0.5 ml solution for injection in a pre-filled syringe Choriogonadotropin alfa Subcutaneous use.",16,12
"3180","es","en","Oxaliplatino el Día 1, cada 3 semanas Capecitabina oral dos veces al día durante","Oxaliplatin on Day 1, every 3 weeks Capecitabine oral twice daily for 2",13,14
"3181","es","en","Óxido de hierro negro(E172) Propilenglicol Shellac.","Black Iron Oxide-Synthetic (E172) Propylene glycol Shellac.",7,6
"3182","es","en","Óxido de polietileno Celulosa microcristalina Povidona All-rac-α -tocoferol Sílice coloidal anhidro Sodio estearil fumarato Butilhidroxitolueno (E321)","Polyethylene oxide Microcrystalline cellulose Povidone All-rac-α -Tocopherol Colloidal anhydrous silica Sodium stearyl fumarate Butylhydroxytoluene (E321)",15,16
"3183","es","en","Oy Leiras Finland Ab Yliopistonkatu 34 A 20100 Turku, Finland","Oy Leiras Finland Ab Yliopistonkatu 34 A 20100 Turku, Finland",10,10
"3184","es","en","P-value (stratified Cochran-Mantel-Haenszel test) = 0.002.","P-value (stratified Cochran-Mantel-Haenszel test) = 0.002.",6,6
"3185","es","en","Pabianickie Zakł ady Farmaceutyczne Polfa S. A., ul. Marszał ka J.","Pabianickie Zakł ady Farmaceutyczne Polfa S. A., ul. Marszał ka J.",11,11
"3186","es","en","Pacientes adultos con artritis reumatoide","Adult patients with rheumatoid arthritis",5,5
"3187","es","en","Pacientes adultos sometidos a diálisis peritoneal El tratamiento se divide en dos fases:","Adult patients on peritoneal dialysis The treatment is divided into two stages:",12,13
"3188","es","en","Pacientes ancianos No hay experiencia clínica en pacientes de más de 65 años de edad.","Elderly patients There is no clinical experience in patients over 65 years of age.",14,15
"3189","es","en","Pacientes coinfectados con VHC/ VIH:","Patients co-infected with HCV/ HIV:",5,5
"3190","es","en","Pacientes con alteración de la función hepática:","Patients with impaired hepatic function:",5,7
"3191","es","en","Pacientes con bajo peso corporal","Patients with low body weight",5,5
"3192","es","en","Pacientes con cáncer tratados con quimioterapia","Cancer patients receiving chemotherapy",4,6
"3193","es","en","Pacientes con disfunción hepática:","Patients with hepatic impairment:",4,4
"3194","es","en","Pacientes con insuficiencia renal crónica","Chronic renal failure patients",4,5
"3195","es","en","Pacientes con insuficiencia renal o hepática:","Patients with renal or hepatic impairment:",6,6
"3196","es","en","Pacientes con insuficiencia renal:","Patients with renal impairment:",4,4
"3197","es","en","pacientes con neutropenia Ciprofloxacino debe coadministrarse con un","Inhalation anthrax post-exposure prophylaxis and curative treatment for persons requiring parenteral treatment Drug administration should begin as soon",18,8
"3198","es","en","Pacientes de edad avanzada (> 6 5 años):","Elderly patients ( 65 years):",5,8
"3199","es","en","Pacientes de edad avanzada No se requiere ningún ajuste de la dosis en pacientes de edad avanzada.","Elderly No dose adjustment is required in the elderly.",9,17
"3200","es","en","Pacientes pediátricos: las reacciones adversas en niños fueron generalmente similares a las observadas en los pacientes adultos.","Paediatric patients: undesirable effects in children were generally similar to those of adult patients.",14,17
"3201","es","en","Pacientes que están tomando medicamentos que pueden afectar a la función renal:","Patients receiving medicinal products that may affect renal function:",9,12
"3202","es","en","Paclitaxel pertenece a un grupo de medicamentos denominados taxanos que se utilizan para el tratamiento del cáncer.","Paclitaxel belongs to a group of medicines called taxanes used to treat cancers.",13,17
"3203","es","en","Page 3/ 3 ©EMEA 2006","Page 2/ 2 ©EMEA 2006",5,5
"3204","es","en","Pancitopenia, trombocitopenia idiopática púrpura.","pancytopaenia, idiopathic thrombocytopaenic purpura",4,4
"3205","es","en","Pandemrix puede utilizarse durante el periodo de lactancia.","Pandemrix may be given while you are breast-feeding.",8,8
"3206","es","en","Para administración en agua de bebida.","In drinking water use",4,6
"3207","es","en","Para administración intravenosa and intravesical use","Intravenous use and intravesical use",5,6
"3208","es","en","Para asuntos relativos a la farmacovigilancia de medicamentos de uso humano","For matters relating to pharmacovigilance for medicinal products for human use",11,11
"3209","es","en","Para consultar las condiciones de conservación del medicamento reconstituido, ver sección 6.3.","For storage conditions of the reconstituted medicinal product, see section 6.3.",11,12
"3210","es","en","Para dosis inferiores a 100 mg, se debe disolver un comprimido en 100 ml de agua.","For doses below 100 mg, one tablet should be dissolved in 100 ml of water.",15,16
"3211","es","en","Para el primer día se requerirá el doble de la dosis de mantenimiento.","For the first day, twice the maintenance dosage will be required.",11,13
"3212","es","en","Para evitar esto, vaya rotando los sitios de inyección dentro de la misma zona. en","Prevent this by choosing different injection sites each time within the same area.",13,15
"3213","es","en","Para facilitar la mezcla el cartucho contiene 3 bolitas metálicas.","After mixing, the suspension must have a uniform milky white appearance.",11,10
"3214","es","en","Para facilitar la mezcla, el cartucho contiene 3 bolitas metálicas.","To assist in mixing, three tiny metal balls are present in the cartridge.",13,10
"3215","es","en","Para gatos pequeños ≥ 0,5 kg – 2,5 kg","For small cats ≥ 0.5 kg – 2.5 kg",9,9
"3216","es","en","Para información sobre la reconstitución, ver sección 6.6.","For information on reconstitution, see section 6.6.",7,8
"3217","es","en","Para instrucciones de uso y manipulación vea sección 6.6.","For instructions for use and handling refer to 6.6.",9,9
"3218","es","en","Para la administración se requiere el uso de una jeringa luer-lock.","For administration the use of a luer-lock syringe is required.",10,11
"3219","es","en","Para la carbamazepina, la AUC12h aumentó en un 45%.","For carbamazepine, AUC12h was increased by 45%.",7,9
"3220","es","en","Para la inmunización activa de pollos y patos frente al virus de influenza aviar tipo A, subtipo H5.","For active immunisation of chickens and ducks against avian influenza virus type A, subtype H5.",15,18
"3221","es","en","Para la interrupción del tratamiento se debe tener en cuenta lo siguiente:","Treatment discontinuation may be considered as follows:",7,12
"3222","es","en","Para la lista completa de excipientes, ver apartado 6.1.","For a full list of excipients, see section 6.1.",9,9
"3223","es","en","Para la lista completa de excipientes, ver sección 6.1","For a full list of excipients, see 6.1.",8,9
"3224","es","en","Para la preparación de Lucentis para administración intravítrea, siga las siguientes instrucciones:","To prepare Lucentis for intravitreal administration, please adhere to the following instructions:",12,12
"3225","es","en","Para la psoriasis, se comparó Humira con un placebo durante 16 semanas en 1212 pacientes.","For psoriasis, Humira was compared with placebo over 16 weeks in 1,212 patients.",13,15
"3226","es","en","Para las condiciones de conservación del medicamento diluido, ver sección 6.3.","For storage conditions of the diluted medicinal product, see section 6.3.",11,11
"3227","es","en","Para las instrucciones de reconstitución del producto antes de su administración, ver sección 6.6.","For instructions on reconstitution of the product before administration, see section 6.6.",12,14
"3228","es","en","Para los casos de IUE, la dosis recomendada de Ariclaim es de 40 mg dos veces al día.","For SUI, the recommended dose of Ariclaim is 40 mg twice a day.",13,18
"3229","es","en","Para los compuestos por separado no hubo evidencia de mutagenicidad, clastogenicidad o carcinogénesis.","For the single compounds there was no evidence of mutagenicity, clastogenicity or carcinogenicity.",13,13
"3230","es","en","Para los excipientes, véase la sección 6.1.","For inactive ingredients see section 6.1",6,7
"3231","es","en","Para los excipientes, ver 6.1.","For excipients, see 6.1.",4,5
"3232","es","en","Para mantener la protección, los caballos tienen que ser revacunados.","To retain protection, horses need to be revaccinated.",8,10
"3233","es","en","Para más información acerca de la manipulación, ver sección 6.6.","For further details on handling, see section 6.6.",8,10
"3234","es","en","Para más información sobre las precauciones de uso de las bombas de insulina, ver el manual de uso.","For details on safety precautions in the use of insulin pumps, refer to the operator ’ s manual.",18,18
"3235","es","en","Para más información sobre los medicamentos biosimilares, véase el documento de preguntas y respuestas aquí.","For more information on biosimilar medicines, see the question-and-answer document here.",11,15
"3236","es","en","Para más información, consulte el prospecto.","For more information, see the Package Leaflet.",7,6
"3237","es","en","Para más información, los médicos deben consultar la ficha técnica de Reyataz.","For further information, physicians should refer to the Reyataz Summary of Product Characteristics.",13,12
"3238","es","en","Para más información, ver sección 5.1.","For more information, see section 5.1.",6,6
"3239","es","en","Para mayor información consultar el prospecto.","Contains lactose monohydrate see package leaflet for further information",9,6
"3240","es","en","Para minimizar el riesgo de embarazo múltiple, se recomienda una monitorización cuidadosa de la respuesta ovárica.","To minimise the risk of multiple pregnancy, careful monitoring of ovarian response is recommended.",14,16
"3241","es","en","Para pacientes con peso corporal < 50 kg, n","For patients with body weight < 50 kg, the du",10,9
"3242","es","en","Para preguntas relativas a los certificados de medicamentos autorizados para uso humano","For enquiries concerning certificates for centrally authorised medicines for human or veterinary use",13,12
"3243","es","en","Para prevenir los vómitos, los comprimidos deben administrarse con más de una hora de antelación.","To prevent vomiting, tablets should be given more than 1 hour in advance.",13,15
"3244","es","en","Para qué se utiliza Pradaxa:","What Pradaxa is used for:",5,5
"3245","es","en","Para reducir el riesgo de toxicidad hematológica, se puede utilizar G-CSF como profilaxis.","Prophylactic G-CSF may be used to mitigate the risk of hematological toxicities.",12,13
"3246","es","en","Para un solo uso.","For single use only.",4,4
"3247","es","en","Para uso como excipiente","For use as excipient",4,4
"3248","es","en","Para uso pediátrico solo.","For paediatric use only.",4,4
"3249","es","en","Parámetro Cmáx (máximo, g/l) Cmín (mínimo, g/l) t½ (días)","Parameter Cmax (peak, g/l) Cmin (trough, g/l) t½ (days)",9,9
"3250","es","en","parestesia, insomnio, depresión, confusión, hipoestesia, nerviosismo, sequedad de boca, amnesia","Dizziness Paraesthesia, insomnia, depression, confusion, hypoaesthesia, nervousness, dry mouth, amnesia",10,10
"3251","es","en","PARKE DAVIS, S. L.","PARKE DAVIS, S. L.",4,4
"3252","es","en","Paroxat 20 mg – Filmtabletten","Paroxat 20 mg – Filmtabletten",5,5
"3253","es","en","Paroxetina Davur 20 mg Comprimidos Recubiertos EFT","Paroxetina Davur 20 mg Comprimidos Recubiertos EFT",7,7
"3254","es","en","Parte A Parte B Dictámenes emitidos por sustancias","Part A Part B Opinions adopted by substance",8,8
"3255","es","en","Paseo Pintor Rosales, 44 Bajo Izda.","Paseo Pintor Rosales, 44 Bajo Izda.",6,6
"3256","es","en","Pastilla liofilizada de vacuna para reconstitución.","A lyophilised vaccine pellet for reconstitution",6,6
"3257","es","en","Patrick LE COURTOIS (3) Prde.","France Dr Patrick LE COURTOIS (3) Prof.",7,5
"3258","es","en","Patrick LE COURTOIS Agnès SAINT RAYMOND John PURVES Isabelle MOULON Marisa PAPALUCA AMATI","Committee for Proprietary Medicinal Products Chairman Daniel BRASSEUR Vice-chairman Eric ABADIE",11,13
"3259","es","en","Pauta de dosificación en insuficiencia renal","Dosage in renal impairment",4,6
"3260","es","en","Pauta de escalada de dosis de MIRAPEXIN Semana","Ascending – Dose Schedule of MIRAPEXIN",6,8
"3261","es","en","Paxene 6 mg/ ml de concentrado para solución para perfusión Paclitaxel","Paxene 6 mg/ml concentrate for solution for infusion (paclitaxel)",9,11
"3262","es","en","Pegasys 135 microgramos solución inyectable en jeringa precargada Peginterferón alfa-2a","Pegasys 135 micrograms solution for injection in pre-filled syringe Peginterferon alfa-2a",11,10
"3263","es","en","PegIntron 120 microgramos - vial de polvo","PegIntron 120 micrograms - vial of powder",7,7
"3264","es","en","PegIntron 50 microgramos polvo y disolvente para solución inyectable pluma precargada peginterferón alfa-2b","PegIntron 50 micrograms powder and solvent for solution for injection pre-filled pen peginterferon alfa-2b",14,13
"3265","es","en","PegIntron Cartonaje 120 microgramos polvo y disolvente para solución inyectable","Carton 120 micrograms powder and solvent for solution for injection",10,10
"3266","es","en","PegIntron se presenta en forma de polvo de peginterferón alfa-2b con 100 microgramos para uso individual.","PegIntron is supplied as a powder of peginterferon alfa-2b at a strength of 100 micrograms for single use.",18,16
"3267","es","en","pélvica), incluyendo infección de las trompas de falopio e infección de la membrana mucosa uterina.","including infections of the fallopian tubes and infections of the uterus mucous membrane.",13,15
"3268","es","en","Pelzont se investigó en cuatro estudios principales realizados en pacientes con hipercolesterolemia o dislipidemia mixta.","Pelzont was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.",14,15
"3269","es","en","Pensamientos suicidas, alucinaciones (problemas graves de personalidad y deterioro en el normal funcionamiento social) Trastornos del sistema nervioso:","Thoughts of suicide, hallucinations (severe problems with personality and deterioration in normal social functioning) Nervous system disorders:",17,18
"3270","es","en","Pérdida de peso Murmullos cardíacos, orina anormal","Weight decrease Cardiac murmur, urine abnormal",6,7
"3271","es","en","Perfektastrasse 84A A-1230 Wien","Perfektastrasse 84A A-1230 Wien",4,4
"3272","es","en","Perfil de actividad de NovoMix 70 en Sujetos Sanos Caucásicos","Activity Profile for NovoMix 70 in Healthy Caucasian Subjects.",9,10
"3273","es","en","pericárdico, gasto elevado o presión baja de llenado.","output or low filling pressure",5,8
"3274","es","en","Período de validez del medicamento veterinario acondicionado para su venta:","Shelf-life of the veterinary medicinal product as packaged for sale:",10,10
"3275","es","en","Período de validez después de abierto el envase:","Shelf life after first opening the container:",7,8
"3276","es","en","Periodo de validez tras la primera apertura del tubo:","Shelf-life after first opening of the tube:",7,9
"3277","es","en","Período de validez una vez abierto el vial:","Shelf-life after first opening the vial:",6,8
"3278","es","en","Permita que el vial liofilizado de BeneFIX y la jeringa precargada de disolvente alcancen la temperatura ambiente.","Allow the vial of lyophilised BeneFIX and the pre-filled syringe to reach room temperature.",14,17
"3279","es","en","Pero un buen comienzo no es más que eso.","But a good start is no more than that.",9,9
"3280","es","en","Perros con peso de 15 Kg o más, aplicar 8 gotas en el oído una vez al día.","With dogs weighing 15 kg or more, apply 8 drops to the ear once a day.",16,18
"3281","es","en","Perros que pesen entre 5,1 y 10,0 kg","Dogs weighing 5.1 – 10.0 kg.",6,8
"3282","es","en","Perros y gatos Perros","Cats and dogs Dogs",4,4
"3283","es","en","Peso corporal superior a 30 kg:","Body weight more than 30 kg:",6,6
"3284","es","en","Peso del paciente < 60 kg ≥ 60 kg","Patient weight < 60 kg ≥ 60 kg",8,9
"3285","es","en","Peter JONES Jefe de Unidad CVMP y procedimientos veterinarios Jill ASHLEY-SMITH","Peter JONES Head of Unit CVMP and veterinary procedures Jill ASHLEY-SMITH",11,11
"3286","es","en","Pfizer Animal Health Telephone: +353 (0) 1 467 6500","Pfizer Animal Health Telephone: +353 (0) 1 467 6500",9,9
"3287","es","en","Pfizer Corporation Austria Ges. m. b. H.","Pfizer Corporation Austria Ges.m.b.H.",4,7
"3288","es","en","Pfizer Hellas A. E., Alketou 5, 11633 Atenas Grecia","Pfizer Hellas A. E., Alketou 5, 11633 Athens Greece",9,9
"3289","es","en","Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ, Reino Unido","Ramsgate Road Sandwich, Kent CT13 9NJ, UK",7,10
"3290","es","en","Pfizer Limited Walton Oaks, Dorking Road Walton-0n-The-Hill Surrey KT20 7NS Reino Unido","Pfizer Limited Walton Oaks, Dorking Road Walton-0n-The-Hill Surrey KT20 7NS United Kingdom",12,12
"3291","es","en","Pfizer Ltd Ramsgate Road Sandwich Kent CT13 9NJ Reino Unido","Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom",10,10
"3292","es","en","Pfizer Luxembourg SARL, branch office","Pfizer Luxembourg SARL, branch office Dubravska cesta 2, 841 04 Bratislava, Slovak Republic",13,5
"3293","es","en","Pfizer S. A., Boulevard De La Plaine 17 B-1050 Brussels Bélgica","Pfizer S. A., Boulevard De La Plaine 17 B-1050 Brussels Belgium",11,11
"3294","es","en","Pharma-Cos House Triq C.","Pharma-Cos House Triq C.",4,4
"3295","es","en","PhotoBarr está contraindicado en pacientes con insuficiencia hepática grave.","PhotoBarr is contraindicated in patients with severe hepatic impairment.",9,9
"3296","es","en","Pida ayuda al médico de su hijo inmediatamente.","Contact your child’ s doctor immediately for advice.",8,8
"3297","es","en","Pinche aquí para obtener más información.","See here for information on the outcome of the resubmission",10,6
"3298","es","en","Pirlimicina clorhidrato equivalente a 50 mg de pirlimicina en cada jeringa de 10 ml","Pirlimycin hydrochloride equivalent to 50 mg pirlimycin per 10 ml syringe",11,14
"3299","es","en","Piroxicam 10 Mg Capsules","Piroxicam 10 Mg Capsules",4,4
"3300","es","en","Piroxicam Expanpharm 10 Mg, Gélule","Piroxicam Expanpharm 10 Mg, Gélule",5,5
"3301","es","en","Piroxicam Palbian 10 Mg, Gélule","Piroxicam Palbian 10 Mg, Gélule",5,5
"3302","es","en","Piroxicam- Ratiopharm 20mg Zäpfchen 10231.00.01","Piroxicam- Ratiopharm 20mg Zäpfchen 10231.00.01",5,5
"3303","es","en","PL-02-222 Warszawa Tel.: + 48-(0)22 478 41 50","Tel.: + 48-(0)22 478 41 50",6,8
"3304","es","en","Placebo (n = 40)","Placebo (n = 40)",4,4
"3305","es","en","Placebo Bondronat 50 mg valor de p n=277 N=287","Bondronat 50 mg p-value n=287",5,9
"3306","es","en","Pluma precargada (vidrio) (SureClick)","pre-filled pen (glass) (SureClick)",4,4
"3307","es","en","Plumas en uso Para las condiciones de conservación, ver sección 6.3.","For storage precautions, see section 6.3.",6,11
"3308","es","en","Plynárenska 7/B SK- 824 78 Bratislava 26 Tel: +421 233 552 600","Plynárenska 7/ B SK- 824 78 Bratislava 26 Tel: +421 233 552 600",13,12
"3309","es","en","Poco frecuente: agitación Raros: agresividad, confusión, depresión, alucinación, insomnio Muy raro: tic","Uncommon: agitation Rare: aggression, confusion, depression, hallucination, insomnia Very rare: tic",11,12
"3310","es","en","Poco frecuentes (> 1/ 1.000- < 1/ 100) Hiperglucemia","Uncommon (> 1/ 1,000- < 1/ 100) Hyperglycaemia",8,9
"3311","es","en","Poco frecuentes Anorexia, Polidipsia Muy raras Frecuencia Desconocida","Dysphagia, Gastritis, Faecal incontinence, Faecaloma Intestinal obstruction, Pancreatitis, Lip swelling, Cheilitis",11,8
"3312","es","en","Poco frecuentes Bloqueo auriculoventricular, Bloqueo de rama, Fibrilación auricular, Bradicardia sinusal, Palpitaciones","Tachycardia Atrioventricular block, Bundle branch block, Atrial fibrillation, Sinus bradycardia, Palpitations",11,12
"3313","es","en","Poco frecuentes Nefrolitiasis, hematuria, polaquiuria Raras Insuficiencia renal","Uncommon Nephrolithiasis, haematuria, pollakiuria Rare Renal insufficiency",7,8
"3314","es","en","Poco frecuentes: cambios en la pigmentación de las uñas o decoloración en la base de la uña","Uncommon: changes in nail pigmentation or discoloration of nail bed",10,17
"3315","es","en","Poco frecuentes: impotencia Trastornos generales:","Antihypertensive agents and vasodilators Concomitant use of these agents may increase the hypotensive effects of perindopril.",16,5
"3316","es","en","Poco frecuentes: malestar, aumento de peso.","Uncommon: malaise, weight gain.",4,6
"3317","es","en","Poco frecuentes: neumonía, infección del tracto urinario, gastroenteritis, faringitis.","Uncommon: pneumonia, urinary tract infection, gastroenteritis, pharyngitis.",7,9
"3318","es","en","Poco frecuentes: rubefacción, accidente cerebrovascular∗.","Uncommon: flushing, cerebrovascular accident ∗.",5,5
"3319","es","en","Podría esperarse un descenso en la exposición del inmunosupresor (inducción CYP3A4).","Decreased exposure of the immunosuppressant may be expected (CYP3A4 induction).",10,11
"3320","es","en","Podría necesitar atención médica urgente u hospitalización.","You may need urgent medical attention or ho spitalisation.",9,7
"3321","es","en","Podría sobrevenir excepcionalmente una reacción de hipersensibilidad, que pudiera necesitar un tratamiento sintomático apropiado.","These are rare and appropriate symptomatic treatment should be administered.",10,14
"3322","es","en","Points to consider on the evaluation of new anti-fungal agents for invasive fungal infections.","Points to consider on the evaluation of new anti-fungal agents for invasive fungal infections",14,14
"3323","es","en","Poli (alcohol vinílico) Dióxido de titanio Macrogol 3350","Poly (vinyl alcohol) Titanium dioxide Macrogol 3350 Talc Soya Lecithin Indigo carmine aluminium lake (E132)",15,8
"3324","es","en","poliuria, disuria, polaquiuria exantema, acné, fotosensibilidad, hiperhidrosis, piel grasa, prurito, lesión en la piel","polyuria, dysuria, pollakiuria rash, acne, photosensitivity, hyperhidrosis, oily skin, pruritus, skin lesion",12,14
"3325","es","en","Pollos Entre 8-14 días de edad:","From 8 to 14 days old:",6,6
"3326","es","en","Pollos y pavos: tratamiento de la coccidiosis","Chickens and turkeys: treatment of coccidiosis",6,7
"3327","es","en","Polska Abbott Laboratories Poland Sp. z o.o.","Polska Abbott Laboratories Poland Sp. z o.o.",7,7
"3328","es","en","Polska Bayer Sp. z o. o.","Polska Bayer Sp. z o. o.",6,6
"3329","es","en","Polska Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820","Polska Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820",12,12
"3330","es","en","Polska JANSSEN–CILAG Polska Sp. z o.o., ul.","Polska JANSSEN–CILAG Polska Sp. z o.o., ul.",7,7
"3331","es","en","Polska Novartis Poland Sp. z o. o.","Polska Novartis Poland Sp. z o.o.",6,7
"3332","es","en","Polska Roche Polska Sp. z o. o.","Polska Roche Polska Sp.z o.o.",5,7
"3333","es","en","Polska Takeda Global Research and Development Centre (Europe) Ltd., Wielka Brytania Tel.: + 44 (0)203 116 8000","Polska Takeda Global Research and Development Centre (Europe) Ltd., Wielka Brytania Tel.: + 44 (0)203 116 8000",17,17
"3334","es","en","Polvo 10 jeringa precargada:","Powder 10 pre-filled syringes:",4,4
"3335","es","en","Polvo blanco a blanquecino.","White to off-white powder.",4,4
"3336","es","en","Polvo en vial: conservar en nevera (entre 2ºC y 8ºC).","Powder in vial: store in a refrigerator (2 °C - 8 °C).",12,10
"3337","es","en","Polvo liofilizado de blanco a amarillo pálido o amarillo verdoso.","A white to either light yellow or green-yellow lyophilised powder.",10,10
"3338","es","en","Polvo liofilizado de color blanco a casi blanco.","White to almost white lyophilised powder.",6,8
"3339","es","en","polvo para concentrado para solución para perfusión","Pharmaceutical Form Powder for concentrate for solution for infusion",9,7
"3340","es","en","Polvo para solución inyectable (polvo para inyectable).","Powder for solution for injection (powder for injection).",8,7
"3341","es","en","Polvo para solución oral","Powder for oral solution",4,4
"3342","es","en","Polvo para solución para","Powder for solution for infusion",5,4
"3343","es","en","Polvo para solución para perfusión.","Powder for solution for infusion.",5,5
"3344","es","en","Polvo para suspensión para perfusión","Powder for suspension for infusion",5,5
"3345","es","en","Polvo y disolvente para solución inyectable","Powder and solvent for solution for injection",7,6
"3346","es","en","Polvo y disolvente para solución inyectable o para perfusión","Powder and solvent for solution for injection or infusion",9,9
"3347","es","en","Polvo y disolvente para suspensión inyectable en jeringa precargada.","Powder and solvent for suspension for injection in pre-filled syringe.",10,9
"3348","es","en","Polvo y disolvente para Vía intramuscular suspensión inyectable","Pó e veículo para suspensão injectável",6,8
"3349","es","en","polvo y disolvente para Via intravenosa solución inyectable","Powder and solvent for Intravenous use Powder: vial (glass) solution for injection Solvent: prefilled syringe (glass)",16,8
"3350","es","en","Polvo: sacarosa, histidina, hidrocloruro de histidina monohidrato y polisorbato 20.","Powder: sucrose, histidine, histidine hydrochloride monohydrate and polysorbate 20.",9,10
"3351","es","en","Polvo: vial (vidrio) Disolvente:","powder: vial (glass); solvent: cartridge (glass)",6,4
"3352","es","en","Ponga el vial conteniendo el polvo sobre una superficie limpia y sólida.","Place the powder vial upright on a firm, clean surface.",10,12
"3353","es","en","Ponga la pluma a cero y púrguela otra vez (ver “Purgando la Pluma KwikPen” pasos 2 A-D).","Dial the Pen down to zero and prime the Pen again (see “Priming the Pen” steps 2 A-D).",18,17
"3354","es","en","Póngalo a la altura de sus ojos.","Bring to eye level.",4,7
"3355","es","en","Póngase en contacto con su médico si nota cambios en la grasa corporal.","Contact your doctor if you notice changes in body fat.",10,13
"3356","es","en","Póngase en contacto con su médico.","Please contact your doctor.",4,6
"3357","es","en","Póngase en contacto inmediatamente con su médico si se queda embarazada durante el tratamiento con VFEND.","Contact your doctor immediately if you become pregnant while taking VFEND.",11,16
"3358","es","en","Por consiguiente, las concentraciones mínimas de sirolimus que están dentro del intervalo terapéutico habitual pueden producir niveles subterapéuticos.","As a result, sirolimus trough concentrations that fall within the usual therapeutic range may result in sub-therapeutic levels.",18,18
"3359","es","en","Por consiguiente, no se proporciona un punto de corte de sensibilidad.","Therefore, no breakpoint for susceptibility is given.",7,11
"3360","es","en","Por dosis de 0,2 ml de vacuna:","Per dose of 0.2 ml vaccine:",6,7
"3361","es","en","Por ejemplo, si pesa 60 Kg, su dosis diaria será de 30 MU.","For example, if you weigh 60 kg, your daily dose will be 30 MU.",14,13
"3362","es","en","Por ello, el tratamiento concomitante sólo debe iniciarse si el paciente está estabilizado con su tratamiento alfabloqueante.","Therefore, concomitant treatment should be initiated only if the patient is stable on his alpha blocker therapy.",17,17
"3363","es","en","Por ello, no se puede descartar una posible relación entre el daño hepático y el mitotano.","Therefore, the possibility of mitotane-induced liver damage cannot be excluded.",10,16
"3364","es","en","Por favor consulte a su médico","Please consult your doctor",4,6
"3365","es","en","Por favor, consulte la Ficha Técnica de Emtriva 200 mg cápsulas duras.","Please refer to the Summary of Product Characteristics for Emtriva 200 mg hard capsules.",14,12
"3366","es","en","Por favor, lea las instrucciones atentamente y sígalas paso a paso.","Please read the instructions carefully and follow them step by step.",11,11
"3367","es","en","Por favor, siga cuidadosamente las instrucciones del veterinario.","Please carefully follow the instructions of the veterinarian.",8,8
"3368","es","en","por Hib en las 1-2 semanas tras la vacunación.","r ge observed within 1-2 weeks following vaccination.",8,9
"3369","es","en","Por lo que, filgrastim no está indicado en estas enfermedades.","Therefore, filgrastim is not indicated for use in these conditions.",10,10
"3370","es","en","Por lo tanto no se debe utilizar AVAGLIM durante el embarazo y se recomienda el uso de insulina.","Therefore, AVAGLIM should not be used during pregnancy and the use of insulin is recommended.",15,18
"3371","es","en","Por lo tanto no se recomienda la utilización de Kivexa en combinación con zalcitabina.","Kivexa is therefore not recommended to be used in combination with zalcitabine.",12,14
"3372","es","en","Por lo tanto, Caelyx no debería utilizarse durante el embarazo excepto si fuese claramente necesario.","Therefore, Caelyx should not be used during pregnancy unless clearly necessary.",11,15
"3373","es","en","Por lo tanto, cuando reciba cualquier otro tratamiento, comunique al profesional sanitario que está utilizando AZARGA.","Talk to your doctor.",4,16
"3374","es","en","Por lo tanto, debe evitarse el uso de tales combinaciones en niños.","Therefore, such combinations should be avoided in children.",8,12
"3375","es","en","Por lo tanto, debe tenerse precaución cuando se administre Renagel a pacientes con estos trastornos.","Consequently, caution should be exercised when Renagel is used in patients with these disorders.",14,15
"3376","es","en","Por lo tanto, deberá vigilarse el tiempo de sangrado. • Glibenclamida (usada para el tratamiento de la diabetes).","Therefore the bleeding time should be monitored. • glibenclamide (used to treat diabetes).",13,18
"3377","es","en","Por lo tanto, en el caso de neutropenia, no se recomienda volver a administrar el fármaco.","Therefore, in the event of neutropenia, rechallenge is not recommended.",10,16
"3378","es","en","Por lo tanto, es necesario que haya estimulación sexual para que vardenafilo produzca sus efectos terapéuticos beneficiosos.","Sexual stimulation is therefore required for vardenafil to produce its beneficial therapeutic effects.",13,17
"3379","es","en","Por lo tanto, la combinación de litio y Irbesartan Hydrochlorothiazide BMS no está recomendada (ver sección 4.4).","Therefore, the combination of lithium and Irbesartan Hydrochlorothiazide BMS is not recommended (see section 4.4).",15,17
"3380","es","en","Por lo tanto, no deben utilizarse preparaciones herbales que contengan hipérico en combinación con ritonavir.","Herbal preparations containing St John’ s wort must not be used in combination with ritonavir.",15,15
"3381","es","en","Por lo tanto, no es necesario un ajuste de dosis en el caso de pacientes con alteración hepática.","Therefore dosage adjustment is not necessary in patients with hepatic impairment.",11,18
"3382","es","en","Por lo tanto, no se debe utilizar en este grupo de edad.","Therefore it should not be used in this age group.",10,12
"3383","es","en","Por lo tanto, no se puede recomendar el uso de Comtan en niños.","Therefore the use of Comtan in children cannot be recommended.",10,13
"3384","es","en","Por lo tanto, no se recomienda el tratamiento en estos grupos de pacientes.","Therefore, treatment is not recommended in these patient groups.",9,13
"3385","es","en","Por lo tanto, no tome SIFROL si está embarazada a menos que su médico se lo indique.","Therefore, do not take SIFROL if you are pregnant unless your doctor tells you to do so.",17,17
"3386","es","en","Por lo tanto, se propuso incluir una advertencia general en el RCP.","Therefore, a general caution was proposed to be included in the SPC.",12,12
"3387","es","en","Por lo tanto, se recomienda la administración de STOCRIN con el estómago vacío y preferiblemente antes de acostarse.","It is recommended that STOCRIN be taken on an empty stomach, preferably at bedtime.",14,18
"3388","es","en","Por lo tanto, se recomienda precaución.","Caution is therefore recommended.",4,6
"3389","es","en","Por lo tanto, se recomienda que no amamante a su hijo mientras esté tomando Ziagen.","You are therefore recommended not to breast-feed your baby while taking Ziagen.",12,15
"3390","es","en","Por lo tanto, se recomienda una rigurosa monitorización de la glucosa sanguínea.","Close blood glucose monitoring is therefore recommended.",7,12
"3391","es","en","Por lo tanto, su médico deberá controlar la eficacia de su tratamiento.","Your doctor will therefore be monitoring the effectiveness of your treatment.",11,12
"3392","es","en","Por otra parte, la mejora de la documentación se traducirá en unos procedimientos más eficientes.","The gain, from the resulting benefits of improved dossiers, will be more efficient procedures.",14,15
"3393","es","en","Por tanto, debe cepillarse los dientes con dentífrico fluorado de forma habitual dos veces al día.","Therefore, you should brush your teeth regularly with fluoride toothpaste twice daily.",12,16
"3394","es","en","Por tanto, debe tenerse especial precaución cuando se utiliza atorvastatina junto con estos medicamentos (ver sección 4.4).","White elliptical, film-coated tablets debossed ""20"" on one side and ""PD 156"" on the other.",15,17
"3395","es","en","Por tanto, debe tenerse precaución cuando se prescriba Thymanax a estos pacientes (ver sección 4.4).","Therefore, caution should be exercised when prescribing Thymanax to these patients (see section 4.4).",14,15
"3396","es","en","Por tanto, el Comité recomendó conceder a Siklos la autorización de comercialización.","The Committee recommended that Siklos be given marketing authorisation.",9,12
"3397","es","en","Por tanto, la actividad antiviral de Kaletra se debe a lopinavir.","Patients without prior antiretroviral therapy",5,11
"3398","es","en","Por tanto, los pacientes deben tener precaución durante la conducción o el manejo de máquinas (ver sección 4.8).","Therefore, patients must be cautious when operating machinery, or when driving (see section 4.8).",14,18
"3399","es","en","Por tanto, los pacientes hemofílicos deben ser advertidos del riesgo de aumento de hemorragias.","Haemophiliac patients should therefore be made aware of the possibility of increased bleeding.",13,14
"3400","es","en","Por tanto, no es necesario ajustar la dosis en pacientes con alteración renal.","Thus no dose adjustment is necessary in patients with renal impairment.",11,13
"3401","es","en","Por tanto, no es necesario llevar una monitorización rutinaria de las concentraciones plasmáticas de pregabalina.","Therefore, there is no need for routine monitoring of plasma concentrations of pregabalin.",13,15
"3402","es","en","Por tanto, no se puede recomendar su uso en mujeres en periodo de lactancia.","Its clinical use, therefore, cannot be recommended in breast-feeding women.",10,14
"3403","es","en","Por tanto, no se recomienda el uso de Karvezide.","Therefore, the use of Karvezide is not recommended.",8,9
"3404","es","en","Por tanto, no se recomienda iniciar el tratamiento cerca de la pubertad.","It is therefore not recommended to initiate treatment near onset of puberty.",12,12
"3405","es","en","Por tanto, no se recomienda su utilización en estos pacientes.","Therefore, its use is not recommended in these patients.",9,10
"3406","es","en","Por tanto, se aplicarán las medidas de apoyo adecuadas.","Therefore appropriate supportive measures should be instituted.",7,9
"3407","es","en","Por vía sistémica, la dexametasona induce CYP3A4 y, por tanto, puede reducir la exposición a darunavir.","Systemic dexamethasone induces CYP3A4 and thereby may decrease darunavir exposure.",10,16
"3408","es","en","Porcentaje de pacientes (%) con valores de HbA1c ≤ 7%","Proportion of patients (%) achieving HbA1c ≤ 7%",8,10
"3409","es","en","Porcentaje de pacientes con ARN del VIH < 50 copias/ ml Respuesta al tratamiento (%)a","AI455-099 (48 weeks) b",4,15
"3410","es","en","Porcentaje medio del cambio en","Mean percent change in AUC, Cmax, Cmin with confidence intervals if availablea (mechanism)",13,5
"3411","es","en","Porcilis PCV emulsión inyectable para cerdos","PORCILIS PCV emulsion for injection for pigs",7,6
"3412","es","en","Porcino (cerdas jóvenes y cerdas","Pigs (gilts and sows)",4,5
"3413","es","en","Portugal Abbott Laboratórios, Lda.","Portugal Abbott Laboratórios, Lda.",4,4
"3414","es","en","Portugal Genzyme Portugal Tel: +351 21 422 0100","Portugal Genzyme Portugal Tel: +351 21 422 0100",8,8
"3415","es","en","Portugal JANSSEN-CILAG FARMACEUTICA, LDA Tel: +351 21-4368835","Portugal JANSSEN-CILAG FARMACEUTICA, LDA Tel: +351 21-4368835",7,7
"3416","es","en","Portugal Rua Agualva dos Açores 16 P-2735-557 Agualva-Cacém Tel: + 351-21 433 93 00","Portugal Rua Agualva dos Açores 16 P-2735-557 Agualva-Cacém Tel: + 351-21 433 93 00",14,14
"3417","es","en","Portugal Smith Kline & French Portuguesa, Produtos Farmacêuticos, Lda.","Smith Kline & French Portuguesa, Produtos Farmacêuticos, Lda.",8,9
"3418","es","en","Posaconazol puede aumentar los","Posaconazole can increase the blood levels of",7,4
"3419","es","en","Posaconazole SP debe prescribirse con precaución a pacientes con hipersensibilidad a otros azoles.","Caution should be used when prescribing Posaconazole SP to patients with hypersensitivity to other azoles.",15,13
"3420","es","en","Posee efectos inmunomoduladores/ inmunosupresores, actúa como agente antiproliferativo y desarrolla propiedades antiinflamatorias.","It has immunomodulating/ immunosuppressive characteristics, acts as an antiproliferative agent, and displays anti-inflammatory properties.",14,12
"3421","es","en","Posibilidad de que Inovelon afecte a otros medicamentos","Potential for Inovelon to affect other medicinal products",8,8
"3422","es","en","Posibles efectos adversos 5 Conservación de STAMARIL 6.","How to store STAMARIL 6.",5,8
"3423","es","en","Posibles efectos adversos 5.","Possible side effects 5.",4,4
"3424","es","en","Posibles efectos adversos 6.","Possible side effects 6.",4,4
"3425","es","en","Position paper on voting in the framework of the discussion and adoption of CPMP opinions","Position paper on voting in the framework of the discussion and adoption of CPMP opinions",15,15
"3426","es","en","Postbus 241 NL-6800 LZ Arnhem","Postbus 241 NL-6800 LZ Arnhem",5,5
"3427","es","en","Pouet de Camilo, 2 E-46394 Ribarroja del Turia (Valencia) Tel: + 34 96 2722800","Pouet de Camilo, 2E-46394 Ribarroja del Turia (Valencia) Tel: + 34 96 2722800",13,14
"3428","es","en","Poulvac FluFend H5N3 RG ha sido autorizado en « circunstancias excepcionales ».","Page 2/ 3 ©EMEA 2008 Poulvac FluFend H5N3 RG has been authorised under “ Exceptional Circumstances”.",16,12
"3429","es","en","Powder and solvent for solution for injection 250 IU, 500 IU, 1000 IU 3 presentations","Company - Name - Origin",5,15
"3430","es","en","Pradaxa Pradaxa Pradaxa Pradaxa Pradaxa Pradaxa Pradaxa Pradaxa","Pradaxa Pradaxa Pradaxa Pradaxa Pradaxa Pradaxa Pradaxa Pradaxa",8,8
"3431","es","en","Prandin 0,5 mg comprimidos 1 mg comprimidos 2 mg comprimidos","Prandin 0.5 mg tablets 1 mg tablets 2 mg tablets",10,10
"3432","es","en","Pre senta los siguientes síntomas: •","The symptoms are as follows: •",6,6
"3433","es","en","Precauciones especiales antes de la inyección","Special care before injection",4,6
"3434","es","en","Precauciones especiales de conservación","Special precautions for storage",4,4
"3435","es","en","PRECAUCIONES ESPECIALES DE ELIMINACIÓN DEL MEDICAMENTO NO UTILIZADO Y DE LOS MATERIALES DERIVADOS DE SU USO (CUANDO CORRESPONDA)","SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE",18,18
"3436","es","en","Precauciones especiales en los pacientes con cáncer","Special precautions in cancer patients",5,7
"3437","es","en","Precauciones especiales para su uso en animales","Special precautions for use in animals",6,7
"3438","es","en","PRECAUCIONES ESPECIALES QUE DEBAN OBSERVARSE AL ELIMINAR EL MEDICAMENTO NO UTILIZADO O, EN SU CASO, SUS RESIDUOS","SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY",13,17
"3439","es","en","PRECAUCIONES ESPECIALES QUE DEBEN OBSERVARSE AL ELIMINAR EL","SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY",13,8
"3440","es","en","PRECAUCIONES ESPECIALES QUE DEBEN OBSERVARSE AL ELIMINAR EL MEDICAMENTO NO UTILIZADO O, EN SU CASO, SUS RESIDUOS","SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIAL, IF ANY",13,17
"3441","es","en","Precauciones especiales que deberá adoptar la persona que administre el medicamento a los animales","Special precautions to be taken by the person administering the veterinary medicinal product to animals",15,14
"3442","es","en","Pregunte a su farmacéutico como deshacerse de los envases y de los medicamentos que no necesita.","Ask your pharmacist how to dispose of medicines that you no longer need.",13,16
"3443","es","en","Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita.","Ask your pharmacist how to dispose of any medicines no longer required.",12,16
"3444","es","en","Pregunte a su médico si usted no está seguro de la","Ask your doctor if you are unsure about the severity of your",12,11
"3445","es","en","Preotact es un polvo y disolvente para solución inyectable.","Preotact is a powder and solvent for solution for injection.",10,9
"3446","es","en","Prepandrix, suspensión y emulsión para emulsión inyectable Vacuna antigripal prepandémica (H5N1) (de virus fraccionados, inactivados, adyuvada)","Prepandrix suspension and emulsion for emulsion for injection Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)",16,16
"3447","es","en","Preparación para eliminar el aire","Priming to expel air",4,5
"3448","es","en","Preparar el lugar de inyección e inyectar la solución de Enbrel h.","Preparing the injection site and injecting the Enbrel solution h.",10,12
"3449","es","en","Prepare la dosis: • Retire la tapa que cubre la parte superior del vial.","Prepare the dose: • Take the cap off the top of the vial",13,14
"3450","es","en","Presentación Cajas con 7, 14, 28, 56, 84 ó 100 sobres.","Pack sizes Boxes containing 7, 14, 28, 56, 84 or 100 sachets.",12,11
"3451","es","en","PRESENTACIÓN EN VIAL DE 3,5 ML","VIAL 3.5 ML PRESENTATION",4,6
"3452","es","en","Presentado como un spray volátil, este medicamento veterinario no requiere masaje.","Presented as a volatile spray, this veterinary medicinal product does not require any massage.",14,11
"3453","es","en","Presentan selectividad por los interferones humanos pero no por los murinos, lo que sugiere una especificidad de especie.","They exhibit selectivity for human but not murine interferons, suggesting species specificity.",12,18
"3454","es","en","Presentó alegaciones verbales el 18 de enero de 2005.","Oral explanation was given by the Marketing Authorisation Holder on 18 January 2005.",13,9
"3455","es","en","presión arterial durante el tratamiento con etoricoxib.","during treatment with etoricoxib.",4,7
"3456","es","en","presión arterial, ya que la dosis puede tener que ajustarse.","blood pressure, because the dose may need to be adjusted.",10,10
"3457","es","en","Presione brevemente el botón rojo y suéltelo. n co","Briefly press and release red button.",6,9
"3458","es","en","Prevention of invasive infections due to Vancomycin resistant enterococci","Prevention of invasive infections due to Vancomycin resistant",8,9
"3459","es","en","Previcox no debe administrarse conjuntamente con corticosteroides u otros AINE.","Previcox must not be administered with corticosteroids or other NSAIDs.",10,10
"3460","es","en","PREZISTA 600 mg comprimidos recubiertos con película darunavir","PREZISTA 600 mg film-coated tablets darunavir",6,8
"3461","es","en","PRILACTONE 80 mg comprimidos Espironolactona","PRILACTONE 80 mg tablets Spironolactone",5,5
"3462","es","en","Principio activo Mavacoxib Mavacoxib Mavacoxib Mavacoxib Mavacoxib","Mavacoxib Mavacoxib Mavacoxib Mavacoxib Mavacoxib",5,7
"3463","es","en","Principios activos que pueden aumentar las concentraciones plasmáticas de imatinib:","Active substances that may increase imatinib plasma concentrations:",8,10
"3464","es","en","Pritor 80 mg comprimidos telmisartán","Pritor 80 mg tablets telmisartan",5,5
"3465","es","en","Privigen también puede reducir los síntomas de algunos trastornos inflamatorios.","Privigen can also reduce the symptoms in certain inflammatory disorders.",10,10
"3466","es","en","Procedimiento para la eliminación correcta","Procedure for proper disposal",4,5
"3467","es","en","Procoralan 5 mg comprimidos recubiertos con película Procoralan 7,5 mg comprimidos recubiertos con película ivabradina","Procoralan 5 mg film-coated tablets Procoralan 7.5 mg film-coated tablets ivabradine",11,15
"3468","es","en","Procure dirigir el chorro del líquido hacia la pared de vidrio y así evitar la formación de espuma.","Aim the stream of liquid against the glass wall in order to avoid foam.",14,18
"3469","es","en","producción de la EMEA.","task of the EMEA.",4,4
"3470","es","en","Producido por tecnología del ADN recombinante en células de levadura (Saccharomyces cerevisiae) 4","Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology 4",11,13
"3471","es","en","Profender para gatos grandes (> 5 – 8 kg)","Profender for Large Cats (> 5 – 8 kg)",9,9
"3472","es","en","Profilaxis de rechazo agudo en transplantes renales","L04A Prophylaxis of acute rejection in renal transplantation",8,7
"3473","es","en","PROHIBICIÓN DE VENTA, DISPENSACIÓN Y/ O USO","PROHIBITION OF SALE, SUPPLY AND/ OR USE",7,7
"3474","es","en","Prolongación del intervalo QTc: algunos azoles se han relacionado con una prolongación del intervalo QTc.","Some azoles have been associated with prolongation of the QTc interval.",11,15
"3475","es","en","ProMeris 160 mg Solución Spot-on para gatos pequeños ProMeris 320 mg Solución Spot-on para gatos grandes","ProMeris 160 mg Spot-on solution for small cats ProMeris 320 mg Spot-on solution for large cats",16,16
"3476","es","en","Prometax 3,0 mg [únicamente en la caja]","Prometax 3.0 mg [folding box only]",6,7
"3477","es","en","Prometax Prometax Prometax Prometax Prometax","Prometax Prometax Prometax Prometax Prometax",5,5
"3478","es","en","ProQuad – Polvo en vial y disolvente en jeringa precargada sin aguja- Envase de 1, 10, 20","ProQuad - Powder in vial and solvent in pre-filled syringe without needle - Pack of 1, 10, 20",18,17
"3479","es","en","PROSPECTO Profender solución para unción dorsal puntual para gatos","PACKAGE LEAFLET Profender spot-on solution for cats",7,9
"3480","es","en","ProStrakan Ltd, Galabank Business Park, Galashiels TD1 1QH Reino Unido","ProStrakan Ltd, Galabank Business Galashiels TD1 1QH UK",8,10
"3481","es","en","Protaphane es un análogo de la insulina idéntico a la insulina fabricada por el páncreas.","Protaphane is a replacement insulin which identical to the insulin made by the pancreas.",14,15
"3482","es","en","Protaphane Penfill 100 UI/ ml suspensión inyectable en un cartucho Insulina humana (ADNr)","Protaphane Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA)",14,13
"3483","es","en","Protector exterior grande de la aguja","Big outer needle cap",4,6
"3484","es","en","Proteger de la congelación y las altas temperaturas","Avoid freezing or excessive temperatures.",5,8
"3485","es","en","Proteger de la luz.","Protect from light. ng lo 12.",6,4
"3486","es","en","proteínas (carnes, pescados, lácteos, cereales y frutos secos) o poco después de ingerirlos.","protein-rich food (such as meats, fish, dairy products, seeds and nuts).",11,13
"3487","es","en","ProteqFlu-Te Suspensión inyectable para caballos","ProteqFlu-Te Suspension for injection for horses",6,5
"3488","es","en","Protopic contiene tacrolimus como principio activo, un inhibidor de la calcineurina.","Protopic contains the active substance tacrolimus, a calcineurin inhibitor.",9,11
"3489","es","en","Protopy contiene tacrolimus como principio activo, un inhibidor de la calcineurina.","Protopy contains the active substance tacrolimus, a calcineurin inhibitor.",9,11
"3490","es","en","PRT Av. da Siderurgia Nacional S.","PRT Av. da Siderurgia Nacional S.",6,6
"3491","es","en","Pruban es una crema blanca o blanquecina cuyo principio activo es el butirato de resocortol, un corticosteroide.","Resocortol butyrate is a corticosteroid.",5,17
"3492","es","en","Przemysł owa 2 35-959 Rzeszów Polonia","Przemysł owa 2 35-959 Rzeszów Poland",6,6
"3493","es","en","Publicado para consulta en julio de 2001","Released for consultation July 2001",5,7
"3494","es","en","Publicado para consulta en noviembre de 2002","Released for consultation November 2002",5,7
"3495","es","en","Publicado para consulta en septiembre de 2002","Released for consultation February 2002",5,7
"3496","es","en","Puede administrarse con o sin alimentos.","It can be taken with or without food.",8,6
"3497","es","en","puede conllevar a una insuficiencia hepática que ponga en peligro su vida (ver sección 4 Posibles efectos adversos).","life-threatening liver failure (see section 4.",6,18
"3498","es","en","Puede conservar su Humalog KwikPen en uso hasta 28 días a la temperatura ambiente (inferior a 30°C).","Keep your Humalog KwikPen in use at room temperature (below 30°C) for up to 28 days.",16,17
"3499","es","en","Puede experimentar también inflamación del riñón, aumento de orina y sensación de sed.","You may also experience inflammation of the kidney, passing a lot of urine and feeling thirsty.",16,13
"3500","es","en","Puede incrementarse la dosis según los requerimientos individuales hasta un máximo de 90 mg una vez al día.","The dosage can be increased according to individual requirements up to a maximum of 90 mg once-daily.",17,18
"3501","es","en","Puede ocurrir que la insulina que inyecte en ese lugar no actúe bien.","Insulin that you inject in such a site may not work very well.",13,13
"3502","es","en","Puede perjudicarles, aun cuando sus síntomas sean los mismos que los suyos.","It may harm them, even if their symptoms are the same as yours.",13,12
"3503","es","en","Puede prescribirse durante la gestación.","Can be used during pregnancy.",5,5
"3504","es","en","Puede producir irritación de la mucosa nasal.","It may cause irritation of the nasal mucosa.",8,7
"3505","es","en","Puede producirse redistribución, acumulación o pérdida de grasa corporal en pacientes que están recibiendo tratamiento antirretroviral combinado.","Redistribution, accumulation or loss of body fat may occur in patients receiving combination antiretroviral therapy.",15,17
"3506","es","en","Puede producirse somnolencia cuando le administren ZYPREXA.","If this happens do not drive or operate any tools or machines.",12,7
"3507","es","en","Puede producirse somnolencia y aturdimiento, lo que puede afectar a la capacidad para conducir y utilizar máquinas.","Drowsiness and dizziness can sometimes occur and may affect the ability to drive and use machines.",16,17
"3508","es","en","Puede que el médico le recomiende utilizar Humalog además de una insulina de acción más prolongada.","Your doctor may tell you to use Humalog as well as a longer-acting insulin.",14,16
"3509","es","en","Puede que necesite un ajuste de la dosis o que cambie alguno de los medicamentos que está tomando.","You may need to have the dose adjusted or change the other medicines you are taking.",16,18
"3510","es","en","Puede que solamente estén comercializados algunos tamaños de envase.","Not all pack sizes may be marketed in your country.",10,9
"3511","es","en","Puede que solamente estén comercializados algunos tamaños de envases.","Not all pack sizes are marketed.",6,9
"3512","es","en","Puede requerir atención médica.","You may require medical attention.",5,4
"3513","es","en","Puede sentarse, estar de pie o caminar - simplemente permanezca en posición erguida.","You can sit, stand or walk – just stay fully upright.",11,13
"3514","es","en","Puede ser necesario ajustar la dosis del antihipertensivo.","Dosage adjustment of the antihypertensive agent may be required.",9,8
"3515","es","en","Puede ser necesario posponer la vacunación hasta que se haya recuperado.","It might be necessary to postpone the vaccination until recovery.",10,11
"3516","es","en","Puede ser necesario un aumento de la dosis de pioglitazona, cuando se coadministre con rifampicina.","The pioglitazone dose may need to be increased when rifampicin is concomitantly administered.",13,15
"3517","es","en","Puede ser necesario un aumento de la dosis del probenecid o de la sulfinpirazona.","Increase in dosage of probenecid or sulfinpyrazone may be necessary.",10,14
"3518","es","en","Puede ser signo de un ataque cerebral.","These may be signs of a stroke.",7,7
"3519","es","en","Puede ser utilizada durante la gestación y la lactancia.","Can be used during pregnancy and lactation.",7,9
"3520","es","en","Puede sufrir una hipoglucemia si su nivel de azúcar en sangre es demasiado bajo.","A hypo means your blood sugar level is too low.",10,14
"3521","es","en","Puede tener una infección gástrica causada por la bacteria Helicobacter pylori.","You may have a gastric infection caused by a bacterium called Helicobacter pylori.",13,11
"3522","es","en","Puede tomar Oprymea con o sin alimentos.","Oprymea can be taken with or without food.",8,7
"3523","es","en","Puede tomar Vimpat con o sin alimentos.","You may take Vimpat with or without food.",8,7
"3524","es","en","Puede tratarse de personas que han nacido con una carencia de anticuerpos (síndrome de inmunodeficiencia primaria IDP).","These can be people who are born with a lack of antibodies (primary immunodeficiency syndrome, PID).",16,17
"3525","es","en","Puede uto comentar esto con su médico.","This can be discussed with your doctor.",7,7
"3526","es","en","Puede volver a utilizar de forma gradual una luz normal en interiores.","You can gradually return to normal indoor lighting.",8,12
"3527","es","en","Pueden ocurrir muy raramente reacciones alérgicas, incluyendo reacciones anafilactoides.","Allergic reactions, including anaphylactoid reactions, may occur very rarely.",9,9
"3528","es","en","Pueden producir casos de hipotiroidismo y/ o alteraciones del control del hipotiroidismo.","Cases of hypothyroidism and/ or reduced control of hypothyroidism may occur.",11,12
"3529","es","en","Pueden ser hasta 6 periodos (ciclos) de tratamiento.","There may be up to 6 treatment periods (cycles).",9,8
"3530","es","en","Puesto que AZOPT se absorbe sistémicamente, estos efectos pueden presentarse tras su administración oftálmica.","AZOPT is absorbed systemically and therefore this may occur with topical administration.",12,14
"3531","es","en","Punto de contacto Barbara FREISCHEM Teléfono directo (44-20) 74 18 85 81 E-mail: barbara.freischem@emea.eudra.org","Contact point Barbara FREISCHEM Direct telephone (44-20) 74 18 85 81 E-mail: barbara.freischem@emea.eudra.org",13,14
"3532","es","en","Punto de contacto Noël WATHION Teléfono directo (44-20) 74 18 85 92 E-mail: noel. wathion@emea. eudra. org","Contact points Jonna SUNELL-HUET Direct telephone (44-20) 74 18 84 65 E-mail: certificate@emea.eudra.org",13,17
"3533","es","en","Puntuación Apache II ≤ 20 Puntuación Apache II > 20","Apache II score ≤ 20 Apache II score > 20",10,10
"3534","es","en","Puregon 150 UI/ 0,5 ml solución inyectable","Puregon 150 IU/ 0.5 ml solution for injection",8,7
"3535","es","en","Puregon 600 UI/ 0,72 ml solución inyectable folitropina beta","Puregon 600 IU/ 0.72 ml solution for injection follitropin beta",10,9
"3536","es","en","Puregon solución inyectable contiene folitropina beta, una hormona conocida como hormona estimulante del folículo (FSH).","Puregon solution for injection contains follitropin beta, a hormone known as follicle-stimulating hormone (FSH).",14,15
"3537","es","en","Purevax RCP es una vacuna.","Purevax RCP is a vaccine.",5,5
"3538","es","en","purgar el aire atrapado dentro de la jeringa.","water for injections should be drawn into the syringe, making sure to purge any air within the syringe.",18,8
"3539","es","en","Purves trabajó en la industria farmacéutica.","From 1972 to 1974, Dr Purves worked in the pharmaceutical industry.",11,6
"3540","es","en","Pylori puede ocasionar resultados falsos negativos.","Suppression of H. pylori might give false negative results.",9,6
"3541","es","en","QD con ritonavir 100 mg QD)","ritonavir 100 mg QD)",4,6
"3542","es","en","Quadrisol 100 mg/ ml puede utilizarse durante la gestación.","Quadrisol 100 mg/ ml can be used during pregnancy.",9,9
"3543","es","en","Quality of modified release dosage forms for veterinary use","Quality of modified release dosage forms for veterinary use Released for consultation July 2002",14,9
"3544","es","en","que aparecen listados al final de este prospecto.","at the end of this leaflet.",6,8
"3545","es","en","QUÉ ES [DENOMINACIÓN DE FANTASÍA] 400 mg comprimidos recubiertos con película Y PARA QUÉ SE UTILIZA","WHAT [INVENTED NAME] 400 MG FILM-COATED TABLETS ARE AND WHAT THEY ARE USED FOR",14,16
"3546","es","en","Qué es Aclasta y para qué se utiliza 2.","What Aclasta is and what it is used for 2.",10,9
"3547","es","en","QUÉ ES AZOMYR Y PARA QUÉ SE UTILIZA","WHAT AZOMYR IS AND WHAT IT IS USED FOR",9,8
"3548","es","en","Qué es BeneFIX y para qué se utiliza 2.","What BeneFIX is and what it is used for 2.",10,9
"3549","es","en","Qué es Ceftriaxona Tyrol Pharma 2 g y para qué se utiliza","What Ceftriaxone Tyrol Pharma 2g is and what it is used for",12,12
"3550","es","en","QUÉ ES CETROTIDE Y PARA QUÉ SE UTILIZA","WHAT CETROTIDE IS AND WHAT IT IS USED FOR",9,8
"3551","es","en","Qué es CRIXIVAN y para qué se utiliza 2.","What CRIXIVAN is and what it is used for 2.",10,9
"3552","es","en","QUÉ ES ECALTA Y PARA QUÉ SE UTILIZA","WHAT ECALTA IS AND WHAT IT IS USED FOR",9,8
"3553","es","en","QUÉ ES EVOLTRA Y PARA QUÉ SE UTILIZA","WHAT EVOLTRA IS AND WHAT IT IS USED FOR",9,8
"3554","es","en","Qué es Fareston y para qué se utiliza 2.","What Fareston is and what it is used for 2.",10,9
"3555","es","en","QUÉ ES GANFORT Y PARA QUÉ SE UTILIZA","WHAT GANFORT IS AND WHAT IT IS USED FOR",9,8
"3556","es","en","Qué es Helixate NexGen 500 UI y para qué se utiliza 2.","What Helixate NexGen 500 IU is and what it is used for 2.",13,12
"3557","es","en","QUE ES HEXAVAC Y PARA QUÉ SE UTILIZA","WHAT IS HEXAVAC AND WHAT IT IS USED FOR",9,8
"3558","es","en","Qué es Humalog Mix25 y para qué se utiliza 2.","What Humalog Mix25 is and what it is used for 2.",11,10
"3559","es","en","Qué es Insulin Human Winthrop Comb 15 y para qué se utiliza 2.","What Insulin Human Winthrop Comb 15 is and what it is used for 2.",14,13
"3560","es","en","QUÉ ES JALRA Y PARA QUÉ SE UTILIZA","WHAT JALRA IS AND WHAT IT IS USED FOR",9,8
"3561","es","en","QUÉ ES LEVITRA Y PARA QUÉ SE UTILIZA","WHAT LEVITRA IS AND WHAT IT IS USED FOR",9,8
"3562","es","en","QUÉ ES LYSODREN Y PARA QUÉ SE UTILIZA","WHAT LYSODREN IS AND WHAT IT IS USED FOR",9,8
"3563","es","en","Qué es Mimpara y para qué se utiliza 2.","What Mimpara is and what it is used for 2.",10,9
"3564","es","en","Qué es Neulasta y para qué se utiliza 2.","What Neulasta is and what it is used for 2.",10,9
"3565","es","en","QUÉ ES OLANZAPINA TEVA Y PARA QUÉ SE UTILIZA","WHAT OLANZAPINE TEVA IS AND WHAT IT IS USED FOR",10,9
"3566","es","en","QUÉ ES ORACEA Y PARA QUÉ SE UTILIZA","WHAT ORACEA IS AND WHAT IT IS USED FOR",9,8
"3567","es","en","Qué es PritorPlus y para qué se utiliza 2.","What PritorPlus is and what it is used for 2.",10,9
"3568","es","en","Qué es REGRANEX y para qué se utiliza 2.","What REGRANEX is and what it is used for 2.",10,9
"3569","es","en","QUÉ ES SERETIDE Y PARA QUÉ SE UTILIZA","WHAT SERETIDE IS AND WHAT IT IS USED FOR",9,8
"3570","es","en","Qué es Sonata y para qué se utiliza 2.","What Sonata is and what it is used for 2.",10,9
"3571","es","en","QUÉ ES SUSTIVA Y PARA QUÉ SE UTILIZA","WHAT SUSTIVA IS AND WHAT IT IS USED FOR",9,8
"3572","es","en","Qué es Tasigna Tasigna es un medicamento que contiene un principio activo denominado nilotinib.","What Tasigna is Tasigna is a medicine containing an active substance called nilotinib.",13,14
"3573","es","en","Qué es Tevagrastim Tevagrastim contiene el principio activo filgrastim.","What Tevagrastim is Tevagrastim contains the active substance filgrastim.",9,9
"3574","es","en","Qué es TRACTOCILE y para qué se utiliza 2.","What TRACTOCILE is and what it is used for 2.",10,9
"3575","es","en","QUÉ ES TWINRIX ADULTOS Y PARA QUÉ SE UTILIZA","WHAT TWINRIX ADULT IS AND WHAT IT IS USED FOR",10,9
"3576","es","en","QUÉ ES VELMETIA Y PARA QUÉ SE UTILIZA","WHAT VELMETIA IS AND WHAT IT IS USED FOR",9,8
"3577","es","en","Qué es VIRACEPT y para qué se utiliza 2.","What VIRACEPT is and what it is used for 2.",10,9
"3578","es","en","Qué es Volibris y para qué se utiliza 2.","What Volibris is and what it is used for 2.",10,9
"3579","es","en","Qué es Xeomin y para qué se utiliza 2.","What Xeomin is and what it is used for 2.",10,9
"3580","es","en","QUÉ ES ZIAGEN Y PARA QUÉ SE UTILIZA","WHAT ZIAGEN IS AND WHAT IT IS USED FOR",9,8
"3581","es","en","QUÉ ES ZYRTEC Y PARA QUÉ SE UTILIZA","WHAT Zyrtec IS AND WHAT IT IS USED FOR",9,8
"3582","es","en","QUE HACER EN CASO DE URGENCIA","WHAT TO DO IN AN EMERGENCY",6,6
"3583","es","en","Qué hacer en caso de urgencia, para más información sobre hipoglucemias.","See 4 What to do in an emergency for more about hypos.",12,11
"3584","es","en","Que presenten tumores próximos a la zona de seudoartrosis.","have any tumour in the vicinity of the non-union site;",10,9
"3585","es","en","Queda por establecer la importancia clínica de estas observaciones.","The clinical relevance of these findings is still uncertain.",9,9
"3586","es","en","quelación y a un efecto no específico sobre la capacidad de absorción del tracto gastrointestinal.","due to a nonspecific effect on the absorption capacity of the gastrointestinal tract.",13,15
"3587","es","en","Quintanrix no debe administrarse a personas hipersensibles (alérgicas) a cualquiera de los principios dic","Quintanrix should not be used in people who may be hypersensitive (allergic) to any of the active lP",18,14
"3588","es","en","Quitar la tapa de plástico del envase de vidrio que contiene el polvo liofilizado","Remove the plastic cover from the glass container containing the powder",11,14
"3589","es","en","Rabigen SAG2 es una vacuna.","Rabigen SAG2 is a vaccine.",5,5
"3590","es","en","Rafe Survana, en sustitución del Dr.","Rafe Survana was appointed Co-Rapporteur, replacing Dr.",7,6
"3591","es","en","Raltegravir atravesó fácilmente la placenta en ratas, pero no penetró en el cerebro en una magnitud apreciable.","Raltegravir readily crossed the placenta in rats, but did not penetrate the brain to any appreciable extent.",17,17
"3592","es","en","RAN ≥ 1,5 x 109/ 1 y recuento de plaquetas ≥ 100 x 109/ l.","ANC ≥ 1.5 x 109/l and platelet count ≥ 100 x 109/l.",12,15
"3593","es","en","Rapamune debe administrarse con corticosteroides.","Rapamune should be given with corticosteroids.",6,5
"3594","es","en","Rara vez se han encontrado elevaciones de las enzimas hepáticas y de la bilirrubina sérica.","Elevation of liver enzymes and serum bilirubin have been reported rarely.",11,15
"3595","es","en","Raramente se ha comunicado la aparición de ampollas e hinchazón.","Blisters and swelling were reported rarely.",6,10
"3596","es","en","Raramente se han notificado casos de edema intestinal en pacientes tratados con inhibidores de la ECA.","Intestinal oedema has been reported rarely in patients treated with ACE inhibitors.",12,16
"3597","es","en","Raras: calambres musculares, dolor en el hombro","Renal and urinary disorders:",4,7
"3598","es","en","Raras: dermatitis exfoliativa, dermatitis, prurito, alopecia.","Rare: exfoliative dermatitis, dermatitis, pruritus, alopecia.",6,6
"3599","es","en","Raros (0,01-0,1%): insomnio, agitación y depresión después de dosis elevadas.","Psychiatric disorders Rare (0.01-0.1%): insomnia, agitation and depression after high doses.",11,10
"3600","es","en","Raros (afectan a menos de 1 de cada 1.000 pacientes):","Rare (affecting less than 1 in 1,000 patients):",8,10
"3601","es","en","Raros: fotosensibilidad, eritema multiforme y eritema nodoso.","Rare: photosensibility, erythema multiforme and erythema nodusum.",7,7
"3602","es","en","Rasilez 300 mg comprimidos recubiertos con película Aliskiren","Rasilez 300 mg film-coated tablets Aliskiren",6,8
"3603","es","en","Rasilez se excretó en la leche de ratas en periodo de lactancia.","Rasilez was secreted in the milk of lactating rats.",9,12
"3604","es","en","Ratiopharm GmbH Graf Arco Strasse 3 89079 Ulm Alemania","Ratiopharm GmbH Graf Arco Strasse 3 89079 Ulm Germany",9,9
"3605","es","en","Ratiopharm GmbH, Graf-Arco-Strasse 3, D-89079 Ulm, Germany","Ratiopharm GmbH, Graf-Arco-Strasse 3, D-89079 Ulm, Germany",7,7
"3606","es","en","RCp = remisión completa en ausencia de recuperación total de las plaquetas","CRp = Complete Remission in the Absence of Total Platelet Recovery PR = Partial Remission",15,12
"3607","es","en","Reacción adversa* Todos los grados","Adverse reaction* All grades",4,5
"3608","es","en","reacción alérgica, erupción vesiculobullosa, erupción pustular, erupción maculopapular, exantema, prurito, urticaria, hiperpigmentación de la piel","allergic reaction, vesiculobullous rash, pustular rash, maculopapular rash, rash, pruritus, urticaria, skin discolouration (increased pigmentation)",15,15
"3609","es","en","Reacciones adversas de tipo hematológico relacionadas con zidovudina","Haematological adverse reactions with zidovudine",5,8
"3610","es","en","Reacciones adversas en ensayos clínicos con pacientes con cáncer Trastornos del sistema inmunológico","Adverse reactions in clinical trials in cancer patients Immune system disorders",11,13
"3611","es","en","Reacciones adversas en los ensayos clínicos y estudios de post-comercialización en pacientes adultos Trastornos del sistema inmunológico","Undesirable Effects in Clinical Studies and Post-marketing in Adult Patients Immune system disorders",13,17
"3612","es","en","Reacciones adversas graves e imprevistas a medicamentos","Serious unexpected adverse drug reactions",5,7
"3613","es","en","Reacciones adversas muy frecuentes ≥ 10% de los pacientes","Uncommon adverse reactions ≥ 0.1 to < 1% of patients",10,9
"3614","es","en","Reacciones adversas notificadas con Abraxane con cualquier dosis en ensayos clínicos.","Adverse reactions reported with Abraxane at any dose in clinical trials.",11,11
"3615","es","en","Reacciones adversas notificadas en los ensayos clínicos de saquinavir potenciado con ritonavir","Adverse reactions from clinical trials where saquinavir was boosted with ritonavir",11,12
"3616","es","en","Reacciones adversas notificadas muy frecuentemente y frecuentemente durante","Adverse reactions very commonly and commonly reported during clinical trials of",11,8
"3617","es","en","Reacciones alérgicas (por ejemplo, urticaria)","Immune system disorders Rare: allergic reactions (e. g. urticaria)",9,5
"3618","es","en","Reacciones alérgicas, incluyendo aquellas que ponen en peligro la vida.","Allergic reactions including those that are life-threatening",7,10
"3619","es","en","Reacciones anafilactoides (incluyendo exantema, urticaria, broncoespasmo, edema laríngeo)","Anaphylactoid reactions (including rash, urticaria, bronchospasm, laryngeal oedema)",8,8
"3620","es","en","Reacciones cutáneas (G3/ 4:","Alopecia; Skin reaction (G3/ 4:",5,4
"3621","es","en","Reacciones de hipersensibilidad Se han recogido notificacionies postautorización de reacciones graves de hipersensibilidad en pacientes tratados con Januvia.","Hypersensitivity Reactions Postmarketing reports of serious hypersensitivity reactions in patients treated with Januvia have been reported.",16,18
"3622","es","en","Reactivación de Hepatitis B","Hepatitis B Reactivation t uc",5,4
"3623","es","en","Realce del contraste en la angiografía por resonancia magnética (ARM).","Contrast enhancement in magnetic resonance angiography (CE-MRA).",7,10
"3624","es","en","Realice la venopunción siguiendo las instrucciones de su médico.","Perform venipuncture as instructed by your physician.",7,9
"3625","es","en","Rebetol cápsulas se administra por vía oral diariamente, dividido en dos tomas (mañana y noche) con los alimentos.","Rebetol capsules are to be administered orally each day in two divided doses (morning and evening) with food.",18,18
"3626","es","en","Rebetol Solución Oral – Dosis Pediátrica","Rebetol Oral Solution - Paediatric Dosage",6,6
"3627","es","en","Rebif 8,8 microgramos/ 0,1 ml Rebif 22 microgramos/ 0,25 ml Solución inyectable Interferon beta-1a Vía SC","Rebif 8.8 micrograms/ 0.1 ml Rebif 22 micrograms/ 0.25 ml Solution for injection Interferon beta-1a SC use",17,16
"3628","es","en","Recibido al menos una dosis Terminado 4 ciclos","Received at least 1 dose Completed 4 cycles",8,8
"3629","es","en","Recibirá de nuevo Temodal una vez al día durante 5 días, seguido por 23 días sin Temodal.","You will again receive Temodal once daily for 5 days, followed by 23 days without Temodal.",16,17
"3630","es","en","RECOMENDACIÓN PARA UNA CORRECTA ADMINISTRACIÓN","ADVICE ON CORRECT ADMINISTRATION",4,5
"3631","es","en","Recomendación sobre la co-administración con efavirenz","Co-administration of efavirenz with medicinal products that alter gastric pH would not be expected to affect efavirenz absorption.",18,6
"3632","es","en","Recomendaciones relativas a la co-administración","Recommendations concerning co- administration",4,5
"3633","es","en","Reconstitución y administración del medicamento","Reconstitution of the product and administration",6,5
"3634","es","en","reconstituido para transferir a una bolsa o frasco intravenoso","Volume of reconstituted CANCIDAS for transfer to intravenous bag or bottle",11,9
"3635","es","en","Reconstituir el liofilizado en condiciones asépticas con 0,3 ml del disolvente estéril suministrado.","Aseptically reconstitute the freeze-dried vaccine with 0.3 ml of the sterile solvent provided.",13,13
"3636","es","en","Reconstituir y diluir antes de utilizar.","Reconstitute and dilute before use.",5,6
"3637","es","en","Recursos científicos a disposición de la EMEA","Scientific resources at the disposal of the EMEA",8,7
"3638","es","en","Reducción del dolor postoperatorio después de ovariohisterectomía o cirugía menor de tejidos blandos","Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.",11,13
"3639","es","en","Reducción o suspensión de la dosis de TMZ durante el tratamiento en monoterapia","TMZ dose reduction or discontinuation during monotherapy treatment",8,13
"3640","es","en","Reduce la carga viral del VIH manteniéndola a un bajo nivel.","It reduces HIV viral load, and keeps it at a low level.",12,11
"3641","es","en","ReFacto AF (incluidos en la sección 6).","AF (listed in section 6).",5,7
"3642","es","en","Registros y servicios de apoyo Farmacovigilancia y","Regulatory affairs and organisational support Pharmacovigilance and post -",9,7
"3643","es","en","Regranex es un gel transparente de incoloro a color amarillento que contiene un 0,01% del principio activo becaplermina.","Regranex is a clear colourless to straw-coloured gel, which contains 0.01% of the active substance becaplermin.",16,18
"3644","es","en","Relajante muscular, agente de acción periférica.","Muscle relaxant, peripherally acting agent ATC code:",7,6
"3645","es","en","Relistor se administra en forma de inyección bajo la piel una vez cada dos días.","Relistor is given as an injection under the skin, once every two days.",13,15
"3646","es","en","Remeron 30 mg comprimidos bucodispersables contiene 30 mg de mirtazapina por comprimido.","Remeron 30 mg orodispersible tablets contain 30 mg mirtazapine per orodispersible tablet.",12,12
"3647","es","en","Remicade se presenta como polvo para concentrado para solución para perfusión.","Remicade is supplied as a powder for concentrate for solution for infusion.",12,11
"3648","es","en","Remover y beber la mezcla completamente.","Stir and drink the entire mixture.",6,6
"3649","es","en","Renagel no contiene calcio.","Renagel does not contain calcium.",5,4
"3650","es","en","renal crónica en diálisis, no tuvieron impacto sobre la farmacocinética de pegfilgrastim. en","au expected to be affected by renal or hepatic impairment.",10,13
"3651","es","en","Repetir el tratamiento diariamente durante 7 días consecutivos.","Repeat the treatment daily for 7 consecutive days.",8,8
"3652","es","en","Repita el procedimiento hasta que el líquido aparezca uniformemente lechoso.","Repeat until the liquid appears uniformly white and cloudy.",9,10
"3653","es","en","Replagal se ha estudiado en dos ensayos clínicos en los que participaron un total de 40 pacientes varones.","Replagal has been examined in two clinical studies, involving a total of 40 male patients.",15,18
"3654","es","en","Reproduction is authorised provided the source is acknowledged ¿Cómo actúa Myozyme?","Reproduction is authorised provided the source is acknowledged.",8,11
"3655","es","en","Reproduction is authorised provided the source is acknowledged ¿Qué tipo de estudios se han realizado con Optisulin?","How has Optisulin been studied?",5,17
"3656","es","en","Reproduction is authorised provided the source is acknowledged. principio activo).","Reproduction is authorised provided the source is acknowledged. sexual episodes in a four-week period.",14,10
"3657","es","en","Resistencia in vivo (pacientes tratados previamente):","In vivo resistance (Therapy experienced patients):",6,6
"3658","es","en","Respétense las condiciones habituales de asepsia.","Apply the usual aseptic procedures.",5,6
"3659","es","en","Responsable de la fabricación Baxter SA Boulevard René Branquart 80 B-7860 Lessines Bélgica","Manufacturer Baxter SA Boulevard René Branquart 80 B-7860 Lessines Belgium",10,13
"3660","es","en","Responsable de la fabricación Les Laboratoires Servier Industrie 905, route de Saran 45520 Gidy Francia","Manufacturer Les Laboratoires Servier Industrie 905, route de Saran 45520 Gidy France",12,15
"3661","es","en","Responsable de la fabricación Novartis Pharma S. A. S.","Manufacturer Novartis Pharma S. A. S.",6,9
"3662","es","en","Responsable de la fabricación:","Manufacturer Responsible for Batch Release:",5,4
"3663","es","en","Responsables de la fabricación Takeda Ireland Limited, Bray Business Park, Kilruddery, County Wicklow, Irlanda.","Takeda Ireland Limited, Bray Business Park, Kilruddery, County Wicklow, Ireland.",10,14
"3664","es","en","Respuesta completa (sin emesis y sin tratamiento de rescate)","Complete Response (no emesis and no rescue therapy)",8,9
"3665","es","en","Respuesta en cuanto a fístulas (%) a Respuesta completa en cuanto a fístulas (%) b","Fistula Response (%) a Complete fistula response (%) b",9,15
"3666","es","en","RESULTADOS DE EFICACIA CLÍNICA A LOS 12 MESES:","CLINICAL EFFICACY RESULTS AT 12 MONTHS:",6,8
"3667","es","en","Resumen de los resultados de eficacia de MabThera plus FC vs.","Overview of efficacy results for MabThera plus FC vs.",9,11
"3668","es","en","Resumen del EPAR para el público general","EPAR summary for the public",5,7
"3669","es","en","Resumen del Programa de Trabajo de la EMEA para 2006 EMEA/ 145896/ 2006 Anexo 4","Summary of the EMEA work programme 2006 EMEA/ 62913/ 2006 Annex 4",12,15
"3670","es","en","RESUMEN GENERAL DE LA EVALUACIÓN CIENTÍFICA DE EFEXOR Y NOMBRES ASOCIADOS (VÉASE ANEXO I)","OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF EFEXOR AND ASSOCIATED NAMES (SEE ANNEX I)",14,14
"3671","es","en","RESUMEN GENERAL DE LA EVALUACIÓN CIENTÍFICA DE SERETIDE EVOHALER Y NOMBRES CONEXOS (VÉASE ANEXO I)","OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF SERETIDE EVOHALER AND ASSOCIATED NAMES (SEE ANNEX I)",15,15
"3672","es","en","Resuspender la insulina será más fácil cuando la insulina haya alcanzado la temperatura ambiente.","Resuspending is easier when the insulin has reached room temperature.",10,14
"3673","es","en","Retacrit 40 000 UI/ 1,0 ml Solución inyectable en jeringa precargada","Retacrit 40000 IU/ 1.0ml solution for injection in pre-filled syringe",10,11
"3674","es","en","Retirada de fármacos que NO inhiben o inducen significantemente la glucuronidación de lamotrigina (ver sección 4.5):","Withdrawal of medicinal products that do NOT significantly inhibit or induce lamotrigine glucuronidation (see section 4.5):",16,16
"3675","es","en","Retirar la aguja del vial.","Pull the needle out of the vial.",7,5
"3676","es","en","Retirar la funda protectora del otro extremo de la aguja de transferencia.","Remove the protective sheath from the other end of the transfer needle.",12,12
"3677","es","en","Retirar los tapones protectores de plástico de los viales.","Flip off the plastic protective caps from the vials.",9,9
"3678","es","en","Retire el protector de la jeringa.","Remove the cap from the syringe.",6,6
"3679","es","en","Retire el protector exterior de la aguja y guárdelo para extraer la aguja usada después de la inyección.","Take off the outer needle cap and keep it to remove the used needle after injection.",16,18
"3680","es","en","Retire el protector interno de la aguja y deséchelo.","Pull off small needle protector and throw away.",8,9
"3681","es","en","Retire la aguja después de cada inyección y conserve NovoLet sin la aguja puesta.","Remove the needle after each injection and store NovoLet without a needle attached.",13,14
"3682","es","en","Retire la jeringa del envoltorio.","Remove the syringe from the wrapping.",6,5
"3683","es","en","Reúna todo lo que vaya a necesitar:","Assemble everything you need:",4,7
"3684","es","en","Reuniones del Comité de Medicamentos de Origen Vegetal","Committee on Herbal Medicinal Products meetings",6,8
"3685","es","en","Revatio puede usarse con epoprostenol (otro medicamento utilizado para tratar la HAP).","Revatio can be used with epoprostenol (another medicine used in PAH).",11,12
"3686","es","en","Revise la sección 6.4 de este manual sobre las instrucciones de cómo conservar SoloStar.","SoloStar is designed to work accurately and safely.",8,14
"3687","es","en","Revise la solución de Humalog.","Inspect the Humalog solution.",4,5
"3688","es","en","Revisión 2, octubre de 2002","Revision 2, October 2002",4,5
"3689","es","en","REYATAZ 100 mg cápsulas duras","REYATAZ 100 mg hard capsules",5,5
"3690","es","en","RHONE D. P. C.","RHÔNE D. P. C.",4,4
"3691","es","en","Ribavirina Teva Cápsulas (ver sección 6, información adicional)","Capsules (see section 6, further information)",6,8
"3692","es","en","Ribavirina Teva es una cápsula dura, blanca, opaca impresa con tinta azul.","Ribavirin Teva is a white, opaque, hard capsule imprinted with blue ink.",12,12
"3693","es","en","Riesgo relativo (intervalo de confianza al 95%)","Placebo relative risk (95% interval)",5,7
"3694","es","en","Rifampicina 600 mg cada día","Rifampicin 600 mg QD",4,5
"3695","es","en","Rimonabant ha sido detectado en leche materna en ratas y rimonabant podría inhibir el reflejo am","Rimonabant has been detected in the milk of lactating rats and rimonabant may inhibit the suckling reflex.",17,16
"3696","es","en","Riprazo indujo un efecto hipotensor aditivo cuando se combinó con hidroclorotiazida y con ramipril.","Riprazo induced an additive blood-pressure-lowering effect when added to hydrochlorothiazide and to ramipril.",13,14
"3697","es","en","RISPERDAL pertenece a un grupo de medicamentos denominados “ antipsicóticos”.","RISPERDAL belongs to a group of medicines called ‘ anti-psychotics’.",10,10
"3698","es","en","Risperdal Quicklet 0.5 mg","Risperdal Quicklet 0.5 mg",4,4
"3699","es","en","Risperdal Risperdal 1 mg 1 mg/ ml, drank","Risperdal Risperdal 1 mg 1 mg/ ml, drank",8,8
"3700","es","en","Risperidona no tuvo efectos teratógenos en ratas y conejos.","Risperidone was not teratogenic in rat and rabbit.",8,9
"3701","es","en","Ritonavir dosificado como agente antirretroviral","Ritonavir dosed as an antiretroviral agent",6,5
"3702","es","en","Ritonavir/ Efavirenz (500 mg dos veces al día / 600 mg una vez al día)","Ritonavir/ Efavirenz (500 mg twice daily/ 600 mg once daily)",10,15
"3703","es","en","Rivastigmina solución oral y rivastigmina cápsulas pueden intercambiarse siempre que las dosis sean iguales.","Rivastigmine oral solution and rivastigmine capsules may be interchanged at equal doses.",12,14
"3704","es","en","riz Administración Dynepo se puede administrar por vía intravenosa o subcutánea.","Administration er ng Dynepo may be administered intravenously or subcutaneously.",10,11
"3705","es","en","RoActemra es un concentrado que se prepara como solución para perfusión (goteo en vena).","RoActemra is a concentrate that is made up into a solution for infusion (drip into a vein).",17,14
"3706","es","en","Roche Austria GmbH, Engelhorngasse 3, 1211","Roche Austria GmbH, Engelhorngasse 3, 1211 Wien",7,6
"3707","es","en","Roche Pharma AG Emil-Barell-Strasse 1 D-79639 Grenzach-Wyhlen Germany","Roche Pharma AG Emil-Barell-Strasse 1 D-79639 Grenzach-Wyhlen Germany",8,8
"3708","es","en","Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW Reino Unido","Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom",15,15
"3709","es","en","România Eli Lilly România S. R. L.","România Eli Lilly România S. R. L.",7,7
"3710","es","en","România Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820","România Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820",12,12
"3711","es","en","România iza Abbott Laboratories S.A.","România Abbott Laboratories S. A.",5,5
"3712","es","en","România JOHNSON AND JOHNSON d. o. o Tel: +40 21 207 1800","România JOHNSON AND JOHNSON d. o. o Tel: +40 21 207 1800",12,12
"3713","es","en","România Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Germania Tel.: +49 (0)69 1503 – 1","România Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Germania Tel.: +49 (0)69 1503 – 1",16,16
"3714","es","en","România Roche România S.R.L.","România Roche România S. R. L.",6,4
"3715","es","en","România Torox srl Tel.: +40 21 300 17 80","România Torox srl Tel.: +40 21 300 17 80",9,9
"3716","es","en","Ropinirol puede inhibir la lactancia, por lo que no debe utilizarse en madres lactantes.","Ropinirole should not be used in nursing mothers as it may inhibit lactation.",13,14
"3717","es","en","Rotar el vial hasta que el contenido quede completamente disuelto, produciendo una solución de color amarillo.","Rotate the vial until the contents have completely dissolved, giving a yellow coloured solution.",14,16
"3718","es","en","Roubaix- Est, rue de Toufflers BP 69 F-59452 Lys-Lez-Lannoy cedex","Roubaix- Est, rue de Toufflers BP 69 F-59452 Lys-Lez-Lannoy cedex",10,10
"3719","es","en","Rua Alfredo da Silva, 3-C P-1300-040 Lisboa Tel: +351-21-361 35 00","Rua Alfredo da Silva, 3-C P-1300-040 Lisboa Tel: +351-21-361 35 00",11,11
"3720","es","en","Rubor, Hipotensión, Crisis hipertensiva","Hiccups, Pharyngolaryngeal pain, Dysphonia",4,4
"3721","es","en","Rue Aaint-Lambert 141 B-1200 Bruxelles Belgium","Rue Aaint-Lambert 141 B-1200 Bruxelles Belgium",6,6
"3722","es","en","Rue de l’ Institut 89, 1330 Rixensart Bélgica","Rue de l’Institut 89 1330 Rixensart Belgium",7,8
"3723","es","en","s ©EMEA 2006 Más información sobre Naxcel:","Other information about Naxcel:",4,7
"3724","es","en","S ≤ 0,5 mg/ l y R > 0,5 mg/ l • Streptococcus pneumoniae:","S ≤ 0.5 mg/ l and R > 0.5 mg/ l • Streptococcus pneumoniae:",14,14
"3725","es","en","S tatistical principles for clinical trials","Statistical principles for clinical trials",5,6
"3726","es","en","S. C Terapia S. A Str.","S. C Terapia S. A Str.",6,6
"3727","es","en","Sacar lentamente del vial la cantidad apropiada de solución reconstituida de drotrecogina alfa (activada).","Slowly withdraw the appropriate amount of reconstituted drotrecogin alfa (activated) solution from the vial.",14,14
"3728","es","en","Sacarosa Las cápsulas duras gastrorresistentes de DULOXETINE BOEHRINGER INGELHEIM contienen sacarosa.","Sucrose DULOXETINE BOEHRINGER INGELHEIM gastro-resistant capsules contain sucrose.",8,11
"3729","es","en","Sacarosa, manitol, ácido acético glacial e hidróxido sódico.","Sucrose, mannitol, glacial acetic acid, and sodium hydroxide.",8,8
"3730","es","en","Sandoz A/ S C. F.","Sandoz A/ S C. F.",5,5
"3731","es","en","Sandoz GmbH, Biochemiestrasse 10, 6250 Kundl, Austria","Sandoz GmbH, Biochemiestrasse 10, 6250 Kundl, Austria",7,7
"3732","es","en","Sangrado en el lugar de inyección.","Bleeding at puncture site",4,6
"3733","es","en","SANOFI PASTEUR MSD SNC 8, rue Jonas Salk F-69007 Lyon Francia","SANOFI PASTEUR MSD SNC 8 rue Jonas Salk F-69007 Lyon France",11,11
"3734","es","en","Sanofi Pasteur MSD, SA, Tel: +351 21 470 45 50 România:","Sanofi Pasteur MSD, SA, Tel: +351 21 470 45 50 România:",11,11
"3735","es","en","Sanofi Pasteur MSD, Tlf: +47.67.50.50.20 Österreich:","Sanofi Pasteur MSD, Tlf: +47.67.50.50.20 Österreich:",6,6
"3736","es","en","SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - Reino Unido","SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - United Kingdom",18,18
"3737","es","en","sanofi-aventis 46 quai de la Papee","sanofi-aventis 46 quai de la Papee",6,6
"3738","es","en","Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main, Alemania.","Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main, Germany.",8,8
"3739","es","en","sanofi-aventis GmbH Tel: +43 1 80 185 – 0","sanofi-aventis GmbH Tel: +43 1 80 185 – 0",9,9
"3740","es","en","sanofi-aventis GmbH Tel: +43 1 80 185 – 0 tor","Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0 lon",11,10
"3741","es","en","sanofi-aventis, s. r. o.","sanofi-aventis, s. r. o.",4,4
"3742","es","en","Sanofi-Chimie Route d’ Avignon 30390 Aramon Francia","Sanofi Chimie Route d’ Avignon 30390 Aramon France",8,7
"3743","es","en","SBL Vaccin AB S-105 21 Estocolmo, Suecia","SBL Vaccin AB 105 21 Stockholm, Sweden",7,7
"3744","es","en","Schering Nederland B. V, Van Houten Industriepark","Schering Nederland B. V, Van Houten Industriepark",7,7
"3745","es","en","Schering-Plough Europe, 73, Rue de Stalle, B-1180 Brussels, Bélgica","Schering-Plough Europe, 73, Rue de Stalle, B-1180 Brussels, Belgium",9,9
"3746","es","en","Se acepta la justificación para no incluir la información en Braille","Justification for not including Braille accepted.",6,11
"3747","es","en","Se aceptan los beneficios de la vacuna Bovilis BVD.","The benefits of Bovilis BVD vaccine are accepted.",8,9
"3748","es","en","Se aconseja precaución en estos pacientes.","Caution is advised in these patients.",6,6
"3749","es","en","Se aconseja seguir una técnica aséptica estricta durante la manipulación de VELCADE, puesto que carece de conservantes.","Aseptic technique must be strictly observed throughout handling of VELCADE, since it contains no preservative.",15,17
"3750","es","en","Se aconseja un control más frecuente de las concentraciones plasmáticas de amoníaco cuando tengan que utilizarse estos fármacos.","More frequent monitoring of plasma ammonia levels is advised when these medications have to be used.",16,18
"3751","es","en","Se administrará únicamente bajo prescripción veterinaria","To be supplied only on veterinary prescription.",7,6
"3752","es","en","Se administrará únicamente bajo prescripción veterinaria..","Veterinary medicinal product subject to prescription.",6,6
"3753","es","en","Se administraron transfusiones de plaquetas en el 10% de los pacientes, en el 4% de los ciclos.","Platelet transfusions were given to 10% of patients in 4% of courses.",12,17
"3754","es","en","Se advertirá al paciente que deberá contactar de inmediato con su médico si apareciesen estos síntomas.","Abbott Laboratórios, Lda Rua Cidade de Còrdova, 1-A Alfragide, 2720-100 Amadora",11,16
"3755","es","en","Se aleatorizaron un total de 573 pacientes para recibir o TMZ + RT (n=287) o RT sola (n=286).","A total of 573 patients were randomised to receive either TMZ + RT (n=287) or RT alone (n=286).",18,18
"3756","es","en","Se armonizaron asimismo las secciones 4.5, 4.6, 4.7, 4.8 y 4.9.","Sections 4.5, 4.6, 4.7, 4.8 and 4.9 were also harmonised.",10,11
"3757","es","en","Se asocia al fosfato en la hiperfosfatemia","Phosphate binder in hyperphosphataemia",4,7
"3758","es","en","Se comercializa en forma de comprimidos redondos de color rojo (10 mg).","It is available as red, round tablets (10 mg).",9,12
"3759","es","en","Se consideraba que podía haber problemas de salud pública graves relacionados con su uso.","These issues were considered to be of serious public health concern.",11,14
"3760","es","en","Se consideró aceptable una recomendación en la sección 4.2 “ Posología y método de administración”.","A recommendation in section 4.2 “ Posology and method of administration” was considered acceptable.",14,15
"3761","es","en","Se consideró que estos efectos estaban relacionados con el avance de la enfermedad.","These effects were deemed to be related to the progression of the disease.",13,13
"3762","es","en","Se convierte en el organismo en ácido micofenólico, que bloquea una enzima llamada « inosin monofosfato deshidrogenada ».","By preventing the production of new DNA, Mycophenolate mofetil Teva reduces the rate at which the lymphocytes multiply.",18,18
"3763","es","en","Se convierte en homocisteína que posteriormente se suele convertir en cisteína durante la digestión.","It is converted into homocysteine which is then normally converted into cysteine during digestion.",14,14
"3764","es","en","Se debe administrar la solución reconstituida inmediatamente.","The reconstituted solution should be administered immediately.",7,7
"3765","es","en","Se debe analizar la presencia de anticuerpos frente a somatropina en los pacientes que no respondan al tratamiento.","Testing for antibodies to somatropin should be carried out in any patient who fails to respond to therapy.",18,18
"3766","es","en","Se debe comprobar la etiqueta de la pluma para asegurarse de que contiene la insulina correcta.","The label on the pen should be checked to make sure it contains the correct insulin.",16,16
"3767","es","en","Se debe considerar la rigurosa monitorización de la glucemia (ver sección 4.4).","Close monitoring of glycaemic control should be considered (see section 4.4).",11,12
"3768","es","en","Se debe considerar una disminución gradual de la dosis a la hora de abandonar el tratamiento con olanzapina.","Gradual tapering of the dose should be considered when discontinuing olanzapine.",11,18
"3769","es","en","Se debe continuar tomando precauciones adecuadas.","Appropriate precautions should continue to be taken.",7,6
"3770","es","en","Se debe controlar la presión arterialde todos los pacientes, especialmente al inicio del tratamiento con Aranesp.","Blood pressure should be monitored in all patients, particularly during initiation of Aranesp therapy.",14,16
"3771","es","en","Se debe evaluar cualquier síntoma inflamatorio y recurrir al tratamiento cuando sea necesario.","Any inflammatory symptoms should be evaluated and treatment instituted when necessary.",11,13
"3772","es","en","Se debe evitar el uso de tales combinaciones en pacientes con insuficiencia hepática.","Such combinations should be avoided in patients with hepatic impairment.",10,13
"3773","es","en","Se debe evitar el uso simultáneo de concentrados de complejos de protrombina, activados o no.","Simultaneous use of prothrombin complex concentrates, activated or not, should be avoided.",12,15
"3774","es","en","Se debe hacer un seguimiento de los pacientes para detectar signos de daño hepático.","Patients should be monitored for signs of hepatic injury.",9,14
"3775","es","en","Se debe interrumpir la lactancia mientras se reciba tratamiento con Xeloda.","Breast-feeding should be discontinued while receiving treatment with Xeloda.",9,11
"3776","es","en","Se debe posponer la administración de DUKORAL en personas con enfermedad gastrointestinal aguda o con enfermedad febril aguda.","Administration of DUKORAL should be postponed for subjects suffering from acute gastrointestinal illness or acute febrile illness.",17,18
"3777","es","en","Se debe proteger OptiSet del polvo y la suciedad.","OptiSet has to be protected from dust and dirt.",9,9
"3778","es","en","Se debe reevaluar el beneficio del tratamiento durante intervalos regulares.","The benefit of treatment should be re-assessed at regular intervals.",10,10
"3779","es","en","Se debe señalar que en la mayoría de los casos notificados la tuberculosis fue extrapulmonar, es decir, diseminada.","It should be noted that in the majority of those reports, tuberculosis was extra-pulmonary, i. e. disseminated.",17,18
"3780","es","en","Se debe suspender permanentemente el tratamiento con filgrastrim en aquellos pacientes que desarrollen alguna reacción alérgica grave.","Filgrastim should be permanently discontinued in patients who experience a serious allergic reaction.",13,17
"3781","es","en","Se debe tener cuidado al manipular y preparar la solución de MabCampath.","Caution should be exercised in the handling and preparation of the MabCampath solution.",13,12
"3782","es","en","Se debe tener en cuenta que los efectos adversos pueden intensificarse.","should be noted that the side effects may be intensified.",10,11
"3783","es","en","Se debe tener especial precaución al perfundir a pacientes con enfermedad subyacente grave de las vías respiratorias.","Special care should be taken when administering an infusion in patients with severe underlying airway disease.",16,17
"3784","es","en","Se debe tener la precaución de garantizar condiciones asépticas cuando se prepare la perfusión.","Care must be taken to ensure aseptic handling when preparing the infusion.",12,14
"3785","es","en","Se debe tener precaución cuando se trata a pacientes con miastenia grave.","Caution should be exercised when treating patients with myasthenia gravis.",10,12
"3786","es","en","Se debe tener precaución en cualquier paciente con un historial de convulsiones.","Caution must be taken in any patient with a history of seizures.",12,12
"3787","es","en","Se debe tirar del botón de inyección hasta donde sea posible para cargar la pluma.","button should be pulled out as far as it will go in order to load the pen.",17,15
"3788","es","en","Se deben recoger un mínimo de 500.000 cuentas para obtener imágenes óptimas.","A minimum of 500k counts should be collected for optimal images.",11,12
"3789","es","en","Se deben tomar precauciones en pacientes con antecedentes de cálculos renales.","Caution should be exercised in patients with a history of renal calculi.",12,11
"3790","es","en","Se deben tratar todos los perros del hogar.","All dogs in a household should be treated.",8,8
"3791","es","en","Se deben usar equipos de administración que no contienen PVC, por ejemplo, los que están recubiertos de polietileno.","Non- PVC containing administration sets, such as those which are polyethylene-lined, should be used.",14,18
"3792","es","en","Se deberá controlar estrechamente a los pacientes en cuanto a signos o síntomas de trastornos psiquiátricos.","Patients should be closely monitored for any signs or symptoms of psychiatric disorders.",13,16
"3793","es","en","Se deberá tener precaución cuando se administren conjuntamente, debido a su potencial para reducir la eficacia de CellCept.","Caution should be used during concomitant administration because of the potential to reduce efficacy of CellCept.",16,18
"3794","es","en","Se desaconseja el uso de Bondenza durante la lactancia.","Bondenza should not be used during lactation.",7,9
"3795","es","en","Se desconoce el efecto de Pradaxa sobre la capacidad para conducir y utilizar máquinas.","The effect of Pradaxa on the ability to drive and use machines is not known.",15,14
"3796","es","en","Se desconoce el mecanismo de esta interacción.","The mechanism of this interaction is unknown.",7,7
"3797","es","en","Se desconoce el riesgo para el bebé durante el embarazo.","The potential risk to your unborn child is unknown.",9,10
"3798","es","en","Se desconoce el riesgo potencial en seres humanos.","The potential risk for humans is unknown.",7,8
"3799","es","en","Se desconoce la etiología de la hipofosfatemia asociada al Nexavar.","The aetiology of hypophosphataemia associated with Nexavar is not known.",10,10
"3800","es","en","Se desconoce la frecuencia (ver sección 4.4).","The frequency of this is unknown (see section 4.4).",9,7
"3801","es","en","Se desconoce la trascendencia de estos hallazgos tumorales en roedores para el riesgo en seres humanos.","The relevance of these tumour findings in rodents in terms of human risk is unknown.",15,16
"3802","es","en","Se desconoce si aliskiren se excreta en la leche materna.","It is not known whether aliskiren is excreted in human milk.",11,10
"3803","es","en","Se desconoce si el temsirolimus se elimina en la leche humana.","It is unknown whether temsirolimus is excreted in human breast milk.",11,11
"3804","es","en","Se desconoce si emtricitabina se excreta en la leche materna.","It is not known if emtricitabine is excreted in human milk.",11,10
"3805","es","en","Se desconoce si estos tumores fueron causados por ISENTRESS.","It is not known if these cancers were caused by ISENTRESS.",11,9
"3806","es","en","Se desconoce si la histamina atraviesa la placenta.","It is not known whether histamine crosses the placenta.",9,8
"3807","es","en","Se desconoce si la sitagliptina se excreta en la leche materna humana.","It is not known whether sitagliptin is excreted in human milk.",11,12
"3808","es","en","Se desconoce si omalizumab se excreta en la leche materna.","It is not known whether omalizumab is excreted in human breast milk.",12,10
"3809","es","en","Se describen frecuentemente elevaciones asintomáticas de las enzimas hepáticas que no constituyen necesariamente una contraindicación para usar VIRAMUNE.","Asymptomatic elevations of liver enzymes are frequently described and are not necessarily a",13,18
"3810","es","en","Se designarán ponentes y ponentes adjuntos en cada reunión","Changes to marketing legislation authorisations are known as variations, which can be either",13,9
"3811","es","en","Se determina la dosis de carga requerida usando la fórmula siguiente:","The required loading dose is determined using the following formula:",10,11
"3812","es","en","Se dispensa en un vial que contiene una suspensión inyectable.","It is a vial containing a suspension for injection.",9,10
"3813","es","en","Se dispone de datos hasta el final del mes 24.","Data are available up to the end of month 24.",10,10
"3814","es","en","Se dispone de información detallada de este medicamento en la página web de {nombre de Estado Miembro/Agencia}","Detailed information on this medicine is available on the web site of {name of MA/Agency}",15,17
"3815","es","en","Se dispone de un manual del usuario para enseñar a los pacientes el uso correcto de la pluma.","A User Manual is also available to instruct patients on the correct use of the pen.",16,18
"3816","es","en","Se emplea en pacientes con madurez ósea (que ya han dejado de crecer).","It is used in skeletally mature patients (who have stopped growing).",11,13
"3817","es","en","Se encuentran disponibles los siguientes envases de Remeron 15 mg comprimidos recubiertos con película en blisters:","For Remeron 15 mg film-coated tablets in blisters the following pack sizes are available:",14,16
"3818","es","en","Se esperaba que corrigiese la frecuencia cardiaca alterada actuando sobre la actividad eléctrica del músculo cardiaco.","It is expected to correct altered heartbeat by affecting the electrical activity of the heart muscle.",16,16
"3819","es","en","Se estima que la exposición sistémica a pegaptanib es muy baja después de la administración ocular.","The systemic exposure to pegaptanib is expected to be very low after ocular administration.",14,16
"3820","es","en","Se evitará el uso de otros productos tópicos en las lesiones tratadas del SK.","The use of other topical products on treated KS lesions should be avoided.",13,14
"3821","es","en","se excreta en la leche humana.","Although clinical data have shown that systemic exposure from application of tacrolimus ointment is ic",15,6
"3822","es","en","Se fabrica por un proceso de biotecnología.","It is made by a biotechnology process.",7,7
"3823","es","en","Se ha comunicado incompatibilidad física con verapamilo, ondansetrón y ranitidina.","Physical incompatibility has been reported with verapamil, ondansetron and ranitidine.",10,10
"3824","es","en","Se ha demostrado la estabilidad de uso química y física durante 60 días a 37 ºC.","Chemical and physical in use stability has been demonstrated for 60 days at 37°C.",14,16
"3825","es","en","Se ha demostrado que dosis de hasta 3 mg/ kg de peso corporal son seguras.","Doses up to 3 mg/ kg body weight have shown to be safe.",13,15
"3826","es","en","Se ha demostrado que todos los metabolitos principales son farmacológicamente inactivos.","All major metabolites have been shown to be pharmacologically inactive.",10,11
"3827","es","en","Se ha demostrado una estabilidad física y química de 48 horas entre 2°C - 8°C.","Chemical and physical stability has been demonstrated for 48 hours at 2 – 8 C.",15,15
"3828","es","en","Se ha establecido la compatibilidad con líneas de perfusión de PVC con filtros de flujo.","Compatibility with PVC infusion lines with in-line filters has been established.",11,15
"3829","es","en","Se ha informado de sequedad bucal en el 10% de pacientes tratados con venlafaxina.","Dry mouth is reported in 10% of patients treated with venlafaxine.",11,14
"3830","es","en","Se ha notificado muy raramente pancitopenia prolongada, que podría ocasionar anemia aplásica.","Prolonged pancytopenia, which may result in aplastic anaemia has been reported very rarely.",13,12
"3831","es","en","Se ha notificado necrosis en el lugar de inyección en pacientes que utilizan Betaferon (ver sección 4.8).","Injection site necrosis has been reported in patients using Betaferon (see section 4.8).",13,17
"3832","es","en","Se ha notificado torsade de pointes asociada a la sobredosis combinada de RISPERDAL y paroxetina.","Torsade de Pointes has been reported in association with combined overdose of RISPERDAL and paroxetine.",15,15
"3833","es","en","Se ha observado hipotensión clínicamente significativa después de la comercialización, con el uso concomitante de risperidona y antihipertensivos.","Clinically significant hypotension has been observed postmarketing with concomitant use of risperidone and antihypertensive treatment.",15,18
"3834","es","en","Se ha observado que estos anticuerpos presentan reacciones ic","Since the liver is thought to be the principal route of no",12,9
"3835","es","en","Se ha sugerido una relación causal, aunque no se ha elucidado el mecanismo.","A causal relationship had been evoked, although the mechanism of action had not been elucidated.",15,13
"3836","es","en","Se han comunicado casos de cálculos renales acompañados de dolores e inflamación renal.","Kidney stones have been reported, as well as associated pain and kidney swelling.",13,13
"3837","es","en","Se han comunicado casos de pancreatitis","Cases of pancreatitis have been reported",6,6
"3838","es","en","Se han comunicado las siguientes interacciones de acuerdo con la experiencia acumulada con glimepirida y otras sulfonilureas.","Based on the experience with glimepiride and with other sulphonylureas the following interactions have to be mentioned.",17,17
"3839","es","en","Se han comunicado trastornos dentales y de las encías, que pueden llevar a la caída de dientes, en","In addition, dry mouth could have a damaging effect on teeth and",12,18
"3840","es","en","Se han descrito casos aislados de reacciones alérgicas no graves a GONAL-f.","There have been isolated reports of non-serious allergic reactions to GONAL-f.",11,12
"3841","es","en","Se han descrito erupciones cutáneas inespecíficas asociadas a la epoyetina alfa.","Non-specific skin rashes have been described in association with epoetin alfa.",11,11
"3842","es","en","Se han identificado dos isoformas, COX-1 y COX-2.","Two isoforms, COX-1 and COX-2, have been identified.",8,8
"3843","es","en","Se han llevado a cabo dos ensayos en pacientes coinfectados con VIH y VHC.","HCV/ HIV Co-infected patients Two trials have been conducted in patients co-infected with HIV and HCV.",16,14
"3844","es","en","Se han manifestado trastornos gastrointestinales como dolor abdominal, diarrea, náuseas, vómitos y estreñimiento en ensayos clínicos.","Nausea Gastro-intestinal complaints such as abdominal pain, diarrhoea, nausea, vomiting and constipation have been reported in clinical trials.",18,16
"3845","es","en","Se han notificado casos aislados de rabdomiólisis.","Isolated cases of rhabdomyolysis have been reported.",7,7
"3846","es","en","Se han notificado casos de abortos espontáneos en pacientes tratados con Cellcept.","Cases of spontaneous abortions have been reported in patients exposed to CellCept.",12,12
"3847","es","en","Se han notificado casos de meningitis aséptica tras la vacunación frente a sarampión, parotiditis y rubéola.","Cases of aseptic meningitis have been reported following measles, mumps, and rubella vaccination.",13,16
"3848","es","en","Se han notificado casos de reacciones de hipersensibilidad, incluyendo anafilácticas, después de la administración intravenosa de proteínas.","Anaphylactic and other hypersensitivity reactions have been reported following the intravenous administration of proteins to patients.",16,17
"3849","es","en","Se han notificado casos de sobredosis accidental procedentes de los ensayos clínicos y de los datos post-comercialización.","Cases of accidental overdose have been reported from the clinical studies and post-marketing data.",14,17
"3850","es","en","Se han notificado casos muy raros (< 1/ 10.000) de alteraciones hepáticas, principalmente aumento de las enzimas hepáticas.","Very rare cases of hepatic reactions (< 1/ 10,000), mainly increase of liver enzymes, have been reported.",17,18
"3851","es","en","Se han notificado casos raros de angioedema con vildagliptina con una incidencia similar a los controles.","Rare cases of angioedema have been reported on vildagliptin at a similar rate to controls.",15,16
"3852","es","en","Se han notificado convulsiones febriles en niños que recibieron ProQuad.","Febrile seizures have been reported in children receiving ProQuad.",9,10
"3853","es","en","Se han notificado los siguientes efectos adversos durante la vigilancia post-comercialización.","The following adverse events have been reported during post-marketing surveillance.",10,11
"3854","es","en","Se han notificado muy raramente (< 1/ 10.000) acontecimientos de vasculitis cutánea en pacientes tratados con Neulasta.","Very rare (< 1/ 10,000) events of cutaneous vasculitis have been reported in patients treated with Neulasta.",17,17
"3855","es","en","Se han notificado otras reacciones adversas (< 0,1%) asociadas con buprenorfina en monoterapia.","Other undesirable effects (< 0.1%) have been reported in association with buprenorphine alone.",13,13
"3856","es","en","Se han notificado otros efectos adversos menos frecuentes y algunos fueron graves.","Other less common side effects have been reported and some of these were serious.",14,12
"3857","es","en","Se han notificados casos de embolismo pulmonar en algunos casos con desenlace fatal.","Cases of pulmonary embolism, in some cases with fatal outcome, have been reported.",13,13
"3858","es","en","Se han observado reacciones adversas en el 5-14% de pacientes que reciben ciprofloxacino.","Adverse reactions have been reported in 5-14% of patients receiving ciprofloxacin.",11,13
"3859","es","en","Se han propuesto varios lugares de escisión (hidrólisis) en la","A number of cleavage (hydrolysis) sites on the human insulin",10,10
"3860","es","en","Se han realizado ensayos clínicos de terapia combinada con insulina Hagedorn Protamina Neutra (NPH) o tiazolidindionas.","Trials of combination therapy with Neutral Protamine Hagedorn (NPH) insulin or thiazolidinediones have been performed.",15,16
"3861","es","en","Se han realizado estudios con Biograstim para demostrar que es similar al medicamento de referencia, Neupogen.","Biograstim was studied to show that it is comparable to the reference medicine, Neupogen.",14,16
"3862","es","en","Se han realizado tres ensayos clínicos controlados con placebo sobre la ziconotida IT.","There were three placebo-controlled clinical trials of IT ziconotide.",9,13
"3863","es","en","Se han reconocido varios factores de riesgo que al parecer predisponen a la cardiotoxicidad con terfenadina.","Several risk factors have been recognised which appear to predispose to cardiotoxicity with terfenadine.",14,16
"3864","es","en","Se identificaron todos los casos adquiridos en la comunidad de insuficiencia renal, miotoxicidad, insuficiencia hepática fulminante y muerte.","All cases of community acquired renal failure, myotoxicity, fulminant hepatic failure or death were identified.",15,18
"3865","es","en","Se incluye en la caja una jeringa oral con un adaptador de presión para el cuello del frasco.","An oral syringe with a push-in bottle-neck adapter is included in the carton.",13,18
"3866","es","en","Se incluyeron un total de 118 pacientes:","A total of 118 patients were enrolled:",7,7
"3867","es","en","Se incorporó a la EMEA el 1 de mayo de 2002.","He joined the EMEA on 1 May 2002.",8,11
"3868","es","en","Se incorporó a la EMEA en agosto de 1996 como jefe del Sector de biotecnología y productos biológicos.","research fellow in the State University of Rome on projects in",11,18
"3869","es","en","Se incorporó a la EMEA en octubre de 1994.","Mr Wathion first worked as pharmacist in a retail pharmacy.",10,9
"3870","es","en","Se inyecta de una vez en una vena (vía intravenosa).","It is given into a vein (intravenously) as a single injection.",11,10
"3871","es","en","Se llevaron a cabo estudios de carcinogenicidad a dos años con pregabalina en ratas y ratones.","Two-year carcinogenicity studies with pregabalin were conducted in rats and mice.",11,16
"3872","es","en","Se mantendrán una supervisión y un control estrictos hasta que el paciente se recupere.","Close medical supervision and monitoring should continue until the patient recovers.",11,14
"3873","es","en","Se notificaron otras reacciones adversas con una frecuencia menor o igual.","Other adverse reactions were reported with lower or equal frequency.",10,11
"3874","es","en","Se observó hipotensión postural en casi todos los sujetos que recibieron dosis intravenosas altas de ziconotida.","Postural hypotension was observed in almost all subjects who received high intravenous doses of ziconotide.",15,16
"3875","es","en","Se observó un aumento del riesgo relativo de episodios tromboembólicos (RR 1,67; IC 95%:","An increased relative risk of thromboembolic events (RR 1.67, 95% CI:",11,14
"3876","es","en","Se observó un caso en el grupo de la vacuna frente a 10 casos en el grupo control.","One case was observed in the vaccine group versus 10 cases in the control group.",15,18
"3877","es","en","Se observó una considerable variabilidad interindividual e intraindividual en la farmacocinética de raltegravir.","Considerable inter- and intra-individual variability was observed in the pharmacokinetics of raltegravir.",12,13
"3878","es","en","Se observó una tendencia favorable respecto a la tasa de mortalidad (82 muertes en el grupo placebo vs.","Concomitant administration can lead to increased plasma concentrations of atorvastatin.",10,18
"3879","es","en","Se obtuvieron muestras de plasma 56 días (pacientes) o 36 días (voluntarios) después de la inyección.","Plasma samples were obtained out to 56 days (patients) or 36 days (volunteers) post-injection.",14,16
"3880","es","en","Se oirá “ clic” que cesará cuando el botón de inyección esté completamente presionado.","A clicking sound can be heard, which will stop when the injection button has been pressed. in completely.",18,14
"3881","es","en","Se permitió la disminución de corticosteroides después de la semana 8.","Corticosteroid taper was permitted after week 8.",7,11
"3882","es","en","Se permitió que los pacientes hubieran recibido tratamiento hormonal previo para la enfermedad metastásica.","Prior hormonal therapy for the treatment of metastatic disease was allowed.",11,14
"3883","es","en","Se presenta en cartuchos diseñados para uso con un dispositivo de inyección de la gama OptiPen.","It comes in cartridges designed for use in an injection device of the OptiPen series.",15,16
"3884","es","en","Se presenta en comprimidos bucodispersables (que se disuelven en la boca) de 5, 10, 15 y 20 mg.","It is available as 5, 10, 15, and 20 mg orodispersible tablets (that dissolve in the mouth).",17,18
"3885","es","en","Se presenta en comprimidos de liberación prolongada de color blanco (2 mg).","It is available as white prolonged- release tablets (2 mg).",10,12
"3886","es","en","Se presenta en envases de 3, 4, 5, 6, 9 10 plumas de 3 ml.","Packs of 3, 4, 5, 6, 9 and 10 pens of 3 ml are available.",15,15
"3887","es","en","Se presenta en forma de cápsulas (de color amarillo y blanco:","It is available as capsules (yellow and white:",8,11
"3888","es","en","Se presentan en este documento los datos de los cuatro principales estudios. o","than 13,500 patients treated with tacrolimus",6,13
"3889","es","en","Se presentan en tiras blíster que contienen 14, 28, 30, 50, 90 o 98 comprimidos.","The tablets are supplied in blister packs containing either 14, 28, 30, 50, 90 or 98 tablets.",17,15
"3890","es","en","Se produce muerte celular por agotamiento de energía y por apoptosis.","Cell death occurs from energy depletion and apoptosis.",8,11
"3891","es","en","Se proporcionan instrucciones por separado para pacientes adultos y pediátricos.","Guidance is given separately for adult and paediatric patients.",9,10
"3892","es","en","Se puede administrar la terapia antiemética antes o después de la administración de TMZ.","Anti-emetic therapy may be administered prior to or following administration of TMZ.",12,14
"3893","es","en","Se puede haber usado hidróxido de sodio o ácido clorhídrico para ajustar el pH.","Sodium hydroxide or hydrochloric acid may have been used to adjust the acidity.",13,14
"3894","es","en","Se puede hacer una excepción si el médico ha recetado expresamente Fentanyl-ratiopharm.","An exception can be made if the doctor has expressly prescribed Fentanyl-ratiopharm.",12,12
"3895","es","en","Se puede intentar la administración de carbón activado mezclado con agua.","Administration of activated charcoal as a slurry with water may be attempted.",12,11
"3896","es","en","Se puede utilizar una emulsión de dimeticona o silicona para tratar los tapones de los viales.","Dimeticone or silicone emulsion may be used to treat the vial stoppers.",12,16
"3897","es","en","Se pueden presentar hemorragias y manchado inesperados durante los primeros meses de tratamiento.","Breakthrough bleeding and spotting may occur during the first months of treatment.",12,13
"3898","es","en","Se pueden suministrar viales estériles adicionales si así se solicita.","Additional sterile vials will be supplied on request.",8,10
"3899","es","en","Se pulveriza sobre la superficie afectada, evitando los ojos.","It is sprayed on the affected area, avoiding the eyes.",10,9
"3900","es","en","Se realizarán análisis de sangre con regularidad.","Control blood tests will be performed regularly.",7,7
"3901","es","en","Se realizó un análisis combinado pre-especificado de los ensayos de Fase 3 (ARIES-C).","A pre-specified combined analysis of the Phase 3 studies (ARIES-C) was conducted.",12,13
"3902","es","en","Se recibió un informe adicional de leucoencefalopatía multifocal progresiva confirmada por biopsia en la población adulta.","There was a single additional report of biopsy confirmed progressive multifocal leukoencephalopathy in the adult population.",16,16
"3903","es","en","Se recomienda a las mujeres que pudiesen quedarse embarazadas que utilicen un método anticonceptivo eficaz durante el tratamiento.","Women who might become pregnant are advised to use effective contraception during treatment.",13,18
"3904","es","en","Se recomienda anotar en el envase la fecha en la que se ha sacado de la nevera.","It is advised to write the date of removal from the refrigerator on the package.",15,17
"3905","es","en","Se recomienda anotar en la etiqueta la fecha del primer uso del vial.","It is recommended that the date of the first use be noted on the label.",15,13
"3906","es","en","Se recomienda el consejo de un hepatólogo.","The advice of a hepatologist is recommended.",7,7
"3907","es","en","Se recomienda monitorizar la concentración terapéutica.","Therapeutic concentration monitoring recommended.",4,6
"3908","es","en","Se recomienda monitorizar la toxicidad potencial de saquinavir.","Monitoring for potential saquinavir toxicities is recommended.",7,8
"3909","es","en","Se recomienda no administrar nunca más de tres inyecciones durante cualquier período de 24 horas.","No more than three injections should be given in any 24-hour period.",12,15
"3910","es","en","Se recomienda precaución al usar sapropterina en pacientes con predisposición a convulsiones.","Caution is advised when sapropterin is used in patients with predisposition to convulsions.",13,12
"3911","es","en","Se recomienda precaución y monitorización clínica.","Caution is warranted and clinical monitoring is recommended.",8,6
"3912","es","en","Se recomienda que se utilice la solución incolora, 16 transparente a opalescente inmediatamente después de su reconstitución.","It is recommended that after reconstitution the colourless, clear to opalescent solution should be used immediately.",16,17
"3913","es","en","Se recomienda reducir la dosis de prociclidina si se observan efectos anticolinérgicos.","Concomitant use of paroxetine and NSAIDs/ acetylsalicylic acid can lead to an increased haemorrhagic risk.",15,12
"3914","es","en","Se recomienda tener precaución ya que en algunos pacientes este ajuste de dosis puede no ser suficiente.","Caution is warranted since this dosage adjustment might be insufficient in some patients.",13,17
"3915","es","en","Se recomienda un ajuste cuidadoso de ladosis en pacientes debilitados o desnutridos.","Careful dose titration is recommended in debilitated or malnourished patients.",10,12
"3916","es","en","Se recomienda una cuarta dosis en el segundo año de vida.","A fourth dose is recommended in the second year of life.",11,11
"3917","es","en","Se recomienda usar Cerezyme con precaución durante el embarazo y la lactancia.","Cautious use of Cerezyme during pregnancy and breastfeeding is recommended.",10,12
"3918","es","en","Se recomienda utilizar el producto inmediatamente después de su reconstitución.","After reconst. immediate use recommended.",5,10
"3919","es","en","Se recomienda utilizar un sistema de vacunación multidosis cerrado.","It is recommended to use a closed multidose vaccination system.",10,9
"3920","es","en","Se recomienda vigilar la hemoglobina cada dos semanas hasta que se estabilice y luego, de manera periódica.","It is recommended that haemoglobin is monitored every two weeks until stabilized and periodically thereafter.",15,17
"3921","es","en","Se recomienda, por tanto, controlar los niveles de lípidos.","Monitoring of lipid levels is, therefore, recommended.",7,9
"3922","es","en","Se requiere un ajuste de dosis cuando voriconazol y efavirenz se administren concomitantemente (ver secciones 4.2 y 4.4).","Dose adjustments are required when voriconazole is co-administered with efavirenz (see sections 4.2 and 4.4).",15,18
"3923","es","en","Se suministra en viales o como cartuchos.","It is supplied in vials or as cartridges.",8,7
"3924","es","en","Se trata de una enfermedad heterogénea que puede ser relativamente inocua o agresivamente maligna.","It is a heterogeneous disease which can be relatively innocent or aggressively malignant.",13,14
"3925","es","en","Seamus HEALY Assistant Secretary Department of Agriculture, Food and Forestry Agriculture House Kildare Street Dublin 2 Ireland Tel.","human_experts@emea. eudra. org vet_experts@emea. eudra. org inspectors_experts@emea. eudra. org",9,18
"3926","es","en","Sebivo es un medicamento que contiene el principio activo telbivudina.","Sebivo is a medicine that contains the active substance telbivudine.",10,10
"3927","es","en","Sedge Close Headway, Great Oakley Corby, Northhants NN18 8HS Reino Unido","Sedge Close Headway, Great Oakley Corby, Northhants NN18 8HS United Kingdom",11,11
"3928","es","en","segmento de intestino se introduce dentro de otro segmento).","bowel becomes enfolded within another segment).",6,9
"3929","es","en","Seguimiento suplementario específico para niños y adolescentes Seguimiento del tiroides:","Supplemental monitoring specific for children and adolescents Thyroid Monitoring:",9,10
"3930","es","en","Seguir desarrollando la implantación del sistema electrónico de gestión de documentos.","Continue the implementation of the electronic document management system:",9,11
"3931","es","en","Seguir las instrucciones que vienen en el juego de transferencia.","Follow the instructions that come with the transfer set.",9,10
"3932","es","en","Según el conocimiento actual, no se recomienda el tratamiento de las verrugas uretrales, intravaginales, cervicales, rectales o intraanales.","Based on current knowledge, treating urethral, intra-vaginal, cervical, rectal or intra-anal warts is not recommended.",15,18
"3933","es","en","Según esto, estos pacientes no se deben considerar para ser re-tratados","Accordingly, such patients should not be considered for re-treatment.",9,11
"3934","es","en","Según los estudios in vitro, no se espera un desplazamiento significativo a las concentraciones terapéuticas de estos medicamentos.","According to in vitro studies, significant displacement is not anticipated at therapeutic concentrations of the medicinal products.",17,18
"3935","es","en","Selamectina puede afectar adversamente a peces o ciertos organismos de vida acuática que se alimentan de ésta.","Selamectin may adversely affect fish or certain water-borne organisms on which they feed.",13,17
"3936","es","en","Seleccione su dosis (en el siguiente ejemplo, la dosis seleccionada es de 30 unidades).","Select your required dose (in the example below, the selected dose is 30 units).",14,14
"3937","es","en","SEMANA 2 (día 8-14) 2 comprimidos = 25 mg una vez al día","WEEK 2 (Day 8-14) 2 tablets = 25 mg once daily",11,13
"3938","es","en","semana 4 y siguientes","week 4 and beyond",4,4
"3939","es","en","Semivida terminal: de 2,8 a 3,9 horas.","The terminal half-life ranged from 2.8 to 3.9 hours.",9,7
"3940","es","en","sensación de cuerpo extraño en el ojo","foreign body in eye",4,7
"3941","es","en","Separe el pelo del cuello del gato en la base del cráneo hasta que la piel sea visible.","Part the fur on the cat's neck at the base of the skull until the skin is visible.",18,18
"3942","es","en","Seretide 25/ 50 microgramos no se considera adecuado en adultos y niños con asma grave.","Seretide 25/ 50 microgram strength is not appropriate in adults and children with severe asthma.",15,15
"3943","es","en","Serono Europe Limited 56 Marsh Wall London E14 9TP Reino Unido","Serono Europe Limited, 56 Marsh Wall, London E14 9TP, United Kingdom",11,11
"3944","es","en","Servicios de conferencias Reuniones de la EMEA","Opinions and lists of questions adopted for old substances 1995-2000",10,7
"3945","es","en","Servicios prestados Servicios prestados: publicación","publication of improved tables,",4,5
"3946","es","en","Servier (Ireland) Industries Ltd Gorey road Arklow – Co.","Servier (Ireland) Industries Ltd Gorey road Arklow – Co.",9,9
"3947","es","en","Shock anafiláctico, impotencia y malestar general","Angioedema, bronchial Anaphylactic shock, constriction, fever. impotence and general malaise",10,6
"3948","es","en","Shock, hipotensión, sudoración nocturna, reacción de hipersensibilidad*","Shock, Hypotension, Night sweats, Hypersensitivity reaction*",6,7
"3949","es","en","Si al cabo de 12 semanas el estado del paciente empeora, el médico deberá revisar el tratamiento.","If after 12 weeks the patient’ s condition is getting worse, then the doctor should review the treatment.",18,17
"3950","es","en","Si asa más Cerezyme del que debiera No se han notificado casos de sobredosis de Cerezyme.","If you use more Cerezyme than you should There are no cases of overdose of Cerezyme reported.",17,16
"3951","es","en","Si considera que alguno de los efectos adversos que sufre es grave o si aprecia cualquier efecto","if their symptoms are the same as yours.",8,17
"3952","es","en","Si desea más información, consulte el Resumen de las Características del Producto, que también forma parte del EPAR.","For more information, see the Summary of Product Characteristics (also part of the EPAR).",14,18
"3953","es","en","Si el dolor persiste más de 12 horas después del examen médico, diríjase de nuevo a un facultativo.","If pain persists for more than 12 hours after medical examination, the doctor should be contacted again.",17,18
"3954","es","en","Si el liofilizado se le disgrega prematuramente en las manos, láveselas a fondo.","If the lyophilisate disintegrates prematurely in your hands, wash your hands thoroughly.",12,13
"3955","es","en","Si el nódulo pulmonar solitario queda marcado por NeoSpect, es probable que sea maligno.","If the solitary pulmonary nodule is labelled with NeoSpect, it is likely to be malignant.",15,14
"3956","es","en","Si el tratamiento fracasa, debe emplearse la dosis de 30 mg una vez al día.","If the treatment fails the dose 30 mg once daily should be used.",13,15
"3957","es","en","Si ello no es posible, deberán tomar el comprimido con menor frecuencia.","If this is not possible, they should take the tablets less often.",12,12
"3958","es","en","Si es así, debe devolverlo a la farmacia.","Take it back to your supplier.",6,8
"3959","es","en","Si es así, usted no debe utilizar Arixtra.","If they do, you must not use Arixtra.",8,8
"3960","es","en","Si es casi la hora de su siguiente dosis, no se tome la dosis olvidada.","If it is almost time for your next dose anyway, forget about the missed dose.",15,15
"3961","es","en","Si es clínicamente apropiado, puede considerarse el cambio directo de la monoterapia a las asociaciones fijas.","When clinically appropriate, direct change from monotherapy to the fixed combination may be considered",14,16
"3962","es","en","Si es un paciente con una enfermedad renal, Epoyetina alfa HEXAL debe administrarse mediante inyección en una vena.","If you are a kidney patient Epoetin alfa HEXAL has to be given by injection into a vein.",18,18
"3963","es","en","Si está disponible se incluyen entre paréntesis los intervalos de confianza (IC) del 90%.","If available, 90% confidence intervals (CI) are shown in parentheses.",10,14
"3964","es","en","Si está embarazada o puede quedarse embarazada, consulte con su médico antes de utilizar NEVANAC.","If you are pregnant, or might get pregnant, talk to your doctor before you use NEVANAC.",16,15
"3965","es","en","Si está embarazada, no comience a utilizar Avonex.","If you are pregnant do not start using Avonex.",9,8
"3966","es","en","si está tomando alguno de los siguientes medicamentos:","if you are currently taking any of the following medicines:",10,8
"3967","es","en","Si está tomando cualquiera de estos fármacos, consulte a su médico para cambiar a otro medicamento.","If you are taking any of these, ask your doctor about switching to another medicine.",15,16
"3968","es","en","Si está turbia no debe utilizarse.","It must not be used if cloudy.",7,6
"3969","es","en","Si esto le ocurriera, no debe conducir ni manejar máquinas hasta que desaparezcan estos síntomas.","If you are affected you should not drive or use machines until this resolves.",14,15
"3970","es","en","Si esto ocurre, debe consultar lo antes posible a su médico.","Should these occur, you should promptly consult your doctor.",9,11
"3971","es","en","Si esto ocurre, el paciente debe consultar al médico.","If this occurs, the patient should consult a doctor.",9,9
"3972","es","en","Si esto ocurre, no conduzca ni maneje herramientas o máquinas.","If this happens, do not drive or use any tools or machines.",12,10
"3973","es","en","Si estos efectos le preocupan, consulte a su médico o farmacéutico.","If you are worried, talk to your doctor or pharmacist.",10,11
"3974","es","en","Si estos síntomas continúan o se agravan, consulte a su médico.","If these events continue or become severe, tell your doctor. lP",11,11
"3975","es","en","Si experimenta mareos mientras toma CELSENTRI, no conduzca ni maneje máquinas o herramienta alguna.","If you experience dizziness while taking CELSENTRI do not drive and do not operate any tools or machines.",18,14
"3976","es","en","Si fuera necesaria la asociación, se requerirá una cuidadosa monitorización cardíaca (ver sección 4.4).","If the combination appears necessary, close cardiac monitoring is needed (see section 4.4).",13,14
"3977","es","en","Si ha olvidado tomar varias dosis, informe a su médico y siga sus consejos.","If you have missed several doses, please inform your doctor and follow the advice given to you.",17,14
"3978","es","en","Si ha pasado un día entero, consulte con su médico.","If an entire day has gone by, check with your doctor.",11,10
"3979","es","en","Si ha tomado demasiadas cápsulas o si alguien accidentalmente traga alguna no existe peligro inmediato.","If you have taken too many capsules or if someone accidentally swallows some, there is no immediate danger.",18,15
"3980","es","en","Si ha usado más KOGENATE Bayer 1000 UI del que debiera, por favor, informe a su médico.","If you have used more KOGENATE Bayer 1000 IU than you should, please inform your doctor.",16,17
"3981","es","en","Si hay algo que usted no entienda, pregunte a su medico o enfermera para que se lo explique.","If there is anything you do not understand, ask the doctor or nurse to explain.",15,18
"3982","es","en","Si hay infección de las vías urinarias, deberá instaurarse un tratamiento antibiótico adecuado.","If urinary tract infection is present, an appropriate antibacterial therapy should be started.",13,13
"3983","es","en","Si interrumpe el tratamiento con CHAMPIX","If you stop taking CHAMPIX",5,6
"3984","es","en","Si interrumpe el tratamiento con Remeron → Deje de tomar Remeron sólo si lo consulta con su médico.","If you stop taking Remeron → Only stop taking Remeron in consultation with your doctor.",15,18
"3985","es","en","Si interrumpe el tratamiento con Zerene","If you stop taking Zerene",5,6
"3986","es","en","Si la crema se aplica accidentalmente en estas áreas, quítela y/o enjuáguese con agua.","If accidentally applied to these areas, the cream should be thoroughly wiped off and/or rinsed with water.",17,14
"3987","es","en","Si la encima no está presente, el amoniaco no puede descomponerse y se acumula en la sangre.","If the enzyme is not present, ammonia cannot be broken down and it builds up in the blood.",18,17
"3988","es","en","Si la insulina está fría, la inyección es más dolorosa.","Cold insulin is more painful to inject.",7,10
"3989","es","en","Si la mujer decide quedarse embarazada, el uso de este medicamento debe ser cuidadosamente revaluado.","If women decide to become pregnant, the use of this product should be carefully re-evaluated.",15,15
"3990","es","en","Si la preparación entra en contacto con los ojos, puede causar una grave irritación.","If the preparation comes into contact with the eyes, this may cause serious irritation.",14,14
"3991","es","en","Si lo considera necesario, su médico le aconsejará que tome suplementos vitamínicos.","If necessary, your doctor may advise you to take vitamin supplements.",11,12
"3992","es","en","Si lo hace, pueden reaparecer los síntomas de la gripe.","If Tamiflu is stopped earlier than your doctor told you, the symptoms of influenza may reoccur.",16,10
"3993","es","en","Si los síntomas no desaparecen, debe consultar a su médico.","These usually disappear after a few weeks of taking your insulin.",11,10
"3994","es","en","Si no aparece sangre, inyecte la solución lentamente empujando el émbolo con suavidad.","If no blood appears, inject the solution slowly by pushing the plunger gently forward.",14,13
"3995","es","en","Si no es así, no lo utilice.","If it is not, do not use.",7,7
"3996","es","en","Si no es así, su hijo podría no estar totalmente protegido frente a estas enfermedades.","If not, your child may not be fully protected against the diseases.",12,15
"3997","es","en","Si no está seguro de la cantidad de Emtriva debe consultar con su médico o farmacéutico.","If you are unsure how much Emtriva you should take ask your doctor or pharmacist.",15,16
"3998","es","en","Si no está seguro de poder identificarlos, hable con su médico o farmacéutico.","Ask your doctor or pharmacist for more information if you are not sure how to recognise this.",17,13
"3999","es","en","Si no está seguro, consulte a su médico. • infecciones:","If you are not sure, please contact your doctor.  Infections:",11,10
"4000","es","en","Si no puede controlarse la tensión arterial, debe interrumpirse el tratamiento con Silapo.","If blood pressure cannot be well controlled, Silapo treatment should be discontinued.",12,13
"4001","es","en","Si no se usa inmediatamente, la vacuna se debe conservar en nevera (entre 2ºC y 8ºC).","If not used immediately, the vaccine should be stored in a refrigerator (2°C – 8°C).",15,16
"4002","es","en","Si observa algún cambio en el aspecto de los comprimidos, comuníqueselo a su farmacéutico.","Tell your pharmacist if you notice any change in the appearance of the tablets.",14,14
"4003","es","en","Si observa cualquier síntoma de infección informe a su médico inmediatamente.","If you notice any symptoms of infection, please inform your doctor immediately.",12,11
"4004","es","en","Si olvida tomar una dosis, tómela tan pronto como se acuerde.","If you miss a dose, take it as soon as you remember.",12,11
"4005","es","en","Si olvidó tomar Atripla","If you forget to take Atripla",6,4
"4006","es","en","Si olvidó tomar Emtriva","If you forget to take Emtriva",6,4
"4007","es","en","Si olvidó tomar Procoralan:","If you forget to take Procoralan:",6,4
"4008","es","en","Si olvidó usar Dynepo No se administre una dosis doble para compensar la dosis olvidada.","Do not take a double dose to make up for a forgotten individual dose.",14,15
"4009","es","en","Si olvidó usar Elaprase","If you forget to have Elaprase",6,4
"4010","es","en","Si olvidó usar Orgalutran No use una dosis doble para compensar.","If you forget to use Orgalutran Do not inject a double dose to make up for a dose.",18,11
"4011","es","en","Si piensa que puede estar embarazada dígaselo en seguida a su médico.","If you think that you may be pregnant speak with your doctor right away.",14,12
"4012","es","en","Si por algún motivo, usted no pudiese tomar ribavirina, sólo recibirá Pegasys.","Pegasys is used alone only if you cannot take ribavirin for any reason.",13,12
"4013","es","en","Si presenta estos síntomas debe consultar a su médico antes de realizar dichas actividades.","If you experience these, you should consult your doctor before attempting such activities.",13,14
"4014","es","en","Si procede, se instaurará el tratamiento pertinente.","Treatment should be initiated as appropriate.",6,7
"4015","es","en","Si puede identificarse o se identifica con alguna de estas situaciones, informe inmediatamente a su médico.","If any of these applies to you, or might apply, tell your doctor at once.",15,16
"4016","es","en","Si se detectan anormalidades tiroideas, deberá evaluarse el status tiroideo del paciente y tratarse clínicamente de modo apropiado.","If thyroid abnormalities are detected, the patient’s thyroid status should be evaluated and treated as clinically appropriate.",17,18
"4017","es","en","Si se diagnostica enfermedad pulmonar intersticial, se debe interrumpir la administración de cetuximab y tratar al paciente adecuadamente.","If interstitial lung disease is diagnosed, cetuximab must be discontinued and the patient be treated appropriately.",16,18
"4018","es","en","Si se le ha olvidado una perfusión de Fabrazyme, póngase en contacto con su médico.","If you forget to use Fabrazyme If you have missed an infusion of Fabrazyme, please contact your doctor.",18,15
"4019","es","en","Si se olvida una dosis, debe continuarse el tratamiento con la siguiente dosis, tal como estaba planificado.","If a dose is missed, treatment should be continued with the next dose as planned.",15,17
"4020","es","en","Si se produce exposición de los ojos al medicamento, lávelos inmediatamente con agua limpia.","If eye exposure occurs, flush eyes immediately with clean water.",10,14
"4021","es","en","Si se produce exposición directa de los ojos, deberá lavarlos inmediatamente con agua limpia.","If Zactran comes in direct contact with the eyes, they should be flushed immediately with clean water.",17,14
"4022","es","en","Si se produce fotosensibilidad, el tratamiento debe interrumpirse.","When photosensibility occurs the treatment must be discontinued.",8,8
"4023","es","en","Si se produce sobreinfección durante el tratamiento, se deberán tomar las medidas adecuadas.","If superinfection occurs during therapy, appropriate measures should be taken.",10,13
"4024","es","en","Si se producen efectos adversos, puede que deba solicitar atención médica.","If side effects occur, they may need medical attention.",9,11
"4025","es","en","Si se queda embarazada o está planeando un embarazo mientras utiliza Rebif consulte con su médico.","If you become pregnant or plan to become pregnant while using Rebif ask your doctor for advice.",17,16
"4026","es","en","Si se rompe o abre accidentalmente una cápsula, lávese la piel con agua y jabón.","If a capsule breaks open accidentally, wash any powder from your skin with soap and water.",16,15
"4027","es","en","Si se salta una comida o la comida no contiene grasa, no deberá tomarse el medicamento.","If a meal is missed or contains no fat, Alli should not be taken.",14,16
"4028","es","en","Si se siente fatigado o débil no conduzca y no maneje máquinas.","If you feel tired or weak, do not drive and do not use machines.",14,12
"4029","es","en","Si STRONGHOLD entra en contacto con los ojos, láveselos inmediatamente con agua y consulte a un médico.","People with sensitive skin or known allergy to products of this type should handle STRONGHOLD with caution.",17,17
"4030","es","en","Si su azúcar en sangre está baja, tome comprimidos de glucosa, azúcar o una bebida azucarada.","If your blood sugar is low, eat glucose tablets, sugar or drink a sugary drink.",15,16
"4031","es","en","Si su médico determina que el metotrexato no es apropiado, Humira puede administrarse solo.","If your doctor determines that methotrexate is inappropriate, Humira can be given alone.",13,14
"4032","es","en","Si su médico se lo receta, puede tomar Prandin junto con metformina, otro medicamento para la diabetes.","You can take Prandin with metformin, another medicine for diabetes, if your doctor prescribes it.",15,17
"4033","es","en","Si su nivel de glucosa en sangre aumenta muy rápido puede causar sensación quemante, de hormigueo o calambres.","When you start taking insulin, water retention may cause swelling around your ankles and other joints.",16,18
"4034","es","en","Si sufre cualquiera de estos síntomas, acuda a su médico.","If you notice any of these symptoms please inform your doctor.",11,10
"4035","es","en","Si tiene alguna duda sobre si su pluma funciona correctamente, utilice un nuevo OptiSet.","If in any doubt whether the pen is working correctly use a new OptiSet.",14,14
"4036","es","en","Si tiene cualquier duda, pregunte a su médico, enfermera o farmacéutico.","Discuss with your doctor, nurse or pharmacist if you are unsure about anything.",13,11
"4037","es","en","Si tiene cualquier otra duda sobre el uso de este producto, consulte a su médico o farmacéutico.","If you have any further questions on the use of this product, ask your doctor.",15,17
"4038","es","en","Si tiene cualquier otra duda sobre el uso de este producto, pregunte a su médico o enfermera.","If you have any further questions on the use of this medicine, ask your doctor or nurse.",17,17
"4039","es","en","Si tiene cualquier otra duda sobre el uso de este producto, pregunte a su médico o farmacéutico","If you have any further questions on the use of this product, ask your doctor or pharmacist.",17,17
"4040","es","en","Si tiene dudas consulte con su médico o farmacéutico.","You should check with your doctor or pharmacist if you are unsure.",12,9
"4041","es","en","Si tiene dudas sobre cuánto tiempo debe tomar Tasigna, consulte con su médico.","If you have questions about how long to take Tasigna, talk to your doctor.",14,13
"4042","es","en","Si tiene frecuentes hipoglucemias o dificultades para reconocerlas, por favor, no deje de comentárselo a su médico.","If you often have hypoglycaemia or have difficulty recognising them, please discuss this with your doctor.",16,17
"4043","es","en","si tiene historia de enfermedad hepática, incluyendo hepatitis crónica activa.","if you have a history of liver disease, including active chronic hepatitis.",12,10
"4044","es","en","Si tiene una hipoglucemia","If you get a hypo (hypoglycaemia)",6,4
"4045","es","en","Si tiene una reacción alérgica, deje de tomar Velmetia y llame inmediatamente a su médico.","If you have an allergic reaction, stop taking Velmetia and call your doctor right away.",15,15
"4046","es","en","Si toma más Ebixa del que debiera","If you take more Ebixa than you should",8,7
"4047","es","en","Si toma más Lamictal del que debiera Si alguien toma demasiado Lamictal:","If you take more Lamictal than you should If anyone takes too much Lamictal:",14,12
"4048","es","en","Si toma más Pritor del que debiera","If you take more Pritor than you should",8,7
"4049","es","en","Si toma más Truvada del que debiera","If you take more Truvada than you should",8,7
"4050","es","en","Si toma una comida con alto contenido en grasa no debe tomar una dosis mayor que la recomendada.","If you eat a high-fat meal, do not take more than the recommended dose.",14,18
"4051","es","en","Si usa más KOGENATE Bayer 1000 UI del que debiera:","If you use more KOGENATE Bayer 1000 IU than you should:",11,10
"4052","es","en","Si usa más Rebif del que debiera","If you use more Rebif than you should",8,7
"4053","es","en","Si usted nota cualquiera de estas afecciones, comuníquelo a su médico antes de comenzar a usar Livensa.","If you have any of the above, tell your doctor before you start to use Livensa.",16,17
"4054","es","en","Si usted padece la enfermedad de Parkinson, puede experimentar los siguientes efectos adversos:","If you suffer from Parkinson’ s disease, you may experience the following side effects (regardless of indication):",17,13
"4055","es","en","Si usted puede quedarse embarazada debe utilizar un método anticonceptivo adecuado mientras esté utilizando TRAVATAN.","If you could become pregnant you must use adequate contraception whilst you use TRAVATAN.",14,15
"4056","es","en","Si usted se va a inyectar este medicamento por sí mismo, debe ser instruido sobre cómo hacerlo.","If you are injecting this medicine yourself, you will be instructed how to give the injection.",16,17
"4057","es","en","Si usted tiene infección por hepatitis B, su médico considerará cuidadosamente el mejor régimen de tratamiento para usted.","If you have hepatitis B infection, your doctor will carefully consider the best treatment regimen for you.",17,18
"4058","es","en","Si usted toma más Agopton del que debiera","If you take more Agopton than prescribed",7,8
"4059","es","en","Si usted vomita el comprimido (justo después de haber tomado Atripla), debe tomar otro comprimido.","If you throw up the tablet (just after taking Atripla), you should take another tablet.",15,15
"4060","es","en","Si usted/su hijo presenta un aumento del tamaño de las amígdalas (hipertrofia amigdalar).","if you/your child has enlarged tonsils (tonsillar hypertrophy).",8,13
"4061","es","en","Si ve burbujas, tire del émbolo ligeramente.","If you see any bubbles, pull the plunger slightly back.",10,7
"4062","es","en","Si vuelve a exponerse a los virus más adelante, el sistema inmunitario podrá fabricar anticuerpos con mayor rapidez.","The vaccine is ‘ adsorbed’.",5,18
"4063","es","en","Si vuelven a aparecer las anomalías de la función hepática, VIRAMUNE debe interrumpirse permanentemente.","If liver function abnormalities recur, VIRAMUNE should be permanently discontinued.",10,14
"4064","es","en","Siempre lleve la caja del medicamento consigo, incluso si está vacía.","Always take the outer carton or the pre-filled pen of medicine with you, even if it is empty.",18,11
"4065","es","en","SIFROL 0,088 mg comprimidos Pramipexol","SIFROL 0.088 mg tablets Pramipexole",5,5
"4066","es","en","Siga detenidamente las instrucciones de uso del prospecto incluido en el envase de Levemir Penfill.","Levemir Penfill is accompanied by a package leaflet with detailed instruction for use to be followed.",16,15
"4067","es","en","Siga detenidamente todas las instrucciones de su médico.","Carefully follow all instructions given to you by your doctor.",10,8
"4068","es","en","Siga exactamente las instrucciones de administración de Advagraf indicadas por su médico.","Always take Advagraf exactly as your doctor has told you.",10,12
"4069","es","en","Siga exactamente las instrucciones de administración de AZOPT indicadas por su médico.","Always use AZOPT exactly as your doctor has told you.",10,12
"4070","es","en","Siga exactamente las instrucciones de administración de CELSENTRI indicadas por su médico.","Always take CELSENTRI exactly as your doctor has instructed.",9,12
"4071","es","en","Siga exactamente las instrucciones de administración de Competact indicadas por su médico.","Always take Competact tablets exactly as your doctor has told you.",11,12
"4072","es","en","Siga exactamente las instrucciones de administración de Ebixa indicadas por su médico..","Always take Ebixa exactly as your doctor has told you.",10,12
"4073","es","en","Siga exactamente las instrucciones de administración de Enbrel indicadas por su médico.","Always use Enbrel exactly as the doctor has told you.",10,12
"4074","es","en","Siga exactamente las instrucciones de administración de Glubrava indicadas por su médico.","Always take Glubrava tablets exactly as your doctor has told you.",11,12
"4075","es","en","Siga exactamente las instrucciones de administración de Humalog BASAL KwikPen indicadas por su médico.","Always use Humalog BASAL KwikPen exactly as your doctor has told you.",12,14
"4076","es","en","Siga exactamente las instrucciones de administración de Jalra indicadas por su médico.","Always take Jalra exactly as your doctor has told you.",10,12
"4077","es","en","Siga exactamente las instrucciones de administración de Kivexa indicadas por su médico.","Always take Kivexa exactly as your doctor has told you.",10,12
"4078","es","en","Siga exactamente las instrucciones de administración de Liprolog Basal Pen indicadas por su médico.","Always use Liprolog Basal Pen exactly as your doctor has told you.",12,14
"4079","es","en","Siga exactamente las instrucciones de administración de LYRICA indicadas por su médico.","Always take LYRICA exactly as your doctor has instructed you.",10,12
"4080","es","en","Siga exactamente las instrucciones de administración de Preotact de su médico.","Always use Preotact exactly as your doctor has told you.",10,11
"4081","es","en","Siga exactamente las instrucciones de administración de Rasilez HCT indicadas por su médico.","Always take Rasilez HCT exactly as your doctor has told you.",11,13
"4082","es","en","Siga exactamente las instrucciones de administración de SUSTIVA indicadas por su médico.","Always take SUSTIVA exactly as your doctor has told you.",10,12
"4083","es","en","Siga exactamente las instrucciones de administración de TRITACE indicadas por su médico.","Always take TRITACE exactly as your doctor has told you.",10,12
"4084","es","en","Siga exactamente las instrucciones de administración de Valtropin de su médico.","Always use Valtropin exactly as your doctor has told you.",10,11
"4085","es","en","Siga exactamente las instrucciones de administración de Vimpat indicadas por su médico.","Always take Vimpat exactly as your doctor has told you.",10,12
"4086","es","en","Siga exactamente las instrucciones de administración de Xenical indicadas por su médico.","Always take Xenical exactly as your doctor has told you.",10,12
"4087","es","en","Siga las instrucciones de su médico.","Please follow the instructions of your doctor.",7,6
"4088","es","en","Siga llevando ropa oscura de tejido denso.","Continue to wear dark, closely woven clothing.",7,7
"4089","es","en","Siga siempre exactamente las instrucciones de administración de RELISTOR indicadas por su médico.","Always use RELISTOR exactly as your doctor has told you.",10,13
"4090","es","en","Sigma-Tau Industrie Farmaceutiche Riunite S. p. A.","Sigma-Tau Industrie Farmaceutiche Riunite S. p. A.",7,7
"4091","es","en","significativamente a otras proteínas plasmáticas, incluyendo el factor 4 plaquetario (FP4). en","significantly to other plasma proteins, including platelet factor 4 (PF4).",10,12
"4092","es","en","Signos agudos de sobredosis pueden incluir náuseas, vómitos, cefalea y diarrea.","Acute signs of overdose may include nausea, vomiting, headache and diarrhoea.",11,11
"4093","es","en","Siguen existiendo algunos Estados miembros que todavía no han actuado como Estados miembros de referencia.","There are still some Member States who have not acted as reference Member State.",14,15
"4094","es","en","Siklos es un medicamento que debe manipularse con cuidado.","Siklos is a medicinal product that must be handled with care.",11,9
"4095","es","en","Silapo 40 000 UI/ 1,0 ml Solución inyectable en jeringa precargada","Silapo 40000 IU/1.0ml solution for injection in pre-filled syringe",9,11
"4096","es","en","Sími: + 354 530 3700","Sími: + 354 530 3700",5,5
"4097","es","en","SímiTel: +354 535 7000","Sími: +354 535 7000",4,4
"4098","es","en","Simulect también se presenta en viales con 10 mg de basiliximab.","Simulect is also available in vials with 10 mg basiliximab.",10,11
"4099","es","en","Sin (> 1/ 10.000, < 1/ 1.000)","Rare (> 1/ 10,000, < 1/ 1,000)",7,7
"4100","es","en","Sin embargo el PET no está aún ampliamente distribuido en Europa.","However PET is not widely available throughout Europe.",8,11
"4101","es","en","Sin embargo, como tenofovir estructuralmente está relacionado con los análogos de nucleósidos, el riesgo no puede ser excluido.","However, as tenofovir is structurally related to nucleoside analogues, this risk cannot be excluded.",14,18
"4102","es","en","Sin embargo, en estos casos, M-M-RVAXPRO puede no ser capaz de prevenir el desarrollo del sarampión.","However, M-M-RVAXPRO may not always be able to prevent measles developing in these cases.",14,16
"4103","es","en","Sin embargo, en tratamientos a largo plazo el aumento de la actividad de las enzimas hepáticas fue frecuente.","However, with long-term treatment increases in liver enzyme activities were common.",11,18
"4104","es","en","Sin embargo, es improbable que se produzca la absorción por vía oral en el niño.","Oral absorption by the child is however unlikely.",8,15
"4105","es","en","Sin embargo, esto no se ha investigado in vivo y su significación clínica es incierta.","However, this has not been investigated in vivo and its clinical significance is uncertain.",14,15
"4106","es","en","Sin embargo, estos cambios no se consideraron clínicamente relevantes.","These changes are, however, not considered to be clinically relevant.",10,9
"4107","es","en","Sin embargo, existen ciertos problemas metodológicos que dificultan la obtención de conclusiones sobre el riesgo relativo entre estatinas.","The analysis of spontaneous data suggests that the risk of myotoxicity increases particularly from 0.4 mg.",16,18
"4108","es","en","Sin embargo, la dosificación necesaria para terneros es 40 mg/ kg de peso corporal.","The dosage required for calves is however 40 mg/ kg bodyweight.",11,14
"4109","es","en","Sin embargo, la influencia potencial de la insuficiencia hepática en la farmacocinética de SIFROL no ha sido investigada.","However, the potential influence of hepatic insufficiency on SIFROL pharmacokinetics has not been investigated.",14,18
"4110","es","en","Sin embargo, la vida media de eliminación no se modificó significativamente.","However the terminal half-life was not significantly altered.",8,11
"4111","es","en","Sin embargo, no existe experiencia clínica con el uso de flumazenil como antídoto para una sobredosis con Sonata.","However, there is no clinical experience with the use of flumazenil as an antidote to a Sonata overdose.",18,18
"4112","es","en","Sin embargo, no se ha demostrado una relación con el tratamiento con Protopic pomada.","However, a link to Protopic ointment treatment has not been shown.",11,14
"4113","es","en","Sin embargo, no se requiere un ajuste sistémico de la dosis.","However, no systematic dosage adjustment is required.",7,11
"4114","es","en","Sin embargo, puede ser necesario ajustar la dosis de Actraphane.","However, the Actraphane dosage may need to be adjusted.",9,10
"4115","es","en","Sin embargo, puede ser necesario ajustar la dosis de Mixtard.","However, the Mixtard dosage may need to be adjusted.",9,10
"4116","es","en","Sin embargo, se debe tener cuidado cuando se coadministren anidulafungina y anestésicos.","Nevertheless, care should be taken when co-administering anidulafungin and anaesthetic agents.",11,12
"4117","es","en","Sin embargo, se recomienda precaución al conducir o utilizar máquinas si persisten la fatiga y la astenia.","However, caution should be observed when driving or operating machines if fatigue and asthenia persist.",15,17
"4118","es","en","Sin embargo, una dosis demasiado alta de FSH puede conducir a hiperestimulación de los ovarios (ver sección 4.4).","Too high a dosage of FSH may lead to hyperstimulation of the ovaries (see section 4.4).",16,18
"4119","es","en","Sin tocar el botón rojo, presione la pluma precargada contra la piel para desbloquear el protector de seguridad.","Press the pre-filled pen onto the skin to unlock the safety guard.",12,18
"4120","es","en","Síncope, migraña, temblor, trastornos del sueño.","syncope, migraine, tremor, sleep disturbances",5,6
"4121","es","en","Síncope2 Hipotensión ortostática 2 Aumento de la tensión arterial Frialdad periférica","Endocrine disorders Hypo- thyroidism Metabolism and Nutrition Disorders",8,11
"4122","es","en","Síndrome de Stevens- Johnson, Edema angioneurótico","Stevens- Johnson Syndrome Angio-neurotic oedema",5,6
"4123","es","en","SINGULAIR puede usarse en madres lactantes sólo si se considera claramente necesario.","SINGULAIR may be used in breast-feeding mothers only if it is considered to be clearly essential.",16,12
"4124","es","en","Síntomas psiquiátricos: se han notificado reacciones adversas psiquiátricas graves en pacientes tratados con efavirenz.","Psychiatric symptoms: serious psychiatric adverse reactions have been reported in patients treated with efavirenz.",14,14
"4125","es","en","Siriusdreef 51 NL-2132 WT Hoofddorp Tel: + 31 (0) 888 222 688","Siriusdreef 51 NL-2132 WT Hoofddorp Tel: + 31 (0) 888 222 688",12,12
"4126","es","en","SK-811 01 Bratislava Tel: + 421 (2) 5920 2712","SK-811 01 Bratislava Tel: + 421 (2) 5920 2712",9,9
"4127","es","en","Slovenija AMGEN zdravila d. o. o.","Slovenija AMGEN zdravila d. o. o.",6,6
"4128","es","en","Slovenija AstraZeneca UK Limited Tel: +386 1 30 94 500","Tel: +386 1 30 94 500",6,10
"4129","es","en","Slovenija Dunajska 22 SI-1000 Ljubljana Tel: + 386 01 3001070","Slovenija Dunajska 22 SI-1000 Ljubljana Tel: + 386 01 3001070",10,10
"4130","es","en","Slovenija Johnson & Johnson d. o. o.","Slovenija Johnson & Johnson d. o. o.",7,7
"4131","es","en","Slovenija Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Nemčija Tel: +49 (0)69 1503 - 1","Slovenija Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Nemčija Tel: +49 (0)69 1503 - 1",16,16
"4132","es","en","Slovenija PLIVA Ljubljana d.o.o.","Slovenija PLIVA Ljubljana d.o.o.",4,4
"4133","es","en","Slovenija Wyeth-Lederle Pharma GmbH Tel: + 43 1 89 1140 Faks: + 43 1 89 114600","Slovenija Wyeth-Lederle Pharma GmbH Tel: + 43 1 89 1140 Faks: + 43 1 89 114600",16,16
"4134","es","en","Slovenská republika Biogen Idec (Slovak Republic) s.r.o +421 2 32410188","Slovenská republika Biogen Idec (Slovak Republic) s.r.o +421 2 32410188",10,10
"4135","es","en","Slovenská republika Eli Lilly Slovakia, s. r. o.","Slovenská republika Eli Lilly Slovakia, s. r. o.",8,8
"4136","es","en","Slovenská republika Johnson & Johnson s.r.o.","Slovenská republika Johnson & Johnson s.r.o.",6,6
"4137","es","en","Slovenská republika Novartis Slovakia s. r. o.","Slovenská republika Novartis Slovakia s.r.o.",5,7
"4138","es","en","Slovenská republika ratiopharm Slovensko s. r. o.","Slovenská republika ratiopharm Slovensko s. r. o.",7,7
"4139","es","en","Snaygill Industrial Estate Keighley Road Skipton North Yorkshire, BD23 2RW Reino Unido (UK)","Snaygill Industrial Estate Keighley Road Skipton North Yorkshire BD23 2RW United Kingdom",12,13
"4140","es","en","sobre los niveles del medicamento","An alternative anticonvulsant should be considered.",6,5
"4141","es","en","Socobom N. V Louizalaan 149 B24 1050 Bruselas Bélgica","Socobom N. V Louizalaan 149 B24 1050 Brussel Belgium",9,9
"4142","es","en","Solamente el 1-2% de la dosis se recuperó en la orina, siendo nelfinavir inalterado el componente principal.","Only 1-2% of the dose was recovered in urine, of which unchanged nelfinavir was the major component.",17,17
"4143","es","en","Solamente para uso animal Se administrará únicamente bajo prescripción veterinaria.","For animal treatment only – to be supplied only on veterinary prescription.",12,10
"4144","es","en","Solamente un paciente pudo dejar de utilizar la silla de ruedas.","Only one patient became wheelchair-free.",5,11
"4145","es","en","Solicitudes de designación de medicamentos huérfanos 2000-2002","Applications for orphan medicinal product designation 2000-2002",7,7
"4146","es","en","Soliris es un concentrado para solución para perfusión.","Soliris is a concentrate that is made up into a solution for infusion.",13,8
"4147","es","en","Sólo contiene trazas de IgA (inferiores a 0,05 mg/ ml).","It contains trace amounts of IgA (lower than 0.05 mg/ ml).",11,10
"4148","es","en","Solo debe tomar estos medicamentos, mientras está siendo tratado con Seretide, si está indicado por su médico.","Only take these medicines whilst on Seretide, if told to do so by your doctor.",15,17
"4149","es","en","Sólo debe utilizarlo si su apariencia es como la del agua.","You must use it only if it looks like water.",10,11
"4150","es","en","Sólo debe utilizarse tipranavir durante el embarazo si el beneficio potencial justifica el riesgo potencial para el feto.","Tipranavir should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.",18,18
"4151","es","en","Solo deben ser inmunizados animales sanos.","Only healthy animals should be immunised.",6,6
"4152","es","en","Sólo para uso cutáneo.","For external use only.",4,4
"4153","es","en","Sólo se administrarán las cápsulas de CRIXIVAN a los niños que sean capaces de tragar cápsulas duras.","CRIXIVAN hard capsules should only be given to children who are able to swallow hard capsules.",16,17
"4154","es","en","Sólo se deben usar jeringas de inyección diseñadas para esta concentración de insulina (100 UI por ml).","Only injection syringes designed for this strength of insulin (100 IU per ml) are to be used.",17,17
"4155","es","en","Sólo se deben utilizar las soluciones trasparentes e incoloras, sin partículas.","Only clear and colourless solutions without particles should be used.",10,11
"4156","es","en","Sólo se lo inyectará en músculo si su médico así se lo indica.","You should only inject it into a muscle if your doctor has told you to.",15,13
"4157","es","en","Solución acuosa, transparente, de incolora a color paja, con un olor cítrico a naranja característico.","Clear, colourless-to-straw aqueous solution with a characteristic citrus-orange odour.",9,15
"4158","es","en","Solución de cloruro sódico saturada (SCSS) 1 (Ver sección 1.) abajo) 4.","Saturated sodium chloride solution (SSCS)1 (1 See section 1.) below) 4.",11,12
"4159","es","en","Solución de transparente a opalescente, de color ligeramente amarillo a marrón.","Clear to opalescent, slightly yellow to brown solution.",8,11
"4160","es","en","Solución inyectable 10 ml (1, 10 viales) 15 ml (1, 10 viales) 20 ml (1, 10 viales)","Solution for injection 10 ml (1, 10 vials) 15 ml (1, 10 vials) 20 ml (1, 10 vials)",18,17
"4161","es","en","Solución inyectable 2 viales de 10 ml","Solution for injection, 2 x 10 ml vials",8,7
"4162","es","en","Solución inyectable en un cartucho","Solution for injection in a cartridge",6,5
"4163","es","en","Solución inyectable o para perfusión","Solution for injection or infusion",5,5
"4164","es","en","Solución inyectable. en una pluma precargada de un solo uso (0,6 ml).","Solution for injection in a single use pre-filled pen (0.6 ml).",11,12
"4165","es","en","Solución reconstituida y solución para perfusión:","Reconstituted solution and infusion solution:",5,6
"4166","es","en","Solución transparente, de incolora a amarillo pálido pH:","Clear, colourless to pale yellow solution. pH:",7,8
"4167","es","en","Somatropina 1,3 mg (4 UI/ ml) en un vial.","Somatropin 1.3 mg (4 IU)/ ml in a vial.",9,9
"4168","es","en","Somavert 10 mg polvo y disolvente para solución inyectable.","SOMAVERT 10 mg powder and solvent for solution for injection.",10,9
"4169","es","en","Son muy frecuentes (> 10%) la sensación de quemazón y picor.","Burning sensation and itching are very common (> 10%).",9,11
"4170","es","en","Son personas con alto riesgo de candidiasis invasora pacientes quirúrgicos y aquellos cuyo sistema inmune es deficiente.","Persons at high risk for invasive candidiasis include surgical patients and those whose immune systems are deficient.",17,17
"4171","es","en","SonoVue se usa sólo con fines de diagnóstico.","SonoVue is for diagnostic use only.",6,8
"4172","es","en","SP Europe 73, rue de Stalle B-1180 Bruxelles 240 Bélgica","SP Europe 73, rue de Stalle na",7,10
"4173","es","en","SP Labo N. V.","SP Labo N. V.",4,4
"4174","es","en","Specific requirements for poultry","Specific requirements for poultry",4,4
"4175","es","en","Spoo L-2546 Luxembourg Tel:","Spoo L-2546 Luxembourg Tel:",4,4
"4176","es","en","Sprimeo pertenece a nueva clase de medicamentos llamados inhibidores de la renina.","Sprimeo belongs to a new class of medicines called renin inhibitors.",11,12
"4177","es","en","SPRYCEL no se debe usar durante el embarazo a menos que sea claramente necesario.","SPRYCEL is not to be used during pregnancy unless clearly necessary.",11,14
"4178","es","en","Stada Arzneimittel AG Stadastrasse 2-18 D-61118 Bad Vilbel, Alemania","Stada Arzneimittel AG Stadastrasse 2-18 D-61118 Bad Vilbel, Germany",9,9
"4179","es","en","Stalevo 150 mg/ 37,5 mg/ 200 mg comprimidos recubiertos con película Levodopa/ carbidopa/ entacapona","Stalevo 150 mg/ 37.5 mg/ 200 mg film-coated tablets Levodopa/ carbidopa/ entacapone",12,14
"4180","es","en","STAMARIL es una vacuna inyectable frente a la grave enfermedad infecciosa llamada fiebre amarilla.","STAMARIL is an injectable vaccine against a serious infectious disease called yellow fever.",13,14
"4181","es","en","Staphylococcus aureus3 4 Staphylococcus spp","Staphylococcus aureus3,4 Coagulase positive",4,5
"4182","es","en","STARTVAC Emulsión inyectable para bovino.","STARTVAC Emulsion for injection for cattle",6,5
"4183","es","en","STOCRIN 50 mg cápsulas duras","STOCRIN 50 mg hard capsules",5,5
"4184","es","en","STOCRIN, tomado en combinación con otros medicamentos antirretrovirales, reduce la cantidad del virus en la sangre.","STOCRIN taken in combination with other antiretroviral medicines reduces the amount of the virus in the blood.",17,16
"4185","es","en","Strada Statale 156 Km 50 04010 Borgo San Michele (Lt) Italia","Strada Statale 156 Km 50 04010 Borgo San Michele (Lt) Italy",11,11
"4186","es","en","Streptococcus agalactiae Streptococcus pneumoniae S. pneumoniae PEN-R Streptococcus pyogenes Gramnegativos aerobios Acinetobacter spp.","Streptoococus agalactiae Streptococcus pneumoniae S. pneumoniae PEN-R Streptococcus pyogenes Gram-negative aerobes Acinetobacter spp.",13,13
"4187","es","en","STRONGHOLD contiene selamectina, que es un medicamento antiparasitario perteneciente al grupo de las “avermectinas”.","STRONGHOLD contains selamectin, which is an antiparasitic medicine that belongs to the ‘avermectin’ class.",14,14
"4188","es","en","Su capacidad de concentración o de reacción puede verse reducida si:","Your ability to concentrate or react may be reduced if:",10,11
"4189","es","en","Su hijo no debe recibir Synagis","Your child should not be given Synagis:",7,6
"4190","es","en","Su médico comprobará si necesita alguna vacuna antes de recibir MabThera.","Your doctor will check if you should have any vaccines before you receive MabThera.",14,11
"4191","es","en","Su médico comprobará su función renal antes de reanudar el tratamiento.","The doctor will check your kidney function before restarting treatment.",10,11
"4192","es","en","Su médico controlará su respuesta y estado para determinar qué tratamiento de CANCIDAS es necesario.","Your doctor will monitor your response and condition to determine what CANCIDAS treatment is needed.",15,15
"4193","es","en","Su médico decidirá cuántos días de tratamiento necesita.","Your doctor will decide how many days ’ treatment you need.",11,8
"4194","es","en","Su médico decidirá si Usted puede recibir Privigen durante el embarazo o mientras esté dando el pecho.","Your doctor will decide whether you can receive Privigen during your pregnancy or while you are breast-feeding.",17,17
"4195","es","en","Su médico decidirá también la velocidad de la perfusión.","Your doctor will decide on the speed at which the infusion should be given.",14,9
"4196","es","en","Su médico determinará si es necesario realizar algún ajuste de otros medicamentos que pueda usted estar tomando.","Your physician will determine if any adjustments should be made to other medicines you may be taking.",17,17
"4197","es","en","Su médico le aconsejará sobre cómo debe interrumpir gradualmente el tratamiento con Efexor.","Your doctor will advise you on how you should gradually discontinue Efexor treatment.",13,13
"4198","es","en","Su médico le debe indicar cómo tratar el bajo nivel de azúcar en sangre.","Your doctor should tell you how to treat low blood sugar.",11,14
"4199","es","en","Su médico le dirá cuándo debe interrumpir el tratamiento.","Your doctor will tell you if and when you should stop the treatment.",13,9
"4200","es","en","Su médico le explicará la combinación de medicamentos más conveniente para usted.","Your doctor will discuss with you which combination of medicines is best for you.",14,12
"4201","es","en","Su médico le indicará el número exacto de comprimidos de Stalevo que debe tomar al día.","Your doctor will tell you exactly how many tablets of Stalevo to take each day.",15,16
"4202","es","en","Su médico le indicará qué es lo mejor para usted","Your doctor will tell you which is the best for you.",11,10
"4203","es","en","Su médico le informará en caso de que deba cambiar la dosis.","Your doctor will inform you if your dose changes.",9,12
"4204","es","en","Su médico le mostrará en qué área de la piel debe inyectarse Insuman Rapid.","Your doctor will show you in which area of the skin you should inject your insulin.",16,14
"4205","es","en","Su médico le puede recomendar que interrumpa temporalmente el tratamiento con Humira.","Your doctor may recommend temporary discontinuation of Humira.",8,12
"4206","es","en","Su médico le recetará Invirase en combinación con Norvir (ritonavir) y otros medicamentos contra el VIH.","Your doctor will prescribe Invirase in combination with Norvir (ritonavir) and other HIV medicines.",14,16
"4207","es","en","Su médico o ayudante le dirán qué tamaño de aguja debe usar.","Your doctor or his/her assistant will tell you what size of needle to use.",14,12
"4208","es","en","Su médico o profesional de enfermería le indicará con cuánta frecuencia debe administrarse el medicamento.","Your doctor or nurse will tell you how frequently it should be injected.",13,15
"4209","es","en","Su médico o su enfermero/a le enseñará como ponerse la inyección usted mismo.","You will be instructed by your doctor or his/ her assistant on the technique of self-injection.",16,13
"4210","es","en","Su médico puede ajustar la dosis inicial hasta que se controle su enfermedad.","The starting dose may be adjusted by your doctor until your condition is controlled.",14,13
"4211","es","en","Su médico puede considerar recetarle otro medicamento diferente o cambiar la dosis de los inhibidores de la proteasa.","Your doctor may consider giving you an alternative medicine or changing the dose of the protease inhibitors.",17,18
"4212","es","en","Su médico puede evaluar la gravedad de su trastorno hepático antes de decidir si puede utilizar INTELENCE.","Your doctor may evaluate how severe your liver disease is before deciding if you can take INTELENCE.",17,17
"4213","es","en","Su médico puede tener que considerar recetarle un anticonvulsivante diferente","Your doctor may need to consider giving you a different anticonvulsant.",11,10
"4214","es","en","Su médico siempre considerará los posibles riesgos y beneficios de DaTSCAN.","Your doctor will always consider the possible risks and benefits of DaTSCAN.",12,11
"4215","es","en","Su nivel de azúcar en sangre puede subir o bien bajar si toma:","Your blood sugar level may either rise or fall if you take:",12,13
"4216","es","en","Su profesional sanitario será el responsable de la conservación, uso y eliminación correctos de Faslodex.","Your health care professional will be responsible for the correct storage, use and disposal of Faslodex.",16,15
"4217","es","en","Su uso en esta indicación debe sopesarse contra el riesgo notificado de acontecimientos tromboembólicos.","Its use in this indication must be balanced against the reported risk of thromboembolic events.",15,14
"4218","es","en","Succursale belge/ Belgisch bijhuis Tél: +32 (0) 800 38693 MSDBelgium_info@merck. com","Succursale belge Tél: +32 (0) 800 38693 MSDBelgium_info@merck. com",9,11
"4219","es","en","Sudores nocturnos Sudores fríos Reacciones de fotosensibilidad Aumento de la tendencia a que se produzcan hematomas","Urticaria Dermatitis contact Cold sweat Photo- sensitivity reactions Increased tendency to bruise",12,16
"4220","es","en","Suecia expuso los motivos del desacuerdo a la EMEA el 31 de marzo de 2006.","Sweden referred the reasons for disagreement to the EMEA on 31 March 2006.",13,15
"4221","es","en","Suelen producirse al comienzo del tratamiento con somatropina y son dependientes de la dosis.","at the start of treatment with somatropin and are dose-dependent.",10,14
"4222","es","en","Suelen ser leves o moderados y duran poco tiempo.","These effects are usually mild or moderate and only last for a short time.",14,9
"4223","es","en","Sugammadex puede administrarse a distintos tiempos tras la administración de rocuronio o vecuronio:","Sugammadex can be administered at several time points after administration of rocuronium or vecuronium bromide:",15,13
"4224","es","en","suicida4 Ideación suicida4 Alucinaciones","and anger 5 Mania",4,4
"4225","es","en","Sujetar el dispensador (ver figura 2) y pulsar el émbolo completamente hasta abajo hacia la punta del dispensador.","Take the dispenser (see figure 2) and push the plunger completely down toward the tip of the dispenser.",18,18
"4226","es","en","Sujete la jeringa ligeramente inclinada con el vial hacia abajo.","Hold the syringe slightly tilted with the vial facing downwards.",10,10
"4227","es","en","Sulfadiazina 33,3 Trimetoprim 6,7","Active constituents %w/ w:",4,4
"4228","es","en","Sulfadiazina 333 mg Trimetoprim 67 mg","Sulfadiazine 333 mg Trimethoprim 67 mg",6,6
"4229","es","en","Sulfato hidróxidofosfato de aluminio amorfo y borato sódico en cloruro sódico al 0,9%","Amorphous aluminium hydroxyphosphate sulphate and sodium borate in 0.9% sodium chloride",11,13
"4230","es","en","Sumando todos los ensayos, se suministró Actos a aproximadamente 7.000 pacientes.","Almost 7,000 patients received Actos in all trials combined.",9,11
"4231","es","en","Suomi/ Finland Boehringer Ingelheim Finland Ky Puh/ Tel: +358 10 3102 800","Suomi/ Finland Boehringer Ingelheim Finland Ky Puh/ Tel: +358 10 3102 800",12,12
"4232","es","en","Suomi/ Finland Oy H.","Suomi/ Finland Oy H.",4,4
"4233","es","en","Suomi/ Finland Pfizer Oy Puh/ Tel: +358 (0)9 43 00 40","Suomi/Finland Pfizer Oy Puh/Tel: +358 (0)9 43 00 40",9,11
"4234","es","en","Suomi/ Finland sanofi-aventis Oy Puh/ Tel: +358 (0) 201 200 300","Suomi/Finland sanofi-aventis Oy Puh/Tel: +358 (0) 201 200 300",9,11
"4235","es","en","Suomi/ Finland ScanVet Eläinlääkkeet Oy Tyrvännöntie 769 FIN-14610 Lepaa Puh/ Tel: + 358 (0)3 630 3100","Suomi/ Finland ScanVet Eläinlääkkeet Oy Tyrvännöntie 769 FIN-14610 Lepaa Puh/ Tel: + 358 (0)3 630 3100",16,16
"4236","es","en","Suomi/Finland Abbott OY Pihatörmä 1B/Gårdsbrinken 1B FIN-02240 Espoo/Esbo Puh/Tel: + 358 (0) 9 7518 4120","Suomi/Finland Abbott OY Pihatörmä 1B/Gårdsbrinken 1B FIN-02240 Espoo/Esbo Puh/Tel: + 358 (0) 9 7518 4120",15,15
"4237","es","en","Suomi/Finland JANSSEN-CILAG OY Vaisalantie/Vaisalavägen 2 FIN-02130 Espoo/Esbo Puh/Tel: +358 20 753 1300","Suomi/ Finland JANSSEN-CILAG OY Vaisalantie/ Vaisalavägen 2 FIN-02130 Espoo/ Esbo Puh/ Tel: +358 20 753 1300",16,12
"4238","es","en","Suomi/Finland Mauno LINDROOS (7) Hannes WAHLROOS","Suomi/Finland Mauno LINDROOS (7) Hannes WAHLROOS",6,6
"4239","es","en","Suomi/Finland PL 3/PB 3 FIN-02201 Espoo/Esbo Puh/Tel: + 358-(0)20-7570 300","PL 3/PB 3 FIN-02201 Espoo/Esbo",5,10
"4240","es","en","Supervivencia (meses) Mediana (95% I. C.)","Survival (months) Median (95% C. I.)",6,6
"4241","es","en","Suspensión inyectable 10 jeringas 10 x 1 dosis 1 dosis (0,5 ml)","Suspension for injection 10 syringes 10 x 1 dose 1 dose (0.5 ml)",13,12
"4242","es","en","Suspensión inyectable en Vía intramuscular jeringa precargada","Suspension for injection in pre- filled syringe",7,7
"4243","es","en","Suspensión oleosa blanca a blanquecina.","Ear drops suspension White to off-white oily suspension",8,5
"4244","es","en","Suspensión oral en aplicador oral precargado 1 aplicador oral precargado 1 dosis (1,5 ml)","Oral suspension in pre-filled oral applicator 1 pre-filled oral applicator 1 dose (1.5 ml)",14,14
"4245","es","en","Suspensión y emulsión para emulsión inyectable.","Suspension and emulsion for emulsion for injection",7,6
"4246","es","en","SUSTIVA puede disminuir o aumentar la cantidad de anticonvulsivante en su sangre.","SUSTIVA can reduce or increase the amount of anticonvulsant in your blood.",12,12
"4247","es","en","SUSTIVA, tomado en combinación con otros medicamentos antirretrovirales reduce la cantidad del virus en la sangre.","SUSTIVA taken in combination with other antiretroviral medicines reduces the amount of the virus in the blood.",17,16
"4248","es","en","Suvaxyn Aujeszky 783 + O/ W, liofilizado y disolvente para emulsión inyectable, para cerdos.","Suvaxyn Aujeszky 783 + O/ W, powder and solvent for emulsion for injection.",13,14
"4249","es","en","Sverige Baxter Medical AB Torshamnsgatan 35 S-164 40 Kista Tel: + 46 8 6326400","Sverige Baxter Medical AB Torshamnsgatan 35 S-164 40 Kista Tel: + 46 8 6326400",14,14
"4250","es","en","Sverige Eli Lilly Industries Ltd Elanco Animal Health Priestley Road Basingstoke RG24 9NL","Sverige Eli Lilly Industries Ltd Elanco Animal Health Priestley Road Basingstoke RG24 9NL",13,13
"4251","es","en","Sverige GlaxoSmithKline AB Tel: + 46 (0) 8 638 93 00 info. produkt@gsk. com","Sverige GlaxoSmithKline AB Tel: + 46 (0)8 638 93 00 info. produkt@gsk. com",13,14
"4252","es","en","Sverige Meda AB Box 906 170 09 Solna Tel: +46 (0)8 630 1900","Sverige Meda AB Box 906 170 09 Solna",8,13
"4253","es","en","Sverige Orion Pharma AB Tel: +46 8 623 6440","Sverige Orion Pharma AB Tel: +46 8 623 6440",9,9
"4254","es","en","Sverige Sandoz AB Berga Allé 1E S-254 52 Helsingborg Tel: + 46 42 152065","Sverige Sandoz AB Berga Allé 1E S-254 52 Helsingborg Tel: + 46 42 152065",14,14
"4255","es","en","Sverige TIBOTEC, en division inom JANSSEN-CILAG AB Box 7073 S-192 07 Sollentuna Tel: +46 8 626 50 00","Sverige TIBOTEC, en division inom JANSSEN-CILAG AB Box 7073 S-192 07 Sollentuna Tel: +46 8 626 50 00",18,18
"4256","es","en","Swensweg 5 2031 GA Haarlem Holanda","Swensweg 5 2031 GA Haarlem The Netherlands",7,6
"4257","es","en","Tabla 1: ajuste posológico en la insuficiencia renal","Table 1: dosage adjustment in renal impairment",7,8
"4258","es","en","Tabla 3a Normas de modificación de la dosis para PegIntron en monoterapia Valores de laboratorio","Table 3a Dose modification guidelines for PegIntron monotherapy",8,15
"4259","es","en","Tadalafilo Lilly 20 mg comprimidos tadalafilo","Tadalafil Lilly 20 mg tablets tadalafil",6,6
"4260","es","en","Tal acción interrumpe la replicación de la célula bacteriana, conduciendo a la muerte rápida de la célula.","Such impairment disrupts replication of the bacterial cell, leading to rapid cell death.",13,17
"4261","es","en","También contiene cloruro sódico y agua para preparaciones inyectables.","Also contains sodium chloride and water for injections.",8,9
"4262","es","en","También contiene: dihidrógeno fosfato potásico; hidrogenofosfato de disodio, anhidro; cloruro sódico; sacarosa; manitol (E421); glicina.","It also contains potassium dihydrogen phosphate; disodium phosphate, anhydrous; sodium chloride; sucrose; mannitol (E421); glycine.",15,15
"4263","es","en","También están disponibles como medicamentos por separado.","These are also available as separate medicines.",7,7
"4264","es","en","También están presentes en el plasma la insulina glargina sin modificar y productos de degradación.","Unchanged insulin glargine and degradation products are also present in the plasma.",12,15
"4265","es","en","También hay un ligero aumento del riesgo cuando diltiazem se usa con simvastatina 80 mg.","There is also a slight increase in risk when diltiazem is used with simvastatin 80 mg.",16,15
"4266","es","en","También le recomendamos que solicite a su médico o enfermero/ a que le enseñen cómo emplearlo.","We also suggest you consult your doctor or nurse for a demonstration.",12,16
"4267","es","en","También presenta enlaces con otras páginas web sobre enfermedades raras y medicamentos huérfanos.","There are also links to other websites about rare diseases and treatments.",12,13
"4268","es","en","También previene esta situación en pacientes que han respondido al tratamiento con ABILIFY.","It also prevents this condition from returning in patients who have responded to the treatment with ABILIFY.",17,13
"4269","es","en","También puede aparecer de forma gradual en un período de varias semanas.","Alternatively, it may emerge gradually over a period of several weeks.",11,12
"4270","es","en","También puede intervenir en la cicatrización de la úlcera.","It may also play a role in ulcer healing.",9,9
"4271","es","en","También puede ser necesario ajustar la dosis si el paciente cambia su actividad física o su dieta habitual.","Adjustment of dosage may also be necessary if patients change physical activity or their usual diet.",16,18
"4272","es","en","También pueden sufrir episodios depresivos.","They may also have episodes of depression.",7,5
"4273","es","en","También se asignaron ponentes para estudiar la necesidad de actualizar las directrices.","It will be finalised in 2002.",6,12
"4274","es","en","También se cambió el nombre del medicamento, de ReFacto a ReFacto AF.","The name of the medicine was also changed from ReFacto to ReFacto AF.",13,12
"4275","es","en","También se detectó pérdida de grasa en las piernas, brazos y cara.","Loss of fat from the legs, arms and face may also happen.",12,12
"4276","es","en","También se expresó la reserva de si EXULETT podría fabricarse asegurando una calidad constante.","There were also concerns over whether EXULETT could be manufactured with consistent good quality.",14,14
"4277","es","en","También se ha notificado osteonecrosis del maxilar en pacientes con osteoporosis sometidos a tratamiento de bifosfonatos orales.","Osteonecrosis of the jaw has also been reported in patients with osteoporosis receiving oral bisphosphonates.",15,17
"4278","es","en","También se han notificado de forma muy rara ataque cardíaco y accidente cerebrovascular en hombres que toman CIALIS.","Heart attack and stroke have also been reported rarely in men taking CIALIS.",13,18
"4279","es","en","También se notificó dolor abdominal leve en el 4% de los pacientes.","Mild abdominal pain was also reported amongst 4% of patients.",10,12
"4280","es","en","También se observaron reducciones en el C-no HDL, colesterol total y apo-B.","Reductions were also seen for non-HDL-C, Total-C and Apo B.",10,12
"4281","es","en","También se observó una mayor variabilidad en la exposición.","An increased variability in exposure was also observed.",8,9
"4282","es","en","También se puede administrar en la pared abdominal, en la región glútea o en la región deltoidea.","tho gluteal region or the deltoid region may also be used.",11,17
"4283","es","en","También se puede administrar, en la región glútea o en la región deltoidea.","If convenient, the abdominal wall, the gluteal region or the deltoid region may also be used.",16,13
"4284","es","en","También son síntomas de sobredosis el aumento o descenso de las frecuencias cardiacas.","Increased or decreased heart rates are also a symptom of overdosage.",11,13
"4285","es","en","Tamiflu 75 mg cápsulas duras esta disponible en blísters de 10 cápsulas.","Tamiflu 75 mg hard capsules are available in blister packs of 10.",12,12
"4286","es","en","Tamiflu para una dosis","mixture for one dose",4,4
"4287","es","en","Tandemact 30 mg/ 4 mg","Tandemact 30 mg/ 4 mg",5,5
"4288","es","en","Tarceva + gemcitabina (n = 200)","Tarceva + gemcitabine (n = 200)",6,6
"4289","es","en","Taś mowa 7 PL-02-677 Warszawa Tel.: + 48-(0)22 478 41 50","Taśmowa 7 PL-02-677 Warszawa Tel.: + 48-(0)22 478 41 50",10,11
"4290","es","en","Tasa de mejora de 60% en mEASI (Variable principal de valoración)§§","Response rate of ≥ 60% improvement in mEASI (Primary Endpoint)§§",10,11
"4291","es","en","Tasa de respuesta global (%):","Overall Response Rate (%):",4,5
"4292","es","en","Taurusavenue 19-21 NL-2132 LS HOOFDDORP Países Bajos","Taurusavenue 19-21 NL-2132 LS HOOFDDORP The Netherlands",7,7
"4293","es","en","Tejidos diana Otras disposi-","Target tissues Other provisions",4,4
"4294","es","en","Tekturna se estudió en 14 estudios principales en los que participaron 10.000 pacientes con hipertensión esencial.","Tekturna was studied in 14 main studies involving over 10,000 patients with essential hypertension.",14,16
"4295","es","en","Telecom Ardens - Medialaan 40 B-1800 Vilvoorde Bélgica","Telecom Ardens - Medialaan 40 B-1800 Vilvoorde Belgium",8,8
"4296","es","en","Telmisartán se metaboliza por conjugación para formar un acilglucurónido farmacológicamente inactivo.","Telmisartan is metabolised by conjugation to form a pharmacologically inactive acylglucuronide.",11,11
"4297","es","en","Telzir se utiliza para tratar la infección por VIH (virus de la inmunodeficiencia humana).","Telzir is used to treat HIV (human immunodeficiency virus) infection.",10,14
"4298","es","en","Temodal 20 mg cápsulas duras temozolomida","Temodal 20 mg hard capsules temozolomide",6,6
"4299","es","en","Temodal se administra en monoterapia a estos pacientes.","Temodal is used on its own in these patients.",9,8
"4300","es","en","Tendrán cuidado de que Fendrix no se administre en un vaso sanguíneo o bajo la piel.","They will take care that Fendrix is not given into a blood vessel and into the skin.",17,16
"4301","es","en","Tenga cuidado al desechar Mixtard 40 NovoLet, quitando previamente la aguja.","Dispose of your used Mixtard 40 NovoLet carefully without the needle attached.",12,11
"4302","es","en","Tenga cuidado de evitar el contacto de la suspensión con la piel.","Care should be taken to avoid contact of the skin with the suspension.",13,12
"4303","es","en","Tenga cuidado de no doblar ni torcer el capuchón mientras lo quita para evitar dañar la aguja.","Be careful not to bend or twist the cover during removal to avoid damage to the needle.",17,17
"4304","es","en","Tenga en cuenta que Noxafil sólo se puede utilizar en adultos (mayores de 18 años de edad).","Please note that Noxafil is only for use in adults (older than 18 years of age).",16,17
"4305","es","en","tengan los mismos síntomas, ya que puede perjudicarles.","their symptoms are the same as yours.",7,8
"4306","es","en","Tercica Europe Limited Riverside One Sir John Rogerson’s Quay Dublin 2 República de Irlanda","Tercica Europe Limited Riverside One Sir John Rogerson’s Quay Dublin 2 Republic of Ireland",14,14
"4307","es","en","Terfenadium CF 6 120","Terfenadium CF 6 120",4,4
"4308","es","en","TESAVEL es un medicamento que contiene el principio activo sitagliptina.","TESAVEL is a medicine containing the active substance sitagliptin.",9,10
"4309","es","en","Teva Pharma Loratadine Syrup","Teva Pharma Loratadine Syrup",4,4
"4310","es","en","TEVA Pharmaceutical Works Private Limited Company Pallagi út 13.","Manufacturers Teva Pharmaceutical Works Private Limited Company Pallagi út 13.",10,9
"4311","es","en","Teva Pharmaceuticals Polska Sp. z o. o.","TEVA UK Limited Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG United Kingdom",14,7
"4312","es","en","Tevagrastim es una solución para inyección o perfusión (goteo en vena) que contiene el principio activo filgrastim.","It contains the active substance filgrastim.",6,17
"4313","es","en","TEXTO DEL CARTONAJE Fertavid 75 UI/ 0,5 ml 5 viales","OUTER CARTON TEXT Fertavid 75 IU/ 0.5 ml 5 vials",10,10
"4314","es","en","TEXTO DEL CARTONAJE Puregon 50 UI 3 ampollas","OUTER CARTON TEXT Puregon 50 IU 3 ampoules",8,8
"4315","es","en","TEXTO DEL ESTUCHE (1 VIAL)","OUTER CARTON TEXT (1 VIAL)",5,5
"4316","es","en","TEXTO PARA LA ETIQUETA DE LA JERINGA – EU/ 1/ 99/ 126/ 016-018 (Jeringa precargada)","TEXT FOR PRE-FILLED SYRINGE – EU/ 1/ 99/ 126/ 016-018 (50 mg Pre-filled Syringe)",14,15
"4317","es","en","The European Agency for the Evaluation of Medicinal Products Pre-authorisation Evaluation of Medicines for Human Use","The European Agency for the Evaluation of Medicinal Products Pre-authorisation Evaluation of Medicines for Human Use",16,16
"4318","es","en","Therabel Pharma S. A. - Rue Egide Van Ophem 108 - B-1180 Bruselas, Bélgica","Therabel Pharma S. A. - Rue Egide",7,14
"4319","es","en","Thymanax no debe administrarse a niños y adolescentes (menores de 18 años).","Thymanax is not intended for use in children and adolescents (under 18 years old).",14,12
"4320","es","en","Tiazidas, glucocorticoides, hormonas tiroideas y beta-simpaticomiméticos, hormona de crecimiento y danazol. co","ge Thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol.",11,12
"4321","es","en","ticlopidina ó clopidogrel), y los AINEs.","Spinal / Epidural anaesthesia ed",5,6
"4322","es","en","Tiempo Día 1 Día 3 Día 7 Día 14 Día 28","Time Day 1 Day 3 Day 7 Day 14 Day 28",11,11
"4323","es","en","tiempo relativamente corto, conviene realizar una evaluación médica general que incluya la función hepática.","relatively short period of time, a general medical evaluation including liver function should be considered.",15,14
"4324","es","en","Tiene 191 aminoácidos y un peso molecular de 22.125 Da.","It has 191 amino acid residues and a molecular weight of 22,125 daltons.",13,10
"4325","es","en","Tiene que tomar un comprimido al día.","One tablet should be taken once daily.",7,7
"4326","es","en","Timolol es un betabloqueante que actúa reduciendo la formación de fluido en el interior del ojo.","Timolol is a beta blocker which works by reducing the production of fluid within the eye.",16,16
"4327","es","en","Tiomersal Cloruro de sodio Agua para preparaciones inyectables.","ris Sodium chloride Water for injections.",6,8
"4328","es","en","Tirar de la funda de la aguja - no girar.","Pull sheath away from the needle – do not twist.",10,10
"4329","es","en","Titular de la autorización de comercialización","UCB Pharma Oy Finland Malminkaari 5 FI-00700 HELSINKI",8,6
"4330","es","en","TITULAR DE LA AUTORIZACIÓN DE FABRICACIÓN RESPONSABLE DE LA IMPORTACIÓN Y LIBERACIÓN DE LOS LOTES","MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE",7,15
"4331","es","en","Titular(es) de Autorización de Comercialización","mg tablett filmdrasjert + Norethisterone acetate 0.1 mg",8,5
"4332","es","en","TITULARES DE LA(S) AUTORIZACIÓN(ES) DE FABRICACIÓN RESPONSABLES DE LA LIBERACIÓN DE LOS LOTES","MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE",7,13
"4333","es","en","Título de anticuerpos vironeutralizantes obtenido después de inyección de la vacuna en el cobayo","Vironeutralising antibody titre after vaccine injection in guinea pigs",9,14
"4334","es","en","Tlf: + 47 22 70 20 00 firmapost@gsk. no","Tel: + 43 1 970 75-0 at. info@gsk. com",9,9
"4335","es","en","to activo insulina humana.","active substance insulin human.",4,4
"4336","es","en","to EU/ 1/ 01/ 184/ 026","EU/ 1/ 01/ 184/ 026",5,6
"4337","es","en","Tocilizumab regulariza la expresión de estas enzimas","Tocilizumab normalises expression of these enzymes.",6,7
"4338","es","en","Toda anomalía tiroidea detectada en ese momento deberá ser tratada mediante tratamiento convencional.","Any thyroid abnormality detected at that time must be treated with conventional therapy.",13,13
"4339","es","en","Todas las especies destinadas a la alimentación (para su uso como excipiente)","All food producing species (For use as excipient)",8,12
"4340","es","en","Todos ≤ 10,6 > 10,6","All ≤ 10.6 > 10.6",5,5
"4341","es","en","Todos esos pacientes habían recibido también medicamentos como azatioprina o 6-mercaptopurina.","All of these patients had also received drugs known as azathioprine or 6-mercaptopurine.",13,11
"4342","es","en","Todos los grupos de cerdos estudiados mostraban estos signos.","The actual groups of pigs studied were all showing clinical signs.",11,9
"4343","es","en","Todos los pacientes deben someterse a una exploración oftalmológica basal.","All patients should have a baseline eye examination.",8,10
"4344","es","en","Todos los pacientes tenían GIST.","All patients had GIST.",4,5
"4345","es","en","Toma de EMEND con los alimentos y bebidas EMEND puede tomarse con o sin alimentos.","Taking EMEND with food and drink EMEND can be taken with or without food.",14,15
"4346","es","en","Toma de Kinzalkomb con los alimentos y bebidas Puede utilizar Kinzalkomb comprimidos con o sin alimentos.","Taking Kinzalkomb with food and drink",6,16
"4347","es","en","Toma de Xiliarx con los alimentos y bebidas Puede tomar Xiliarx con o sin comida.","Taking Xiliarx with food and drink You can take Xiliarx with or without food.",14,15
"4348","es","en","tomando medicamentos que diluyen la sangre para el tratamiento de embolias.","the blood for the treatment of blood clots.",8,11
"4349","es","en","Tome alimentos que contengan hidratos de carbono en los 10 minutos siguientes a la inyección para evitar hipoglucemias.","Eat a meal or snack containing carbohydrates within 10 minutes of the injection to avoid hypoglycaemia.",16,18
"4350","es","en","Tome el número de cápsulas que le haya indicado su médico.","Take the number of capsules or tablets as instructed by your doctor.",12,11
"4351","es","en","Tome la dosis siguiente a la hora habitual.","Take your next dose at the usual time.",8,8
"4352","es","en","Tome la jeringa grande de 3 ml.","Pick up the 3 ml large syringe.",7,7
"4353","es","en","Tome la siguiente dosis a la hora habitual.","Just take your next dose at the usual time.",9,8
"4354","es","en","Tome los comprimidos exactamente tal y como le ha indicado su médico.","Take the tablets exactly as your doctor has told you.",10,12
"4355","es","en","Tome REYATAZ cápsulas con alimento (una comida o merienda).","Take REYATAZ capsules with food (a meal or a substantial snack).",11,9
"4356","es","en","Tome siempre RISPERDAL exactamente como le ha dicho su médico.","Always take RISPERDAL exactly as your doctor has told you.",10,10
"4357","es","en","Tome una jeringa estéril apropiada (mínimo 50 ml) y conecte una aguja adecuada.","Take an appropriate sterile syringe (minimum 50 ml) and attach a suitable needle.",13,13
"4358","es","en","torácicos o ronchas cutáneas) mientras esté tomando esta medicación, acuda inmediatamente al","ed while on thi s medication seek medical help immediately.",10,12
"4359","es","en","Tos Se ha notificado la aparición de tos con el uso de inhibidores de la ECA.","Cough Cough has been reported with the use of ACE inhibitors.",11,16
"4360","es","en","Total del artículo 1 1 4","Article 1 1 4 — Total",6,6
"4361","es","en","TOVIAZ está disponible en envases blíster de 7, 14, 28, 56, 84 y 98 comprimidos de liberación prolongada.","TOVIAZ is available in blister packs of 7, 14, 28, 56, 84 and 98 prolonged-release tablets.",16,18
"4362","es","en","toxicidad mitocondrial (ver sección 4.5).","mitochondrial toxicity (see section 4.5).",5,5
"4363","es","en","Toxoide alfa de Clostridium perfringens Tipo A","Clostridium perfringens Type A alpha toxoid",6,7
"4364","es","en","Toxoide diftérico1 Toxoide tetánico1 Bordetella pertussis (inactivada)2 Antígeno de superficie de hepatitis B2,3 1","Diphtheria toxoid1 Tetanus toxoid1 Bordetella pertussis (inactivated)2 Hepatitis B surface antigen2,3 1",12,14
"4365","es","en","TP, siguiendo una clasificación de Órganos y Sistemas [COS]) y no en número de casos.","Organ Class [SOC]) and not number of cases.",8,15
"4366","es","en","Tracleer reduce el número de nuevas úlceras digitales que aparecen.","Tracleer reduces the number of new finger ulcers that appear.",10,10
"4367","es","en","Tragar el comprimido entero con agua, con o sin los alimentos.","Swallow the tablet whole with water, with or without food.",10,11
"4368","es","en","Trague el comprimido con un vaso de agua No utilice Levitra más de una vez al día.","Swallow one tablet with a glass of water",8,17
"4369","es","en","Tras el dictamen del CHMP, la Comisión Europea suele tardar unos 2 meses en conceder la autorización.","Following CHMP opinion, it usually takes around 2 months for the European Commission to give a licence.",17,17
"4370","es","en","Tras el uso de la tigecilina se han notificado reacciones anafilácticas/anafilactoides potencialmente letales (ver sección 4.3 y 4.8).","Anaphylaxis/ anaphylactoid reactions, potentially life-threatening, have been reported with tigecycline (see sections 4.3 and 4.8).",15,18
"4371","es","en","Tras inyecciones repetidas anualmente, el perfil de seguridad de INTANZA es similar al de las inyecciones previas.","After repetitive yearly injections the safety profile of INTANZA is similar to the previous injections.",15,17
"4372","es","en","Tras la administración oral, las concentraciones plasmáticas máximas de gabapentina se observaron a las 2 - 3 horas.","Following oral administration, peak plasma gabapentin concentrations are observed within 2 to 3 hours.",14,18
"4373","es","en","Tras la administración subcutánea, la biodisponibilidad absoluta es de alrededor del 70%.","Following subcutaneous administration, the absolute bioavailability is about 70%.",9,12
"4374","es","en","Tras la interrupción del tratamiento, todos estos órganos diana presentaron recuperación parcial o total.","All these target organs have shown partial to full recovery following discontinuation of treatment.",14,14
"4375","es","en","Tras la reconstitución, 1 mililitro de la solución inyectable contiene 1 miligramo de bortezomib.","After reconstitution, 1 ml of solution for injection contains 1 mg bortezomib.",12,14
"4376","es","en","Tras un año de trabajo en banca fue director financiero de una empresa privada de 1988 a 1995.","After a year in merchant banking, he was finance director of a private company from 1988 to 1995.",18,18
"4377","es","en","Tras una cuidadosa evaluación, el CHMP consideró que está indicación es aceptable.","After careful evaluation, the CHMP considered that this indication is acceptable.",11,12
"4378","es","en","Trastorno periodontal no especificado, trastorno dental no especificado§","Periodontal disorder NOS, dental disorder NOS§",6,8
"4379","es","en","Trastornos cardíacos Frecuentes: taquicardia","Cardiac disorders Common: tachycardia",4,4
"4380","es","en","Trastornos cardíacos Muy raras (< 1/ 10.000) Hipotensión, vasculitis","Vascular disorders Very rare (< 1/ 10,000) Hypotension, vasculitis",9,9
"4381","es","en","Trastornos cardíacos: bloqueo cardíaco, paro cardíaco, arritmia, síncope, bradicardia, insuficiencia cardíaca, insuficiencia cardíaca congestiva.","Cardiac disorders: heart block, cardiac arrest, arrhythmia, syncope, bradycardia, cardiac failure, congestive heart failure.",14,14
"4382","es","en","Trastornos de la piel y del tejido Alopecia (G3/ 4:","Skin and subcutaneous tissue disorders",5,10
"4383","es","en","Trastornos de la piel y del tejido subcutáneo","Muscoskeletal and connective tissue disorders",5,8
"4384","es","en","Trastornos de la piel y del tejido subcutáneo Frecuentes: prurito Poco frecuentes: equimosis","Skin and subcutaneous tissue disorders Common: pruritus Uncommon: ecchymosis",9,13
"4385","es","en","Trastornos de la piel y del tejido subcutáneo Muy raros:","Skin and subcutaneous tissue disorders:",5,10
"4386","es","en","Trastornos de la piel y del tejido subcutáneo Poco frecuente: dermatitis exfoliativa, exantema eritematoso, prurito","Skin and subcutaneous tissue disorders Uncommon: exfoliative dermatitis, erythematous rash, pruritus",11,15
"4387","es","en","Trastornos de la piel y del tejido subcutáneo Trastorno de la piel","Skin and subcutaneous tissue",4,12
"4388","es","en","Trastornos de la piel y No conocida:","Skin and subcutaneous tissue disorders Not known:",7,7
"4389","es","en","Trastornos de la sangre y del sistema linfático","Blood and lymphatic system disorder",5,8
"4390","es","en","Trastornos de la sangre y del sistema linfático (ver sección 4.4) Muy frecuentes: trombocitopenia, neutropenia, anemia.","Blood and the lymphatic system disorders (see section 4.4) Very common:",11,16
"4391","es","en","Trastornos de la sangre y del sistema linfático Trastornos del sistema inmunológico","lymphatic system disorders Immune system disorders Endocrine disorders",8,12
"4392","es","en","Trastornos de la sangre y del sistema linfático: mayor posibilidad de hemorragia.","Blood and lymphatic system disorders: increased bleeding tendency.",8,12
"4393","es","en","Trastornos del aparato reproductor y de la mama","Reproductive system and breast disorders",5,8
"4394","es","en","Trastornos del metabolismo y de la nutrición","Metabolism and nutrition disorders",4,7
"4395","es","en","Trastornos del metabolismo y de la nutrición muy frecuentes: frecuentes:","Metabolism and nutrition disorders very common: common:",7,10
"4396","es","en","Trastornos del metabolismo y Disminución del apetito de la nutrición","Hypersensitivity Hypokalaemia, Hyponatremia, Hypomagnesaemia, Hypocalcaemia, Hyperglycaemia",6,10
"4397","es","en","Trastornos del metabolismo y nutrición:","Metabolism and nutrition disorders:",4,5
"4398","es","en","Trastornos del oído y del laberinto","Ear and labyrinth disorders",4,6
"4399","es","en","Trastornos del oído y del laberinto Trastornos cardíacos Trastornos vasculares","Ear and labyrinth disorders Cardiac disorders Vascular disorders",8,10
"4400","es","en","Trastornos del sistema inmunológico","Very Common Uncommon Rare Very",5,4
"4401","es","en","Trastornos del sistema inmunológico Reacciones anafilácticas, reacciones anafilactoides (incluyendo urticaria), reacciones alérgicas (incluyendo prurito)","Immune system disorders Anaphylactic reactions, anaphylactoid reactions (including urticaria), allergic reactions (including pruritus)",13,14
"4402","es","en","Trastornos del sistema inmunológico6 vasculitis alérgica reacciones de hipersensibilidad7","Immune system disorders6 allergic vasculitis hypersensitivity reactions7",7,9
"4403","es","en","Trastornos del sistema nervioso frecuente","Nervous system disorders 33 common",5,5
"4404","es","en","Trastornos del sistema nervioso Frecuentes:","Nervous system disorders Common: dizziness",5,5
"4405","es","en","Trastornos del sistema nervioso Muy frecuentes: - neuropatía periférica.","Nervous System Disorders Very Common: - peripheral neuropathy.",8,9
"4406","es","en","Trastornos del sistema nervioso somnolencia","Nervous system disorders somnolence",4,5
"4407","es","en","Trastornos del sistema nervioso Trastornos oculares","Nervous system disorders Eye disorders",5,6
"4408","es","en","trastornos digestivos, molestias abdominales, dispepsia, gastritis, náuseas, estreñimiento Gingivitis por la","Gastrointestinal inflammation, digestive disturbances, abdominal discomfort, dyspepsia, gastritis, nausea, constipation",10,11
"4409","es","en","Trastornos en la coagulación,","coagulation disorders, aplastic anaemia,",4,4
"4410","es","en","Trastornos gastrointestinales Diarrea, náuseas, vómitos Trastornos de la piel y del tejido Prurito, erupción, urticaria","Headache Dizziness, migraine Amnesia, burning sensation, dysarthria, dysgeusia, insomnia",9,15
"4411","es","en","Trastornos gastrointestinales Muy frecuentes Poco frecuentes","Gastrointestinal disorders Very common Uncommon",5,6
"4412","es","en","Trastornos gastrointestinales Muy raras (< 1/ 10.000) Vómitos, náuseas, diarrea, dolor abdominal","Gastrointestinal disorders Very rare (< 1/ 10,000) Vomiting, nausea, diarrhoea, abdominal pain",12,12
"4413","es","en","Trastornos gastrointestinales: muy frecuentes: pérdida de apetito frecuentes: vómitos to","r rare: collapse or shock-like state (hypotonic-hyporesponsiveness episode), convulsions",9,10
"4414","es","en","Trastornos generales y alteraciones en el lugar de","Patients should be informed that nausea has been reported during treatment with Kaletra (see section 4.8).",16,8
"4415","es","en","Trastornos generales y alteraciones en el lugar de administración Frecuentes: edema periférico","General disorders and administration site conditions Common: peripheral oedema",9,12
"4416","es","en","Trastornos generales y alteraciones en el lugar de administración Muy frecuentes:","General disorders and administration site conditions Very common:",8,11
"4417","es","en","Trastornos generales y alteraciones en el lugar de administración:","General disorders and administration site conditions:",6,9
"4418","es","en","Trastornos generales y alteraciones en el lugar de administración: fiebre","General disorders and administration site conditions: fever",7,10
"4419","es","en","Trastornos generales y alteraciones en el lugar de am","General disorders and administration site conditions na",7,9
"4420","es","en","Trastornos generales y alteraciones en el lugar de la administración","Xeloda in combination therapy:",4,10
"4421","es","en","Trastornos generales y alteraciones en el lugar frecuentes","General disorders and administration site conditions common",7,8
"4422","es","en","Trastornos hepatobiliares Frecuentes Poco frecuentes Raras","Hepatobiliary disorders Common Uncommon Rare",5,6
"4423","es","en","Trastornos músculoesqueléti- cos y del tejido conjuntivo (incluyendo las exploraciones complementarias)","Gastrointestinal Disorders incl. related Investigations",5,11
"4424","es","en","Trastornos musculoesqueléticos y del tejido conjuntivo","Lupus-like syndrome, photosensitivity reactions, skin vasculitis, toxic epidermal necrolysis",9,6
"4425","es","en","Trastornos músculoesqueléticos y del tejido conjuntivo","Musculoskeletal and connective tissue disorder",5,6
"4426","es","en","Trastornos músculoesqueléticos y del tejido conjuntivo Artritis, debilidad muscular","Musculoskeletal and connective tissue disorders Arthritis, muscular weakness",8,9
"4427","es","en","Trastornos musculoesqueléticos y del tejido conjuntivo Muy frecuentes:","Musculoskeletal and connective tissue disorders General disorders and",8,8
"4428","es","en","Trastornos musculoesqueléticos y del tejido conjuntivo Muy frecuentes: artralgia, mialgia","Musculoskeletal and connective tissue disorders Very common: arthralgia, myalgia",9,10
"4429","es","en","Trastornos musculoesqueléticos y del tejido conjuntivo:","Musculoskeletal and connective tissue disorders:",5,6
"4430","es","en","Trastornos musculoesqueléticos y del tejido subcutáneo:","Musculoskeletal, connective tissue and bone disorders:",6,6
"4431","es","en","Trastornos oculares Frecuencia no conocida: deterioro visual.","Eye disorders Frequency not known: visual disturbance.",7,7
"4432","es","en","Trastornos oculares Poco frecuentes:","Ear and labyrinth disorders Uncommon:",5,4
"4433","es","en","Trastornos renales y urinarios","Renal and urinary disorders",4,4
"4434","es","en","Trastornos renales y urinarios Poco frecuentes: disuria, hematuria, cromaturia.","Renal and urinary disorders Uncommon: dysuria, haematuria, chromaturia.",8,9
"4435","es","en","Trastornos respiratorios, No conocida: torácicos y mediastínicos Trastornos gastrointestinales:","Respiratory, thoracic and mediastinal disorders:",5,9
"4436","es","en","Trastornos respiratorios, torácicos y del mediastino Trastornos de la piel y del tejido subcutáneo","Respiratory, thoracic and mediastinal disorders",5,14
"4437","es","en","Trastornos respiratorios, torácicos y mediastínicos Frecuentes:","Respiratory, thoracic and mediastinal disorders Common:",6,6
"4438","es","en","Trastornos respiratorios, torácicos y mediastínicos poco frecuentes","Respiratory, thoracic and mediastinal disorders uncommon",6,7
"4439","es","en","Trastornos tiroideos (incluyendo bocio) Hipopotasemia, incremento de lípidos, trastornos alimentarios (incluyendo anorexia), hiperuricemia","Hypokalaemia, lipids increased, appetite disorders (including anorexia), hyperuricaemia",8,13
"4440","es","en","Tratamiento concomitante Timolol puede interaccionar con otros medicamentos (ver sección 4.5).","Concomitant therapy Timolol may interact with other medicinal products (see section 4.5).",12,11
"4441","es","en","Tratamiento de combinación con ribavirina:","Combination therapy with ribavirin:",4,5
"4442","es","en","Tratamiento de dermatitis húmeda aguda localizada","Treatment of acute localised moist dermatitis.",6,6
"4443","es","en","TRATAMIENTO DE LA ANEMIA HEMOLÍTICA Y ARREGENERATIVA (hemoglobina, bilirrubina, haptoglobina, reticulocitos)","MANAGEMENT OF HAEMOLYTIC AND AREGENERATIVE ANAEMIA (haemoglobin, bilirubin, haptoglobin, reticulocytes) Contra-indication",11,11
"4444","es","en","Tratamiento de la úlcera duodenal La dosis recomendada es de 30 mg cada 24 horas, durante dos semanas.","The recommended dose is 30 mg once daily for 2 weeks.",11,18
"4445","es","en","Tratamiento de piojos masticadores (perros y gatos)","Treatment of biting lice (cats and dogs)",7,7
"4446","es","en","Tratamiento del dolor postoperatorio tras cirugía de derivación (bypass) coronaria (ver secciones 4.8 y 5.1).","Treatment of post-operative pain following coronary artery bypass graft (CABG) surgery (see section 4.8 and 5.1).",16,15
"4447","es","en","Tratamiento y profilaxis de las hemorragias en pacientes con hemofilia A (deficiencia congénita de factor VIII).","Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).",14,16
"4448","es","en","Trate de mantener a la persona despierta hasta que llegue el servicio de urgencias.","Try to keep the person awake until emergency help arrives.",10,14
"4449","es","en","Travoprost por sí solo ya ha sido aprobado en la Unión Europea bajo el nombre de TRAVATAN.","Travoprost on its own has already been approved in the European Union under the name TRAVATAN.",16,17
"4450","es","en","Trayectoria profesional hasta la fecha:","Ms Nuttall held several posts in the Irish Civil",9,5
"4451","es","en","Trazas de tiomersal Trazas de formaldehido","Excipient Thiomersal traces Formaldehyde traces",5,6
"4452","es","en","Treatment of Familial Adenomatous Polyposis (FAP)","Treatment of Familial Adenomatous Polyposis (FAP)",6,6
"4453","es","en","Treatment of indolent non-Hodgkin lymphoma","Treatment of indolent non- Hodgkin lymphoma",6,5
"4454","es","en","Treatment of low flow priapism","Treatment of low flow priapism",5,5
"4455","es","en","Treatment of systemic sclerosis","Treatment of systemic sclerosis",4,4
"4456","es","en","Trece de los aislados anteriormente caracterizados como resistentes a efavirenz resultaron también resistentes a nevirapina y delavirdina.","Thirteen isolates previously characterised as efavirenz-resistant were also resistant to nevirapine and delavirdine.",13,17
"4457","es","en","Très le Bois 22600 LOUDEAC Francia","Très le Bois 22600 Loudéac France",6,6
"4458","es","en","Triludan OTC 200 suspensie","Triludan OTC 200 suspensie",4,4
"4459","es","en","TRISENOX se ha autorizado en “ circunstancias excepcionales”.","TRISENOX has been authorised under “ Exceptional Circumstances”.",8,8
"4460","es","en","TRITACE HCT 5/ 25 Tabletta","TRITACE HCT 5/ 25 Tabletta",5,5
"4461","es","en","Tritazide y nombres asociados debe empezar a administrarse en la dosis más baja disponible.","Tritazide and associated names should be started at the lowest available dosage.",12,14
"4462","es","en","Trizivir está contraindicado en pacientes con enfermedad renal en fase terminal.","Trizivir is contraindicated in patients with end-stage renal disease.",9,11
"4463","es","en","Trombosis arterial, trombosis venosa","Arterial thrombosis, Venous thrombosis",4,4
"4464","es","en","Trometamol, Etanol al 96%, Cloruro sódico, Ácido clorhídrico (para el ajuste del pH), Agua para inyección","Trometamol, Ethanol 96%, Sodium chloride, Hydrochloric acid (for pH adjustment), Water for injections",13,16
"4465","es","en","Trudexa puede causar la reactivación del VHB en personas portadoras de este virus.","Trudexa can cause reactivation of 122 HBV in people who carry this virus.",13,13
"4466","es","en","Tuberculosis activa no tratada (ver sección 4.4).","Active untreated tuberculosis (see section 4.4).",6,7
"4467","es","en","tuberculosis y el complejo de Mycobacterium avium relacionado con el SIDA: claritromicina, rifabutina, rifampicina.","mycobacterium avium complex: clarithromycin, rifabutin, rifampicin.",6,14
"4468","es","en","Tubos de 15, 30, 60 y 100 gramos.","Tubes of 15, 30, 60 and 100 grams.",8,8
"4469","es","en","Twinrix Adultos es una vacuna.","Twinrix Adult is a vaccine.",5,5
"4470","es","en","Tyverb 250 mg comprimidos recubiertos con película lapatinib","Tyverb 250 mg film-coated tablets lapatinib",6,8
"4471","es","en","UE/ 1/ 97/ 035/ 003 Refludan","EU/ 1/ 97/ 035/ 003",5,6
"4472","es","en","ul EU/ 1/ 01/ 184/ 050 envase unitario EU/ 1/ 01/ 184/ 062 envase de 4 unidades","EU/ 1/ 01/ 184/ 050 1 pack EU/ 1/ 01/ 184/ 062 4 pack ct",15,17
"4473","es","en","ul Shire Pharmaceutical Contracts Ltd","is Shire Pharmaceutical Contracts Ltd",5,5
"4474","es","en","ul supervivencia global, entre los pacientes tratados con eritropoyetina humana recombinante y el grupo control.","with recombinant human erythropoietin and controls.",6,15
"4475","es","en","Úlcera gástrica y úlcera duodenal, gastritis, vómitos, nauseas, estreñimiento, flatulencia","Gastric ulcer and duodenal ulcer, gastritis, vomiting, nausea,",8,10
"4476","es","en","Ultratard es una insulina de acción muy prolongada. dic","Ultratard is a very long-acting insulin.",6,9
"4477","es","en","Un blíster contiene 7 ó 10 comprimidos.","One blister contains 7 or 10 tablets.",7,7
"4478","es","en","Un comprimido recubierto con película contiene 20 mg de","One film-coated tablet contains 20 mg rimonabant.",7,9
"4479","es","en","Un diseño similar se ha observado con los pacientes tratados de TVP y EP.","A similar pattern is observed in DVT and PE treatment patients.",11,14
"4480","es","en","Un efecto adverso poco frecuente (observado en menos de 1 de cada 100 pacientes) es náusea.","An uncommon side effect (likely to occur in fewer than 1 in 100 patients) is nausea.",16,16
"4481","es","en","Un estudio comparativo entre la formulación liofilizada y la solución inyectable demostró la bioequivalencia de ambas formulaciones.","A comparative study between the freeze-dried and the liquid formulation showed bioequivalence between the two formulations.",16,17
"4482","es","en","Un estudio in vivo demostró que voriconazol inhibe el metabolismo de efavirenz.","An in-vivo study showed that voriconazole inhibited the metabolism of efavirenz.",11,12
"4483","es","en","un filtro en la vena cava.","and no experience in patients requiring thrombolysis, embolectomy or insertion of a vena cava filter.",15,6
"4484","es","en","Un lento incremento de la dosis puede también mejorar la tolerancia gastrointestinal.","A slow increase of the dose may also improve gastrointestinal tolerability.",11,12
"4485","es","en","Un mililitro contiene 5000 U de Toxina Botulínica Tipo B (10.000 U por vial)","One ml contains 5000 U of Botulinum Toxin Type B (10,000 U per vial)",14,14
"4486","es","en","Un mililitro de solución contiene 100 Unidades del","One millilitre of the solution contains 100 Units of the",10,8
"4487","es","en","Un ml de Insuman Comb 50 contiene 40 UI (Unidades","One ml of Insuman Comb 50 contains 40 IU (International",10,10
"4488","es","en","Un ml de solución contiene 7,5 mg de atosiban como base-libre en forma de acetato de atosiban.","One ml solution contains 7.5 mg atosiban free-base in the form of atosiban acetate.",14,17
"4489","es","en","Un vial con polvo para solución inyectable contiene 500 UI de octocog alfa (UI significa Unidades Internacionales).","One vial with powder for solution for injection nominally contains 500 IU octocog alfa (IU equals International Units).",18,17
"4490","es","en","Un vial contiene 15 mg de porfímero sódico.","One vial contains 15 mg porfimer sodium.",7,8
"4491","es","en","Un vial contiene 6 mg/ ml del principio activo paclitaxel.","One vial contains 6 mg/ ml of the active substance paclitaxel.",11,10
"4492","es","en","Un vial de polvo contiene 5 mg de somatropina","One vial of powder contains 5 mg somatropin",8,9
"4493","es","en","Una aplicación correcta minimizará la posibilidad de lamer el punto de aplicación.","Correct application will minimise licking of the application site.",9,12
"4494","es","en","Una dosis de 0,5 ml contiene:","One dose of 0.5ml contains:",5,6
"4495","es","en","Una dosis oral única de 30 mg inhibe la secreción ácida gástrica de pentagastrina estimulada en un 80%.","A single oral dose of 30 mg inhibits pentagastrin-stimulated gastric acid secretion by about 80%.",15,18
"4496","es","en","Una inhalación dos veces al día Una inhalación dos veces al día Una inhalación dos veces al día","One inhalation twice a day One inhalation twice a day One inhalation twice a day",15,18
"4497","es","en","Una jeringa precargada contiene 400 microgramos de metoxi-polietilenglicol epoetina beta* a una concentración de 667 microgramos/ ml.","One pre-filled syringe contains 400 micrograms of methoxy polyethylene glycol-epoetin beta* at a concentration of 667 micrograms/ ml.",18,17
"4498","es","en","Una pluma contiene 60 millones de UI de interferón alfa-2b en 1,2 ml de solución.","One pen contains 60 million IU of interferon alfa-2b in 1.2 ml of solution.",14,15
"4499","es","en","Una vez abierta por primera vez la bolsa de aluminio:","After first opening the foil overwrap:",6,10
"4500","es","en","Una vez abierto el tubo, su contenido debe utilizarse en un plazo de 12 meses.","Once opened, the tube should be used within 1 2 months.",11,15
"4501","es","en","Una vez abierto el vial, deberá eliminarse cualquier resto de solución sin utilizar.","Upon opening of the vial, any unused solution should be discarded.",11,13
"4502","es","en","Una vez extraída Zypadhera del vial y pasada a la jeringuilla, debe inyectarse de forma inmediata.","Once ZYPADHERA has been removed from the vial into the syringe, it should be injected immediately.",16,16
"4503","es","en","Una vez fuera de la nevera, el medicamento deberá utilizarse dentro de este período.","Once removed from the refrigerator the medicinal product must be used within this period.",14,14
"4504","es","en","Una vez que se haya disuelto el polvo, extraiga la disolución con la jeringa.","Once the powder has dissolved, draw the solution back into the syringe.",12,14
"4505","es","en","Una vez reconstituida cada torta, deberá comprobarse de forma visual si el material liofilizado se ha disuelto completamente.","After reconstitution of each cake, it should be checked visually whether all freeze-dried material has dissolved completely.",17,18
"4506","es","en","Una vez reconstituida, la solución contiene 50 UI de folitropina beta por ml","After reconstitution, the solution contains 50 IU of follitropin beta per ml.",12,13
"4507","es","en","Únicamente para uso veterinario - medicamento sujeto a prescripción veterinaria.","For animal treatment only - to be supplied only on veterinary prescription",12,10
"4508","es","en","Únicamente para uso veterinario.","For animal treatment only.",4,4
"4509","es","en","Únicamente para vía intravítrea.","Single-use vial for intravitreal use only.",6,4
"4510","es","en","Unidad de comunicaciones y redes","Communications and networking Unit",4,5
"4511","es","en","Unidad de evaluación de medicamentos de uso humano","Evaluation of Human Medicines Unit 6",6,8
"4512","es","en","UNIPRILDIUR 5mg + 25 mg compresse","UNIPRILDIUR 5mg + 25 mg compresse",6,6
"4513","es","en","United Kingdom Amgen Limited Tel: +44 (0)1223 420305","United Kingdom Amgen Limited Tel: +44 (0)1223 420305",8,8
"4514","es","en","United Kingdom Dr David JEFFERYS Dr Patrick WALLER (7)","United Kingdom Dr David JEFFERYS Dr Patrick WALLER (7)",9,9
"4515","es","en","United Kingdom GlaxoSmithKline UK Tel: + 44 (0)800 221441 customercontactuk@gsk.com","United Kingdom GlaxoSmithKline UK Tel: + 44 (0)800 22 1441 customercontactuk@gsk.com",11,10
"4516","es","en","United Kingdom Ipsen Ltd.","United Kingdom Ipsen Ltd.",4,4
"4517","es","en","United Kingdom Merck Sharp and Dohme Limited Tel: +44 (0) 1992 467272 medinfo_uk@merck .com","United Kingdom Merck Sharp and Dohme Limited Tel: +44 (0) 1992 467272 medinfo_uk@merck. com",14,14
"4518","es","en","United Kingdom Pfizer Limited Tel: +44 (0)1304 616161","United Kingdom Pfizer Limited Tel: +44 (0)1304 616161",8,8
"4519","es","en","United Kingdom Takeda UK Ltd Tel: + 44 (0)1628 537 900","United Kingdom Takeda UK Ltd Tel: + 44 (0)1628 537 900",11,11
"4520","es","en","United Kingdom/Ireland Genzyme Therapeutics (United Kingdom), Tel: +44 1865 405200","United Kingdom/Ireland Genzyme Therapeutics (United Kingdom), Tel: +44 1865 405200",10,10
"4521","es","en","Urticaria en el lugar de aplicación, Hinchazón","Application site urticaria, Swelling",4,7
"4522","es","en","Use técnicas asépticas durante la reconstitución y posterior dilución de pemetrexed para su administración mediante perfusión intravenosa.","Use aseptic techniques during the reconstitution and further dilution of pemetrexed for intravenous infusion administration.",15,17
"4523","es","en","Uso con otros antídotos contra el cianuro","Use with other cyanide antidotes",5,7
"4524","es","en","Uso de Insuman Comb 50 con los alimentos y bebidas","Using Insuman Comb 50 with food and drink",8,10
"4525","es","en","Uso de otros medicamentos am","Using other medicines rod",4,5
"4526","es","en","Uso de otros medicamentos No hay interacciones conocidas de Azomyr con otros medicamentos.","Taking other medicines There are no known interactions of Azomyr with other medicines.",13,13
"4527","es","en","Uso de Revatio con alimentos y bebidas Revatio puede tomarse con o sin alimentos.","Taking Revatio with food and drink Revatio can be taken with or without food.",14,14
"4528","es","en","Uso de Trudexa con los alimentos y bebidas","Using Trudexa with food and drink i dic",8,8
"4529","es","en","Uso en mujeres en edad fértil","Use in women of child-bearing potential",6,6
"4530","es","en","Uso en niñas y adolescentes:","Use in children and adolescents:",5,5
"4531","es","en","Uso en niños VIRAMUNE suspensión oral puede utilizarse en niños de todas las edades.","VIRAMUNE oral suspension can be taken by children of all age groups.",12,14
"4532","es","en","Uso en pacientes con insuficiencia hepática:","Use in hepatic impairment:",4,6
"4533","es","en","Uso en pacientes con insuficiencia renal:","Use in renal impairment:",4,6
"4534","es","en","Uso en trasplante cardíaco:","Use in cardiac transplant:",4,4
"4535","es","en","Uso intravenoso Uso intravenoso Uso intravenoso Uso intravenoso Uso intravenoso","Route of administration Intravenous use Intravenous use Intravenous use Intravenous use Intravenous use",13,10
"4536","es","en","Usted recibirá Epoyetina alfa HEXAL durante las tres semanas anteriores a la intervención.","You will receive Epoetin alfa HEXAL during the 3 weeks before your surgery.",13,13
"4537","es","en","Utilice cada jeringa para una sola inyección.","Only use each syringe for one injection.",7,7
"4538","es","en","Utilice el método de inyección que le enseñó su profesional sanitario.","Use the injection method as instructed by your healthcare professional.",10,11
"4539","es","en","Utilice siempre agujas que han sido aprobadas para utilizar con OptiSet.","Only use needles that have been approved for use with OptiSet.",11,11
"4540","es","en","Utilice todo el contenido del vial.","Withdraw the entire contents of the vial.",7,6
"4541","es","en","Utilice un sistema de goteo por gravedad o una bomba de perfusión para su administración.","Use a gravity drip or an infusion pump for administration.",10,15
"4542","es","en","Utilícese únicamente de acuerdo con la evaluación beneficio/ riesgo realizada por el veterinario responsable.","Use according to the benefit/ risk assessment by the responsible veterinarian.",11,14
"4543","es","en","Utilícese únicamente de acuerdo con la evaluación beneficio/riesgo realizada por el veterinario responsable.","Use only according to the benefit/risk assessment by the responsible veterinarian.",11,13
"4544","es","en","Utilizando un agua hipodérmica y una jeringa, extraiga el producto disuelto del vial.","Using a hypodermic needle and syringe, draw the dissolved product out of the vial.",14,13
"4545","es","en","Utilizar el contenido una sola vez.","This product is for single use only.",7,6
"4546","es","en","Utilizar jeringas y agujas estériles.","Use sterile syringe and needles.",5,5
"4547","es","en","Utilizar sólo la solución transparente.","Use only clear solution.",4,5
"4548","es","en","uto Hörgatún 2 IS-210 Garðabær Sími: + 354 535 70 00","IS-210 Garðabær Sími: + 354 535 70 00",8,11
"4549","es","en","Vacuna en suspensión y granulado efervescente para solución oral","Suspension of vaccine and effervescent granules for oral solution",9,9
"4550","es","en","Vacunar únicamente animales en buen estado de salud.","Vaccinate only healthy animals.",4,8
"4551","es","en","Vacunas antigripales, código ATC J07BB01","Influenza vaccines, ATC Code J07BB01",5,5
"4552","es","en","Vacunas Los inmunosupresores pueden afectar la respuesta a las vacunas.","Vaccinations Immunosuppressants may affect responses to vaccination.",7,10
"4553","es","en","Vagajeva ulica 4 SI-1000 Ljubljana Tel: +386 1 25 71 496","Vagajeva ulica 4 SI-1000 Ljubljana Tel: +386 1 25 71 496",11,11
"4554","es","en","vaginitis, gastroenteritis Neoplasias benignas, malignas y no especificadas (incl quistes y pólipos) Frecuentes:","Blood and lymphatic system disorders",5,13
"4555","es","en","Valdoxan Valdoxan Valdoxan Valdoxan Valdoxan Valdoxan Valdoxan Valdoxan","Valdoxan Valdoxan Valdoxan Valdoxan Valdoxan Valdoxan Valdoxan Valdoxan",8,8
"4556","es","en","validaciones con un resultado negativo","preparation of documents for the EMEA subscription service validations with a negative outcome",13,5
"4557","es","en","valores individuales de hemoglobina superiores o inferiores a los niveles deseados.","Haemoglobin variability should be addressed ed",6,11
"4558","es","en","Valsartán muestra una cinética de eliminación multiexponencial (t½α < 1 h y t½ß aproximadamente 9 h).","Valsartan shows multiexponential decay kinetics (t½α < 1 h and t½ß about 9 h).",14,16
"4559","es","en","VANDRAL RETARD150 mg 150 mg cápsulas de liberación prologada","VANDRAL RETARD150 mg 150 mg cápsulas de liberación prologada",9,9
"4560","es","en","Vasopresores simpaticomiméticos y otros sustancias (por ejemplo, adrenalina) que pueden reducir el efecto antihipertensivo del ramipril:","Vasopressor sympathomimetics and other substances (epinephrine) that may reduce the antihypertensive effect of ramipril:",14,16
"4561","es","en","Vea también la advertencia en 2 Antes de usar Insulatard.","See also warning in 2 Before you use Insulatard.",9,10
"4562","es","en","Vectibix no ha sido estudiado en mujeres embarazadas.","Vectibix has not been tested in pregnant women.",8,8
"4563","es","en","VELCADE es un agente citotóxico.","VELCADE is a cytotoxic agent.",5,5
"4564","es","en","Velmetia debe administrarse con las comidas para reducir los problemas estomacales asociados a la metformina.","Velmetia should be taken with food to avoid any stomach problems caused by metformin.",14,15
"4565","es","en","Velosulin puede causar hipoglucemia (bajos niveles de glucosa en sangre).","As with all insulins, Velosulin may cause hypoglycaemia (low blood glucose).",11,10
"4566","es","en","Venlafaxina 50 mg TID (Indinavir 800 mg SD) ANTAGONISTAS DEL CALCIO","Venlafaxine 50 mg TID (Indinavir 800 mg SD) CALCIUM CHANNEL BLOCKERS",11,11
"4567","es","en","Ventavis 10 microgramos/ ml solución para inhalación por nebulizador Iloprost","Ventavis 10 microgram/ ml nebuliser solution Iloprost",7,10
"4568","es","en","Venus, 26 Can Parellada Industrial 08228 Terrassa España","Venus, 26 Can Parellada Industrial 08228 Terrassa Spain",8,8
"4569","es","en","Ver el recuadro que aparece al final de este prospecto para más información.","See the box at the end of this leaflet for further information.",12,13
"4570","es","en","Ver en 3 Cómo usar Protaphane.","See 3 How to use Protaphane.",6,6
"4571","es","en","Ver instrucciones al dorso.","See overleaf for detailed instructions.",5,4
"4572","es","en","Ver las condiciones de conservación en el envase.","Refer to the storage conditions on the carton.",8,8
"4573","es","en","Ver precauciones, en 4.4.","diabetic ketoacidosis which is potentially lethal.",6,4
"4574","es","en","Ver prospecto, sección 2.","See package leaflet, section 2.",5,4
"4575","es","en","Ver sección 4.3 para más información sobre la insuficiencia hepática grave.","For severe hepatic impairment see section 4.3.",7,11
"4576","es","en","Ver sección 6.6 para instrucciones de preparación.","See section 6.6 for preparation instructions.",6,7
"4577","es","en","Ver Tablas 1 y 2 para más información.","See Tables 1 and 2 for more information.",8,8
"4578","es","en","Ver también la sección 4.4.","See also section 4.4.",4,5
"4579","es","en","Ver también más abajo Experiencia post-comercialización.","See also Post-marketing experience below.",5,6
"4580","es","en","Vértigo, alteración/ pérdida de audición, tinnitus, dolor de oídos","Vertigo, hearing impairment/ loss, tinnitus, earache",6,9
"4581","es","en","VFEND se ha estudiado también en 61 niños.","VFEND has also been studied in 61 children.",8,8
"4582","es","en","Via G Fabbroni 6, 00191 Roma, Italia","Via G Fabbroni 6, 00191 Rome Italy",7,7
"4583","es","en","Vía intramuscular Leer el prospecto antes de utilizar este medicamento Agitar bien antes de usar","Intramuscular use Read the package leaflet before use Shake well before use",12,15
"4584","es","en","Vía oral Administrar con alimento o directamente en la boca Agitar bien antes de su uso.","Shake well before use.",4,16
"4585","es","en","Vía oral Blister (PVC/ PVDC)","Blister (PVC/ PVDC) Blister (PVC/ PVDC)",6,5
"4586","es","en","Via oral Leer el prospecto antes de utilizar éste medicamento.","Oral use Read the package leaflet before use.",8,10
"4587","es","en","Via Palermo, 26/ A 43100 Parma Italia","Via Palermo, 26/ A 43100 Parma Italy",7,7
"4588","es","en","Via San Martino 12 I-20122 Milan Italia","Via San Martino 12 I-20122 Milan Italy",7,7
"4589","es","en","Vía subcutánea Leer el prospecto antes de utilizar","Subcutaneous use Read the package leaflet before use",8,8
"4590","es","en","Vía subcutánea o intravenosa","Subcutaneous or intravenous use",4,4
"4591","es","en","Vía subcutánea o intravenosa Leer el prospecto antes de utilizar este medicamento.","For intravenous or subcutaneous use Read the package leaflet before use.",11,12
"4592","es","en","Vía subcutánea o intravenosa.","Subcutaneous or intravenous use.",4,4
"4593","es","en","Vía subcutánea y intramuscular","Subcutaneous and intramuscular use",4,4
"4594","es","en","Vial de vidrio de Tipo I con tapón de butilo y sellado con una cápsula de aluminio.","Type I glass vial with butyl rubber stopper sealed with an aluminium flip-off seal.",14,17
"4595","es","en","VIAL TEXTO Fertavid 50 UI/ 0,5 ml","VIAL TEXT Fertavid 50 IU/ 0.5 ml",7,7
"4596","es","en","Viale Certosa, 130 20156 Milano Italia","Viale Certosa, 130 20156 Milano Italia",6,6
"4597","es","en","Viales reconstituidos: conservar a temperatura entre 2-8°C (en nevera).","Store at 2°C – 8°C (in a refrigerator).",8,9
"4598","es","en","Viani Dosier-Aerosol FCKW-frei 25 µg/ 125 µg Druckgasinhalation, Suspension","Viani Dosier-Aerosol FCKW-frei 25 µg/ 125 µg Druckgasinhalation, Suspension",9,9
"4599","es","en","Vida media de la pluma en uso:","Shelf life for pen in use:",6,7
"4600","es","en","vigentes, al Plan de Farmacovigilancia o a las actividades de minimización de riesgos.","Pharmacovigilance Plan or risk minimisation activities,",6,13
"4601","es","en","VIH-1 ARN < 50 copias/mla VIH-1 ARN < 400 copias/mla","HIV-1 RNA < 50 copies/mla HIV-1 RNA < 400 copies/mla",10,10
"4602","es","en","Vimpat 50 mg Vimpat 100 mg Vimpat 150 mg Vimpat 200 mg comprimidos recubiertos con película Lacosamida","Vimpat 50 mg Vimpat 100 mg Vimpat 150 mg Vimpat 200 mg film-coated tablets Lacosamide",15,17
"4603","es","en","VIRACEPT 50 mg/ g polvo oral.","VIRACEPT 50 mg/ g oral powder.",6,6
"4604","es","en","Viraferon 10 millones de UI/ ml solución inyectable","Viraferon 10 million IU/ ml solution for injection",8,8
"4605","es","en","Viraferon no debe administrarse a: • pacientes con antecedentes de enfermedad cardíaca grave, to","Viraferon should not be used in: uc",7,14
"4606","es","en","Viraferon puede volver a introducirse en la nevera en cualquier momento durante este periodo de siete días.","Viraferon can be put back in the refrigerator at any time during this seven-day period.",15,17
"4607","es","en","Viraferon se administra tres veces por semana, en días alternos, por ejemplo en lunes, miércoles y viernes.","Viraferon is given three times a week, every other day, for example on Monday, Wednesday, and Friday.",17,17
"4608","es","en","ViraferonPeg 100 microgramos polvo y disolvente para solución inyectable pluma precargada peginterferón alfa-2b","ViraferonPeg 100 micrograms powder and solvent for solution for injection pre-filled pen peginterferon alfa-2b",14,13
"4609","es","en","ViraferonPeg 50 microgramos se presenta en forma de:","ViraferonPeg 50 micrograms is supplied as:",6,8
"4610","es","en","ViraferonPeg no debe administrarse a pacientes con: • antecedentes de enfermedad cardíaca grave,","For a list of all restrictions with ViraferonPeg, see the Package Leaflet.",12,13
"4611","es","en","ViraferonPeg se ha concebido solamente para un solo uso.","ViraferonPeg is intended for single use only.",7,9
"4612","es","en","Viread tampoco debe administrarse simultáneamente con adefovir dipivoxil.","Viread should also not be administered concurrently with adefovir dipivoxil.",10,8
"4613","es","en","Virus IBR con delección gE inactivado, al menos 0,75 U. VN*.","adjuvant: light paraffin oil",4,11
"4614","es","en","Visite a su médico inmediatamente para que pueda revisar su estado y evaluar la medicación que necesita.","See your doctor immediately so they can review your condition and assess the medication you need to take.",18,17
"4615","es","en","Vivanza 20 mg, comprimidos recubiertos con película (vardenafilo)","Vivanza 20 mg film-coated tablets Vardenafil",6,8
"4616","es","en","Volibris 5 mg comprimidos","Volibris 5 mg tablets",4,4
"4617","es","en","Volumen administrable con la pluma = 0,5 ml.","Deliverable volume from pen = 0.5 ml.",7,8
"4618","es","en","Volumen de inyección adecuado por","Preferred injection volume per kg fish (depending on fish size)* Total kg of fish",14,5
"4619","es","en","Volver a su calendario habitual, le ayudará a recordar cuándo ha de cambiarse el parche.","Returning to your regular schedule will help you remember when to change your patch.",14,15
"4620","es","en","Waarderweg 39 NL - 2031 BN Haarlem Países Bajos","Waarderweg 39 NL - 2031 BN Haarlem Netherlands",8,9
"4621","es","en","Wilzin 50 mg cápsulas duras Acetato de zinc dihidrato","Wilzin 50 mg hard capsules Zinc acetate dihydrate",8,9
"4622","es","en","Wim de Köverstraat, 35 5831 AN Boxmeer - Holanda","Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands",9,9
"4623","es","en","Win de Körverstraat 35 5831 AN Boxmeer Holanda","Intervet International BV Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands",12,8
"4624","es","en","Winthrop Arzneimittel Gmbh Industriestr.","Winthrop Arzneimittel Gmbh Industriestr.",4,4
"4625","es","en","Wolfova 1 SI-1000 Ljubljana Tel: +386 1 2364700","Wolfova 1 SI-1000 Ljubljana Tel: +386 1 2364700",8,8
"4626","es","en","Wyeth Europa Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, Reino Unido","Wyeth Europa Ltd Huntercombe Lane South Taplow, Maidenhead, Berkshire, SL6 0PH United Kingdom",13,13
"4627","es","en","Wyeth Medica Ireland Little Connell Newbridge, Co.","Wyeth Medica Ireland Little Connell Newbridge, Co.",7,7
"4628","es","en","Wyeth-Lederle Pharma GmbH Storchengasse 1 A-1150 Viena Austria","Wyeth-Lederle Pharma GmbH Storchengasse 1 A-1150 Vienna Austria",8,8
"4629","es","en","Xarelto 10 mg, comprimidos recubiertos con película Rivaroxaban","Xarelto 10 mg film-coated tablets Rivaroxaban",6,8
"4630","es","en","Xeomin tiene un efecto menor o moderado en la capacidad para conducir y utilizar máquinas.","Xeomin has minor or moderate influence on the ability to drive and use machines.",14,15
"4631","es","en","Xigris drotrecogin alfa (activated) Part A","Xigris drotrecogin alfa (activated)",4,6
"4632","es","en","Xolair 150 mg polvo para solución inyectable Omalizumab Vía subcutánea","Xolair 150 mg powder for solution for injection Omalizumab Subcutaneous use",11,10
"4633","es","en","Xyrem tiene potencial para inducir depresión respiratoria.","Xyrem has the potential to induce respiratory depression",8,7
"4634","es","en","y alteraciones en el lugar de administración Frecuentes Frecuentes Muy frecuentes Muy","Common Common Very common Very common",6,12
"4635","es","en","y productos biológicos Jefe adjunto de Sector Jefe del Sector de nuevas sustancias químicas Jefe adjunto de Sector","During 2000 the Unit for the Evaluation of Medicines",9,18
"4636","es","en","YENTREVE puede provocar una sensación de inquietud o incapacidad para permanecer sentado o estar quieto.","YENTREVE may cause a sensation of restlessness or an inability to sit or stand still.",15,15
"4637","es","en","Yondelis fue más eficaz cuando se administró una vez cada tres semanas que en la otra pauta.","Yondelis was more effective when it was given once every three weeks than the alternative dosing schedule.",17,17
"4638","es","en","ZALASTA 7,5 mg comprimidos bucodispersables","BLISTER FOR ZALASTA 7.5 mg ORODISPERSIBLE TABLETS",7,5
